ࡱ>  z|opqrstuvwxy]1bjbjzz 81\1\ V V 8d~LwzDDDD3n!$"AwCwCwCwCwCwCw$yV|gwQL933L9L9gwDDwFpFpFpL90DDAwFpL9AwFpFpstDw0:jdt-ww0wtP}j P}4tP}t\Y#>*,Fp/$3eY#Y#Y#gwgwnY#Y#Y#wL9L9L9L9P}Y#Y#Y#Y#Y#Y#Y#Y#Y#V > : SULPYCO METHOD A NEW QUANTUM AND INTEGRATIVE APPROACH TO DEPRESSION Publisher AKUMED doo , Zagreb, Croatia Cover design Sandro Dukic, croatian artist Copyright Dr Maja Roje Novak, 2012  HYPERLINK "http://www.dr-roje.com" www.dr-roje.com All rights reserved, ISBN 978-953-57016-1-3 Smashwords Edition, License Notes This ebook is licensed for your personal enjoyment only. This ebook may not be re-sold or given away to other people. If you would like to share this book with another person, please purchase an additional copy for each recipient. If youre reading this book and did not purchase it, or it was not purchased for your use only, then please return to Smashwords.com and purchase your own copy. Thank you for respecting the hard work of this author. Contents  HYPERLINK \l "a01disc" Disclaimer  HYPERLINK \l "a02intro" Introduction  HYPERLINK \l "a03depre" Depression: a short overwiev of common knowledge  HYPERLINK \l "a04antidepre" Conventional antidepressants  HYPERLINK \l "a05homeo" Homeopathy and quantum medicine  HYPERLINK \l "a06disc" Discovery of a SULPYCO method  HYPERLINK \l "a07study" Observational study  HYPERLINK \l "a08chem" Chemical model of possible interactions of sulpiride and Coenzyme compositum  HYPERLINK \l "a09clin" Clinical experience with the SULPYCO method  HYPERLINK \l "a10appli" Application of SULPYCO method  HYPERLINK \l "a11after" Afterword  HYPERLINK \l "a12ref" References  HYPERLINK \l "ref_TOC" DISCLAIMER All information in this book is presented only for the purpose of sharing ideas. It is not intended to be a substitute for the services of health care professionals. Neither the author nor publisher is responsible for any consequences incurred by those employing the remedies or treatments herein. Any application of the material set forth in the following pages is at the reader's discretion and is his or her sole responsibility.  HYPERLINK \l "ref_TOC" 1. Introduction The use of SULPYCO for treating depression and related disorders is a simple innovative method that involves a combination of two known, but very different, medicinal drugs: dissolved parenteral sulpiridea classical neuroleptic generic drugand Coenzyme Compositum solution (Heel, Germany), a parenteral complex and over-the-counter homeopathic and isopathic medication. The term SULPYCO stands for SULP (sulpiride), Y (and), plus CO (coenzyme); this drug was discovered accidentally, but has benefited many. The SULPYCO trademark and the hybrid content of SULPYCO are internationally patented. This bizarre blend works so well in clinical settings that it has the potential to revolutionize antidepressant therapy. Generally, it is used as a subcutaneous injection, like insulin. I am a neurologist; I work mainly in the field of integral neurorehabilitation. The SULPYCO method emerged accidentally, from own clinical observation and integrated medicine rationale, but outside of my core field of work. Herein, I present a detailed description of the SULPYCO method, in a subjective manner. I am a clinical doctor who observes patients every day in my line of work, while at the same time I try to be free of any medical ideology. Ideological (dogmatic) medical thinking emerging from conventional education often favors only a one-dimensional attitude toward medical treatment, thereby reducing the repertoire of therapeutic possibilities. So I compared my observations to conventional medical knowledge and hopefully overcame some basic misconceptions while creating new medical quality. Throughout the course of this book, I have revealed my medical personality, as a sincere and enthusiastic physician of integrated health orientation who is looking for authentic clinical evidence and improvements.  HYPERLINK \l "ref_TOC" 2. Depression: a short overview of common knowledge Depression is a common condition characterized by a disordered and low mood. Depressed patients may feel sad, guilty, anxious, helpless, empty, hopeless, and worthless. They may also have the following problems: loss of appetite or overeating, loss of interest in activities that were once pleasurable, concentration problems, contemplating or attempting suicide, insomnia or oversleeping, loss of energy, as well as physical pain and aches of various forms. However, depression can also be a normal reaction to a particular life crisis or to medical conditions, and it can be a side effect of some medical treatments. Depressive illness is one of the highest causes of disability in the world. According to predictions of experts, depression will be the second leading cause of disability among people of all ages by the year 2020. Currently, the percentage of major depression for people seen in primary care is between 5 and 10%. The main types of depression are as follows: major depressive disorder is when a patient is unable to perform daily activities owing to disability; dysthymia is a form of a chronic, less severe, nondisabling depression; minor depression involves minor symptoms that last for more than two weeks; psychotic depression involves delusions; postnatal depression; seasonal depression; and bipolar disorder. Another very common disorder is anxiety disorder, which is characterized by an abnormally high degree and quality of fear and anxiety of various forms, with neurotransmitter and etiological dynamics similar to those of depressive disorders. At present, depression is known to have connections to altered brain neurochemistry. Although no single cause of depression is recognized, several hypotheses that try to explain the biology of depression probably work in concordance. 1. Monoamine hypothesis (most popular) The monoamine hypothesis postulates that a deficiency of certain neurotransmitters is responsible for the corresponding features of depression. Those neurotransmitters are the monoamines, namely serotonin, dopamine, and norepinephrine. However, the available evidence does not convincingly favor this theory because some studies show that the depletion of monoamines fails to cause depression in healthy subjects. In addition, some medications can consistently benefit patients with depression and are known to operate outside the monoamine system. Monoamine oxidase A (MAO-A), an enzyme that antagonizes monoamines, may be excessively active in depressed people. This results in a subsequent lowering of the levels of monoamines. This hypothesis was acknowledged by positron emission tomography studies that found significantly elevated activity of MAO-A in the brains of some depressed patients. However, in some depressed young individuals, lowered MAO-A activity was observed as a consequence of intense stress. Thus, the data are still contradictory. 2. Altered neuroplasticity In chronic stress and depression, synaptic and dendritic plasticity are reduced. Fortunately, antidepressant medications can enhance neuroplasticity at both molecular and dendritic levels. 3. Genetic factors Several studies have attempted to identify genes that might influence the development of depression and its underlying mechanism. The most popular studies were those investigating depressive episodes, considering allelic variations of the serotonin-transporter-linked polymorphic region (5-HTTLPR), via gene-environment interaction. The results of some studies were positive while those of others were negative; therefore, no consistent conclusions could be drawn. In addition, brain-derived neurotropic factor (BDNF) gene polymorphism was investigated as well, but again contrasting results were obtained. 4. Circadian rhythm theory Depression may be connected to the brain mechanisms that control the cycles of sleep and wakefulnessthe so-called circadian rhythm. Depressed individuals can exhibit a significant lift in mood after a night of sleep deprivation, which can increase serotonergic system activity. 5. Abnormalities in brain regions Depressed patients usually show disturbed functioning of interactions between islands of cell neurons in the brain. Some of the nuclei show overfunction while others show underfunction. The raphe nucleus, suprachiasmatic nucleus (SCN), nucleus accumbens (NAcc), anterior cingulate cortex (ACC), and subgenual cingulate are the most important areas of the brain. 6. Hypothalamic-pituitary-adrenal (HPA) axis The hypothalamic-pituitary-adrenal axis is a system of endocrine structures that are activated during the bodys response to stressors. It often shows increased activation in depression, and drugs that reduce its activity are sometimes effective in reducing symptoms. 7. Fructose and tryptophan Fructose malabsorption and tryptophan deficiency can cause depression in some patients. 8. Inflammation and depression. The inflammatory hypothesis of depression emphasizes the role of psychoneuroimmunological dysfunctions. Subsets of patients with depression have an altered peripheral immune system, with impaired cellular immunity and increased levels of cytokines. In addition, acute administration of cytokines causes altered behavior similar to depression, and patients undergoing cytokine treatment develop depressive symptoms. 9. Social circumstances and depression Researchers found that a significant percentage of very low income people met the criteria for a diagnosis of depression, which is also often connected to alcoholism and drug abuse. 10. Cultural aspects of depression A persons cultural environment may influence the his/her being diagnosed with depression, variability of symptoms, and treatment outcomes. Particularly, considering increasing globalization, Western-oriented diagnostic tools may be at least partially inappropriate for patients from other cultural backgrounds. 11. Viral theory of depression Some animals infected with the Borna disease virus displayed depressive behavior; moreover, some patients taking antiviral drugs were relieved of their depressive symptoms. In this way, depression was also regarded as a viral disease. Personal perspective Many patients have depressive syndromes or related conditions. They visit a neurologist because their psychological realm carries over into their body. Individual patient responses to life and life stressors are highly varied. Some people are resilient and some dwell on minor difficulties. This individuality manifests in responses to therapeutic procedures like electroacupuncture. For instance, some cannot endure even minute electrical stimulation while others want more and more stimulation. Therefore, whether the glass is half full or half empty depends most probably on the genetic makeup of the individuals brain and on a unique combination of the etiological aspects described above. The interplay of these factors will make a person more or less prone to anxiety or depression. Therefore, the reasons for these diseases are complex and multileveled and the rationale for integrative medicine is justified. In the conventional therapeutic approach, depression is corrected by antidepressant drugs. Possibly, the SULPYCO method can emerge as a new unconventional treatment for depression.  HYPERLINK \l "ref_TOC" Contemporary antidepressant medications for depression and other disorders Antidepressant drugs are used to treat depression and its subtypes and have more recently been used for treating generalized anxiety disorder, panic disorder, bulimia nervosa, anorexia nervosa, obsessive-compulsive disorder, and post-traumatic stress disorder. In controlled studies, these antidepressant agents have been effective in treating smoking addiction, alcoholism, premenstrual dysphoric disorder, borderline personality disorder, obesity, and migraine. The most common antidepressant drugs include monoamine oxidase inhibitors, tricyclic antidepressants, tetracyclic antidepressants, selective serotonin reuptake inhibitors, and serotonin-norepinephrine reuptake inhibitors. Other medications, including antipsychotics in low doses and benzodiazepines, can also be used. The following are common side effects of more or less all antidepressant medications that are evident at three to six weeks: Dry mouth Nausea Headache Sleepiness Dizziness Insomnia (numbness) Constipation Increased blood pressure Excessive sweating Tremor Agitation Muscle weakness Sexual dysfunction Amphetamine, methylphenidate, or modafinil is sometimes added to an antidepressant treatment regimen. In addition, antiepileptic drugs can also be added. Lithium remains the standard treatment for bipolar disorder and is often used in conjunction with other medications. Alternative therapies, like herbalism and nutritional therapy, are sometimes used for mild cases of depression but have not yet shown convincing benefits. Unfortunately, between 30 and 50% of individuals treated with a given conventional antidepressant do not show a favorable response. Even among cases of good response, relapse rates are high. In addition, antidepressant drugs tend to lose efficacy over time. Personal perspective Conventional antidepressant therapy is the preferred and frequently prescribed therapy. Clinical doctors cannot do without it because depression and its consequences are very common. Problems arise mostly with delayed onset of antidepressant action and unpleasant side effects. Therefore, antidepressant drugs require improvements, and new therapies involving different paradigms are warranted.  HYPERLINK \l "ref_TOC" 3. Homeopathy and quantum medicine SULPYCO consists of two components: the well-known chemical sulpiride and a homeopathic Coenzyme Compositum (Heel). Hence, I shall provide some basic information regarding the dilemma of homeopathy because it is not popular among average medical doctors. Homeopathy is a medical system that treats diseases by using a special kind of medical product called remedy. What is specific about homeopathy is that highly diluted substances (a millionth part or less) are used, so they are present in a solution in traces of mass or there is no substance at all (dilution beyond C30 that is 1/10030 dilution). However, because of dilution, homeopathy is regarded as placebo among classical medicine proponents. Sign D refers to decimal dilution and sign C to centesimal dilution range. For example: Belladonna D6 means that Belladonna tincture is diluted 10X6 times (i.e.,1 part of Belladonna and 10x6 parts of the solution) and Belladonna C30 means that Belladonna tincture is diluted 100X30 times (1 part of Belladonna and 100x30 parts of the solution). Homeopathy treats by the principle likes cures like. That is, a substance that causes symptoms in a large dose can treat those same symptoms in a small dose. For example, smoking too many cigarettes can cause irritability, but if you are irritable you can take nicotine at a dilution of 1/108. Homeopathic medicines (which homeopaths call remedies) are prepared not only by dilution but also by using a careful process of dilution and succussion (vigorous shaking). The principle of treating like with like goes back to Hippocrates (460377 B.C.E.), but in its current form has been widely used for more than 200 years. It was discovered by a German doctor, Samuel Hahnemann. Homeopathy gained popularity in Europe and the U.S.A. in the 19th century because good treatment outcomes were achieved during epidemics of cholera, yellow fever, typhoid, scarlet fever, etc. Isopathy is a system of treating the disease that comes as an extension to the like cures like principle. For example, if Escherichia coli is one of the etiological factors of a disease, then homeopathized E. coli is administered to the patient as a remedy. Gunther Enderlein developed an extensive system of isopathic healing with various bacteria and fungi, thereby bringing isopathy to a high technological level. Dr. Reckeweg was another expert of homeopathy. Among other useful insights, he connected dysfunctional cell metabolism; namely, energy production system in the cell, the citric acid cycle (Krebs cycle), with possible isopathic treatment for disturbed cycle with homeopathized (diluted and potentized) components of this same cycle. According to Dr. Reckeweg, disturbed energy production in the cell (its mitochondria) can be the beginning of a more complex pathology that becomes an organic disorder. A cell that is lacking energy reduces its functioning to a minimum, using large quantities of glucose in a metabolic route that does not require oxygen, thereby polluting the surrounding connective tissue; this process occurs in the mitochondria. Clearly, it is important to keep this sequence of biochemical reactions as efficient as possible for both the catabolic and anabolic aspects of cell functions. Therefore, according to Dr. Reckeweg, people with chronic diseases need stimulation of the citric acid cycle function. Treatment with citric cycle components in a diluted and dynamized form offer exceptional therapeutic possibilities in this domain. Coenzyme Compositum used in SULPYCO is a complex homeopathic and isopathic remedy that contains these components as well as other polychrest (medicine that serves for many uses or diseases) homeopathic substances. Nevertheless, conventional medicine disregards these claims as purely fictional and nonscientific. Therefore, every package of these remedies has to carry a without proven medical effect label. Only clinical application of such substances can give us more insight into their potential usefulness. Debate on whether or not homeopathy is a placebo continues. However, with time, more and more evidence shows that homeopathy produces clear clinical results. For example, the hormone thyroxine, prepared as a homeopathic 30C dilution, can partially halt the metamorphosis of tadpoles into frogs. Evidence for homeopathy is listed in the reference section of this book. Despite the fact that we do not know exactly how homeopathy works, it is a good tool to use in my workjust as I do not know exactly how a car motor works, but I use it in my everyday life. Even though we assume that homeopathy is not a placebo, we still want to know how it works. Because a homeopathic solution contains few or no molecules of the active ingredient, we cannot count on a classic biochemical mechanism of action. Therefore, we attempt to explain it in terms of energetic phenomena and nonlinear physics. Currently, homeopathy is a domain of quantum medicine and theory of complex systems. Principles of quantum medicine In order to become familiar with quantum medicine it is necessary to define the terms. Quantum medicine refers to quantum world, quantum phenomena, and quantum theory, which describes the world on a very small scale. Quantum medicine also applies facts from the quantum world to biological phenomena and various medical treatments. Quantum originally meant quantity or a proper amount of a given parameter. The small scale of existence is the basis for atoms, molecules, and other more complex structures of nonliving and living matter. The term was invented by the well-known physicist Max Planck who was experimenting with cavity radiation. He postulated that a vibrating, charged particle emits radiation not in a smooth flow but instead in lumps, like cannon balls from a cannon, called quanta. Thus, quantum theory came into existence. Quantum physics refers to a behavior of the subatomic world, which is a world of subatomic particles. Here, we come face-to-face with a speed limit in nature, find space and time mixed together, and learn that mass can change to energy and energy can change to mass. Quantum physics has postulated rules that were systematized in quantum mechanics and in the special theory of relativity. The major formula, coined by Albert Einstein for special relativity (the physics of very fast) E = mc2, brings energy and mass into correlation. It states that mass contains a lot of energy but a lot of energy is needed to get a small quantity of mass. In addition, for quantum physics (mechanics), there is another well-known equation by Planck, which is E = fh that states that the greater the frequency of a wave, the greater is the amount of energy. So Plancks equation correlates frequency and energy. Therefore, if we have a high frequency wave it will be very strong and penetrating, like gamma rays, for example. Thus, the two major constant values in physics are speed of light, c and Plancks constant, h. A brief analysis of a subatomic world If you crash your car, you will experience force, trauma, and severe damage. Here, we are faced with the tough solidity of matter. However, if we go more deeply into the structure of matter, we encounter completely new dimensions. Ultimately, all matter is made up of atoms. Atoms consist of subatomic particles and a lot of empty space. In school, we learned of three major subatomic particles: electrons, protons, and neutrons abiding in empty space, a vacuum. At present, the empty space is regarded as a sea of energy (of zero point). Today, a standard model of the subatomic world describes 24 fundamental particles. We can roughly divide these into two major types of particlesfermions and bosons. Fermions are leptons (electrons and mu and tau particles together with their neutrinos) and quark-building blocks of protons. Bosons are particles that mediate fundamental forces; the well-known ones are gluons, photons, gravitons, and W and Z bosons. The properties of fermions and bosons differ in regard with their respective spins (i.e., angular momentum). However, if the superstring theorists are right, there may be smaller, simpler structures that are yet to be discovered. In daily life, we are not usually aware that we are surrounded and bombarded by subatomic particles: protons that come from space as primary cosmic radiation, neutrinos that can pass through our hands, photons that are light particles from the sun, and muons that are part of so-called background radiation. The subatomic world occupies small dimensions and travels very fast. We use a femtometer (10-15 m) to describe length and speed of light to describe velocity (3 108 m/s). Quantum object spin is a rotational movement or angular momentum of a given particle. It is interesting that for an electron to make a full rotation, it needs to rotate not 360 degrees but 720 degreessomething completely different from our everyday perception. Atoms and molecules spin as well. They also vibrate, more with more kinetic energy and less with less kinetic energy. Heat, an infrared photon energy, enhances the vibrational kinetic energy of a system. Subatomic particles and their product, atoms, are brought together in certain types of arrangements. Subatomic particles are related; their relation is postulated by physical forces that exert power over them, forming structures of matter. Matter always tends to be in a state of least energy. There are four fundamental physical forces, each mediated by corresponding boson particles that are being exchanged in an event called force. Force can be defined as a capacity to exert some action; a field is a space where a force can be detected. Fundamental forces in nature 1. Gravitation Gravitation is a physical force by which physical objects attract each other. The larger the mass, the larger the force. Gravitation is mediated by gravitons. 2. Weak force Weak interaction is caused by the exchange (emission or absorption) of W and Z bosons. The best known is  decay, a form of radioactivity. The Z and W bosons are heavy particles that cause the very short range of the weak interaction. Weak force also initiates a process of hydrogen fusion in stars. 3. Strong force Strong force binds the parts of an atomic nucleus together, as well as their components, quarks that form protons and neutrons. The strong interaction is thought to be mediated by gluons. 4. Electromagnetic force An electromagnetic force has the power to attract and repel charges. The electromagnetic force is generated by three types of fields: electrostatic field, magnetostatic field, and the electromagnetic field. It is mediated by the exchange of photons. Quantum weirdness When we observe the quantum world, which is the world of the incredibly fast and the incredibly small, we must make a logical shift to approach it. In a macroscopic world, we make conclusions in accordance with our perceptive experience, i.e., that solid matter is always solid, that an objects mass is stable, that one cause will have a predictable effect, that input of certain information makes an accurate output, and that one object can only be in one place at one time. However, in a subatomic world, things prove to be very different. Solid matter is mostly empty space, time is dissolving, mass is gained or lost in a collision, and cause and effect are inconsistent. Thus, the principles of our macro world become deconstructed, and we observe the quantum world as being more like form is in postmodern art. Therefore, the behavior of the quantum world becomes strange, unpredictable, and counterintuitive. Several principles are used to describe the weirdness of the quantum world: 1. Uncertainty principle (known as the Heisenberg principle of uncertainty) We cannot ascertain the position of a particle and its velocity at the same time. For example, if we know a position of an electron, we cannot know its velocity. That tells us that measurements in the quantum world are limited and so is our possibility to know about them. Therefore, we use probabilities, not predictions, to best describe the characteristics of particles. 2. The granular nature of energy Energy travels in quanta and lumps, not in a smooth flow. 3. Dual nature of matter (principles of complementarity) A particle can have features of a wave or of a particle, however, not simultaneously. According to Milo Wolffs theory, an electron is composed of two spherical waves, which form a standing wave that has layers like an onion; therefore, it is a very dense wave. On the other hand, an electron is not a particle circling around the nucleus but is more like a fog of probability taking one particular position only when observed (quantum collapse). Therefore, it can be assumed that wave and particle depend on external conditions. 4. Quantum jump An electron jumps across the energy levels (orbits) in a discrete way, but at the same time, it does not go through the interspace (space between). Therefore, it is not gliding from position to position but rather jumping, disappearing from one point to appear at the other. 5. Nonlocality and quantum entanglement Two parts of a single quantum system remain entangled, no matter how distant in space and time they are, meaning that if we act upon one particle, the other one will also react. These particles can exert force one upon another even across distant space, if they were once related. This type of action at a distance, especially if it occurs instantaneously, violates both our common sense and the theory of relativity, which posits that nothing can travel faster than light. For example, if two electrons were together in a system and then separatedboth being in distant parts of the universeand we observe one of them, our act of observing will instigate the quantum collapse of a wave function. Quantum collapse takes place when one state is determined, out of the many possible states of a quantum system. The other entangled electron will then also show the same quantum changes as the first one does. Thus, those two particles exchange information nonlocally, which means that no material force is being shared between them. This entanglement happens immediately and is therefore faster than the speed of light. 6. Superposition One subatomic object can exist in many different states simultaneously, so those states seem to be superposed one onto another. Only in a measurement situation does it take one certain and concrete state. When the subatomic object is not observed, it behaves like a wave; when we observe it, it behaves like a particle. This is called collapse of a wave function. 7. Quantum tunneling Particles go through barriers, although that should not happen according to common prediction. Classical mechanics states that particles that do not have enough energy to classically triumph over a barrier will not be able to reach the other side, or that, lacking the energy to penetrate a barrier, they would be reflected or absorbed. In quantum mechanics, with a very small probability, these particles can tunnel to the other side, subsequently crossing the barrier. This process is illustrated by the sun and is the reason why the sun shines. 8. Energy contribution to mass Because a neutron has greater mass than the sum of the quarks of which it is composed, the extra mass comes from added energy. It is interesting that perpetual motion in a quantum world is commonplace, as an electron in an atom never gets tired and friction never slows it down. 9. Quantum coherence Two waves can aggregate to create a wave with an amplitude that is greater than that of either wave (constructive interference) or they can subtract from each other to create a wave with low amplitude (destructive interference). Change of paradigms In a Newtonian worldview, nature and the universe are perceived as parts of a large mechanical clock, where the parts are always the same, unchanged, be it alone or in a system, exerting forces one onto another as in a game of marbles. This is our conventional worldview based on our everyday experiences. It is phylogenetically imprinted into our minds as a biological heritage of our evolutionary ancestors. If we look at the tiger chasing a gazelle, we can observe that at a certain moment he abandons the chase if the gazelle is running too fast. That is because he is able to calculate speed and the cost-benefit of the chase. Without this simple calculation, physical survival would be impossible. In addition, our language is commonly structured in a way that mirrors those same logical principles. Therefore, the quantum world behaves counterintuitively to our natural common sense. Quantum weirdness helps us to explain some phenomena that were previously treated as impossible or paradoxical. Quantum medicine is currently a fashionable term that embraces various sorts of therapies outside of a biochemical paradigm in two ways. First, it focuses on the application of quantum entities in healing; for example, photons in laser therapy, light therapy, and magnetic therapy; and electrons in electro acupuncture, etc. Very often, other complementary methods are regarded as quantum medicine. For instance to consider acupressure, needle acupuncture, herbal and nutritional therapy as quantum medicine is not justified, because those comply with the classical positions of physiology and neurophysiology if we understand quantum medicine properly. For example, in acupuncture, we are concerned with energy channels called meridians, while a metal needle pricked into the body exerts local microcurrents generated by electrical and frictional interactions of the metal of the needle and electrolyte interstitial tissue fluid. These microcurrents stimulate nerve endings, thereby stimulating nerves. This process can be traced all the way up to the brain cortex and is shown by PET scans. This phenomenon is purely neurophysiological. At the same time, meridians as energy channels might exist as well but are not needed to explain effects of needling if we understand the principles of neurology. Therefore, not everything that is labeled quantum is necessarily so. Second, quantum weirdness is used to create theories about experienced phenomena that were previously paradoxical because they did not fit into the classical worldview. Therefore, quantum medicine gives a frame of reference for therapies emerging from complementary and alternative medicine (CAM) that were previously disregarded as scams, such as radionics, distant healing, and prayer. In a quantum worldview, the body is regarded as a very dense fabric of waves since matter particles are, in fact, waves. Therefore, the body is susceptible to influences from other waves, fields, subatomic particles, and physical forces (the electromagnetic smog, for instance) in terms of local influences. Therefore, we use quantum locality to describe and hypothesize about a possible mechanism of influence. Quantum phenomena in biology help us define the DNA molecule as a quantum antenna that can emit and receive waves, principles of actin and myosin molecules as quantum mechanical and the dynamics of biophotons as information carriers inside the body and across bodies, etc. Quantum jazz is a term that postulates how molecules and matter waves in the tissues vibrate in coherence, especially important for water molecules, as a greater part of the body contains water molecules. The nonlocal phenomena of quantum physics are events, as mentioned above, where two objects are connected in a way that bypasses exchanges of material particles as in quantum entanglement. These nonlocal phenomena are transcribed to the other areas of life like entangled minds and distant healing; what we have here is the information exchange. Information can be defined as a set of data giving a description or a meaning to something or can be simply defined as knowledge. Roughly, we can say that information answers the questions what, why, where, how, and how much. Further, one can speculate that information is a huge nonlocal force in nature (meaning it exists beyond space and time, therefore being a vast field) containing the blueprint for all material forms of the nonliving and living world as well for all knowledge. Since the basic particles, forces, and fields are common for all known matter, it is the information itself that gives these basic constituents of matter, organizational input in order to finally expresses itself as certain formbe it living or nonliving. This informational field is also called consciousness and universal intelligence. In quantum medicine, we can say the informational field is active when the power of intention is in play, because our own intelligence, conscious thoughts, and emotions are the mediators of the informational field like bosons in the area of fundamental forces. The informational field is working outside the dimension of space. Furthermore, every form of matter is highly connected to its informational blueprint that organizes it. With informational waves, a virtual part is always carried on a real frequency wave, structuring it in forms of energy and matter. These are borderline theories involving science and philosophy, and many scientists dispute these concepts as being obscure. However, observing the development of scientific thought over time, we can see one firm principle: what was once perceived as science fiction is today considered ordinary technology; therefore, it is wise to be open to new ideas since our picture of nature is certainly as limited now as it was before, but on a different level. In medicine, we talk about the vital bodyan energetic body, which is in fact an informational body. This body can be targeted for informational healing like radionics, for example, and maybe homeopathy. We can also speak about doctor-remedy-patient entanglement where the intention of a doctor to heal and that of the patient to be healed are imprinted into a water component of any remedy in a quantum way, thus raising the very potential of healing. Here, the work of Masaru Emoto can be referred to. Integrative medicine must fill the ideological gap between the exclusively Newtonian approach of the physician toward the patient and a quantum approach that deals with local and nonlocal energy fields and forces constituting the energetic level of existence. The question of interest would be where does the quantum end and the Newtonian begin? In this sense, we can say that the quantity of non-Newtonian entities (particles) changes the quality of physical laws, meaning that many small objects with quantum properties make up a visible world of Newtonian objects (with Newtonian quality). Therefore, the laws of physics applied depend on the quantity of matter. Nonlocality also emphasizes that everything in the universe can be interconnected through the subtle informational exchange that could possibly justify, for example, the credibility of hermetic laws. Here again, science meets philosophy and mysticism. The law of attraction, as a hermetic law, is observed as a consciousness phenomenon where thoughts (bits of consciousness or information) are becoming things, meaning that thoughts applied in a certain system can create changes in the physical world. This is an example of another bizarre nonlocal phenomenon, as a link between informational and fundamental forces of nature. There is a growing body of evidence supporting the idea that intelligence and consciousness can exist without the body and that directed intention, like prayer or affirmation, can have a positive effect on health. Highly controversial scalar waves are considered a vehicle for carrying information beyond the space and time dimensions. Scalar waves are nonlinear waves. They travel faster than the speed of light and do not decay over time or distance. A scalar wave is a mathematical wave of force having quantity and magnitude but without direction. Why is homeopathy regarded as quantum medicine? Homeopathy either contains traces of mass or no mass at all (beyond the dilution of C30). Theory based on the ArndtSchulz law (ArndtSchulz rule) may explain how homeopathy works in low potencies. High concentrations of a substance kill; medium concentrations suppress or inhibit; and low, or minute, concentrations stimulate. Although this can be true for some substances, for most of them this is dubious and consequently unconvincing. For example, one can be poisoned by kitchen salt or develop hypertension if salt is taken inappropriately, yet salt (NaCl) in small doses is needed to maintain life; does this theory hold true for the agrimony plant? At the level of the ArndtSchulz law, homeopathy can be explained within the biochemical paradigm of molecules interacting with molecules. Even so, this theory has many shortcomings. Molecules of the active substance are diluted in water to a very high extent. This solution becomes even more diluted when it encounters the water in the body. Therefore, we cannot trust that the solutions molecules can interact with the biological structures of the body, namely receptors, in order to produce biological effects. In that sense, homeopathy should work outside the intermolecular communication model. Therefore, if we postulate that homeopathy does work, it should work in some other way than that described above. Although it is still unclear exactly how homeopathy works, quantum medicine gives us a theoretical frame for a hypothesis about an underlying mechanism, based on the nonlocality principle. It is all about the informational fields of the active substance, water, and the patient. The informational field of a given substance can be described with a certain quantum frequency, each respective to the given substance. This frequency acts as a hologram, an informational blueprint. The hologram is imprinted, as a mirror picture, in the correspondent counterpart of water. Therefore, the smallest part of the solution carries the whole picture. The homeopathic solution is then introduced into the body. It becomes further diluted to the three or more levels of magnitude and then eventually is expelled through the kidney and out of the body. Somehow, it has an impact on the informational body (vital body) of the patient, functioning as a frequency model, a tuning fork, thereby changing the quantum frequency of the vital body, eventually creating changes to the physical body according to the principle of as above, so below. Influencing the patients vital body is a process similar to growing a fractal where the fractal is one multiplying informationand information is a sort of a form, like meaning is form in semiotics. Therefore, because molecules do not interact with molecules but fields do interact with fields, we say that homeopathy might work on a nonlocal quantum level. Another theory that originates from local quantum phenomena, namely quantum electrodynamics, is a theory of quantum coherent domains of matter and liquid. Such domains exist in superconductors and superfluids at extremely low temperatures. At room temperature, only 28% of the volume displays coherent domain characteristics. How can this theory translate into the homeopathic mechanism of action? Each molecule, each atom, or larger clusters of molecules have a characteristic electromagnetic frequency that describes it. When a substance that is to be diluted is brought into the water, it transfers its unique electromagnetic value to the water molecules. This process is multiplied with vigorous succussion and mixing of the solution. As living systems are sensitive to electromagnetic fields, a homeopathic remedy could influence it in this way. Another theory of local quantum influence is that of formation of clusters by means of electrical fundamental force. Water molecules are dipoles that interact electrically with each other. When exposed to a diluted substance, water molecules form clusters that work as a sort of imprint of the original substance that was diluted into the water. In high dilutions, the original substance is gone but the water clusters save the memory of that substance. Thus, we can refer to the memory of water. Personal perspective Although we do not yet know how a homeopathic remedy can produce a biological effect, it should not stop us from using it in our practice if we perceive it as useful. This is a rationale of integrative medicine, after all: to restore health as soon as possible with no or minimum collateral damage. I am convinced that homeopathy is not a placebo, based on my day-to-day clinical observations, although I can state that only for injectable homeopathic remedies as I work only with them. Apart from the use of SULPYCO, there have been instances in neurological practice when I have used Belladonna and Cuprum as well, for treating striated muscle spasticity. It works so well that my training personnel notice whether or not a patient has received the injection because those who receive it are able to stretch the spastic muscles with less difficulty. It is also true for nosode isopathic therapy, which works excellently in cases of chronic inflammation (multiple sclerosis, transverse myelitis, and polyradiculoneuritis).  Figure 1: Hologram: unique information in all parts  Figure 2: Fractal: a growing similarity  HYPERLINK \l "ref_TOC" 4. Discovery of a SULPYCO method My clinic is a private clinic for integrative neurology. Although we deal mostly with cerebral palsy and multiple sclerosis, we occasionally treat depressive and somatoform disorders by integrated medicine. These are very frequently encountered and the patients can show symptoms that sometimes mimic neurological diseases. Integrative medicine is a treatment modality for the whole person (body, mind, and spirit) that also takes lifestyle aspects into account. It makes use of all appropriate therapies, both conventional and alternative, which show evidence of safety and effectiveness. I use the following therapies: chemical neurological drugs, acupuncture, electroacupuncture, homeopathy, chiropractic, nutritional therapy, magnetic resonance therapy, electrical stimulation of nerves and muscles, physical therapy, pranic healing, and autohemotherapy. Whenever possible, I use injectables as a way to bypass the digestive system as it is often an obstacle for absorption of therapeutic agents into the blood. The principles of integrative medicine, as defined by Dr. Andrew Weill, are: 1. A partnership between patient and practitioner in the healing process 2. Appropriate use of conventional and alternative methods to facilitate the body's innate healing response 3. Consideration of all factors that influence health, wellness, and disease, including mind, spirit, and community, as well as body 4. A philosophy that neither rejects conventional medicine nor uncritically accepts alternative therapies 5. Recognition that good medicine should be based on good science, be inquiry driven, and be open to new paradigms 6. Use of natural, effective, less-invasive interventions whenever possible 7. Use of the broader concepts of promotion of health and the prevention of illness, as well as the treatment of disease 8. Training of practitioners to be models of health and healing, committed to the process of self-exploration and self-development In my work, all of these principles are implemented. Freedom in medicine is also respected and patients that come to me are able to choose what kind of therapies they want, after a consultation with me. Needless to say, they all passed through conventional medicine protocols in the institutions of a conventional system without satisfactory results before seeking new solutions for their health problems. The SULPYCO method was discovered by observing patients treated on the freedom of choice principle. One group of depressive syndrome patients chose to be treated only by low dose parenteral sulpiride (chemical-allopathic therapy in a low dose); a second group was treated by complex homeopathy only with a parenteral remedy, Coenzyme compositum (Heel GmbH, Germany; homeopathic/ isopathic therapy); and the last group chose to take both substances simultaneously as two separate s.c. injections as a true integrated therapy. Sulpiride was chosen because it is a good atypical antidepressant and can be given parenterally, on the grounds of low dose neuroleptic treatment. Coenzyme compositum was chosen for its capacity for regulating cellular energy production according to isopathic philosophy and theory. As a blend, these two substances could possibly work synergistically, each on its own level (biochemical and quantum/nonlinear, respectively), thereby acting transparadigmatically, with one optimizing the other. This was the rationale for combining the two therapies. The results of this investigation were systemized in an observational study where the antidepressant effects in the three groups were measured in terms of the Hamilton scale and compared. The present study was conducted using female patients only, although the SULPYCO method can be used in male patients as well.  HYPERLINK \l "ref_TOC" Integrative Sulpiride with an Atypical Adjuvant Therapy for Treating Depressive Syndrome- An Observational Study Author: Dr Maja Roje Novak, MD, MS, neurologist and homeopath Croatia;  HYPERLINK "http://www.dr-roje.com" www.dr-roje.com  HYPERLINK "mailto:info@dr-roje.com" info@dr-roje.com Abstract: In this observational study, patient records were analyzed after antidepressant treatment. One group of patients chose to be treated by integrated medicine consisting of two separate subcutaneous injections of a low dose (20 mg) of sulpiride and a 2.2 ml complex homeopathic solution based on the Krebs cycle elements; each injection was administered once daily. Another group of depressed patients chose to receive conventional therapy of 20 mg sulpiride only. The third group chose to be treated with homeopathy only. The HAMD scores differences were evaluated before and after 3 months of treatment in these three groups of patients. The HAMD score yielded a statistically significant decrease in favor of the group treated with combined sulpiride and homeopathy. This observation suggests that a low parenteral dose (20 mg) of sulpiride, when administered subcutaneously with a complex homeopathic remedy, may give better therapeutic results for mild and moderate depression than either sulpiride or complex homeopathy alone. Keywords: allohomeo, depression, homeopathy, sulpiride Introduction Sulpiride is an atypicial antipsychotic drug used mainly in treating psychosis and depression (Komossa et al., 2010). It is a selective antagonist of the dopamine D2 and D3 receptors and this action predominates for doses over 600 mg daily. At doses of 6001600 mg, sulpiride is mildly sedating and antipsychotic. At low doses (100200 mg daily), its prominent feature is antagonism of presynaptic inhibitory dopamine receptors, which accounts for some antidepressant activity and a stimulating effect. It also alleviates vertigo. The oral bioavailability of sulpiride is only 2535% (Mart Mass et al., 2011). In Croatia, parenteral sulpiride is available at a dose of 100 mg per vial. Oral sulpiride is available in a 50 mg per tablet dose. When used for depression, this drug is usually administered orally in a 3 x 50 mg daily dose (Jo and Lee, 2010). Material and Methods This observational study analyzed patient records after treatment in order to determine whether the therapeutic action of sulpiride given parenterally by subcutaneous injection would improve if it were combined with a liquid homeopathic complex remedy based on Krebs cycle elements suitable for parenteral use. The remedy was a commercial preparation produced and sold by the German company Heel, called Coenzyme Compositum, which comes in 2.2 ml vials and is sold as an over-the-counter drug. Preparation of the combined drug A dose of 0.4 ml (20 mg) of an isotonic solution of sulpiride was combined in two separate syringes with 2.2 ml of an isotonic solution of mixed homeopathic substances. The dose of sulpiride was measured using a micropipette. These two injections (one with sulpiride and the other with the homeopathic remedy) were applied simultaneously in the waist region using a 23 G (0, 6x25) needle, once daily at 10 a.m. Homeopathic substances present in this complex parenteral isotonic preparation were mainly compounds involved in the Krebs cycle as well as some herbal homeopathic remedies, all in equal volume amounts up to 2.2 ml: 1. Intermediates: Citric acid (D8), cis-aconitic acid (D8), alpha ketoglutaric acid (D8), succinic acid (D10), fumaric acid (D8), DL malic acid (D8), sodium diethyloxalateoacetate (D6), sodium pyruvate (D8), and barium oxalosuccinate (D10) 2. Vitamins, Nucleosides, and Their Biosynthetic Intermediates: Coenzyme A (D8), nicotinamide adenine dinucleotide (NAD) (D8), adenosine triphosphate (ATP) (D10), ascorbic acid (D6), thiamine hydrochloride (D6), sodium riboflavin phosphate (D6), pyridoxine hydrochloride (D6), nicotinamide (D6), cysteine (D6), and DL-alpha-lipoic acid (D6) 3. Minerals: Magnesium orotate (D6), cerium oxalate (D8), and manganese phosphate (D6) 4. Herbal Extracts: Pulsatilla (D6) and Beta vulgaris (D4) 5. Miscellaneous Ingredients: Sulfur (D10) and Hepar sulfuris (D10) The letter D in the parentheses stands for decimal dilution, whereas the numbers that follow the D represent the number of (decimal) dilution procedures repeated according to basic homeopathy principles (Weingarther, 2007). In this manner, D means that the corresponding solution of a given active homeopathic ingredient (drug) is obtained by decimal dilution of the starting mother solution. According to the German Homeopathic Pharmacopoeia by Driehsen et al. (2003), a solution of six (6) repeated decimal dilutions in a predefined diluent-water or aqueous ethanol, e.g., 1 ml of mother solution (defined by the HAB), is diluted with 9 ml of diluent to give D1; this D1 solution (1 ml) is subsequently diluted with 9 ml of diluent, giving a D2 solution, etc. After the present study, sulpiride and the complex homeopathic remedy were mixed together; thereby creating a new drug, which was patented and was approved as new and inventive by international evaluation. Preparation of the Single Drug Sulpiride In a 5 ml syringe, 0.4 ml (20 mg) of isotonic sulpiride solution was combined with a 2.2 ml of isotonic NaCl solution. The quantity of sulpiride was measured using a micropipette. This one injection was applied simultaneously in the waist region using a 23 G (0.6x25) needle, once daily at 10 a.m. Preparation of the Single Drug Complex homeopathy One syringe with 2.2 ml of an isotonic solution of mixed homeopathic substances in relatively equal amounts was used. Homeopathic substances present in this complex parenteral isotonic preparation were mainly Krebs cycle compounds as well as some herbal homeopathic remedies, all in equal volume amounts up to 2.2 ml: 1. Intermediates: Citric acid (D8), cis-aconitic acid (D8), alpha ketoglutaric acid (D8), succinic acid (D10), fumaric acid (D8), DL malic acid (D8), sodium diethyloxalateoacetate (D6), sodium pyruvate (D8), barium oxalosuccinate (D10) 2. Vitamins, Nucleosides, and Their Biosynthesis Intermediates: Coenzyme A (D8), nicotinamide adenine dinucleotide (NAD) (D8), adenosine triphosphate (ATP) (D10), ascorbic acid (D6), thiamine hydrochloride (D6), sodium riboflavin phosphate (D6), pyridoxine hydrochloride (D6), nicotinamide (D6), cysteine (D6), DL-alpha-lipoic acid (D6) 3. Minerals: Magnesium orotate (D6), cerium oxalate (D8), manganese phosphate (D6) 4. Herbal Extracts: Pulsatilla (D6) and Beta vulgaris (D4) 5. Miscellaneous Ingredients: Sulfur (D10) and Hepar sulfuris (D10) This one injection was applied to the waist region using a 23 G (0.6x25) needle, once daily at 10 a.m. This group was treated in the period before that the first and second groups were treated. Patient Groups The subjects of this study of antidepressant activity were sixty-seven (67) women, 4480 years of age, who were suffering from depressive syndrome. One day prior to this experiment (day 0), all patients were tested by a 17-item version of the Hamilton rating scale for depression (HAMD test). These patients came to my clinic for antidepressant treatment. Some of them wanted combined treatment and some of them wanted single conventional or homeopathic treatment, since my clinic is a private integrated medicine clinic. After the treatment was completed, we analyzed the patients HAMD scores and compared them to scores taken before the treatment and we noticed some significant differences. The third group of patients (15 women, 3456 years of age) was treated in previous period only with the complex homeopathy remedy described here and was also tested before and after treatment. Consequently, 1. The first group (N=35) received one dose of the combined drug (sulpiride and complex homeopathy) as 2 separate injections daily in the morning for 3 months. 2. The second group (N=32) received one dose of the single drug (sulpiride only) daily in the morning for 3 months. 3. The third group (N=15) received one dose of a complex homeopathy remedy as 1 injection daily in the morning for 3 months, but in an earlier period. At the beginning of this study, the third group was tested for HAMD score before and after treatment, so those data were used for statistical analysis. This study used the Hamilton rating scale for depression, also known as the HAM-D or HAMD test, which is generally accepted as a gold standard for quantifying severity of depression symptoms such as low mood, anxiety, agitation, insomnia, and weight loss. It was performed on day 90 of taking the injections. For the 17-item version of the HAMD test, scores can range from 054. In relation to depression, scores between 0 and 6 indicate a normal person, between 7 and 17 indicate mild depression, between 18 and 24 indicate moderate depression, and scores over 24 indicate severe depression. Results The average HMD score in the three groups prior to the study was 20.27.1. In the second group (N=32), prior to the study, the HAMD score was 18.8 9.2 and after the study it was 17.38.8 (Table 1). In the first group (N=35), prior to the study, the HAMD score was 21.35.0 and after the study it was 8.84.1 (Table 1). In the third group ( N=15), prior to the treatment, the HAMD score was 20.74 and after the study it was 19.44.5 Table 1. Mean HAMD score before and after the therapy  The results in Table 1 were subjected to a paired t-test. The pairs were chosen to reflect changes during the study in the control groups (rows 1 and 3) and the experimental group (rows 2 and 4). A paired t-test is usually chosen to establish the difference between groups; i.e., their mean values during the study. The results of the paired t-test, performed with the Analyse-it version 2. 21 software, are shown in Table 2. Table 2. Paired t-test parameters for second and first groups  The results from the HAMD test strongly suggest that the combined therapy has a strong antidepressant activity (see the mean difference in Table 2). The HAMD mean score decreased by 12.5 points in the first group and overshadowed the results from the sulpiride only and complex homeopathy only treatments. No side effects, such as sedation, constipation, dryness of the mouth, or prolactinogenic activity, were observed . Discussion Sulpiride is an atypical antipsychotic drug used mainly to treat psychosis and depression. For productive psychosis, treatment uses rather high doses (more than 600 mg daily). It can be administered orally or parenterally. For psychosis with negative symptoms, long-term treatment uses moderate doses (approximately 600 mg daily). Depression and vertigo are treated with low to moderate doses (100200 mg daily) (Komossa et al., 2010; Mart Mass, 2011; Jo and Lee, 2004). Sulpiride is absorbed slowly from the gastrointestinal tract. Its oral bioavailability is only 25 to 35%, with marked differences according to the individuals. The peak plasma concentration is reached 4.5 hours after oral dosing. The usual half-life is 68 hours. Ninety-two percent (92%) is excreted unchanged in the urine. Sulpiride is usually given in 2 or 3 divided doses (Jo and Lee, 2004). Sulpiride is a HYPERLINK "http://en.wikipedia.org/wiki/Binding_selectivity"selective HYPERLINK "http://en.wikipedia.org/wiki/Receptor_antagonist"antagonist of the HYPERLINK "http://en.wikipedia.org/wiki/Dopamine"dopamine HYPERLINK "http://en.wikipedia.org/wiki/D2_receptor"D2 and HYPERLINK "http://en.wikipedia.org/wiki/D3_receptor"D3 receptors. This action predominates at doses exceeding 600 mg daily. At low doses (in particular 50200 mg daily), its prominent feature is antagonism of presynaptic inhibitory HYPERLINK "http://en.wikipedia.org/wiki/Dopamine"dopamine receptors, which accounts for some antidepressant activity and a stimulating effect. Therefore, at these doses, it is used as a second line antidepressant. Additionally, it alleviates vertigo (Komossa et al., 2010; Mart Mass, 2011; Jo and Lee, 2004). For depression, sulpiride is given orally, at 100200 mg daily, divided into 3 doses. Sulpiride has a bioavailability of 2535% when given orally. If 20 mg is given subcutaneously (s.c.), one part of the drug is lost in the process of injection. According to my rough estimation, only about 17.5 mg reaches the s.c. tissue because the process of injection incurs some losses. The bioavailability of an s.c. application is also rarely or never the value of 1 compared to an i.v. application. Therefore, the overall quantity of sulpiride in blood after 20 mg has been present in the syringe is even less than 17.5 mg. In the case of a 150 mg daily dose (which is the average dose prescribed for sulpiride to treat depression), the drug would be present in the blood at 37.552.5 mg at approximately 4.5 hours after oral dosing (Mart Mass, 2011). In this study, I explored whether sulpiride given parenterally s.c. at a low dose (20 mg) would act better if combined with the complex homeopathic remedy than with isotonic NaCl solution. In this study, sulpiride was administered at a 20 mg dose, combined either with a complex homeopathic/isopathic remedy mainly based on diluted and potentized Krebs cycle elements or with isotonic NaCl solution. Anecdotally, homeopathized (potentized) Krebs cycle components act as a nonspecific metabolism activator (Witt et al., 2007, according to the Reckeweg theory of isopathy and homotoxicology). According to integrative medicine principles, we combine paradigmatically different therapeutic actions in time and space in order to possibly magnify therapeutic potential in a given patient. This is achieved by means of synergy, which is defined as a cooperative action of discrete agencies such that the total effect is greater than the sum of the two effects that act independently (Rocha, 1999). Using a combination of sulpiride and a complex homeopathic remedy followed integrative medicine principles. Two paradigmatically different substances were used together in order to multiply the therapeutic potential. We can define a paradigm as a mental model, a way of seeing, a filter for ones perceptions, a frame of reference, a framework of thought or belief through which ones world or reality is interpreted, an example used to define a phenomenon, and a commonly held belief among a group of people such as scientists of a given discipline (Kuhn, 1970). Thomas Kuhn, a philosopher of science, says that a paradigm is a constellation of concepts, values, perceptions and practices shared by a (scientific) community that forms a particular vision of reality that is the basis of the way a (scientific) community organizes itself (Kuhn, 1970). Conventional medicine is mainly based on a biochemical paradigm, so drugs are perceived as acting by interacting with receptors on cells. Health and disease are perceived as purely biochemical processes (Becker, 2004). Although medicine strongly holds for a biochemical paradigm of biological processes, we are now in a process of revising the past centurys biochemical concept. Therefore, major biological processes can also be electromagnetic in nature. Thus, we come to a concept of energy medicine where illness is regarded also and at the same time as a disturbance in energy fields and can be addressed via interventions into those energies and energy fields (Becker, 2004). The paradigm shift, as a change from one way to another, is not a transformative revolution but a sort of gradual metamorphosis driven by agents of small bits of slow change (Kuhn, 1970), and integrative medicine is surely one of those small bits. Consequently, sulpiride acts at a biochemical level or paradigm, while homeopathy surely does not, since the quantity of diluted matter is so small it cannot satisfy the receptor theory in a biochemical paradigm (Taylor et al., 2000; Bell et al., 2004). Many dispute about how homeopathy works or whether it works at all. Although many suppose that homeopathy is a placebo, others hold a different opinion (Linde et al., 1997; Vickers, 2009; Ludtke and Rutten, 2008). Nevertheless, even though we do not fully understand how homeopathy works, it is usually perceived as being energetically programmed water interacting with water in the body, which affects cells on an energetic (quantum field) level (Vicker, 2009). This is the proposed mechanism of action for high dilutions/potencies, which integrate global dynamics also by electromagnetic regulation. Another model emerging from nonlinear complex systems theory has been proposed for low potencies (Rocha, 1999). A quantum and nonlinear physical model for homeopathy may work in concordance as well, so at the same time both mechanisms of action may be in play. The findings of the present study indicate that sulpiride at a low dose, given subcutaneously in combination with a complex homeopathic remedy, acts better than sulpiride with isotonic NaCl solution does. How can that be? My opinion is that the body exists on different levels or in different paradigms that are mutually related concurrently. Therefore, we cannot say definitively that the body is just a machine or just a computer or just a quantum operator. It is all of these at the same time. For example, if a bone is fractured, it should first be treated mechanically, i.e., operated on with osteosynthesis (mechanical paradigm). In order for it to be healed, growing processes (biochemical paradigm) should be applied. If we apply magnetic therapy to a fracture site, it can grow even faster (energetic paradigm), so by intervening with mechanical, biochemical and energetic processes, we may achieve positive synergy and multiply the healing potential. Thus, we see that the body is a complex system, which means at least two things: 1. It is a system composed of interconnected parts that, as a whole, exhibits one or more properties that are not obvious from the properties of the individual parts; the whole is more than merely the sum of its parts. 2. It is also a network of heterogeneous components that interact nonlinearly. In a linear system, an effect is always directly proportional to cause, whereas in a complex system, a small perturbation may cause a large effect (the butterfly effect), a proportional effect, or even no effect at all. Here, we come to the principle of chaos theory (Rocha, 1999). In the context of this study, I speculate that a homeopathic remedy can make a small change in cellular energy production so that sulpiride can perform better and at a smaller dose. The foremost problem with sulpiride in low doses is a strong stimulation of prolactin secretion; whether this may contribute to the development of breast cancer in women is currently not known, but in this study, no milk production or breast stimulation was observed. If such combined allohomeo(R) therapy is really a therapeutic possibility that needs to be investigated in further studies, it will have a paramount significance. It would enable us to reduce the dose of the chemical drug, thereby helping to avoid drug side effects while still achieving the desired therapeutic effect. Conclusion This study confirms that sulpiride at a low dose (20 mg) taken parenterally has a statistically better effect on depression if combined with a complex homeopathic/isopathic remedy based on Krebs cycle components than if combined with an isotonic solution of NaCl. It also presupposes that homeopathy is not a placebo. Further experiments are necessary to determine whether this observation is based on a firm grounding. References for this study can be found in the REFERENCE section. After I became aware of the great potential of a combined or hybrid drug, I administered it to myself as a mix of two in one syringe (not in two separate syringes as was done with the patients). As an overworked doctor, I was a potential burn-out syndrome victim, so I wanted to try the therapy on myself to see what would happen. The results were astonishing. Sleep was regulated after the first injection. The very same night, I had a deep healthy sleep with nice dreams, lasting 8-9 hours, and I awakened completely refreshed. After one more day, my mood and concentration were elevated and my burn-out symptoms had subsided. After 5 more days, I discontinued the injections because I felt completely well and did not need them anymore. Fantastic! Therefore, a new drug was born, as well as a new medication system called ALLOHOMEO therapy. It is innovative because chemical drugs are combined with homeopathic therapies, and these show synergistic properties. At the present time, I am developing more ALLOHOMEO drugs with other chemical and homeopathic compounds. Afterwards, I patented the hybrid drug internationally and it passed with high degree. The method was given the name SULPYCO, which is the registered trademark of the method. Later administration was continued by giving two separate injections merely for administrative reasons. When I administer it to myself, I mix the two components together in the same syringe and give it in a subcutaneous manner in the region of the lower waist. Just to mention again, both sulpiride and Coenzyme compositum (Heel GmbH, Germany) are registered drugs; the latter being OTC and safe even for self administration, but labeled: Without proven medical efficacy or indication. No drug interactions are probable nor observed since Coenzyme compositum, in a chemical sense, contains mostly saline and only infinitesimal quantity of other molecules. This was confirmed by chemical modeling made by an independent Croatian chemist, Ivica Cepanec, PhD, shown in the subsequent text.  HYPERLINK \l "ref_TOC" Analysis of possible chemical interactions between sulpiride (1) and ingredients of Coenzyme compositum (Heel GmbH, Germany) A) Project task: Analysis of all theoretically possible chemical interactions of (R, S)-()-5-(aminosulfonyl)-N-[(1-ethylpyrrolidin-2-yl)methyl]-2-methoxy benzamide, known under generic name of sulpiride (1):  and all 26 ingredients of so-called modified Krebs solution, a homeopathic product of Coenzyme compositum of the manufacturer Heel GmbH, Germany, of the following composition:  B) The concept of the SULPYCO therapy: Anti-depressive SULPYCO therapy is carried out by subcutaneous administration of a freshly prepared mixture of sulpiride (0.4 ml; 20 mg) and 2.2 ml of Coenzyme compositum (Heel GmbH) solution. From this administration regime follows the fact that the contact time of sulpiride and Coenzyme compositum ingredients is very short, <5 min; administration is conducted immediately after mixing of the parenteral solutions in a syringe. Analysis 1. Reactivity of sulpiride (1)  Concerning the structure of sulpiride, theoretically, the following degradation reactions can be expected: (i) hydrolysis of the amide group to 4-methoxy-3-carboxy-benzene sulfonamide (1a) and 2-aminomethyl-N-ethyl-pyrrolidine (1b);  R Reactions of hydrolysis of secondary amide function usually proceed under harsh reaction conditions, e.g., at reflux temperature of water-dioxane mixture in the presence of strong mineral acids at 100 oC for several hours. From the standpoint of stability of the sulpiride solution, this is the most important product of spontaneous hydrolytic degradation. The process eventually proceeds by autocatalytic action of tertiary amino group of the same molecule (participation of neighboring group). (ii) hydrolysis of sulfonamide to the respective sulfonic acid 1c:  Hydrolysis of the sulfonamide function of sulpiride takes place under more drastic reaction conditions than the hydrolysis of amide in the reaction under (i). (iii) oxidation of sulpiride at the tertiary hydrogen atom in the vicinal position next to the tertiary amino group of pyrrolidine, furnishing the Shiffs base 1d, which subsequently undergoes hydrolytic cleavage into further degradation products:  2. Possible chemical interactions between sulpiride and ingredients of Coenzyme compositum (Heel GmbH) 1. L-Ascorbic acid (2):  At a homeopathic concentration of D6, no chemical interaction with sulpiride can be expected. Possible catalytic hydrolysis of the amide function of sulpiride is not likely to occur, due to the fact that 2 is a weak acid. At the same time, on account of its significant reductive action, ascorbic acid preventively protects sulpiride and also other ingredients of Coenzyme compositum (which are sensitive to oxygen) from oxidation. Because of a short time of contact in the solution, all of these interactions are not relevant. Ascorbic acid itself undergoes oxidation in the solution. The stability issue is presumably solved during technological development of the Coenzyme compositum product. 2. Thiamine chloride (3):  At a homeopathic concentration of D6, no chemical interaction with sulpiride can be expected. The 2-Amino-pyrimidine function of thiamine is of too weak a basicity and thus of a weak nucleophilicity to be able to catalyze possible hydrolysis of the amide function of sulpiride. 3. Sodium riboflavin phosphate (4):  At a homeopathic concentration of D6, no chemical interaction with sulpiride can be expected. Riboflavin is sensitive to light and bases. Stability in the solution of the composition is presumably solved during the development of Coenzyme compositum. 4. Pyridoxine hydrochloride (5):  At a homeopathic concentration of D6, no possible reaction with sulpiride exists. Pyridoxine itself is sensitive to oxidation at the hydroxymethyl function at 4-position of pyridine ring. The intensity of oxidation is probably minimized under influence of ascorbic acid. 5. Nicotinamide (6):  At a homeopathic concentration of D6, not a single chemical reaction with sulpiride is possible. Nicotinamide is generally a very stable compound with practically only one possible degradation reaction, that of hydrolysis of the amide function into nicotinic acid (pyridine-3-carboxylic acid). 6. cis-Aconitic acid (7):  At a homeopathic concentration of D8, not a single chemical interaction with sulpiride is possible except for the formation of the corresponding salt (sulpiride aconitate; neutralization reaction). Despite a fact that aconitic acid is a stronger carboxylic acid (K1= 1. 5x10-3; 25 oC), potential acid-catalyzed hydrolysis of the amide function of sulpiride at a measurable level is not likely to occur. 7. Citric acid (8):  At a homeopathic concentration of D8, no chemical interaction with sulpiride is possible, except for formation of the salt (sulpiride citrate). Citric acid itself is chemically stable, both as a bulk substance and in a solution. Although it can be a substrate for microbial growth, this is a parenteral product that is, by definition, sterile and thus potential microbial decay is not relevant. 8. Fumaric acid (9):  At a homeopathic concentration of D8, no chemical interaction with sulpiride can be expected, except formation of the salt (sulpiride fumarate; neutralization reaction). Despite the fact that fumaric acid is a stronger carboxylic acid (K1= 3. 03; 25 oC), potential acid-catalyzed hydrolysis of the amide function of sulpiride at measurable intensity is not likely to occur. In addition, the theoretically possible Michael 1, 4-addition of the nitrogen atom of sulfonamide function of sulpiride to fumaric acid with generation of 9a at room temperature and within short period of time is not likely to occur.  9. a-Ketoglutaric acid (10):  At a homeopathic concentration of D7, a-ketoglutaric acid certainly forms a salt with sulpiride (sulpiride a-ketoglutarate). Except for the neutralization reaction, the reaction of the sulfonamide group of sulpiride and keto-function of the acid 10 is possible, giving N-alkylidene-sulfonamide 10a:  Because of the high level of dilution of the system, the short period of time of reactants 1 and 10, and the very mild reaction conditions (room temperature, and pH close to neutral), the probability of occurrence of this reaction is negligible. 10. DL-Malic acid (11):  At the homeopathic concentration of D8, no chemical interaction with sulpiride is possible, except for the formation of the salt (sulpiride DL-malate). Malic acid itself is chemically very stable, with the exception of the oxidation reaction (in which gives 2-keto-butan-1, 4-dicarboxylic acid), from which it is probably protected by the presence of ascorbic acid in the composition. 11. Succinic acid (12):  At the homeopathic concentration of D8, no chemical reaction of succinic acid with sulpiride is possible, except for the formation of the salt (sulpiride succinate). Succinic acid is chemically very stable. 12. Barium oxalosuccinate (barium salt of oxalosuccinic acid; 13):  Compound 13 can react with supiride (1) in a neutralization reaction and in a reaction for generation of the respective N-alkylidene-sulpiride 13a:  As in the case of a-ketoglutaric acid, due to the high level of dilution of the system (compound 13 is at a homeopathic concentration of D8), the short time of contact of reactants 1 and 13, and the very mild reaction conditions (room temperature, pH close to neutral), the probability of occurrence this reaction is negligible. 13. Sodium pyruvate (sodium 2-ketopropionate; 14):  A theoretically possible reaction of compound 14 and sulpiride (1) furnishes the corresponding N-alkylidene-sulpiride 14a:  Due to the short time of contact of reactants 1 and 14, and the very mild reaction conditions (room temperature, pH close to neutral), the probability of occurrence of this reaction and eventual degree of its conversion are considered as irrelevant. 14. L-Cysteine (15):  Cysteine itself is prone to an oxidation reaction, with the formation of the dimeric amino acid cystine (15a) by the following reaction:  The oxidation is fast in alkaline solution, while under acidic conditions it is slow. Since this is a parenteral type of composition with a pH close to neutral, it is possible that the issue of cysteine stability has not been resolved. In this case, it is possible that a significant part of the cysteine in the composition is actually present in the form of cystine (15a). Cysteine cannot react with sulpiride, except in the neutralization reaction. 15. Extract of Pulsatilla pratensis (16) According to the literature, the extract of the plant Pulsatilla pratensis L. (Small Pasque Flower) contains the following pharmacologically active ingredients: coumarin the glycoside esculin (16a), its aglycone esculetin (16b), the terpene anemonine (16c), the triterpene glycoside anemoside (16d), and the isoquinoline alkaloids berberine (16e), palmatine (16f), and jatrorrhizine (16g) [Y. Hu, X. Chen, H. Duan, Y. Hu, X. Mu: Pulsatilla decoction and its active ingredients inhibit secretion of NO, ET-1, TNF-alpha, and IL-1 in LPS-induced rat intestinal macrovascular endothelial cells, Cell. Biochem. Funct. 27 (2009) 284-288; for the structure of terpene anemonine (16c) see: I. L. Karle, J. Karle: The Crystal and Molecular Structure of Anemonin, C10H8O4, Acta Cryst. 20 (1966) 555-559].    Isoquinoline alkaloids 16e-g are chemically very stable and cannot react with sulpiride. Esculin (16a), esculetin (16b), and anemoside (16d) cannot react with sulpiride at neutral pH and under mild reaction conditions. Esculin (16a) and anemoside (16d) theoretically can react under conditions of pH<7 (acidic medium), where hydrolysis of the glycoside bond occurs and where the released sugar molecule can subsequently react with sulpiride to yield an imine of the sugar aldehyde group and sulfonamide function of sulpiride. Considering the very short time of contact of sulpiride and Coenzyme compositum and the very mild reaction conditions (neutral pH and room temperature), the probability of occurrence this reaction is negligible. Anemonine (16c) can react with sulpiride (1) by the 1, 4-conjugate Michael addition, giving derivative 16c1:  However, the probability of occurrence of this reaction and the degree of its conversion are negligible. 16. Hepar sulfuris: In homeopathy and pharmacy, the term hepar sulfuris (sulfurated potash) represents a mixture of potassium sulfide (K2S), potassium polysulfide (K2Sx; x=2-6), potassium thiosulfate (K2S2O5) and potassium sulfate (K2SO4), which is produced by reaction (heating) of potassium carbonate (K2CO3) with excess of sulfur (S) in absence of air at 250 oC. At a homeopathic concentration of D10 (as well as at higher concentrations), potassium sulfide (K2S) from hepar sulfuris undergoes hydrolysis accompanied with liberation of hydrogen sulfide (H2S; odor of rotten eggs). In the same manner, potassium polysulfides (K2Sx) are prone to hydrolysis accompanied with generation of polysulfane acids, H2Sx, which rapidly undergo degradation to hydrogen sulfide and elemental sulfur. At a homeopathic concentration of D10, not a single ingredient of hepar sulfuris or product of its hydrolysis (H2S, sulfur) can react with sulpiride. 17. Sulfur: At a homeopathic concentration of D10 and under the conditions of the SULPYCO therapy, precipitated sulfur cannot chemically react with sulpiride. 18. Adenosine triphosphate (17):  Adenosine triphosphate (ATP) can react with sulpiride at room temperature by phosphorylation of its sulfonamide group, yielding N-phosphoryl sulpiride (17a):  However, N-phosphoryl sulpiride (17a) presumably undergoes hydrolysis with formation of sulpiride (1) and phosphoric acid (H3PO4) by hydrolytic cleavage of P-N bond. Because of the short time of the contact of sulpiride and Coenzyme compositum solution containing ATP, the probability of occurrence of this reaction and its conversion is negligible. 19. Nicotinamide adenine dinucleotide (NAD; 18):  Theoretically, NAD can react with sulpiride (1) by phosphorylation of the nitrogen atom of the sulfonamide group, giving derivatives 18a or 18b;  At a homeopathic concentration of NAD of D8, this reaction is very unlikely to occur. Also, derivatives 18a or 18b in aqueous solution certainly undergo further hydrolytic cleavage of P-N bonds, which results in regeneration of sulpiride (1). 20. Coenzyme A (19):  Coenzyme A can react with sulpiride in the sense of phosphorylation yielding compounds 18b or 19a:  Possibilities for these reactions are irrelevant. Coenzyme A (19) itself is prone to relative rapid oxidation to disulfide 19b:  The issue of stability of coenzyme A within the composition of Coenzyme compositum is presumably solved somehow during the development of the product. 21. Beet (Beta vulgaris ssp. vulgaris var. conditiva e radice) extract (20): 1. Beet (Beta vulgaris ssp. vulgaris var. conditiva e radice) extract (20): According to the literature, beet extract contains a dozen substances of nutritive significance, including, vitamins of the B group (thiamine (B1), riboflavin (B2), nicotinamide (B3), panthotenic acid (B5), and folic acid (B9)), as well as ascorbic acid (C). It contains a high content of iron (Fe2+/3+; 0.8 mg/100 g), zinc (Zn2+; 0.35 mg/100 g), and calcium (Ca2+; 16 mg/100 g). In addition, it provides significant amounts of the natural pigments, betanin (20a; E162) and indicaxanthin (20b).  Potential chemical interaction between compounds of the B group of vitamins for the present analysis is not relevant, because these compounds are present in very small concentrations in the beet. Consequently, their absolute concentration in the Coenzyme compositum of D4 is extremely small. The presence of some concentration of iron (Fe2+/3+) and zinc (Zn2+) might theoretically influence catalytically in certain possible reactions of sulpiride and relatively reactive ingredients of Coenzyme compositum. Furthermore, pigments 20a and 20b can react with sulpiride (1) in a transimination reaction, giving the respective imide 20c, e.g.:  The possibility of this reaction under the conditions of SULPYCO therapy is not significant. 22. Sodium diethyl oxaloacetate (21):  CAS No. 40876-98-0; Mr= 210. 16. Theoretically, this compound can react with sulpiride (1) yielding the corresponding imine 21a  The significance of this reaction under conditions of SULPYCO therapy is negligible. 23. Manganese phosphate [Mn2(PO4)3]: is a stable inorganic compound of extremely low water solubility. It cannot react with sulpiride. Since it releases equilibrium concentrations of manganese(II) (Mn2+) ions, which act as a Lewis acid of significant strength, it theoretically may play a role as catalyst in some of the earlier described organic reactions of sulpiride. 24. Magnesium orotate (22):  Magnesium bis(2, 6-dioxo-3H-pyrimidin-4-carboxylate); CAS No. [27067-77-2]; C10H6MgN4O8 Mr= 334.48. It cannot react with sulpiride under the conditions of SULPYCO therapy. 25. Cerium oxalate (23):  erium(III) oxalate; Ce2(C2O4)3; CAS No. [139-42-4]; Mr= 544.29. It cannot react with sulpiride under the conditions of SULPYCO therapy. It is also of very low water solubility. It releases equilibrium concentrations of cerium(III) ions (Ce3+), which may catalyze some of the earlier mentioned reactions of sulpiride and some of the relatively reactive components of Coenzyme compositum. 26. Lipoic acid (24):  This substance cannot react with sulpiride under the conditions of SULPYCO therapy. 3. Conclusion (1) Theoretically, sulpiride (1) in solution undergoes three degradation reactions: (a) hydrolysis of the amide function; (b) hydrolysis of the sulfonamide function; and (c) oxidation of tertiary hydrogen in pyrrolidine ring. The stability of sulpiride is presumably resolved during development of the corresponding parenteral product, ensuring sufficient stability within the limits of the product specification during whole declared shelf life period. (2) Analysis of possible chemical reactions of sulpiride and all of ingredients of Coenzyme compositum in conditions of the SULPYCO therapy showed the following: (A) 16 ingredients cannot react: L-ascorbic acid (2), thiamine chloride (3), sodium riboflavin phosphate (4), pyridoxine hydrochloride (5), nicotinamide (6), cis-aconitic acid (7), citric acid (8), DL-malic acid (12), succinic acid (12), L-cysteine (10), hepar sulfuris, sulfur, magnesium orotate (22), -lipoic acid (24), manganese phosphate, and cerium oxalate (23); (B) theoretically, total of 10 ingredients can react: fumaric acid (9), a-ketoglutaric acid (10), barium oxalosuccinate (13), sodium pyruvate (14), extract of Pulsatilla pratensis (16), adenosine triphosphate (17), nicotinamide adenine dinucleotide (18), coenzyme A (19), extract of Beta vulgaris (20), and sodium diethyl oxaloacetate (21); and there are also (C) ingredients that cannot react, but act as sources of catalytically active metals, which can further influence some reactions of sulpiride and certain reactive components of Coenzyme compositum under point (B); these are: magnesium phosphate [Mn2(PO4)3], cerium oxalate [Ce2(C2O4)3 (23)] as well as metals from the beet [Beta vulgaris; iron(Fe2+/3+) and zinc (Zn2+)] extract. (3) In conclusion, the probability of occurrence of theoretically possible reactions of sulpiride and certain reactive components of Coenzyme compositum is very small or negligible due to the following facts: (A) the methodology of the SULPYCO therapy, which includes mixing of sulpiride and Coenzyme compositum solutions immediately before the parenteral administration; so the contact time of sulpiride and Coenzyme compositum solutions is very short, less than 5 minutes; (B) conditions of potential reactions of sulpiride and certain reactive components of Coenzyme compositum, which involves: (a) aqueous medium; (b) room temperature; and (c) extremely high level of dilution of Coenzyme compositum ingredients (D4-D10). In conclusion, no new chemical compounds would be observed in a mix of sulpiride and Coenzyme compositum. Each one of the SULPYCO drug components has its own pharmacological identity, known and defined because they have long been present on the market. They are not changed by mixing at room temperature prior to injecting. In addition, no interactions are likely once these substances enter the body.  HYPERLINK \l "ref_TOC" Clinical experience with the SULPYCO method SULPYCO works quickly. Although data in the observational study suggested 3 months of use, I found later, with more experience, that results come much earlier. The treatment will usually show results in first 5 days, with a maximum by the tenth day. If it does not show results in 10 days, then it is futile to continue. What we observe is: 1. Deep healthy sleep with pleasant dreams 2. Feeling alert and fresh upon waking 3. Mood is stabilized and brightened 4. Concentration improves 5. Motivation for everyday work, social interaction, and self grooming is raised 6. Sexual desire is better 7. Conflict tendencies are less 8. Working capacity is heightened 9. Anxiety is significantly reduced No side effects were noticed. Galactorrhea, as a typical sulpiride side effect, was not observed. The treatment is appropriate for mild, moderate, and less severe cases of depression and anxiety, dysthymia, chronic fatigue, involutive depression, and depression of a chronic disease. It is interesting how often depression adds to the gait difficulty in multiple sclerosis patients. When depression is resolved, the gait improves. It can also be administered over other antidepressant conventional therapy that the patient already takes. Very often, the SULPYCO method works better than sulpiride 3x50 mg orally. I have no experience with hospitalized depressive patients nor with bipolar disorders. The SULPYCO method for an average patient with depression/anxiety usually requires about 20 injections. In the first few days, it is given every day; in the later stages, it is given every other day, and then even once or twice a week. The frequency of injections can be gradually reduced over a few weeks. I use one injection per day for people of average weight. The heaviest person was about 100 kg and also responded to one single injection daily. The SULPYCO method is appropriate for mild or moderate depressive and anxiety disorders.  HYPERLINK \l "ref_TOC" Application of SULPYCO method There are two ways to apply the SULPYCO method that take into account administrative barriers that may occur: 1. To give it as two separate injections: first sulpiride in a 20 mg dose(0.4ml in a 1 ml insulin needle) and then Coenzyme compositum in a second injection. A 23G (0.6x25) needle is used. The site of injection is usually the lower waist region of the lateral lumbar region, over the gluteus medius muscle. 2. To mix Sulpiride with a Coenzyme compositum in the same 5ml syringe, use a 23 G (0.6x25) needle and inject it into the lower waist region. In this way, 18 mg (0.36 ml of liquid isotonic sulpiride) is sucked into the syringe because precisely 20 mg is hard to measure, considering the marks on the 5 ml syringe. In this way, the dose error is 10% with respect to the original dose of 20 mg. Any other way of mixing and applying it in the same syringe is completely impractical for everyday use, so I risked the difference. The effect is in fact the same. It is better to give 20% less than 20% more compared to original 20 ml of sulpiride because I found that a 20% overdose may cause excitation. When I apply the method to myself, I use a combined drug. I also tried to take it separately: it is still effective, but the mix is even better, according to my experience. How to prepare a SULPYCO drug in two syringes without micropipette: 1. take one 1 ml insulin syringe with needle 2. withdraw 0.4 ml of sulpiride into the syringe 3. take one 5 ml syringe 4. withdraw the contents of 1 vial of Coenzyme compositum into the 5 ml syringe 5. give the two injections separately s.c. In one 5 ml syringe without the micropipette: 1. take one 5 ml syringe 2. take one 23 G (0.6x25) needle 3. Withdraw 0.36ml (18mg) from a 100mg/2ml vial of sulpiride. Remember that some sulpiride will be left in the tip of the syringe and this is not a negligible quantity since it is important not to overdose with sulpiride in the sense of this method. Therefore, withdraw sulpiride solution up to the first line of the syringe, indicating a 0.2 ml volume, and the rest will be left in the syringe tip. The tip should be fully filled with sulpiride. The procedure is shown in pictures 1 and 2. (If the SULPYCO drug is made in a vial, then 20 mg of sulpiride should be used, since some losses occur during withdrawal of the substance from the vial, while injecting it, and due to its incomplete absorbance from s.c. injection site.) Picture 1:  Sulpiride must occupy the syringe tip and the 0.2 ml sector of the syringe, and no more than that. Picture 2:  Syringe piston upper edge must underline the 0.2 ml mark on the syringe. 4. Then, open one 2.2ml vial of Coenzyme compositum. Withdraw it completely into the syringe containing the sulpiride. 5. Put a 23 G (0.6x25mm) needle onto the syringe. 6. Injection is done in the lower waist region or at the lumbar lateral region with a 23G (0.6x25mm) needle, as a classical subcutaneous (s.c.) injection. SULPYCO is given once daily, optimally at about 1p.m. If it is given too early in the morning or too late in the day, it might not work well enough. The quantity of sulpiride reaching the blood is even smaller than the quantity in the syringe; namely, one part of the drug is lost in the process of injection since some substance remains in the syringe and needle. The amount of sulpiride reaching the systemic circulation is then even smaller than that, since the bioavailability of s.c. use is always smaller than 1, compared to i.v. use. Therefore, in the SULPYCO method, we deal with really small dose of sulpiride. Usually, the first results are seen within 15 days of use. It is rational to wait until the tenth day: if no effect is seen, SULPYCO has to be discontinued as non functional. Most patients need 10 injections/10 days in a row, 1 injection daily. It can then be slowed down by 1 injection every other day or more. Some patients need it only once a week, which gives them satisfactory effects over several months. No side effects were observed. As life stressors fluctuate, it can be given on demand to patients that previously took it in a row over a certain period of time. Therefore, it is not necessary to take it continually once a primary benefit is reached. Patients that take SULPYCO are mostly very satisfied with the therapy. About 75% of patients respond. Patients describe benefits of the SULPYCO method as follows: 1. ''I feel like I was born again'' 2. '' My sleep is much better'' 3. ''I don't need other medications anymore'' 4. ''I dress up and put on make-up'' 5. ''I go to hairdresser and take care about my styling more than before'' 6. ''I can communicate with people much better'' 7. ''My mood is elevated'' 8. ''My outlook to life is better'' 9. ''I am less negative about life'' 10. ''I go out alone without fear'' 11. ''I have more initiative'' 12. ''I'm less tired and have more energy'' 13. ''I feel like a new man in my body'' 14. ''I do not feel dizzy anymore'' 15. ''I don't panic anymore'' 16. ''My sexual desire is better'' 17. ''I bought myself new clothes'' 18. ''I started working again'' 19. ''I eat better'' 20. ''I feel less fear of people and have fewer conflicts 21. ''I'm less irritable and I feel less gloomy about life'' Advantages of the SULPYCO method are : 1. Quick onset of the effect 2. Low dose of the chemical drug and no side effects 3. No need for long-term continued therapy 4. Possibility for on-demand application 5. Low costs (one combined injection or two separate injections cost about 2.5 Euros) 6. Simplicity of making of the drug it can be mixed or prepared on the spot  HYPERLINK \l "ref_TOC" Afterword The SULPYCO method can possibly change the system of antidepressant medication. It unites two presently opposed worlds, one of chemical drugs and one of homeopathy. This also is proof that good ideas from different and even opposing backgrounds, if put together in the right way, can create a better quality if we just choose to think outside of the box. It also proves that drug discovery is not necessarily connected to high tech laboratories and big companies. As for innovations, imagination is much more important than anything else. It would be perfect if SULPYCO had a chance for mass production, which requires a Pharma partner. I hope this goal can be achieved in the near future. If the SULPYCO method reaches more people, the total sum of human suffering caused by depression and related disorders could significantly decrease. This is my dream.  HYPERLINK \l "ref_TOC" References: 1. Homeopathy Witt CM, Ludtke R, Baur R, et al. Homeopathic medical practice: long-term results of a cohort study with 3981 patients. BMC Public Health, 2005; 5:115. Aickin M. Participant-centered analysis in complementary and alternative medicine comparative trials. J Alternative and Complementary Medicine, 2003; 9 (6):949-57. Witt C, Ludtke R, Weisshuhn TE, Willich SN. High homeopathic potencies are different from potentized solvent when investigated with the REDEM technology. Forsch Komplementarmed Klass Naturheilkd, 2005b; 12 (1):6-13. Cristea A, Nicula S, Darie V. (1997). Pharmacodynamic effects of very high dilutions of belladonna on the isolated rat duodenum. In: Bastide M (ed). Signals and Images. Kluwer Academic Publisherspp. 161-170. Van Wijk R, Wiegant FA. The similia principle as a therapeutic strategy: a research program on stimulation of self-defense in disordered mammalian cells. Alternative Therapies in Health and Medicine, 1997; 3 (2):33-8. Aickin M. The end of biomedical journals: there is madness in their methods. Journal of Alternative and Complementary Medicine, 2005; 11 (5):755-7. Witt CM, Bluth M, Albrecht H, et al. The in vitro evidence for an effect of high homeopathic potencies a systematic review of the literature. Complementary and Therapeutic Medicine, 2007; 15: 128138 Becker-Witt C, Weibhuhn TER, Ludtke R, Willich SN. Quality assessment of physical research in homeopathy. Journal of Alternative and Complementary Medicine, 2003; 9 (1):113-32. Weatherley-Jones E, Thompson E, Thomas K. The placebo-controlled trial as a test of complementary and alternative medicine: observations from research experience of individualised homeopathic treatment. Homeopathy, 2004b; 93 (4):186-9. Bell IR, Baldwin CM, Schwartz GE. Translating a nonlinear systems theory model for homeopathy into empirical tests. Alternative Therapies in Health and Medicine, 2002a; 8 (3):58-66. Vickers AJ, Smith C. Homoeopathic Oscillococcinum for preventing and treating influenza and influenza-like syndromes. Cochrane Database Systematic Reviews, 2006; 3:CD001957. Bell IR, Koithan M. Models for the study of whole systems. Integrative Cancer Therapies, 2006; 5 (4):293-307. Caspi O, Bell IR. One size does not fit all: aptitude-treatment interaction (ATI) as a conceptual framework for outcome research. Part I. What is ATI research? Journal of Alternative and Complementary Medicine, 2004a; 10 (3):580-6. Van Wijk R, Wiegant, FAC. (1994). Cultured Mammalian Cells in Homeopathy Research. The Similia Principle in Self-Recovery. Utrecht, The Netherlands: Universiteit Utrecht. Bell IR, Lewis DA, II, Brooks AJ, et al. Improved clinical status in fibromyalgia patients treated with individualized homeopathic remedies versus placebo. Rheumatology, 2004a; 43 (5):577-82. Elia V, Napoli E, Germano R. The 'Memory of Water': an almost deciphered enigma. Dissipative structures in extremely dilute aqueous solutions. Homeopathy, 2007; 96 (3):163-9. Bell IR, Lewis DA, II, Lewis SE, et al. EEG alpha sensitization in individualized homeopathic treatment of fibromyalgia. International Journal of Neuroscience, 2004; 114 (9):1195-220. Endler PC, Pongratz W, Smith CW, et al. Non-molecular information transfer from thyroxine to frogs with regard to homeopathic toxicology. Veterinary and Human Toxicology, 1995; 37 (3):259-60. Bell IR, Lewis DAI, Schwartz GE, et al. Electroencephalographic cordance patterns distinguish exceptional clinical responders with fibromyalgia to individualized homeopathic medicines. J Alternative and Complementary Medicine, 2004; 10 (2):285-99. Dean ME, Coulter MK, Fisher P, et al. Reporting data on homeopathic treatments (RedHot): a supplement to CONSORT. Journal of Alternative and Complementary Medicine, 2007;13(1):19-23. Frenkel M, Hermoni D. Effects of homeopathic intervention on medication consumption in atopic and allergic disorders. Alternative Therapies in Health and Medicine, 2002; 8(1):76-9. Elia V, Niccoli, M. Thermodynamics of extremely diluted aqueous solutions. Annals of the New York Academy of Sciences, 1999; 879:241-8. Bell IR, Walsh M, Russek LGS, Schwartz GER. Proposed applications of conventional research concepts and tools to homeopathic clinical research. Journal of the American Institute of Homeopathy, 1999; 92 (3):111-28. Caspi O, Bell IR. One size does not fit all: aptitude-treatment interaction (ATI) as a conceptual framework for outcome research. Part II. Research designs and their application. Journal of Alternative and Complementary Medicine, 2004b; 10 (4):698-705. Bellavite P. Complexity science and homeopathy: a synthetic overview. Homeopathy: the Journal of the Faculty of Homeopathy, 2003; 92 (4):203-12. Eizayaga FX, Aguejouf O, Belon P, et al. Platelet aggregation in portal hypertension and its modification by ultra-low doses of aspirin. Pathophysiology of Haemostasis and Thrombosis, 2005; 34 (1):29-34. Bellavite P, Conforti A, Pontarollo F, et al. Immunology and homeopathy. 2. Cells of the immune system and inflammation. Evidence Based Complementary and Alternative Medicine, 2006; 3 (1):13- Frei H, Thurneysen A. Treatment for hyperactive children: homeopathy and methylphenidate compared in a family setting. British Homoeopathic Journal, 2001; 90 (4):183-8. Bellavite P, Signorini A. (2008). The Emerging Science of Homeopathy. Complexity, Biodynamics, and Nanopharmacology. 2nd ed. Berkeley: North Atlantic Books; p. 408. Jacobs J, Williams AL, Girard C, et al. Homeopathy for attention-deficit/hyperactivity disorder: a pilot randomized-controlled trial. Journal of Alternative and Complementary Medicine, 2005; 11 (5):799-806. Belon P, Cumps J, Ennis M, et al. Histamine dilutions modulate basophil activation. Inflammation Research, 2004; 53: 181-8. Coffey DS. Self-organization, complexity, and chaos: The new biology for medicine. Nature Medicine, 1998; 4 (8):882-5. Bertani S, Lussignoli S, Andrioli G, et al. Dual effects of a homeopathic mineral complex on carrageenan-induced oedema in rats. British Homoeopathic Journal, 1999; 88 (3):101-5. Endler PC, Pongratz W, Kastberger G, et al. The effect of highly diluted agitated thyroxine on the climbing activity of frogs. Veterinary and Human Toxicology, 1994; 36 (1):56-9. Betti L, Lazzarato L, Trebbi G, et al. Effects of homeopathic arsenic on tobacco plant resistance to tobacco mosaic virus. Theoretical suggestions about system variability, based on a large experimental data set. Homeopathy, 2003; 92 (4):195-202. Frei H, von Ammon K, Thurneysen A. Treatment of hyperactive children: increased efficiency through modifications of homeopathic diagnostic procedure. Homeopathy, 2006b; 95 (3):163-70. Bikker AP, Mercer SW, Reilly D. A pilot prospective study on the consultation and relational empathy, patient enablement, and health changes over 12 months in patients going to the Glasgow Homoeopathic Hospital. Journal of Alternative and Complementary Medicine,. 2005; 11 (4):591-600. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. New England Journal of Medicine, 2000; 342 (25):1887-92. Biswas SJ, Pathak S, Bhattacharjee N, et al. Efficacy of the potentized homeopathic drug, Carcinosin 200, fed alone and in combination with another drug, Chelidonium 200, in amelioration of p-dimethylaminoazobenzene-induced hepatocarcinogenesis in mice. Journal of Alternative and Complementary Medicine, 2005; 11 (5):839-54. Chang FY, Lee SD, et al. Rat gastrointestinal motorresponses mediated via activation of neurokinin receptors. Journal of Gastroenterology and Hepatology, 1999; 14: 3945. Bootzin RR, Bailey ET. Understanding placebo, nocebo, and iatrogenic treatment effects. Journal of Clinical Psychology, 2005; 61 (7):871-80. B Chaplin MF. The Memory of Water: an overview. Homeopathy, 2007; 96 (3):143-50. Brack A, Strube J, Stolz P, Decker H. Effects of ultrahigh dilutions of 3, 5-dichlorophenol on luminescence of the bacterium Vibrio fischeri. Biochim Biophys Acta, 2003; 1621: 253260. Frei H, Everts R, von Ammon K, Kaufmann F, Walther D, Hsu-Schmitz SF, Collenberg M, Fuhrer K, Hassink R, Steinlin M, Thurneysen A. Homeopathic treatment of children with attention deficit hyperactivity disorder: a randomised, double blind, placebo controlled crossover trial. European Journal of Pediatrics, 2005; 164 (12):758-67. Chapman EH, Weintraub RJ, Milburn MA, et al. Homeopathic treatment of mild traumatic brain injury: A randomized, double-blind, placebo-controlled clinical trial. Journal of Head Trauma Rehabilitation, 1999; 14 (6):521-42. Brizzi M, Lazzarato L, Nani D, et al. A biostatistical insight into the As(2)O(3) high dilution effects on the rate and variability of wheat seedling growth. Forsch Komplementarmed Klass Naturheilkd, 2005; 12 (5):277-83. Caulfield T, DeBow S. A systematic review of how homeopathy is represented in conventional and CAM peer reviewed journals. BMC Complementary and Alternative Medicine, 2005; 5 (1):12. Eizayaga FX, Aguejouf O, Desplat V, et al. Modifications produced by indomethacin and L-NAME in the effect of ultralow-dose aspirin on platelet activity in portal hypertension. Pathophysiology of Haemostasis and Thrombosis, 2006; 35 (5):357-63. Endler PC, Heckmann C, Lauppert E, et al. (1998). The metamorphosis of amphibians and information of thyroxine. In: Schulte J, Endler PC (eds). Fundamental Research in Ultra High Dilution and Homoeopathy. Dordrecht: Kluwer Academic Publishers. Endler PC, Pongratz, W, van Wijk R, Wiegant FAC, Waltl K, Gehrer M, Hilgers H. (1994). A zoological example on ultra high dilution research. Energetic coupling between the dilution and the organism in a model of amphibia. In: PC Endler, Schulte, J., editor, translator and editor Ultra High Dilution. Dordrecht, The Netherlands: Kluwer Academic Publishers; p. 39-68. Fisher P. Homeopathy and The Lancet. Evidence Based Complementary and Alternative Medicine, 2006; 3 (1):145 7. Conforti A, Bellavite P, Bertani S, et al. Rat models of acute inflammation: a randomized controlled study on the effects of homeopathic remedies. BMC Complementary and Alternative Medicine, 2007; 7:1. Frei H, Everts R, von Ammon K, et al. Randomised controlled trials of homeopathy in hyperactive children: treatment procedure leads to an unconventional study design Experience with open-label homeopathic treatment preceding the Swiss ADHD placebo controlled, randomised, double-blind, cross-over trial. Homeopathy, 2007; 96 (1):35-41. Goldstein MS, Glik, D. Use of and satisfaction with homeopathy in a patient population. Alternative Therapies in Health and Medicine, 1998; 4 (2):60-5. Elia V, Niccoli, M. New physico-chemical properties of extremely diluted aqueous solutions. Journal of Thermal Analysis and Calorimetry, 2004; 75:815-36. Guthlin C, Lange O, Walach H. Measuring the effects of acupuncture and homoeopathy in general practice: an uncontrolled prospective documentation approach. BMC Public Health, 2004; 4 (1):4. Frei H, Thurneysen A, von Ammon K. Methodological difficulties in homeopathic treatment of children with ADD/ADHD. Journal of Alternative and Complementary Medicine, 2006a; 12 (2):104; author reply Linde K, Jonas WB, Melchart D, et al. The methodological quality of randomized controlled trials of homeopathy, herbal medicines and acupuncture. International Journal of Epidemiology, 2001; 30 (3):526-31. Haidvogl M, Riley DS, Heger M, Brien S, Jong M, Fischer M, Lewith GT, Jansen G, Thurneysen AE. Homeopathic and conventional treatment for acute respiratory and ear complaints: a comparative study on outcome in the primary care setting. BMC Complementary and Alternative Medicine, 2007; 2;7:7. Kundu SN, Mitra K, Khuda Bukhsh AR. Efficacy of a potentized homeopathic drug (Arsenicum-Aalbum-30) in reducing cytotoxic effects produced by arsenic trioxide in mice: IV. Pathological changes, protein profiles, and content of DNA and RNA. Complementary Therapies in Medicine, 2000; 8 (3):157-65. Jonas WB. Do homeopathic nosodes protect against infection? An experimental test. Alternative Therapies in Health and Medicine, 1999b; 5 (5):36-40. Honda K, Jacobson JS. Use of complementary and alternative medicine among United States adults: the influences of personality, coping strategies, and social support. Preventive Medicine, 2005; 40 (1):46-53. Lamont J. Homeopathic treatment of attention deficit hyperactivity disorder. A controlled study. British Homoeopathic Journal, 1997; 86:196-200. Hyland ME, Lewith GT. Oscillatory effects in a homeopathic clinical trial: an explanation using complexity theory, and implications for clinical practice. Homeopathy, 2002; 91 (3):145-9. Jacobs J, Jimenez LM, Gloyd SS, et al. Treatment of acute childhood diarrhea with homeopathic medicine: a randomized clinical trial in Nicaragua. Pediatrics, 1994; 93 (5):719-25. Marotta D, Marini, A, Banaudha, K., Maharaj, S., Jonas, W. B. Nonlinear effects of glutamate and KCl on glutamate toxicity in cultured rat cerebellar neurons. International Journal of Neuroscience, 2003; 113:45-56. Jacobs J, Jimenez LM, Malthouse S, et al. Homeopathic treatment of acute childhood diarrhea: results from a clinical trial in Nepal. Journal of Alternative and Complementary Medicine, 2000; 6 (2):131-9. Vandenbroucke JP. Homeopathy trials: going nowhere. Lancet, 1997; 350:824. Rao ML, Roy R, Bell IR, Hoover R. The defining role of structure (including epitaxy) in the plausibility of homeopathy. Homeopathy, 2007; 96: 175182. Lussignoli S, Bertani S, Metelmann H, et al. Effect of Traumeel S, a homeopathic formulation, on blood-induced inflammation in rats. Complementary Therapies in Medicine, 1999; 7 (4):225-30. Jacobs J, Jonas WB, Jimenez-Perez M, et al. Homeopathy for childhood diarrhea: combined results and metaanalysis from three randomized, controlled clinical trials. Pediatric Infectious Disease Journal, 2003; 22 (3):229-34. Oberbaum M, Singer SR, Vithoulkas G. The colour of the homeopathic improvement: the multidimensional nature of the response to homeopathic therapy. Homeopathy, 2005; 94 (3):196-9. Jonas W, Lin Y, Tortella F. Neuroprotection from glutamate toxicity with ultra-low dose glutamate. Neuroreport, 2001; 12 (2):335-9. Neville-Smith R. Community hospital homeopathy clinic: audit of the first 12 months activity. British Homoeopathic Journal, 1999; 88 (1):20-3. Jonas WB. The future of hormesis: what is the clinical relevance to hormesis? Critical Reviews in Toxicology, 2001; 31 (4-5):655-8. Mallick P, Mallick JC, Guha B, et al. Ameliorating effect of microdoses of a potentized homeopathic drug, Arsenicum Album, on arsenic-induced toxicity in mice. BMC Complementary and Alternative Medicine, 2003; 3:7. Jonas WB, Kaptchuk TJ, Linde K. A critical overview of homeopathy. Annals of Internal Medicine, 2003; 138 (5):393-9. Jutte R, Riley D. A review of the use and role of low potencies in homeopathy. Complementary and Therapeutic Medicine, 2005; 13 (4):291-6. Marotta D, Marini A, Banaudha K, et al. Non-linear effects of cycloheximide in glutamate-treated cultured rat cerebellar neurons. Neurotoxicology, 2002; 23 (3):307-12. Langman MJS. Homeopathy trials: reason for good ones but are they warranted? Lancet, 1997; 350:825. Reilly D. The Evidence For Homeopathy, Article version 5. 5 January 2003 White A, Ernst E. The case for uncontrolled clinical trials: a starting point for the evidence base for CAM. Complementary and Therapeutic Medicine, 2001; 9: 1115 Lewith GT, Watkins AD, Hyland ME, et al. Use of ultramolecular potencies of allergen to treat asthmatic people allergic to house dust mite: double blind randomised controlled clinical trial. BMJ, 2002; 324 (7336):520-3. Rao ML, Roy R, Bell IR, et al. The defining role of structure (including epitaxy) in the plausibility of homeopathy. Homeopathy, 2007; 96 (3):175-82. Linde K, Clausius N, Ramirez G, et al. Are the clinical effects of homeopathy placebo effects? A meta-analysis of placebo-controlled trials. Lancet, 1997; 350:834-43. Mathie RT. The research evidence base for homeopathy: a fresh assessment of the literature. Homeopathy: the Journal of the Faculty of Homeopathy, 2003; 92:84-91. Reilly D, Taylor MA, Beattie NGM, Campbell JH, McSharry C, Aitchison TC, Carter R, Stevenson RD. Is evidence for homeopathy reproducible? Lancet, 1994; 344:1601-6. Mathie RT, Hansen L, Elliott MF, et al. Outcomes from homeopathic prescribing in veterinary practice: a prospective, research-targeted, pilot study. Homeopathy, 2007; 96 (1):27-34. Oberbaum M, Yaniv I, Ben-Gal Y, et al. A randomized, controlled clinical trial of the homeopathic medication TRAUMEEL S in the treatment of chemotherapy-induced stomatitis in children undergoing stem cell transplantation. Cancer, 2001; 92 (3):684-90. Milgrom LR. Are randomized controlled trials (RCTs) redundant for testing the efficacy of homeopathy? A critique of RCT methodology based on entanglement theory. Journal of Alternative and Complementary Medicine, 2005; 11 (5):831-8. Oberbaum M, Vithoulkas G, Van Haselen R. Clinical trials of classical homeopathy: reflections on appropriate research designs. Journal of Alternative and Complementary Medicine, 2003; 9 (1):105-11. Montagnier L, et al. Electromagnetic signals are produced by aqueous nanostructures derived from bacterial DNA sequences. Interdisciplinary Sciences: Computational Life Sciences, 2009; 1: 81-90. Relton C, Weatherley-Jones E. Homeopathy service in a National Health Service community menopause clinic: audit of clinical outcomes. Journal of the British Menopause Society, 2005; 11 (2):72-3. Sevar R. Audit of outcome in 455 consecutive patients treated with homeopathic medicines. Homeopathy, 2005; 94 (4):215-21. Rey L. Thermoluminescence of ultra-high dilutions of lithium chloride and sodium chloride. Physica A: Statistical Mechanics and its Applications, 2003; 323:67-74. Tiller WA. On chemical medicine, thermodynamics, and homeopathy. Journal of Alternative and Complementary Medicine, 2006; 12 (7):685-93. Riley D, Fischer M, Singh B, et al. Homeopathy and conventional medicine: an outcomes study comparing effectiveness in a primary care setting. Journal of Alternative and Complementary Medicine, 2001; 7 (2):149-59. Shang A, Huwiler-Muntener K, Nartey L, Juni P, Dorig S, Sterne JA, Pewsner D, Egger M. Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy. Lancet, 2005; 366 (9487):726-32. Robinson N, Donaldson J, Watt H. Auditing outcomes and costs of integrated complementary medicine provision--the importance of length of follow up. Complementary and Therapeutic Clinical Practice, 2006; 12 (4):249-57. Thompson EA, Oxon BA, Montgomery A, Douglas D, Reilly D. A Pilot, Randomized, double-blinded, placebo-controlled trial of individualized homeopathy for symptoms of estrogen withdrawal in breast-cancer survivors. Journal of Alternative and Complementary Medicine, 2005; 11 (1):13-20. Roy R, Tiller W, Bell IR, et al. The structure of liquid water: Novel insights from materials research and potential relevance to homeopathy. Materials Research Innovation, 2005; 9 (4):557-608. Sevar R. Audit of outcome in 829 consecutive patients treated with homeopathic medicines. British Homoeopathic Journal, 2000; 89 (4):178-87. Ruiz G, Torres JL, Michel O, et al. Homeopathic effect on heart rate variability. British Homoeopathic Journal, 1999; 88 (3):106-11. Sharples F, van Haselen R, Fisher P. NHS patients perspective on complementary medicine. Complementary Therapies in Medicine, 2003; 11: 2438. Ruiz G, Torres, JL. Homeopathic effect on the sleep pattern of rats. British Homoeopathic Journal, 1997; 86:201-6. Torres JL, Ruiz MAG. Stochastic resonance and the homeopathic effect. British Homoeopathic Journal, 1996; 85:134-40. Sukul A, Sarkar P, Sinhababu SP, et al. Altered solution structure of alcoholic medium of potentized Nux vomica underlies its antialcoholic effect. British Homoeopathic Journal, 2000; 89 (2):73-7. Ruiz-Vega G, Perez-Ordaz L, Leon-Hueramo O, Cruz-Vazquez E, Sanchez-Diaz N. Comparative effect of Coffea cruda potencies on rats. Homeopathy, 2002; 91:80-4. Sukul NC, Ghosh S, Sinhababu SP, et al. Strychnos nux-vomica extract and its ultra-high dilution reduce voluntary ethanol intake in rats. Journal of Alternative and Complementary Medicine, 2001; 7 (2):187-93. Ruiz-Vega G, Poitevin B, Perez-Ordaz L. Histamine at high dilution reduces spectral density in delta band in sleeping rats. Homeopathy, 2005; 94 (2):86-91. Spence D, Thompson E and Barron S. Homeopathic treatment for chronic disease: A 6-Year, university-hospital outpatient observational study. Journal of Alternative and Complementary Medicine, 2005; 5: 793-8. Thompson EA, Reillly D. The homeopathic approach to symptom control in the cancer patient: a prospective observational study. Palliative Medicine, 2002; 16 (3):227-33. Sukul NC, Bala SK, Bhattacharyya B. Prolonged cataleptogenic effects of potentized homoeopathic drugs. Psychopharmacology, 1986; 89:338-9. Torres JL. Homeopathic effect: a network perspective. Homeopathy: the Journal of the Faculty of Homeopathy, 2002a; 91 (2):89-94. Sukul NC, De A, Sukul A, et al. Potentized Mercuric chloride and Mercuric iodide enhance alpha-amylase activity in vitro. Homeopathy: the Journal of the Faculty of Homeopathy, 2002; 91 (4):217-20. Sukul NC, Ghosh S, Sinhababu SP. Reduction in the number of infective Trichinella spiralis larvae in mice by use of homeopathic drugs. Forschende Komplementarmedizin und Klassische Naturheilkunde, 2005; 12 (4):202-5. Szeto AL, Rollwagen F, Jonas WB. Rapid induction of protective tolerance to potential terrorist agents: a systematic review of low- and ultra-low dose research. [Review] [19 refs]. Homeopathy: the Journal of the Faculty of Homeopathy, 2004; 93 (4):173-8. Thompson E, Barron S, Spence D. A preliminary audit investigating remedy reactions including adverse events in routine homeopathic practice. Homeopathy: Journal of the Faculty of Homeopathy, 2004; 93 (4):203-9. Sukul A, Sinhabau SP, Sukul NC. Reduction of alcohol induced sleep time in albino mice by potentized Nux vomica prepared with 90% ethanol. British Homoeopathic Journal, 1999; 88 (2):58-61. Van Wijk R, Bosman S, van Wijk EP. Thermoluminescence in ultra-high dilution research. Journal of Alternative and Complementary Medicine, 2006; 12 (5):437-43. Torres JL. On the physical basis of succussion. Homeopathy, 2002b; 91 (4):221-4. Van Wassenhoven M, Ives G. An observational study of patients receiving homeopathic treatment. Homeopathy, 2004; 93 (1):3-11. Van Wassenhoven M. Priorities and methods for developing the evidence profile of homeopathy. Homeopathy, 2005; 94: 107124. Bell IR, Caspi O, Schwartz GE, et al. Integrative medicine and systemic outcomes research: issues in the emergence of a new model for primary health care. Archives of Internal Medicine, 2002b; 162 (2):133-40. Weatherley-Jones E, Nicholl JP, Thomas KJ, et al. A randomised, controlled triple-blind trial of the efficacy of homeopathic treatment for chronic fatigue syndrome. Journal of Psychosomatic Research, 2004a; 56:189-97. Bell IR. Evidence-based homeopathy: empirical questions and methodological considerations for homeopathic clinical research. American Journal of Homeopathic Medicine, 2003; 96 (1):17-31. Bell IR, Lewis DA, II, Brooks AJ, et al. Individual differences in response to randomly assigned active individualized homeopathic and placebo treatment in fibromyalgia: implications of a double-blinded optional crossover design. Journal of Alternative and Complementary Medicine, 2004b; 10 (2):269-83. Witt C, Keil T, Selim D, Roll S, Vance W, Wegscheider K, Willich SN. Outcome and costs of homoeopathic and conventional treatment strategies: a comparative cohort study in patients with chronic disorders. Complementary and Therapeutic Medicine, 2005a; 13 (2):79-86. Bell IR. All evidence is equal, but some evidence is more equal than others: can logic prevail over emotion in the homeopathy debate? Journal of Alternative and Complementary Medicine, 2005; 11 (5):763-9. Aickin M. Separation tests for early-phase CAM comparative trials. Evidence-Based Integrative Medicine, 2004; 1 (4):225-31. 2. Depression Nolen-Hoeksema S. Gender differences in depression. Current Directions in Psychological Science, October, 2001; 10 (5): 173176. Wright SL, Persad C. Distinguishing between depression and dementia in older persons: Neuropsychological and neuropathological correlates. Journal of Geriatric Psychiatry and Neurology. 2007; 20(4):18998. Orengo C, Fullerton G, Tan R. Male depression: A review of gender concerns and testosterone therapy. Geriatrics, 2004; 59(10):2430. McPherson A, Martin CR. A narrative review of the Beck Depression Inventory (BDI) and implications for its use in an alcohol-dependent population. Journal of Psychiatric and Mental Health Nursing, February, 2010; 17 (1): 1930. Zimmerman M, Chelminski I, Posternak M. A review of studies of the Hamilton depression rating scale in healthy controls: implications for the definition of remission in treatment studies of depression. Journal of Nervous and Mental Disease, September, 2004; 192 (9): 595601. Katz IR. Diagnosis and treatment of depression in patients with Alzheimer's disease and other dementias. The Journal of Clinical Psychiatry. 1998;59 Suppl 9:3844. Dale J, Sorour E, Milner G. Do psychiatrists perform appropriate physical investigations for their patients? A review of current practices in a general psychiatric inpatient and outpatient setting. Journal of Mental Health, 2008;17(3):29398. Salmans S. 1997. Depression: Questions You Have - Answers You Need. People's Medical Society. ISBN 978-1-882606-14-6. Vieweg WV, Julius DA, Fernandez A, Beatty-Brooks M, Hettema JM, Pandurangi AK (May 2006). Posttraumatic stress disorder: clinical features, pathophysiology, and treatment. American Journal of Medicine, 119 (5): 38390. Cadieux RJ. Practical management of treatment-resistant depression. American Family Physician, 1998; 58: 2059-2062. Association AP. Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association. American Journal of Psychiatry, 2000; 157: 1-45. Andersson G. Internet-based cognitive-behavioral self help for depression. Expert Reviews on Neurotherapy, 2006; 6: 1637-1642. de Mello MF, de Jesus Mari J, Bacaltchuk J, Verdeli H, Neugebauer R. A systematic review of research findings on the efficacy of interpersonal therapy for depressive disorders. European Archives of Psychiatry and Clinical Neuroscience, 2005; 255: 75-82. Markowitz JC. Developments in interpersonal psychotherapy. Canadian Journal of Psychiatry, 1999; 44: 556-561. Pampallona S, Bollini P, Tibaldi G, Kupelnick B, Munizza C. Combined pharmacotherapy and psychological treatment for depression: a systematic review. Archives of General Psychiatry, 2004; 61: 714-719. McCullough ME, Larson DB. Religion and depression: a review of the literature. Twin Research, 1999; 2: 126-136. Lurie SJ, Gawinski B, Pierce D, Rousseau SJ. Seasonal affective disorder. American Family Physician, 2006; 74: 1521-1524. Reis S, Grenyer BF. Pathways to anaclitic and introjective depression. Psychology and Psychotherapy, 2002; 75: 445-459. Linden DE. How psychotherapy changes the brain--the contribution of functional neuroimaging. Molecular Psychiatry, 2006; 11: 528-538. Ernst E. The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava. Annals of Internal Medicine, 2002; 136: 42-53. 3. Antidepressants Linde K, Mulrow CD, Berner M, Egger M. Linde, Klaus. ed. St John's wort for depression. Cochrane Database Systematic Review, 2005; (2): CD000448. MacGillivray S, Hatcher S, Ogston S, Reid I, Sullivan F, Williams B, Crombie I. Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis. BMJ, 2003; 326 (7397): 1014. Rocha Araujo DM, Vilarim MM, Nardi AE. What is the effectiveness of the use of polyunsaturated fatty acid omega-3 in the treatment of depression?. Expert Review of Neurotherapeutics, 2010; 10 (7): 11171129. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT (2008). Initial severity and antidepressant benefits: a meta-analysis of data submitted to the food and drug administration. PLoS Medicine, 2008; 5 (2): e45. Nutt DJ, Malizia AL. Why does the world have such a 'down' on antidepressants?. Journal of Psychopharmacology (Oxford), May 2008; 22 (3): 2236. Mischoulon D, Nierenberg AA, Kizilbash L, Rosenbaum JF, Fava M. Strategies for managing depression refractory to selective serotonin reuptake inhibitor treatment: a survey of clinicians. Canaidan Journal of Psychiatry, June 2000; 45 (5): 47681. Fava GA, Park SK, Sonino N (November 2006). Treatment of recurrent depression. Expert Review in Neurotherapy, November, 2006; 6 (11): 173540. Akhondzadeh S, Fallah-Pour H, Afkham K, Jamshidi AH, Khalighi-Cigaroudi, F. Comparison of Crocus sativus L. And imipramine in the treatment of mild to moderate depression: A pilot double-blind randomized trial ISRCTN45683816. BMC Complementary and Alternative Medicine, 2004;4: 12. Benowitz NL. Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annual Review of Pharmacology and Toxicology, 2009; 49: 5771. Rush AJ, Trivedi MH, Wisniewski SR. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. New England Journal of Medicine, 2006; 354 (12): 123142. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatmentCorrection. JAMA, July 12, 2006; 296 (2): 170. Kirsch I, Moore TJ, Scoboria A, Nicholls SS. The emperor's new drugs: An analysis of antidepressant medication data submitted to the U. S. Food and Drug Administration. Prevention and Treatment (American Psychological Association), July, 2002; 5 (1). Schneeweiss S, Patrick AR, Solomon DH, Dormuth CR, Miller M, Mehta J, Lee JC, Wang PS. Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts. Pediatrics, 2010; 125 (5): 87688. Ozmenler NK, Karlidere T, Bozkurt A. Mirtazapine augmentation in depressed patients with sexual dysfunction due to selective serotonin reuptake inhibitors. Human Psychopharmacology, June, 2008; 23 (4): 3216. Bridge JA, Iyengar S, Salary CB . Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA, 2007;297 (15): 168396. Uz T, Ahmed R, Akhisaroglu M, Kurtuncu M, Imbesi M, Dirim Arslan A, Manev H. Effect of fluoxetine and cocaine on the expression of clock genes in the mouse hippocampus and striatum. Neuroscience (Elsevier), 2005; 134 (4): 130916. Malberg JE, Eisch AJ, Nestler EJ, Duman RS. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. Journal of Neuroscience (Society for Neuroscience), December 15, 2000; 20 (24): 910410. Vertes RP, Eastman KE. The case against memory consolidation in REM sleep. Behavioral and Brain Sciences, 2000; 23 (6): 867876. Herreraruiz M, Garciabeltran Y, Mora S, Diazveliz G, Viana G, Tortoriello J, Ramirez G. Antidepressant and anxiolytic effects of hydroalcoholic extract from Salvia elegans&. Journal of Ethnopharmacology, 2006; 107 (1): 53 8. Nemets H., Nemets, B, Apter A, Bracha Z, Belmaker RH. Omega-3 treatment of childhood depression: A controlled, double-blind pilot study. American Journal of Psychiatry, 2006; 163 (6): 10981100. 4. Quantum Mcevoy J , Zarate O. 2007. Introducing Quantum Theory. London:Icon Books Limited. ISBN 978-1-84046-850-2 Goswami A. 2004. Quantum Doctor-The Quantum Physicist Explains the Healing Power of Integral Medicine. 2nd edition. Charlottesville, VA:Hampton Roads Publishing Company, Inc. ISBN 978-1-57174-655-9 Chopra D. 1989. Quantum healing-Exploring the Frontiers of Mind/Body Medicine-3rd edition. New York: Bantam Books ISBN 0-553-34869-8 Yanick P. 2003. Quantum Medicine. North Bergen:Basic Health Publications, Inc. ISBN 1-59120-031-8 Ford K, Goldstein D. 2004. The Quantum World: Quantum Physics for Everyone. ISBN 0- 674-01342-5 Fraser P, Massey H, Wilcox J. 2008. Decoding the Human Body Field: The New Science of Information as Medicine. Rochester: Healing Arts Press ISBN 978-1-59477-225-2 5. Observational study Becker RO. 2004 Exploring new horizons in electromedicine. Journal of Alternative and Complementary Medicine, 2004; 10(1):17-18. Bell IR, Lewis II DA, Brooks AJ, et al. Improved clinical results in fibromyalgia patients treated with individualized homeopathic remedies versus placebo, Rheumatology, 2004:1111 5. Driehsen W. et al. 2003. German Homeopathic Pharmacopoeia, 5th edition, Gauteng, South Africa, Medpharm, November 3, 2003. Jo SH, Lee SY. Response of HERG currents to the antipsychotics tiapride and sulpiride, Korean Journal of Physiology and Pharmacology, 2010 Oct; 14 (5): 305-10. Komossa K, Depping AM, Gaudchau A, Kissling W, Leucht S. Second-generation antipsychotics for major depressive disorder and dysthymia., Cochrane Database Systematic Review, December 8, 2010; 12:CD008121. Review. Kuhn TS. The structure of Scientific Revolutions, Second Edition, Enlarged, University of Chicago Press, Chicago, IL, U.S.A. Linde L, Clausius N, Ramirez G, et al., Are the clinical effects of homeopathy placebo effects? A meta-analysis of placebo controlled trials, Lancet, September 20, 1997; 350:834-843. Ludtke R., Rutten ALB. The conclusions on the effectiveness of homeopathy highly depend on the set of analyzed trials. Journal of Clinical Epidemiology, October 2008; doi:10 1016/j. jclinepi. 2008. 06/015. Mart Mass JF, Ruiz-Martnez J, Bergareche A, Lpez de Munain A, Parkinsonism induced by sulpiride and veralipride: two different stories, Med Clin (Barc). 2011 Feb 3. Rocha LM. (1999). Systems Modeling: Using Metaphors From Nature in Simulation and Scientific Models. BITS: Computer and Communications News. Computing, Information, and Communications Division. Los Alamos National Laboratory. November 1999. Taylor MA, Reilly D, Llewellyn-Jones RH, et al., Randomised controlled trial of homeopathy versus placebo in perennial allergic rhinitis with overview of four trial Series, BMJ, August 19, 2000; 321:471-476. Vickers AJ. Homeopathic Oscillococcinum for preventing and treating influenza and influenza like syndromes. Cochrane Reviews. 2009. Weingarther O., The nature of the active ingredient in ultra molecular dilutions, Homeopathy 2007; 96: 220-226. Witt CM, Bluth M, Albrecht H, Weisshunh TE, Baumgartner S, Willich SN. The in vitro evidence for an effect of high homeopathic potencies a systematic review of the literature. Complementary and Therapeutic Medicine 2007 Jun; 15(2):128-38. Use of the SULPYCO trademark and hybrid drug are licensed by the author. You can contact her through email at HYPERLINK "mailto:info@dr-roje.com"info@dr-roje.com and at the website  HYPERLINK "http://www.dr-roje.com" www.dr-roje.com( ) * L    1 2 3 = Ѳqe]Ke>hPho0JmH sH #jhPhv/'UmH sH hPmH sH jhPUmH sH hoho5CJaJmH sH homH sH h PhmOJQJhm hKh PhKh PmH sH h PmH sH hmhm0JmH sH #jhmhUNIUmH sH jhmUmH sH hmhmmH sH hmhm5CJ aJ mH sH hmmH sH FGHRopq~  ) * L `gd P $`a$gdm$a$gdm   ? j 6 r  W  gdmgd |`gd | $`a$gdm $`a$gd | $`a$gdo= > ? @ Z [ \ h i j k    4 5 6 7 P Q R p q r s yg#johPhv/'UmH sH #jhPhv/'UmH sH #jhPhv/'UmH sH #jhPhv/'UmH sH #jhPhv/'UmH sH hPho0JmH sH #j*hPhv/'UmH sH hPmH sH hohomH sH jhPUmH sH (   ( ) * U V W X r s t ӯӝӋyqqhomH sH #jhPhv/'UmH sH #j7hPhv/'UmH sH #jhPhv/'UmH sH #jShPhv/'UmH sH #jhPhv/'UmH sH hPmH sH hohomH sH hPho0JmH sH jhPUmH sH )     gUH;hmhoaJmH sH ho5CJaJmH sH #hcho0J5CJaJmH sH .jhchv/'5CJUaJmH sH hmh |aJmH sH homH sH h |mH sH hmhmmH sH hmhm5CJaJmH sH #hchm0J5CJaJmH sH .jhchv/'5CJUaJmH sH hc5CJaJmH sH "jhc5CJUaJmH sH Y6 `a,s ""##& &7'Y'((gdzgdm  )*+^_`uv""##9':'(()*r*s*2,3,m.n.s/t/u//333ƮӜӌyyyyyyyyyymeyhY:mH sH hzhz5mH sH hzmH sH hzhzmH sH hzhz5CJaJmH sH #hchz0J5CJaJmH sH .jhchv/'5CJUaJmH sH hc5CJaJmH sH "jhc5CJUaJmH sH hmh |mH sH hSmH sH hmmH sH #()*p**0,W, -1-j..t/u//"333A46P77777788,8G8\8gdz333333?4@4A477777777778 888-8.8H8I8]8^8f8g8r8s888C;D;E;Z;<<<<<簥s"jhc5CJUaJmH sH h |mH sH hmmH sH hzmH sH h>mH sH hzhzmH sH h>hz5mH sH hchz0J5mH sH &jlhchv/'5UmH sH hc5mH sH jhc5UmH sH hzh>mH sH +\8e8q888B:D;E;Z;<<<(=)=(>CAlBDQFGIKLJNOPPPRgd>gdmwgdz<===&='=(=)=r?w?y?z?dBhBiB'EEPPPPUUUVȶȩll`XL>h3:B*^JmH phsH h>h>5mH sH h>mH sH h>h>6mH sH $hNh3:B*H*^JmH phsH !hNh3:B*^JmH phsH h>h>mH sH h>h>5aJmH sH h>5CJaJmH sH #hch>0J5CJaJmH sH "jhc5CJUaJmH sH .jhchv/'5CJUaJmH sH hc5CJaJmH sH RTUoXpXX}YZ\9]m^_ ``b cc+c:cccf#fffgghhkgd>VVnXoXpXX^^^^^ _ _______c+c-c.c9c:cggghkkmm n nUpVpxqyquu}w~wyyzz{{{{ìðİ⽟h3:B*mH phsH h3:B*^JmH phsH h3:B*H*^JmH phsH !hNh3:B*^JmH phsH h>h>5mH sH h>mH sH h>h>mH sH $hNh3:B*H*^JmH phsH 8kk4lmmnAnSpcpvqqu vv{wwwyyz{{{{vGˆgGgd>GݒՔok =͞iìİŰǰ $`a$gdygd>İŰưǰ&()*+DEFfghhiXYǿ}k[PHPHPHPHPHhmH sH hhmH sH hh5CJaJmH sH #hch0J5CJaJmH sH .jV[hchv/'5CJUaJmH sH hc5CJaJmH sH "jhc5CJUaJmH sH hhcmH sH hmH sH hgMmH sH ja:hyhyUmH sH hyhymH sH jNhyhyUmH sH hymH sH ')*hicfVɷ޾gd- $`a$gdlgdgd $`a$gdyY˷̷456'()*ƮӜӌum[uNuBjhpJUmH sH h-h-0JmH sH #j8\h-hqUmH sH h-mH sH jh-UmH sH h-h-mH sH h-h-5CJaJmH sH #hch-0J5CJaJmH sH .j[hchv/'5CJUaJmH sH hc5CJaJmH sH "jhc5CJUaJmH sH hgMmH sH hmH sH hhmH sH )cdeovwx%1 !BRgd-*OPQabenx0!BTU0qr]^<=BQ{|s{|}¶¶¶¶¶®®®®®¢––ŽŽŽŽŽ–ŽŽŽ–Žh'mH sH h'h-5mH sH h-h->*mH sH h-mH sH h-h-5mH sH h-h-mH sH hpJh-0JmH sH jhpJUmH sH #j\hpJh.[UmH sH hpJmH sH 80o[:~ABQyrs{H8gdgd-IJ789opqr\]^_y·ݫݑ~rf[L[jh$?h5>UmH sH h$?h5>mH sH hAhyw\5mH sH hAhA5mH sH h\RmH sH hAh.mH sH hAhAmH sH jh\Rh\RUmH sH h\Rh.5mH sH h.h.mH sH j]h.h.UmH sH h.h.5mH sH h.mH sH hmH sH h-h-mH sH h'mH sH 89oqr\^_yhWSY7gdA $`a$gd\Rgd. $`a$gd.gd$%VWX`abcӯާӉށoӉ#jh$?h5>UmH sH hU/mH sH h$?h5>H*mH sH #jhyw\hG UmH sH hyw\mH sH #jh$?h5>UmH sH #j%h$?h5>UmH sH h$?h5>mH sH jh$?h5>UmH sH #j:h$?h5>UmH sH 'mnIJ  :;<=ȴȬjXHhPh\R5CJaJmH sH #hchA0J5CJaJmH sH .jphchv/'5CJUaJmH sH hc5CJaJmH sH "jhc5CJUaJmH sH hAhlmH sH hPmH sH hAhA5mH sH hAmH sH hAhAmH sH h$?h5>mH sH jh$?h5>UmH sH #jh$?h5>UmH sH 7kGu    g h   <=NO $dha$gdrd $`a$gdlgdA=@LNP   i|Ϸگvn_nSh"Vh"V5mH sH j-h"Vh"VUmH sH h"VmH sH hDwhDw5mH sH hDwhDwmH sH hDwmH sH jh}.h}.UmH sH h$?hrdmH sH hAmH sH h$?h25mH sH h$?h26mH sH h$?h2mH sH hAhAmH sH h:hA5>*mH sH h"VhA5mH sH 9gd: $`a$gd:gd"V $`a$gd"VgdA$dh`a$gdCO~ļ|qeqYNh:hw kmH sH h:h:>*mH sH h$?hI lH*mH sH h$?hI lmH sH hI lhI lmH sH j_h:hw kUmH sH h:h:5mH sH h:h:mH sH j@h:h:UmH sH h:mH sH h"V5mH sH h"Vh"V5>*mH sH h"Vh"VmH sH h"Vh"V5mH sH h:h"V5>*mH sH !!!!!!!##)#*#gd& $`a$gdoMgdw k $`a$gdI lgd:46!!!!!ݽ݉zn`UM>jh}.h}.UmH sH h&mH sH h&h&mH sH h&hw k5>*mH sH hCO~hw k5mH sH jh}.h}.UmH sH hoMhw k5>*mH sH hw khw k5mH sH hI lhI lmH sH jhI lhI lUmH sH hw kmH sH hI lhw k5mH sH hw khw k>*mH sH hw khw kmH sH h:mH sH j{hI lhI lUmH sH !!#(#*#+#-#)$J$L$M$O$]%^%_%s%t%u%v%w%x%&&&&&&Զ{shZsKshj?h&R)h&R)UmH sH hoMhB5>*mH sH hBhBmH sH hBmH sH jr3h&R)h&R)UmH sH h!O:h!O:mH sH h!O:5>*mH sH h!O:h!O:5>*mH sH h!O:mH sH j h}.h}.UmH sH jhh}.h}.UmH sH h&5>*mH sH h&h&5>*mH sH h&h&mH sH h&mH sH *#,#-#)$*$K$L$N$O$^%_%t%u%w%x%&&&&&&R(S(g(h(j(k()gdBgd& $`a$gdoM&''''''O(Q(R(S(g(h(i(k() ****** + +",%,s,t,v,w,x,y,|,ʿʤҳʕҁrgYhNK"hoM5>*mH sH hoMhoMmH sH j)fhoMhoMUmH sH hoMmH sH hNK"hoM5mH sH j[h&R)h&R)UmH sH jKh&R)h&R)UmH sH hoMhB5mH sH hBhoMmH sH hBmH sH hBhBmH sH hNK"hoMH*mH sH hNK"hoMH*mH sH hNK"hoMmH sH  )) ****u,v,x,y,,,,,---......u/_0`0 $`a$gd* $`a$gdoMgdB|,},~,,,,,,,,,-------------#.οδ{ocoZKδjth*h*UmH sH hoM5mH sH hNK"hoM6mH sH hNK"hoM5mH sH  hXhXOJQJ^JmH sH hXhXmH sH #hXhX5OJQJ^JmH sH hNK"hoMmH sH hBhBmH sH j<h*h*UmH sH hBmH sH hNK"hoM5>*mH sH hX5>*mH sH  hX5>*OJQJ^JmH sH #.$.).+......`0x0y0z0|0M111111111#2&2'2)2*2+2=2>2222222v3Ҥ҇xjhXOJQJ^JmH sH jh*h*UmH sH j h*h*UmH sH h\hB5>*mH sH !jh*h*UaJmH sH hAhB5>*mH sH jWh*h*UmH sH hBmH sH hoMhB5>*mH sH hBhBmH sH hBhB5mH sH %`0x0y0{0|0L1M11111(2)2+2u3v3333'4(4*4+4 $`a$gdB4 $`a$gd* $`a$gd\ $`a$gdAgdBgdAv333333333"4%4&4'4(4)4+4Y4Z4_4a4'5<5=5>5@5555555<7?7777꼭yj\hNK"hB45>*mH sH j1 hghgUmH sH jihghgUmH sH hB4h 55>*mH sH h 5h 55mH sH h 5h 5mH sH jlhghgUmH sH h 5mH sH hBhB5mH sH hBhBmH sH jhghgUmH sH hBmH sH hB4hB5>*mH sH #+4&5'5<5=5?5@5555777::::::::8;;=0>1>3>gd] $`a$gdB4$a$gdB4gd 577777778z8}888888899 9#999<9:: :Y:\:::::::::::::::::}nj%dhTMhTMUmH sH jLhTMhTMUmH sH h]mH sH h 5mH sH hNK"hB4H*mH sH hNK"hB45mH sH hNK"hB46mH sH hNK"hB4mH sH h 5h 5mH sH hNK"hB45>*mH sH hNK"hB4>*mH sH hdhB456>*mH sH *:::::A;D;R;U;g;j;;;;;====*>.>/>1>2>4>>>&?'?(?)?C?D?E?F?G?h?i?j?k?l?m?n???????????@ @ݴݥݥݥݥݥݥ hNK"h]B*H*mH phsH hNK"h]B*mH phsH hB4h]5>*mH sH jθh]hB4UmH sH h]h]5mH sH h]h]mH sH h]mH sH jhTMhTMUmH sH 63>4>>>>@ANBOB[BBBCCCCCCCEEGEHEJEKEEE $`a$gdUr $`a$gdB4gd] @ @ @n@o@p@q@@@@@AAAAAdAeAfAgAhA&B'B(B)BOB[BBCCCCCCCCCCCCCCDD1DʾʾʾʾʾʾʾհհՍՁըrՁՁjhB4hB4UmH sH h]h]5mH sH h]h]6mH sH jh6}h6}UmH sH h]mH sH hB4h]5>*mH sH hNK"h]H*mH sH hNK"h]mH sH h]h]mH sH hNK"h]B*mH phsH  hNK"h]B*H*mH phsH ,1D2D3D5D6DEGEHEIEKExEyEEEEEEEEEEHFKFOFRFFFFFFFFEGHGLGOGPGRGȹޭޭޭȞȖqbjҭh6}h6}UmH sH hUrh"M5>*mH sH h"Mh"M5mH sH h"Mh"MmH sH h"MmH sH j"rhUrhUrUmH sH h]h]5mH sH jGh6}h6}UmH sH h]mH sH hB4h]5>*mH sH h]h]mH sH hNK"h]H*mH sH hNK"h]mH sH %EEEFFFFFFQGRGTGUGGGGpHqHH IJJJJ"L $`a$gd2 $`a$gdO7 gd"Mgd] $`a$gdUrRGSGUGGGGGGGGGqH{HHHHHHHH1J3J8J9JFJOJQJSJbJrJtJvJJJJJJJJJJNLPLULaLcLݴݏݏݏtݏݏjhFh6}h6}UmH sH hNK"h"MH*mH sH hNK"h"MmH sH h25>*mH sH hNK"h256>*mH sH hNK"h25>*mH sH j h6}h6}UmH sH h"Mh"M5mH sH h"Mh"MmH sH h"MmH sH j&h6}h6}UmH sH -cLeLMMMMsMvM}MMMMMNN N N N!NcNdNNNNNNNNNNOԨԝzkd`Rh"Mh"M5>*mH sH h"M h"Mh"Mj]h~Zh~ZUmH sH hKh"MmH sH hNK"hK5mH sH hNK"hKH*mH sH hNK"hKmH sH jnh6}h6}UmH sH hCh"M5>*mH sH jh2h2UmH sH h"MmH sH h"Mh"M5mH sH h"Mh"MmH sH hNK"h"MH*mH sH "L~MMMMMMNN N NNNNNNNYPZPvPwPyP&Q'Q@Q $`a$gd~Z $`a$gdC $`a$gd2gd"MOOOOOO OOOOXPZPvPwPxPyPPPPPPPPPPPPPPPPP'Q@QAQBQ׸׌{׌jjjjjת[jh6}h6}UmH sH  hNK"h"MB*H*mH phsH  hNK"h"M6B*mH phsH hNK"h"MB*mH phsH j h6}h6}UmH sH h~Zh"M5>*mH sH h"MmH sH hNK"h"MH*mH sH hNK"h"MmH sH h"Mh"MmH sH h"Mh"M5>*mH sH h"Mh"M5>*H*mH sH #@QAQCQRRRRRR6S7SESFSGSSSS,TUU$WXZZ[]\gdd $`a$gdd $`a$gd~Zgd"MBQCQYQZQ\Q]Q^Q_Q`QaQxQyQ2R4RRRRRRRRRR5S7SESGSUUUUUUUVV;Vwiw]w]w]wh!hd5mH sH h!hd5>*mH sH h!hdmH sH hdhd5>*mH sH jhrohroUmH sH  jhuhu5UmH sH hL$hu5mH sH hdhdmH sH  hNK"hdB*H*mH phsH  hNK"hdB*H*mH phsH hNK"hdB*mH phsH hdmH sH $;V*mH sH hT&hd6mH sH hXOJQJ^JmH sH h!hd5>*mH sH hdhdmH sH j4#h0h0UmH sH h!hdmH sH h!hd5mH sH 7YYYYYYYYYYYYYYYYYYYYYYYZ ZZZZZZZZ[[\p^s^t^讒xphhlmH sH hdmH sH hdhd5>*mH sH h!hd>*mH sH h!hd5>*mH sH hNK"hd5>*mH sH hdhdmH sH hNK"hdH*mH sH h!hdmH sH hT&hd6mH sH hNK"hd5mH sH hNK"hdmH sH hNK"hdH*mH sH %]\q\\\\q^s^t^^^^`?`f````a1aSawaa4deRfTfUffffgddt^u^^^^^^^^``A`B`h`i```````aa3a4aUaVaQfTfUfVfofpfqffffj.j'hchv/'5CJUaJmH sH hlmH sH hdmH sH hdhdmH sH h~Zh~ZaJmH sH hd5CJaJmH sH #hchd0J5CJaJmH sH .j&hchv/'5CJUaJmH sH hc5CJaJmH sH "jhc5CJUaJmH sH $ffAlBlmmmm?m@mpppp$p%p&p(pppppppppppppp`qaqqqwwxx"x#xPxQxuxvxƻάơơƒ|qއއއއއއއhd'hismH sH hd'h mH sH hd'hd'mH sH jimh hisUmH sH h h mH sH ju'h h UmH sH h[ h[ mH sH h mH sH h[ mH sH hdmH sH hd'mH sH hdhdmH sH hdhdCJaJmH sH ,f3hjkkl@lYlllmm=mn*oppp%p'p(pppppp $`a$gd $`a$gdis`gd gddppppp^qq-r.rrtMu:vZv7wwwwx xNxsxxx y.ySygdd' $`a$gd $`a$gdisvxxxxx y y0y1yUyWyzy{yyyyyyyzz0z1zSzTzwzxzzzzzzz|||||||||||5ƮӜӏhd'hd'5CJaJmH sH hd'5CJaJmH sH #hchd'0J5CJaJmH sH .jhchv/'5CJUaJmH sH hc5CJaJmH sH "jhc5CJUaJmH sH hlmH sH hd'mH sH hd'hd'mH sH 0Sywyyyyz-zPztzzzz!{"{I{f{{{{E||||||~Dgdd'567BCDEFSTUjkl;<=vwx()*ַ̇tlatlatlatlatlatlatlatlatlathd'hHmH sH hd'mH sH hd'hd'mH sH hHhH5mH sH hd'5mH sH hHhd'5mH sH hd'hHaJmH sH hd'aJmH sH hd'5CJaJmH sH #hchd'0J5CJaJmH sH "jhc5CJUaJmH sH .jvhchv/'5CJUaJmH sH &DEFTUkl<=wx)*͇·~։gdd'͇̇·}~Չ։׉BCDlmnefgӏԏՏ\]^345123ÒĒŒQRSqrsfghΘϘИƙǙșTUhd'hkmH sH hd'hd'mH sH hd'hHmH sH hd'mH sH U։׉CDmnfgԏՏ]^4523ĒŒRSgdd'SrsghϘИǙșUVHIמ()gdd'UVGHI'()-./  mno89:"#$|}~CDE89:bcdǰȰɰYZ[ɲʲ˲mnoQRShd'mH sH hd'hd'mH sH hd'hkmH sH Y)./ no9:#$}~DEgdd'E9:cdȰɰZ[ʲ˲noRSgdd'*+,?@AûĻŻ()*rst345ֿ׿ؿ{|}123-./ghihkmH sH hd'hd'mH sH hd'hkmH sH hd'mH sH V+,@AĻŻ)*st45׿gdd'׿ؿ|}23./higdd'012GHI123ghi}~   QRS+,-+,-]^_./0}~XYZDhkmH sH hd'mH sH hd'hd'mH sH hd'hkmH sH V12HI23hi~  Rgdd'RS,-,-^_/0~YZEFPQgdd'DEFOPQ-./ghi|}~!"#hijUVWABCABCɽhDZzhd'5mH sH hd'hDZzmH sH hkhd'5aJmH sH hd'hd'mH sH hd'hkmH sH hd'mH sH J./hi}~"#ijgdd'VWBCBC gdd'   QRSwxyIJK123stu@'()h>>%.DIC;C  ;("(;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;A" }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( +o>|WrecyK _@oEz|Njt- )6yE{FO T±]*R >x&?{;ZOx.IZKdxm)EKƦM'ЋR2<n c_=j]1-s*^._slL~jT5'7ٚj'&~(ViR{֤mU)~?^ )BT=.@FRԼÝ/ÿKt?ִ O+j;6xg iWNK9?3洣VPԓP0>*0J^,V>dR0I{5ξAvjPN;N[OoB9ކ@Jݏ]'p#^_3?*+įKO;QXQEQEQET^0O7R6tWf i +6 ( ( ( ( ( ( ( ( ( ( (;2l#EzM.WV,['.z~[Tu[M[ן^3}co[.rQ\ପ6I*0wv4WN/C#ɤb0pFjywM|=avʘH$,ztz0kWcI'kAįpOzR4k,N2 |5iJz( U f~O%P|?\ЬպO ;)Kfă'VS‡ +I@cl#J37sWB'%is6БSËX98u؀$RB%UaM(ix#YAz%<5G ]X7\7>vp(((((((((((>KxOoimqv7#0+ü'=ފOkSPÎ_^u63hB*u[RTTF.NP>w6WdTKYsRGz-s[[,Zk)70^WWF-z[dQ)!waSG!ϡ%v4g=.mYX’wV7F0:TF\"+$᷻ČT_\֡a.K&Dy i֢i-Lyb>N**Nt1Tkj v:?'WFڴKη#mԫ~YԗftQ@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@>//2׿xI[~֔5[F} ?P:Ư=(Sd/0e?]={Պ\,`/]862W-xF?r_ԙ% (3+3WR$Sحi}AvnEu Sa}[֫$]+\5" ƢHCjzi8XJ;I": `1.]C$MC|zuTŊgw $С͡pѝ6Z!fTVyEk"NZm֭Z@)vT%^<񖠸3\uu|1ճ듯:B(((((((((((hz!{oí% sUșl2( l&_QӨ$o8!CYXsFQj.h*7 pV ֥ݜ+&E})|z4G&2GZ+DrO)ze Tr~+{xX\*w-Q\dXJLUzqz8?Tqpqk~3dzA5HQEQEQEQEQEQEQEQEQEQEQWtPeZI1=x문SxrVxkx <O@5{ab0U>7aXW/AKbQ_>sQ@Rs*Q?&txvL]- v'WF=5"vڣ3/'v@vV4p)aOץi>Y z:t\Tm.fTA]}YGj]UȿIP+SO:!_دU,5WCJ:m֬٨- ?!D,%nߐ$p_lj-_^i^w]uj=><ǵG˚MŠ~L{n+ŎpY0?[:7Ν|yj8➢<躎1HXd?:V0(((((cjrdʼPZUVv Y@Mz>wQE.1M<'ӏi B vinyF)Ѣy+4vɭ^}qɆ>ytW:ya1t6\51h#7So >ZM-'JeR|LxD?s)` #8t2U~h.?ySW׵Bj$.G?*xڼJB+*=)B?zLf_o*8.,Yk 6܏:E~g[? _|g+ }y{φ/Qio.YԼR9 @t<֘T.~7ruԘ}+'>𷈮{7 ![ ;+&:c0(?ƹk%s V*;FъAK8-Qjmnx[B=c˯PU1pk>i\|J"MI3Enkּ?+-FEaQ@Q@Kkm-VЩi%`rj*!8a+F*M^>Br*,|O` ]?Z.9Hk]ZXkeF$WZWWGCͣd%לJmy ʳ)tZG&i&~u5ps;}u;*+k/ YY#aTԵմeQ@u;=6^d+CFxdH%]FOb {y-/zƸwg^Sz((({~v֓qbs^C^?#CZ}h [g-@>N:Gڼ(nZ ( ( (uDR״R5\Gw<^ ѽs 3й'5cݨ.U@+2 (u(E<ԷSId \ 3[@:ܞAUnxSTrw{rzWbOuse1y%Þ$&/nY7oZm7-aO1Cm=ZHO\`Cfݿҫ^:2wz>i$ l:ϭ_kk>cJʯ\((߄o|;;{uKQ?ç^O e/Z^+aCorCtA"ןIT[:ZOe3AqzUPx=+mbx!WIǵp߆_Ko6痗7nfi\c&&p1ؤQW2:WB3)?0GTԑ]!zV/D$X{ǭuV0maXg_5N@ axf 6?E,t'k86 `4zncz J_xONJO1$99ֺ;Z&4ZUuf9CRX>ot<^ z ?ž/n!8Uh@XNzL`H<=!!ռG.eq'2<@2zP]㿌:d2//t1z^x/Y>LַɞϦW|> ጒXO]B`:n^L3@-5th0%Cчk__4[y%Jmylrz׎k(\fE.'3~&:?ƽ N͞Go~u"w176ڧ*2g ?*jZdFYꗚ̱<1Z]|r +kWbo jwpd!E nM r3C as+ZDR#ݑ?j^7 WMjQrRI롛?4M,6qu>\'Z>MEGI|ɰ lXrQ]JJ7bmw4WWM/Mbs5QTWC+QTEPEPR=W(ֽծQ#0㎧v\QE~iXnO0}~-kKBYPH>=cqCYq3$+JQ:7n2Gl#;P9$75wQ}enlcG 9=׀k0O&[RdvFEZŠ+SzIֵ->VwGd>L`zskp$>~kZK5 VckH1cT$5 vv}xRr:BD봌Vݏdۣ$Ƞ<Jfε%+X~nbAljD3UMU@Ga-Y-67bA&>Vb+k2QH}3Zqȑ}*X:y W|LO(onv UFmMu8I$h B((((  jW$Eă*j]\p u+OSh+kĶ·+#'kVcJJQpl .x'#4Ք`9Dh+)R2~:g5dxJLmY{J>tΧ#;z*YOdx4\@)9cץEӤǨF{F~4_ SSL.(((((+~c[Pq-s19?p.ƯobF Iڢ!"B"(UQc* Bth:<3 ;r?sg㦯%?vŸb%VrXF8RI'$]HM7f*̸PrEgۥ[Vk9tQ)&~ǚ'C7tEԞרY8n䞃֭_]&4oֹ"~^k ,`+½h q$RdaxDV61ñ fnYSVmݒEum夶 2aF+/麟~(}z׺W|HBN5nd}z~cA NY>c+6 ( ( (:m?~g A'JΏ˪ʿ<?mQZEgk 8"`*ZI+P%Fw91)BnA'cXaHy-VH 8Dh$Ϡk=oWm ħnWaٱshitmOZv~TMI}| QVj"Q*Ω'<w YZVۓ;ʸ![f=&տѬ.5 FkMu;c|C!9o8=cNmn ;K7>uiqbjuEs~ ֟\>om̋ٿMRN"cFMx(Ksgam/_AQB~5ӝ%-"[l?sڧį YK7 -+j[3:ؿԮo%\JykI9 {UjM((AMJ]Z2~?녣"軍8v[I!9gג9|="kxXWC-b]7rqkΫOZlhQZ/}O/<#¸kGFў(إcAШ&R+TSPkVgcqcoWy'[{oK]êh/v1`^G_Sx#`"Ol8|m k݄"ck˫)<[`FO]L diScs4Q:pĮ &zcO3^Yty̗rrbj*(#+QV0(((((((gͬ2j29 }+5M=uYxrͥ{wjanX)6ў~kOK4m48maQƸϹ=I<G4O+kˤingbK1s_/j:2ҹi'?x;+mb+(v0=a<[_ u[sfπ0##@擩ϣp_0% 8uU7hZzY!G޼ŠVWk/$'<~UE(((((icGlWJ(mUXQ|`OڭbjoydO ;??puҨG'tz$?<_qa0U ɅP-_:D:eͭ*I|ّNOָ+QQ@Q@Q@Q@Q@Q@Q@ImMuRJ"Gp#t@O$*:( (ZK[`qm*Ή@\jDx>x!u#o hڭ1:`V2O 4u #"|K׺U d6ʷ@?| dտ6Oy->{F+ 0EFѮtOZ29-^LyP;$v]j:R QZ((+n7b7`5PU) Zպ~d?z͙YuSe C1OguŏzExX{:ަVf \ՉAӚg͕5Gzd:j: ԒEOd'!4\C"H Gk{y牣oFB`CfݿҸeV+!-lr5tko[nokRkX;Jɯy$QE0 ( ( (=ZU~vz+iKhw17czt,簻KnV5j|MbtIjµֵ(;}3.F(O\~ZO9IMyMKW=桪F? E#kY~y}!S p++QQ@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@ZtɄw2B5Vxn4{#QIz)Y^QE0 ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( (? Dd'$# B  C A02R_ xRee~; :F3 xRee~JFIF``C    #%$""!&+7/&)4)!"0A149;>>>%.DIC;C  ;("(;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;s" }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?j( ( GXѝFI4kSKѣ W}M&]8s˩6&H YOW+ 6ũFH]!t>ն4TVvc (((N+C,% }@4KrNs*[`i`$v_@%0]vB;VDҿna60Dld1aW~Dd;[y|˔`tTun+r:+Qk )``'r*OcӜ>%ahfaEPEPE{lw s+*^Y&K{m\ЪBzC5V>X>g+אϱ]Lp⩢3ZRԠY)#s֖g"WNgW9 {J!ĉu Ir<,Yr@ hRs?mQޝVrQ@Q@Q@!HKdkzƛlZ4,LwiB] KJfp-.ίx[+"@>aiZ{\V,NTAGk&+E-H.-Y;ݏ_Z)omBd}GL)k^Xլ 5,aяcMZisΜ:(fQE&hQ45//"eU FA8?流$hԒlњCG%\?W2v6gQ{=I4k)-mLurd9?>F_#XYrJGs[5潜y:Ȋ; ^7evo~8O5yjfkkc4OZj*MJ]M|њ);phsǸ}^򿹚٣5 FA;uG8U AO=UJ/f%B\,'.Lgc6)FUCm:J#rPkU-"Mw7SթF׶i.zNs"ûZZI쿯+Mcl[_&XɌ~@Th}8?慠Ն OIX;@Ӑ?Rj[9ӻ7liH40 []r~ϧ0znI}Om b*ST-˻_H1e[5tOnǚ{vMO–Ku~&W o oijp.i7 Ϳl,$h$.Miem 7rJ7Zpw#O֥#ZxzsHfI SԹɮgT푸T3+(aq\g$նV ]vNr%*7k]Z̷7B)`F0CF鎣yf+]CQ#{R"Y P{^zɮQqOt\uV=m+fI%',0PӚ諟6mGoL=6\Y-R#%cz0CG=CʭN0pIrĖfH] >4mR4;S2$ OV^/%6଑vLJ|Xrxk%%wN/5o5}?OtK˸i>vo[+ҴmSO&Ky$')Q9^L_ʏ&?/O4v05T(=ihAIKEGGcU%%+!QT@i#M[o%+nPqARiV کQ~vINMK/]^zlrn_8olbknPind+Hh'_O5S`E5pVsg 0-(5aȦ1q*}@hՎJ}8 feZbQmߜnp Ʒ}1HvtָO'j`o]%z_{$:^( &RG^?hek ;̿K4h~l!-=Au i )c waRܑ##ZяLS0T/=ԔRZ(5FlR 8})h.:z3IpKmbZ FCW7<X(Z> 2(ǔI*AQ>M[{ing9CǯbOj sQE&vBu$t=շ֟7m{t >a8V-Ƙ0;b((* S|6zbE`S"(;j}2HThP9V]SĐV+[|eGg Jw:p#yRd۔p3:]CIMcm Z,3UBIUoFG%z {yXWS7E,4rOe!ҩ^ژTQSj/AhdQ@ Lh"ǠY=8Gu;Kr3#ʊNIKc} ᑣNFOLdiXd[ܸRF>U85;Z @Z񺺂zZH7\z5s^isKpϒLo2}kj$>wTM 9Ԕr?Dgh\Is!evl#@r 6{#Jt1A&;J_Ȍ&|Ќ~{( ( CҖnnaE(Գ\knEJ1=}[>"&t-M 9}.i`[eSo0|u}A嬬;(JNpW:4l7SoX.NHP~i7W]{}ZI-iSw~[Uա$@|˰:7*J/i= cܚEud?1A{RziO܋_4:U E%RQ@ IE}UN"8=]Hey5&UzY:,lZc=#/Tl͟ lQ]AuCMkipas$]cx/g"y #shxgw3O oD@aa\)jKc9SuS Z))h<Yh}[-Fk?8DT޼V!p9D]xZR(|dh;@tX$m.9a@5J CLC9:M`ڋ%Y@[<ކ~8R +R=N=ꗈ>yԵg1GS6Ƒ&ˉOL}*_TXKh0/Gr?5*&Z)&*ik[Tx)zWkOQt+wB۾0G֝i2勪\Icݱ{ӵ;x&cr:mjS{BBʍeߨ5)U%cݘ7X;l8jWR;tK)*EKz5FG5NN56"}ӷ֥6Xf[h f''Ӛ:5O{"Bw=wWZR!؏+x(})YaSlt٧3[ݪͳr`z0lVkPZ:C$3qç'~+tteV)5%uPd1!" л.}yƹMGPՉ(h|wQ')^[ A .[U_ofM6ecpW;U(+&K͟I@_rA鎼bԵ(TlCno95I`je]!Wӎ նֱ91,Gu#{U7F3KcWrK#kHcrhCH.a$7^G]`E ]%!9+ө{mܵvyu^9 qRz͠]K3"$—Sayo)88zf[hsܫdFQltbک>!kzҋ/0#5ꉬi^O|p~qYHa?JKmfM?M{>4;wOXv+B98OfkCuCD.XV8=I ΛX%Vd^Y2g<r C [ȭkk992#v% *))PӒgJ(_NftѶv(H;(MtEHܐQ '%ε,#vI|X(?cOelgX[_j 5F7q4SұRQE30(dcֱZXH[̟mb?BЪ$tkJJٍ/^[`e Sܟ`9$.K3c'MQ!տ)奻y?SjUOq{5-QT`QEQEP s6חP7wU˷1V1s=+2ͩTPM5{zWWB-fe,:.R9asn%Kqciœ mu=*Ğn}lf$לҼ4oiӷou 潵57 3+^`ʥE4VQEQQEQESHiԘi5+]P{TRUH'Vڵݴ 8^zVG( "+A +7S9 eKw7o8k;8\|JϽ[R+)"kn@hɬ]gPYV2^NFd W=՛=VVVtEFE H?3gGj܊q"4s,}Oе*tkY/=/v8;S-hqQ@Q@Q@\и Tz/jhTV]"Dd$*`]f3Pio,,F3(%ODۺ7V1*ڼ:G,2@)+ ^vwFC=n(̽tZX.F#&Mc{ՍVD1qnҼ rryO4nQK_ݶإ{E\iMy+18voiojm NHE T­H(Y!h(((斊(((((( %P!QE ( ( ( (E(E EP0(((E([Q@Q@Q@qDyK ref_TOCqDyK ref_TOCDyK yK Hhttp://www.dr-roje.com/yX;H,]ą'cDyK yK Hmailto:info@dr-roje.comyX;H,]ą'chPDd `_J  C &ATable1ROouxݬrEO]FOouxݬrEJFIF``C    #%$""!&+7/&)4)!"0A149;>>>%.DIC;C  ;("(;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;" }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?˫+x#1;(>ύ7SI!?뜟jzjmMQjmMU(ύ7Gύ7Wh )T`3/7G$ڧS-mV(ύ7Gύ7Xk:>ZC[f H9!珘g5.-A/K;B_ ǦH/ύ7Gύ7QtdNN}nc?Oҙ .bQ[l$V0XF OjmMQjmMTZWq\*&694K??P/;To o";To o"@S|m)6Ev>6Er?uY<#oUlZIMmL[\Wo@S|m)o(+!?뜟jWB9?Պ((c봿Uc봿Uo<qqᘤMI\ h`\`Ywn|@]uVlWL sau{WIEp?.!;)6H|bss׎RKF]1{"2 ۿ~P#={;ok%퍤FS26I'v]uPEPEPEPEPEPEPEPEPEPEPEPEPEPEPk_Zv}xjJ8 LH<)ZѾuū4OZ=sG,-4k 7XΛƒ#< xze$ZWKr$mB᭑dL۴pǟ^Ί;|_`Y C m@lqKZv:HSNqIt̢MlstojqxJ jY9Le2( <oՊ?}[ QEWB9?Պr%7]аWE;e[߆[e[߆}?EV}?6_ſo.Ci6fKm<:O;}?EV}?6_ſo.,U_ſo.o~ 4Umo~e[߆[e[߆}?EV}?6_ſo.,U_ſo.o~ 4Umo~e[߆[e[߆}?EV}?6_ſo.,U_ſo.o~ 4Umo~e[߆[e[߆}?EV}?6_ſo.,U_ſo.o~ 4Umo~e[߆[e[߆}?EV}?6_ſo. _ZYy.#͏$sqU> * Ѳ~-tf~-tl]Yl]/7@h/7F * Ѳ~-tf~-tl]Yl]/7@jm&e[߆6[ymK̀ƀ.E^OA\kV*֬PEPEP{ ]ڪs[DWw t#O͂ecU ]ڰ]6ٴl26rN(Eʌ,gn^oE`tqUa؏uxt顀=ҫ"70E.'k}CMF+ p ]D'݃o7!QsƓJ;\c ܅He 33-p&#ZɮBSo?BX @<*׈,/`ⵎo:r=0e;=x:(4DFF.'5;v~ŖH*w#n=A_zuȬA(#v G&l..#L"T"Fbz;dEo 4Qgw`TrI'M+%9Xi.yXzeΏsQ8a)$yUou,gߛa#㩮GWmmu[~K3%,Kc$1˂r&궭55rmwNŇTvW#ixK& ++JA1#7;v=X]@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@Q@_1jVuū4QEQEQEQEQEQEQEUyMXշEPy?!sXB'Z@Q@Q@7vCjP_ QEQEQEQEQEW1Z#Vb%'xb(((((((((((({vF-Y/f ( ( ( ( ( ( ( ?}[ ^y@(p;cy _R)i|?$O[\_Fl~evp=yhd9*>sUX+OL?9U(.diN<9S>zB^~qu-mPjz4[“]ܱ$yIRσ$2@'UG &1m@C[=r,bQDd.y#@?'UG ߛ\yq͌0vC??8?'UI_q?nѸ9_i1Wx( ПW_]ZDJʄ9>޴ ʀ é>WB^~qthO@/.GV+*~bY\3V K6'8?BM*B^~qu|])ޡc ]ifZ5( :#`| dkn !Q~#dQoU1P'UG ꦣ^Y?3XUM$ R,{`}j9ϙVLI1WyA o]*1S*p3 y??8Z  _!VG DFP,9ğfe{ 3v0HCր'ПW_]*q+g[[5HeFܠĠg$t5ښ:1FlyK!Y8 ?'UG ٖ0 v(5Aq\ o>u ;'UG ChяEf_:,TFg4WB^~qthO@/._w֚.!!H2~azc4[B^~qthO@/.O`P}f$Iu۷t+k{YEg]R1@Fph ПW_]UѵodPȬŠFM[12u:Tƴf%߬g AbH{d*B^~quKX5;]*l徹FR]B,Ic7/w6sE[CnWuA0hO@/. y( ПW_]]3.xNtΏc>=\L?9R__ZW .FDQ q?R(i|?>'U!JҮm,Q5D3ϱC8V0Umrf[ pS2RYrH(d9*>sUS5K{mFXGJ,r|s`F:20KfS =JeH!ovm ~hd9*>sUEjoe/&_&ۂ>np*0 Tӵg+bn7Y dHF+8 >sUi|?Os&MkgU`* HK|ar2@2A![5:~mLF%|;sn4'T}O⪼^&sG;+"GVnFd3ō I&k~bFӘ>sUi|?TQG,\r ϡhִz-r 2dv@>'T}O⪥.{0#c 4F"FN#rXA :t_2ϜQ4%h$ ܾ~SM]շEPy?!sR47^kbFI'ՈuWdObIeRFpzZ(( ?KPR_"4bqe)Sq9'g8mV(<;yw ^Y]D' c WyC\ +Hj=6&Ibx$B'r1\$d㥢8mGz%XSA%ș]$mt.Y=ڮ CbSfF )fpwŠեΙc}{&Bz2= pkVdH aDv2lF0̱,%Xcb#Th cCl?dfQܝ Y`mJMBy46 ]Y\LeR8'qQ~]n8جi[[\\UicC (-{Oԝ[yN!$>Q\՗ԑK4T_EC 4OjzKQc-,q$sy$aأn (H:xcHxxXGOaM?8=Q@dn/,xePH+y&MM `m%"pŤG|HoH< PrTn_ wzU7A!"#>OhrSA,# ^Ime5٤m|@hFY O;Ԍ!8=="U Ztk]yW)=˱W;`%I n8955- =e ErytP6//fayCt^12Fį_qp3 oEV}>7Ͻo",UϽo"o 4Umo}([}(}>EV}>7Ͻo",UϽo"o 4Umo}([}(}>EV}>7Ͻo",UϽo"o 4Umo}([}(}>EV}>7Ͻo",UϽo"o 4Umo}(uū5xyw?}>EV}>7Ͻo",UϽo"o 4Umo}([}(}>EV}>7Ͻo",UϽo"o 4Umo}(W>oo{EFpo-ARB}TP(+!?뜟jhNkHc M=җQa6R3wd2B'ZXgխIk',R1z{񓌆h׾SEƯGJP ih`L@-󊚀 (+o/Ց}NK{4+{2{8O6D:_KP5۝>Kmr1L9?Ak+kZT>hFU>gmA (Z;VWb#W_H5 (g(#^Rc ϮPɠ iCKaIиqw2(?(GG-5{Q*I #+ʻ&FG9O|)=";ֳ{YT9bA;&wu E$Ou4ЄRJ?NŬg!dh%+&1|Hw9@GM[}꽳0UUrF=%6eWm$)`b=GfhW:v`if b@O?R?"+ \6omFŋ7Ui|n?,7vCjYv Wn<>ehqϫ?vs@{9G]h\Qs@{9@h_?h\P*?vs@{9G]h\Qs@{9@h_?h\P*?vs@{9G]h\Qs@{9@h_?h\P*?vs@{9G]h\Qs@{9@h_?h\P*?vs@{9Is@{9@__ZYWW+iWh(+!?뜟jy}g{+KyȎ5+6' r5msj-FTo`7<Ҁ-ܵ- Ҡsy2:U4YltkY3 J!"Z@Q@7vCjjr]>Vi| $1,o/OY[Qæ\+`<9߱ueyuhKeYW uV rƻ[kî券Uxjx{in!gU0 ezܪ3g\YjRiO *L҂-Em2A4m/"F3zq4 cpq+==+<1\wxh<7"3g͇lgZž7K}D$!HhNwIĢ\mc 90p̧ fvL7VP,RO6 8 g< P- Gmo;"G3`*TX`EYEd9`mmuq d9 #ak̳-1[x!Ne<`>js_\Icio*\Y\_,'*9 ztϰ 4WVP3#k b=NO_p,0yQ\ jVmm;7ݚEunF(pxbdY|e^1xY2h9llDgE!ˎN6>fp ѽ{jm;Z7 |O#Uvm_jvcAsgž[-"@R:]'Od^6i%a1",; ^iz5Ν94-=(q+[{}_JMt𛄻 eݹIz`mlU>SHccpNNxxխn)I[K%\OӢBrߥsxoU㶓I6#s!+'Kg\g6m!JYHM'Pe"9n3ui-ib6a#*%Bp3zTM2[-ARvr03aFOA@u3m*&72L=3pjT&3p|GpVk֒Vvz-d( a>Wq?>x tZ%j=3Gu# J:l`?qomku ;; Q eN19Bp$3b\G`_aY7K7!sբ1ܜ9#5G"MKGPz{/oȲIp@9&:Z_>VV(]*~T~(( /%ď $pI;(Ȋ2n gEG}]ыS*UK2gڀ1}OQ7JƱdr<wz>ϩh)5:$0JJ8aU+ R/C6[nYFb8UTb**ۀ=^YIkk4g9wBc$c&ח-N纤I+`msFzҲ΁,sp4 5RDcctfĪr{UK ^IM'Jª%Irh(r3€:m#RQn- g0J"`#R ʌ0a&9)ݮ-. *2%]c|`0͠]$RZf_#/2``,.-Mqwf~h?jBӀ:mF T` =`]Fr.؄ H۷5|Cq>ךi*m*9oOR7)P(k2MėI_NH0mivKs2|GF(q)qTֵ贉-a=3 H˱Aԟl& Lc@3I*f/mp8w·WIqeZ$K`@7=VN*mά6H>q5R]-~H'͔Ab:N2k~Ɖ2䑿|]6_yoKCK Z[{iYaAnQf$2Nq@% rNq3Cpc"2(gDIJYUATn KΪٺsަlNic1)/@=UoA5bV7hQ@Ob!?뜟jQEQEWP_ WP_ QEQEPEPREQEQEQEQEQE%-PIKE%-PEPEPEPEPk_ZU_1jQEQEQEQEQEQEQE^yV*m&,QER/ᘨW ?}D֫kcyFyO '@b{*ڀ,x?({>S'Uv#55W{>Q}P}݈[lb9٫,7vCjj̈́60Z/&0<[c>x!_{>Q}~q.zJqA# p !=jC!)l`FBg?xuO}}U{LcnQ}]F۵!~9:QQjWh`Mwtav#R6"?EaK=Jɤ"&S"x źLVcXlo^5wP 7/ AGj{>Q}~am, 9>X;p#d{Ap9'N]o*u2ܤnam('8{>Q}} XWHb.-)%dd 8NNp9 "ou6i`JsPdll5P/e D8,L059UZ@v6sŚnD4i ;<6UEpZnbjpKuqmī"C mg5I$$ta8GYaDѨ>[P+kip\opwVRd^6 яB< urt B{Vjޣk[ĪJwRsl?y]s5 ۨO>@ 7x@^%x g$,SogSvNJ(((((V7jW>o(+!?뜟jVYc &@p zTgԿ/KgԿ/KgԿ/[ ]ڬV|vzJUofnmI/z/*ER>?7eG/*ER>?7eG/*ER>?7eG/*ER>?7eG/*ER>?7eG/*ER>?7eG/*ER>?7eG/*ER>?7eG/*ER>?7eG/*ER>?7eG/*ER>?7eG/*ER>?7eG/*ER>?7eG/*ER>?7eG/*ER>?7eG/*ER>?7eG/*ER>?7eG/*=E|zen-/QO>?7e@h_gԿ/>?7e@h_gԿ/>?7e@h_gԿ/>?7e@h_gԿ/>?7e@h_gԿ/>?7e@h_gԿ/>?7e@h_gԿ/>?7e@jm&>?7eK#$XB;y#rhP(QDdE$   J  C &ATable2RP8 \`;H^~fPVF^P8 \`;H^~JFIF``C    #%$""!&+7/&)4)!"0A149;>>>%.DIC;C  ;("(;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;" }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?˙Rhⶂ) 12JS#Nzn7TKO o7YZ,=]H-ı*9ܱ!X+#犚Vvs^ݔeIFP@;b@/ZSVeO}ߴ]cYDbGtݷpD%@HuOtyZSk[k{;iZC pdy1d!ZmoIt Ɓcxh1Y_;\uOtyZS˺i6%Ëhd-"e9Qk.m`msNz!_i|1 6ÌT6@ ^n>n7TKO o7Wh ^n>n7TKO o7Wh ^n>nΧ4)(0:zU4iEVD[³mn-u.-F8Dhַv4RmF(IP%xoE_Z޽]檴5R-;"`Ye7vH7TKO o7Gϥ77*"DxaÄ IOp$/$I CJ*⡱#} ZiMuOuKI3Mok($bdx f`3T6-QOԢrGH*W@KqӕiMuOuMMj,n.tRʻT'jeW!>̹_ZŪIgj/uH G|lF6ʬ^UHϥ7?՘';$IaC")yZSdZI3Yڑ ]7aZ[Pmqh?7TKO o7Gϥ7,ڕ䶗NDĔBxϸ/YT9uMj%6ޞ1e`@Ҥ``1d+uOtyZS̷}սځMCitJ8Rc2wCe$OĤĄrX` S}-?)n>nύ 麒FEF%YܤL1 {c$;im煛j ;) 9tro7TKO o7Gϥ7nO\$6oguo;\ۭ *rFYs ۑZ4ԏ);!`b9vQuOtyZS̰񍖡 e}vVF uFH܃낥et$&, hHn ZuOtyZS|c&!ya4'8<n]O?iMK?B2[[`IK$d`_ZU?/uCZEP'iU[c6#n}/'iS;.W#;+U&9s9W'6LJ1ݬsR"@3BAz`u m#K" TsRqt)\ ih6ik]2ExYe;#hrNU'i@.t[eoKpsme`r0#"'lԵ=PBR1c;WP }"QlRLْEe$u-OsQ-bF/s-$p\ܖL( ;/ e%wѿ()juGrR_6?g7cq 8]jK|ڍȷi1yX3׾siV;[F1!cB#wd)P5߆⻂B{uhcdڛd#*I-'qE.5ďnG0. EQEQE!Tz)Y;o)meyCe =5HP̅<6 s9TcKVJVvA7!Ywd ahj@+0S2w'8۷4/a}edWCQmQE  ( oдlQhn&$2 6㊋@݌ 6y~RXQ䒀=icn~ѦrO$wl/I_:8n!n7evLuPpCIQ(HE `@IEUmCA_5[Pmqh=cL]cLOkx)nB+)AϽEu=.|jJ< aup_4 H1Y閆Wb#2bUJz8''6o!q-Ē̏qn 1z }rsZPxF+'hgQm$R; GUIbCthֲj?mf<(*hQ@ĸՄ=ȔC-+̒E$H<[ʛz !dYi$2i_nl3V((.پ:Kgn7?0iUb x;6Z]jҜ4.|olb{g?pSKN + 9S%ES* w8}0 }~UFւAixҼq8P J7_jyZ*̀ au pÌQ? +~T_}~Q@g?pG*_}~Q@g?pG*\>[(F ㊺zT6_o\ OQ? HZI)7%ȏj 228k˙1[ʸ;*22I@@ g?pG*_}~Q@g?pG*_}~Q@g?pP_>ru 1ApjV?u\__Q? i($!y q'$z̏XӬlb2rJF2#<? >g?pUn5h"̐KI~]=xg]Iyd _$}c*WPg?pG*_}~Q@g?pG*_}~Q@n܁u 9 g?pKw_*z? >g?pPzޝN٤o!&E!ˁnǡ<[ޤ Db —y^hC}~Q@g?pG*_}~Q@g?pG*_ݴGq<*${ ]cր,QE?W?ڵ:h[`Hp1>n!t$@r=pEZO]+G#^ݾ]aKr(^H;xމG.ֺD,2DxL L{W缢9O iw:mݾtU{i~,Ӥ;fbc=@C6bݘ%kŻheDT7~`ABD}O-4[ٴw%YÆP;-d{dI&e''Y{7Xn E5(-n.-c'ym6U.Rr7=69EQEQEQEQEUmCA_5[Pmqh8\vltgU)w<'uA޺j(=[UL@v/vGl 9=O%spSΞVE p38h((((.پOP]dz}W1/wf']V 2lfKny}X3 dQZPEPEPEPEPU?/uCZU?/uCZEPw4R6/O|7HR ^(?W5^-R("h 9PĻ/0*FBX)rB3.Ѽ$\IǹSYЗi]Dך|h<\ # HjQH-&yef0+212e#PA 6eZX[rۧ(Sr =}M8Y6 C f12t1tQւK=1Dc'<1œbg8xJl?f}?t:] sOKQu `PGj4:-8[%RaQ䍸 '?ZaVuvvh3lP~?ïEqoaq5֫<@RhRRm g^:;HIn+%@ۣPA9R9t+L'2 ddUa fMF8|u 7zp_(b o!&BM@8ݼ'#M}cP팺v%Cl߁;wsAvE=i Dș'h p2Im,lEe 0cs@$ڭ};N=Jpͽ /X-6kW/{k <#,ȡn|;z]Sq$~TRG.DF9 v@:7n męY5@!X*7i-FNlƶ JXcq/ X`tfi;\[XA3"GPR@(M[YX$JJws9S:߈4}M.D$7qnP j4{dH\LWveR9 *܏G!i܂L(pXv3N}riQ#c#jQ8 r 7RH4Dh쌟eHD.a\Hk‘i&!F*BbE+ *,4]X)"@() p:Pgn h̀(\=3횥[KkNZIZs9_~c@ 2PjXzE򥼛dMN'z̵_[=-ʷwNk?y=z:[߶e33\%,RX EPEPUFmCA_ gy!%D+"H) CKWG/&ݴ&I TQA^@&?uW2\-(B?SaxSICddKn%m^Is/wNI*rL0YūOgqDnخT3(OSqogԭ'k8ix*v]y(bmKGi^Zsϝ*$09Ӗn0rJQ@Q@Q@]dz}Wf=s:ꖳ\ސWtg_Uk_-\jRL*W- 26E\@ZB730?0ko OePXsڀ2n~k${ihy+#*۾K( \*0>țW@響+Fxdx@ AermT1pB<3@-D#(ԃ$#sk<'q[^Y .|aLu3QTb?*>3QTb?*>3QTb?*>3QTb?*>3QTbj //eq+i ̠ܒB?*>3QTb?*>3QTb?*>3QTb?*>3QTb?*>3QTb?*>3QTUb7Wr )?ک~7}GP*e>/}GP*e>/}GP*e>/}GP*e>/}GP*e>/}GPy?*GDV0eb8bhQ@?OҲZ+[GgLר]̄!Ws'<)ƫ?UOJ+;-X$0G#%.uu$!@%< wo=ZZJvޣr\nSqgbk+V򠺻w)%bpV}:kklu{Y,8O%B؃xMnkUioh+ Xp@10$qUFo.g$%BbF܃ w$Jv2YY݌Nw3.޹8$ŢJG5;ya0(KHonH',NRũ42B-fW#4ߝA?2߉4Ղ;e-$#,|` mM?2ijRM>K[kO)@X@g, H C}=ŕb3108}n3 c~"ҥ;{|p\MwBd}"&ѣO~J!BUeB eTCFiiRjOqsRřxn'o r3]ZYPu |2c"ןKQEQEQEUmCA_5[Pmqh n];MU2<6\eUc Gp 23O-R+5֝99\HN8;Iopn >[Ao,-4Ӌji fU]@;T ghڌW_fGE5푷6鍤0898b*/fԼ3_ܐgi<}M%lRh!<-**<לIcM6)+H]Nr((((.پOP]dz}W15k,BJmmyvsz|j;VvOtߺ |r~PH^'d, *]XAf-q6$RwBtIR8 ]H+B 0݀rFCCEli[ I99'k*btm'UKq7#1wc#t @U  (((*kV*k@(*zrb ( ( ( ( ( ( ( ( (l/1PDžr_(z( ( ( ( ( 65fj /Y(((((( o1SUb(((((_b_b( C=+4I @Zf[ZC2]H;O})'iYi8b,D|u'+@ב@riBMokQgwE rI'gϝ__:>KuN2H(̦'\"X|;Od֭ Z,*UeQ:11'-HvNcxm-Dޒ!B8|C]ʉT]s=43UҭF{nor~cq ZGuL4hn-)fBC0p>|KgXϝ_ }m.n4ۓ*vKfc>vKfc>vKfuaf䭤r#α;Nf=dڶyu,0j̆Mᗮ $"uH*ݘ1UYAVD"I<9 烎x̻}fKH`hLnX+#4i?&K?15xLVW6X\+<$0Ẍ~[N[(cRnY!B~X9y{>ol4?G٥ēא^ &1SZC!W~O#G֩A\x'6syF夆6a9r>Q1+yQi?&K?15]x8c bb00l kL{n9',䁜nNݨK?14}_]-m; ]²pg9-}ApzTzʹf(W;cgVXCH\c#ufch4?XViY] %Ӧ{ֆkxf2F2dq#K@/O|i?&Q@ʹj;yM^Lx8ںzT6_o\ OK?14}_mfAXެ[YĬg@THC.j֑UQ^VSt%ghԐ7p; i?&K?15bi?&K?15bi?&K?15bi?&K?15bi?&4o&`"nL5UF 79$id޺}@ :Z5'oc9+hgoKqj7Z{ıKFB,hlnŨHmJ#hTEF:U(XYG|iȻq2H~UZC4 ,SP@d\eݏ])\U#]isqT#FG1O4={+kfQ]PQU((oJ1q; U$tn4[&k{qb#0:EUgحZ( @9<Z(Cҡ TǥCe&aX-싵V%0`2Gl-gʑtOEQEQEQEQE[PmqjV?u\_]J#"*0PREQEQEQEQEAw_*z=TVLilmv+C9<; =>6 Tw. a1HϭX ( ( ( ( yՊy(*O#G} XC? G>SIPrSQn4cb^K3$|n2 F?>/O}'M5;*P'cW EżBfǸ3Hx;2ϔT}_O*ZV5%mUdvN;s]SWMkx:I2" p,: c2ϔT}_O*Z1G22i \d)2NqViZSIQ?Nk/*ݹ@n.A \ΖYu+BBD뀀^>/e)L?US]SMm5\J""E98g[}B(%K(d4698>i|2ϔU8!  _2ϔT}_O*Q@/O}'Ge)_2ϔT}_O*Q@̸);Y@y9zT6_o\ O>SIQ?eƩckp\(,:FkPr%Ǹ:W> lw2ϔT}_O*k ysI@[;'޽~}'c$4v[:4 1+$R<re)L?Uex}?DogYt/5+wd`3@/O}'Ge)_2ϔT}_O*Q@/O}'P_H}6(17$UF2ϔT}_O*OO.Ws MdK^,}Ǒo-W?ꤔc,I[2ϔT}_O*b@žtwZNa$nǧQ SP37̃B;1sw_2ϔT}_O*ķo1-N AiTNuẺ:͜Q[xj@>/O}'Ge)_2ϔT}_O*Q@/O}'Ge)FCnAr9%=GU7e)nپO@/O}'Ge)&4kar*gz $v;QQimv1&6vq0MZL?Ui|SIQ?EWL?UEs4+Zʀ0>qگy(+\e6Σ +ܼ{f̋ H?J1M&Amxfb4ǗmPOdu{Pn5t4V+x{*)Հʷ$ *4P'uN,[GyrzV, :(l z)fhյϛp bvCwpYWOG3-Vp-8Z)^Rp6]=U jZ}VRZ2qZy`&J>Ck(5|'KftۉmOkG|H[c ˓y8|nڙR;k{ *gQcBP}:X閶`(`!b8&Q@ E%RQ@ E% x[%B=*/KWIC|ז3!S0ɱ )g 1B-1${Ugeie%\!Td'#ݢ0翔$;og|Œ/jb&su6B&x {I-mdLersv(ܟ8j ecyMۓGlL RUlr dgSZ)(ڇn#V* ۯ20k-9 cXJy,YKvRHz jQ@ۦ0.NF4ϩs=Gy_yyڹݳgltZPCjѓIe) >|` Irl\[>{XL8xbCgy5nZ)(Z)(nپOP]dz}W3E)$=PMm4d NN`4BC4ٞ8G#aVC$ cqFxVK.4ۙt{cx :+i#hz-ԣQ bP7 )o=ەAekyg:^NeGGpO?(89'Z)(Zyk@(?J*nmvE:/P*>@OG>@O@誟_?_?[c c n:/Q:/P*>@OG>@O@誟_?_?[c c n:/Q:/P*>@OG>@O@JEPDyK yK zhttp://en.wikipedia.org/wiki/Binding_selectivityyX;H,]ą'cDyK yK zhttp://en.wikipedia.org/wiki/Receptor_antagonistyX;H,]ą'cDyK yK dhttp://en.wikipedia.org/wiki/DopamineyX;H,]ą'cDyK yK jhttp://en.wikipedia.org/wiki/D2_receptoryX;H,]ą'cDyK yK jhttp://en.wikipedia.org/wiki/D3_receptoryX;H,]ą'cDyK yK dhttp://en.wikipedia.org/wiki/DopamineyX;H,]ą'cqDyK ref_TOC(Dd 'B  C A03R.(oH9nN/S (%F(oH9nN/SJFIFExifII*1J2fizACD Systems Digital Imaging2012:10:18 11:11:420210640iR980100i"z    !"#12AQaq B$&'3R ?pqs2E LR0RɌ?7  #ȈrHa"~&8B2LcPB,^v»XUct%q(Ek2}* ΏT|0.g$8cil{9Dᅋ_Ժ3rڭu-#Yyõ݂kHfȃ]68oXPDA#c̱Bb}+ cSYDAD c(dTadTD_5R?@85P٤ƆmP~xNX[fc s\FFF+n|zQgMiVHs1ɨw [lЈc_ :DZvCNIn9vSHধaZ2q,K^]TTySKf*y}>4y5]VVkltb  0wI#hIs%6ͮX8NzTR.ؙٓ&caTE_7`X^Pҥ˦-,mחGl%(ݧlױ~Y*el@ۖ)I :Aȵ gXx?jzm3TzgT{3ZA^]A31bß[uǖWy51[^>`YqhZ),w:FX.{0@ k= DZ\%$tJʱFc kMW&LKMs6bv,l]wiԩk%C9ЖMv(ݤ5hX;>Fpkqς PGGDDz(AЈP1{B CSOD}r&oc^8rÏȂؖ va8LrV!5b(&kޞOQ؝@j,rYK[`koY]}EN),ִ"z{6Q,9kʠ!.l5\t ą^"urr."IbSASSb)9b @btD0NP7_!֚_z8IYMuCP_ZW.kcq|Z+m`9\Vy^kAΕ_R73 CY2h뗳h U_5d]r3tA%docؖX͸GjN9H$^&L!霩 A!!Zqq Qb,ͷjgO3Z/"ud;P`Y5cğ:y lVNpNzo2YaW9걫aD4DE2U&wI8caB\WBb PLN*}l5~1R1H 2pT!2X_T-;PbDDG0BR)%b*I(@ry3v]@(rt&)Ġ |21R#?~)?1U!J>BgCUNCbsukjXM;1s+KIa2XeaR  [5oJT5FȾ6Jf \VSa6 sh.Z)E&q:U$ ͮxHyE3Ϫ67<=^棴N?Szi-q(H.Z7Ɩ3\u[ѽ˯=!ħj:@OZzhkjd_ЁEV42em #QcxH`3|'7kb"pp(wv=C}B?%>q1B=a&kyqMhmDVԿ;RB;]\>X9$]{V%)95e+dS D}+D A$T'cb8gY~(ׂswҐMEbb_`C$Uyl4A2{)WXy }M0"~aBJ7zN߉pEFƮX;Ss>CzÜVV3)˧&X]\pq$LO+T[[X CcPI&u(_P(`(NĂC7dJ^"#0K̰MY^~sZdNi4ϥP,ŚCI[(c=jSgJc>G,S8ؚ/,xy6$x⩽f̺ϑ/RiiEK v~#[+y5Y"e9|r rX`03SF>EeVd88yuEZV]'Nl NϪd{U5dI 2 > dV,,v] vaRvC#֫QU;A3l9_15ėJ&uYg$扭]泶N k@%TU-~0OTL<}B*0PEEMEDlA8sy $J2i9<65<{ŒNg}f *k~xv1Hc ʯv΍1ːC;k8yZC)宠vL v{I]m6"׍u}]]w<꘱i Mnsګ!ewmlLIUJ\j+;,+Ax8ZU}bvt9`͆>̃ClQlkf:9椚OW!!)B1ȀD1@*$) d3pFP%X(f#)drrP< F֨v, inMF(רy;=֭;Xu3wj,Z,Wfd#+ԭS7l_h[>솚՘6Eٰz,n(M讃Ph4/Zc6O Q:="Ff#IIL قw/i&$W۶iv 顒Y*5ITrFʮjۆ{`ʆ36%/]L͝*}լ&svd6z4r8|tv6l3=+gOVb"15EHW*0z *ʲ'"RMNm)LQCd2a3mW6SdNp%=:z̛jfyC@6}JiU]tXɨVS3\_o hi72ð D3\'WhRgJ#CFs<b@>wJ(3U[+N YY 1}l10ε(j8B4D*ܙ<5IP-)4o:߸Dy@U"Y$Q0*^:hBf** EЉqc ݡtGş3eL/mym/ θlxY MTHMЀ>#0r)ыk%;2*kج,S@1uL7XlHwk&d%i&n?_ShuiɽV m˩bc6X4lIOOմCih{{Nv2hr˭(e9MkBa۬{ы0DO0 U~FC3C;4aR;ʲI]1Yj^nVm9i4{pxV0pDžwvͮy%w`j؋#[Vԑ+ڂAu$ťS6wDf41D2[nL=y@ {(@@ PJErڂalSTwc#̍UkV Sa'U*K zh!߿o[ZϘ2ڪk:1eZsί6[V/v7d%e33_eCoeYV,m~vayB,ͱZu[4ӸJ#vuOXE ?v!K&T6ƩBMv&YWjF5ާع549Yu\4.-34ؿ . Hl$_1_#?=NI8 Ѯ3a/0%{s XJ7Jcܞ?$5):L+k 2vŬdr3 >RwAJDE];kv6׫5֘{̲=ϒH%6J"bŨ8vs76EPbtdĀ>')0n9|Q܆WSRwk0J2,*fˍJ0l-"$3gK0g8~MjH6ҷaQ|]b&  rE쪒ۊ*IE欬3lmAì,G8\8嘹gHoɹ*yL潕YJd[ΐT{ l2}Ǡ՘`Y$q8@| ""?>DG?.R\Ȩa ~ `3{oQ#ץP1E,@jyDy$7 %<DɓeQ21u06J,Ce0 NQ* ))D2},O " 5)u1;-J^& cƾv ޶KF1,h,Y꘭MH0Q c C&+ G}vv:o>$zP -ÔaFT塺O߅!="⢘1 3qr" S7^"AP B P7*%+rI 3 NbC$o  H"!/}%IC=J%l֘e;1zҖ3K+CTJ l y̭!껹7H̭Q')gcSಜby/a *'JF+mmuKRtk Y2+6|36?8o$s]>#7Z۞[ jkM^$wL9)^lW<$Tّ欱+mwpX9HM_]Mjd+nӀ[^8ZޡRͦkiѩxf;"gZV ognrw`LUH7^"^a!|8Pـ;ȣbktRUZ?*dem$+7鉱} A,Rp7 >H,VS%`̂P | r Cć(|\6qlbX g9 6W]w]9OF 5"hh &qʯlY9ݭI&sKD'!)Pb"""$?-T#fy; : `s̥rl(n#dnw{lGZ300s33CcT! '}S}U=PFW?q2rRQ LUO#)#m#HPQ>M[I$Z/7a+g[~]Eq(=2/j .|I_aPPl yãY׾ۙ[N եNhk\_ff͘pV3pqpqpE|>D 2"PTF)1 6nN'Dl2X =b $љ6uVSc)bkˎ888889l!k !'cٴ.hå쭲H4[zMyh}d:af7/=·c&2abV-lnaEc-F0lx , XcaJ:Gx88888pQB?2QU $uU8M$΢"/9r&9O5S&Q($ D)B?eLCQ,W)B(|5J%":Jx!b3"2S/6o /HOx$.H&LHZ᭴qXauM-7Q>*U( s(/ )DI`(1·qqqqqqqqqqqq).C(AO>jfNE R'䒞D9x~) dAIl|e ILD[lUO15J]1K$UD}**$/SyerH lUVHER*qqqqqqqDdBB\  C 8A table3finaleallRA})y_9މ9^ -F})y_9މ9^ JFIF``C    #%$""!&+7/&)4)!"0A149;>>>%.DIC;  }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz?RźRiGm̐RF+CcA⏳IsO"&$ڍN!Ĉ^e`a {g翇UVVbM5B̓?ڭlg翇U~je>8u ^eaD3GK_?FLJU2Y.N;cz՟[Ymctpŕq{P_\ymV,dL ˳Ni9鑻S>/զeMnV0^$] d`6Ş&n^儂b#`,d1cKwmk΂ M@$'΃y)*9 73֭G?!.DwO! HXl8sB{dw5őm;C0NEg]xC:y!,4Ie H mjS>owXF/ʔ6 $w1vc#f^V(0dK :hK{ĎCQY!#xYUyT\_CqfBoqᜩ8>gⷆo5M±Z]څH")e_iI_k&-,ʃ|y,|9>gSO8^fMZIj c5t_nby ?I6 kS&R:7xAֵhטx|eA}!A 22dTf4wzESK:tOm%ndH ~u@~U+rxד`]E'F աh2`dy8~~q]-QX֟7jkMGm!sZ60(ͬolQEQE%q|5a]c{VU;dmm~u' F-QEV/G׿qگ_ 1Hp'5Kx';¶\EXvP&C CeIu+k0Iȭ*Zvlտj`QFZd_YGF?Z֭Qқ$I#E1u&J+)ʑGqKҪEMu WQgT|`XέX֟7jkMKjآf?ܷZ((((((_ȏ6E_ҿi\An:j?mpfycoS ~5گzZSRo=!sZ(-(((((+# mWE[(Z({5oڵEQEQLKk7¿(ZդUmKf}d=Zh*'_YAwOg7mIfVV|~n>U]2_dAwͷ:Ʃ#& v$wɣ{9g+=HSW^qOD<Fj2?鯣qerhTJPPXo}Q,m,Ǜ5Զ"MZnVY7!ݖvG vlEԳLT|r~n~#O[ ZJ}QnKF\Kv .#CdkٲNqS+rWIO˯]'_?G"O.:.Et]t]?ܺ?ut+rWIOO<7[;Z4;.o&av-7Te\Bq{0YWIO˯]'_?G"O.:.mRNCjZu,v0:g=Ӛkmn%Mr]cMBXdmk|5E/lr;]'_?G"O.:.Et]t]?ܺʳޘ&")s #2lg=*ciַ@InsHg/4{464Ҭ 3(e 9OXi6oo$Vׁv.]h^[xI.2(K=h n.-#LY( 9syO[jIF3<{U<.+l5Iwqo@ Ҝ.f{X%i. yS7䁒9zni:c{o>9۹Cc;j̾DN|]gkZ\et,Pb`2Pv Z?ܺ?ut+;79: V ?cfԥ > h6aInfGy* 7B[=*QrpN~\Xuқb}SQ7_l@8"7+ 0p'dxSHgut+rWIO]O>pվyZCwbOjG ȭs0cT#ƥu,MFb6[]#/Z_أ햿+xW>|`xT5tԒ<7 p[)OTƛmvʫu52!@ p `:tQ[f)H[nTsPcs!jmqeLF. >QEN\ h"kֳ?/y+|('N$]*2X\08$$ӵ>8yZ)̄68#AZZ][qsDMkpҟ;Ͱ`Y6i`KuIe;3]2$2/r!<`Bh"53[u$BY@ګ$Z+[2\l.2I>0Ͻi}~"lG-/R~"lG-/Q_}~"lG-/V7nZtۀaگiwvJ |1Vk?bZ_أ햿)>k?b{qHʷɿ6}ߵTFإy+q.c$#n ;994[7Y$@MYeE}>k?bZ_أ햿+"xVo><{lSR$Y>f3 c'z-a}ؤe{g9ԕXU6qMT}"K>(tBPX%(-2 <խz拾A8k%V\}>H9y{{y4m=%ZrL.IPOAze{--jy4%\#Ax'a1d9F[YCɥK).NB"39m?Joak?bZ_ؤeE}ʰ%fѺ%ʜ5g>u#uSpYB$fڲ^x+H9y`8#rH6\`Ϯ!^kI(— еYV^U?X6)9^LZXh.&tH2#hiox!mU:'>F7 KhM*vq!jO'Kg$M;Amݺ*IoWݭkZ0SmSѼwZ%[ɴH'#:>5ShcDdfg9LVMͧKxt($Y-Y$ `#f=CVkokhW~"Դhv:#'e79xW7qܧt9V28e#AqV ZOGO(+Ÿ-i?QW?Z ? еG!^kI(B)B֓Qd>~qo2)xKH#؂8 o|/&j)BIvjW?Z ? еG!^kI(B)B֓Qc hj0xKAonUvq}Zx$[÷úW3 u Q,~[s`9ǦH܏^1 iq?? еG!^kI(B)B֓QxS' ʴ[ĺ-0FBd3TD)>mOS6zMR4*&͒ $&rn 5I5:("X˦cfV8+ u|V>5~8bbAxS' ? ZOGO(+Ÿ-i?QW?Z ?K \ ?V!ᛏ SM.Id2Xqɭ?B)B֓QxS' ? ZOGW v0?ǶӼhw;fi=?ZNo hT:J-Av95M4 Nb/"rBU,{oG4S O;dYV~#Зi pn Gꎮ%V)mbgd=S R7"ѣ7hկlA`:Qҋ~buDtx۾oq.%]ьw$Wq8?Ճݎ:{oG4S O;dG%>{oG4|Q ?IC}&)u=$K(UHAFx5 O;dG%>{oG4gG5vhR\e 3tG⯶~5#Ȏ#ɻ,L|ewgCm0=͕*7zmVes[?x{gG4{oG4S O;dG%>S/5jY]Cs]sn2^i&]G}5ΟmK$A @8g֎<-6ԳO92"ev#fũ*aԬ-5"_m+tQzW*LR!e.K`Rs'|=iBٮ#>dc6t#0dss[x%, 2p.S 9k/U{D?K4ӷCq::={k1ri֌ݶ;!9v5/dcfE/ie '?tg>G|S)%WOT\gG#8zmAyZFYQX&~S'Z]ZOthV b?)V93`Iv$g [aZq b~J?y}FaMe$Kv!Q9 'XsҠjvw6:a_Y:p K #wAKy{K[YM&v,>;p1#8cCdu9m'8K.8t4,, ɐX(w*ē9Zlαd舲[.@ǧ'<~zJ/lỷ,$xH[H== fDaf,Ze:i (*Dm*hڳiVL$tGZѿc`hd ?4oX27,?±Mmb3FU)}%~Y4SGӢe$Sfڼ`ߋBcJڠu`hd ?4oX27,? ? Y6z&|Q,Tۦ|cSxW_e̶MnstLslrJV.i/am< wg#f(.-&.6oQK4ltv$<3Y_ Z閲+`vX|6sx44oX27,? ? G@OFE'S%ta ؃˲ggCe$]XY '`V@OFE'Q")AEqd$ݏ5 .y!v[PT00O;sո5Hk6DRNG\`FuvAjqffa YK OltKVV}"&\i8B6< ? G@OFE'Q"*kogV+X"?ڝ QsU4i:x!U. Gl -}H=C\ӦCk'9f'sƯ%G%YV>(:[ukn[4WHoY\:fs✟L]*6:4` U8ɦIqgrftM LԯZE8:cJZg;ּH ;DѰ,d|Ď;<q ElϐF~#8o[nճ%:kq9R7yr1Ą瞂חKK j {1D%OeFs>hR]Zx9nQ{Jn;rFj'}m/IcPE! 2wTi)EIk9K+1\}K>J~K[x7ɔwR0ؘ>*s8K#oIlsap5kl?YFe-HVR܂dV%G%G%H|[qgȳ[K5M;QVW%/InJZkVo',;Y-r٠,mc {%GO5 fk[c?-?-?-?-ﺫ_j^'gI֫FwMV|8qm}aԱj(Om,';\~r='^?f?ܷZo|A{gwƷ6i*-\Ir5mwqzӋvr%؎dAmlIxG,) 6񵤷!f(51xҢ]u{*!kh `H`@@9&XF̻(O 㑑Ks K)kAofNF xKYݥFV<7~V2^+RhmC2,FAj(Rb)1F)k$k mWE[J[N[,⻊4't2>QUZX5V,2AHcnd啶fTfWPD9WujZ(kտjV{Fub `[TRM`sQDžk}6<"1Sheu?cK/ODJH]g8 u$LHj*-0;9o-ˆ᱒I,9|hDA$0+ 3[PD`#2<.9fIi(((n?[U+A6?V袊]jWW_Gڕ,[$ӊbx}-Z7{iV6s",sŘcGei vx(9¨袊DzV{oLYlne\4 fM;FB$x;IH:`^Mku,A bW32_bX.|F!gV$dL$d&^C=n#0efyӓ׎Ӵ,I"Mv @ i/%>ervCiTڄ`=kMV\~Eo jAp<.ӧZ4%kI2c?d8˂3*((+# mWE[((DZV{o[QEQEɿԿ|+"^赭Z(((?nB}RE_ݨ.?{B"Ҵ?oYo=K}Bƭ}[?/Xտo=YVZUqM,@\)q϶i ɖTҵм U-MPXM"\[^bvxU6PY:͘[m݀eUFO\g mǨܾcVۗ,jշr[n_бVz5oQ}Bƭ}[?/Xտo=G mǨܾcVdxXmN}>ۓI7Z]2GG[`9Z}Bƭ}[?/Xտo=G mǨܾcV' :mǨݽgUۗ,ݷܾcVۗ,jշr[n_бVzmQLJu6-(+3s{VgU۷,ݷvWԿۗ,jշݽgUۗ,jշܾcV'gUۗ,շ˭ޘ\3V/sSV 6FeQZۗ,jշr[n_бVzr[n_бVz5oQ{BΫ}/=x{SyǚXܾcVۗ,jշr[n_бVz2U[)֣˜o7?#0ڬp?5AyaBI$ӼE1`yEt4a#.KϛN/|La%b֬cB=B1l~SМEmf'͍\y+ohz.-+os ’2eN g]Og\5^OI r2uBOC\@rk{qq"V Ed`r3ҫeky|e-r9Mq ={/_MAiu u%]"`lR#PkMyh[sxέvQwr܀ fmb$pCypѻ@na΀8+#H 쪇fLG@ێ#Ұ<9@y#{8`x.PfH1+>WuI;O$rqm8ฌ0GZ/t[VgxRH瞄u4QEc٫׽լWpjQȞ iIB {3=zk.l'u)8Y@m߻;\.>^X1^juydk/IU.ۈFrFpA5LP}p(w dluWߩ 6Sĩ1YUlpzyM[w],|)qi3"J6x\*yPZ/>a,e]ȠFzT-K-3$ICTCd|sŏ $IdԒOsZsMfWE kZQMp @#o^ mB->Yhb2A'{}FsJ|Un7̑ϧ :gO{+(tYX]йry;I 1o*2-c@-qN([O_Ц"P]F5 HƠ͉×mA% u rGnU]_ˏ WWra*RuV̰nOEJ׉b2{`\1jOem p$g{Yf ޓ-w.ZD vڼtUuё"w)_N5mʣzcNe ;_ ];\u HP$cC F—$+ H̍o3%Y*N{Steq#j+ .0`H犞m]?Lsr2qþE(.-M'ڼȰ'Lˌ 0u5;kxS$QDQs}BP5]\̹q0Tں GBQйq0Tj.\L?Uں GBQйq0Tj.\L?UdxR$~h3čCq <ǵ^u=YtP0igY\?u.?&*]_ˏ WWracMVW $v]kh_|RG|` Ajʼn|Ɏ8Cd GJItqq=Z͸vyu0 CNUF:|Pib1sg S$3,k2@M0̫ 'NlX\_0Zxf Aho#mrx,bp|;p>Sa⪇=USϵ\\?u.?&*]_ˏ WWra⪮=ljW{G5Վ7MTkFQ5+tr[Sve`BnAatmc!\pm[bJU=H#n3=T&FF[b 0+`9BWK-~Ҧi<&DpORtYf{HMwee' ]$`pr(8,qVZa<1El6aI>y"8?lx988_Gjo0!I#xϯ,u;n5*H7oݟ=r0F-c8--4;w*%{ r@u'Рi%ZtI,0*' 9mZ%̶^Ro@NzR68d;mgX}0P#e2i$GrYPgnA+PXrxv?M`j:ۄ705yȉpX\ohS͝%`I$IA=R((_ȏ6E_ҿi\An(~+(nM!ng]̑8=+ PKϖ}ޤ 䤻`̪+`ֱ0nSQEc#f^Vmo>(ҭUaDY&&9ݷ8$kmڬI%td>[x0ՎڝM-Ç16ՙ$ʊw,Zޫqe%"[ˠb;OV_nb5[F )cH,g7yAI Ќc9?mi#}r[\zNOjJm#c1qwVc& ;UF@'؈#95gLf$>Z֤_YGF?Z֭S]wRHM5=WKC]iztWsưp뜜xܱ36$&Rʬ>FHȬI >wo`A2{g]5v# {qEV5گzZSVv>N <6~Q֬CorxHY\,598r d՟xW $}ҿi't4V u)?ugsG.וu96"=q2 7T3thBF9 Չ_x$Ѵk$cZ}/SY9J;<ڬvϸquG".L"xkE"($Rr qCXFд̴2o{M^Fί)di0\0d@7)ӁMNak9G;S"jr]\q mH_SF sOAیtwQx*-<,N GB{OoIEi q"2NC? Β|Kcl!]'LsIv$ǿ$ JbxW $}ҿi'^'>I?j?I(WO1GڼO@}+>_4VO.|D֖}+M#QWl<wM -DzF!L JbxW $}ҿi'^'>I?Q{ fKg}Ng.uepG'1ɧkܤi7vHԢ8q CVω>I?j?I(WO1GڼO@}+>_4VUψ2Vd0[SH~1 ˡ,?:+m+F#mmu0E*qեf :(& 9ɥn ;I?q&`#0HEFxGQà}NCyGj Jweލ"ǹuIS@8$N4'tg/#^l*@R:4N8 wKHējxTc4G%$U01u#YYmkiIH5*~*InM>Ki5I?gnk}$Cc6"6 I?AgamilZV䜓'1|D@K&J o?x JbxW $}ҿi'^'>I?VѤګ_o7٭pNe\nߌU _\֪V>22YEYT_I%8!U=?e?ݷZZA\QgWc)܏p$6N%KxZY#*ퟘaIysS6I^\6iSC{٭^Z,4sK\L63 \bmHJkQ[$nY݆~PTq3wi5E0B *@ ߯@kno!̶b Hvqq1nmcfVJ"P!Ql|I${YXmmm/݀Tr8Vo$/Yhyg|eAVA\Xs7<#"noֵfR:7xAֵh bY;7, t jCt?L$]1XLdIͱh }Yo?7xx_O&[#:X3l;$innt|3,|KpK)rOJ>Kf7c f2譔{OOmycEq1zzXk1{ԪIԸ lkCI%};n|̮wyh X2)FSD4͕$~lWu9.N?/3oJI?cnD9d$)n=7Z-ILA'c]Eḽʸ\1٭[#:$K#~^>;zf ќgOCz{ԻMK%%׭[0joct'KJ4n7ҿMM_\mee’#+Gbjc[Ak1h?g>ji"`̵Y^ \3E:Z /tC.*uXxt,"YgTNOF'w]4;21,Jrq}(]PXѼ<#܍#mܣ q{갵̖ T`\``il`}A#FF.1JV7J-dj_>LZaP/$`~^J4n7ҿMMd|TtŖCB7p4Q\ܭpjMz#]LpE;"ۛ *J(m?nB4/L~iinu KX09>4);|_*d]+$`nǃx?ٞ/OAfx}?V]E_XaK$7qƵ?]C6ǩ?]C6ǨofAԿ~.OAԟ~.OAԏW-}8S=K$ /3i(?z/F2qj- pK,y͹)Ϩwש9COb]ڹqu>s+i-ExONOh $N|OPǨ~3 = wOǩٞ/OAfx}?Q=GggPٞ/OAfx}?VWe&͹^nUt<7sS3OAԿٞ/OA4EH' ,OAmMMWV*tY#q7̤dކ.)mǨ  33(?z[VMN+ͽEo䀹n=߇7?5?Ji8J"ܕ!bz6@ik V~[[mQA8 8Acsޏ[>m^U!"L*܃׷vp%rGX-Xy=x8#hMyq\]++@I [|ܙONd5:tzk:Nҭ Ʈ9f3&=择 Սx~ݢfU9=w=ō\[ n5 G 0Xݬ"g;qY>&b3\Cs),J,ru$TdZy,eU-!lt^;\w^>x[Ϸ}J7rr8$>5'նѲ-h $t0孬^I4JPߊzE5#3ƱæA9浒1%mCWnH=Fӂ2k> I\I NI`uɈlųΑg(=;(|g">`ۏJMpOU(/mQ(ffB<Z S։$IM]sol{[\nhX428q=Et‘*s @~U%QX֟7jkMY?؍q8>UȮ8ntY*913qKƿuo>2g.?PjOtJ˱-Wiw~D<]g\ȓyCsQ}pˤPE@|=vηCBghLI bif-:- V"wzgKuM:쏢'ې2O01YWix1 H[?*H I+hi7C2y- `}*&6|[sca"[@GjcYܦҴ>R|'$ԱM4}YL78$I. .(J[A궰K Sg̎8U0w֑}JAmp$nwbG`0s.`1+tJ?ҿ)(J*o]+tJg$?k^y|mg]#̵t;Jc"LM~RQ7IGT޺W%Sz_NMgQW]O":4 Fx/54uu@JfJ*o]+tJ?ҿ)(J?H'67-dI~kI l$B4f8p A/P_섋HC=}*e_xTGh6z`ԟR_޻gsq`$IA.:_gľW%6Iyt], #iԿ|+"^赭Z(lcx&H3[[_ۂH7ߴ9#A둤$ 862Mx v*$ZX6* "8L#nsp ?*([O_Ц}7O i.6xr}XėKkf0X>Yp{;O_[ŧlfJ~?OkH㵙eQS֫*;`N0<1S̺&9b҆76|n9NE[GNJ?R?.#?|W_[ ?'x։4Fȭr]9ny8uf8{?%ǐ02*=ϡOJy|YI^?{F8;1#E6@Cє0r=G'TR\dIm/ Z'5?|_C] G'5?|_C] G'5?|_C] G'5?|_C] G'5N%ωfl'2F`B@o0# \Ӵ6lcM!6ҁ>eY v)vih v)vij4+Uh@2F8@sO8<85%^ ^oX([~2*^-e|YhAG v)vih v)vik2LIkUa/! ?y3s]rwI;m-xR 2:X2[܂XIJxS.|y㟠]?R?W-F[Z"U'#8,p:I?R?.5l_"Wki8 )^(A#6ՙ&VylVq3^B'"]#J>`p rJ=GXTHlKm$K崡fa=^jo)k$rkgLA7DY   fyDwu!uA&@U,wWڡmܱū'%kpNN9_0U \{%瓋gB"`'ITrou=n-BKy$^*DZy)vO9%WZ[ɨF?SgἮy:Um*{sJսX.cD\rf>h^#$^ѹ~8dy^Lx3p-i_4o[* 7$|P33u1ᘴ. 9Dh'"eǸKEQEQX3#^mj&'*Q\[UBZq1fS&@ryQXWuZmXeKmf ˹-)r0r /J-;8j({5oڵ[M*,KG2ܾ m`g9$ oWnLljU-dIT3I6hhZemTH$b@֑ kCq(Y{"y#` #<<bI}渹"F,$;QX`9}o&e ̢f`qFQ"F*$ X/WkLB rza?5kwzI,+zԟZ aj?6jQ٫߫?1GCf~V,nt Y Bb5g QWVbjhUټEh ^r9??5g*Fڿ(Ռ<;CH8\ 4FxRQim8>ѯFwvcߊQ$٫߫?1Pϧ^[H-wV BI{A[gKƻ[_s& ?cr ֙c2P$466RQ5(r=Fu?5i(lէ QWVb-G_Zfڤʚ|cxBl }j ZN„*i9aj?6jQ٫߫O1GCf~?Cu^YIq7ukڱܚnt$^/wE$?)k` 'sҜHk b?K{TTwg-n#""n8e{{Te[?*٫߫O1GCf~?Z aj?6jVU~&' rdlvzl՟QWVb-G_Y?5g(l՟ QWVbG_Y?5g(l՟ˡ"''zOU 躄]|Qĭe vPl N&5i(lէ QWVbME^@ПȨ,l.uEv1ePIRkpAH,Q:%ȸMr!σjE1iAvX)mܗ BSҿo[9A#Ru.:r"5i(lէ QWVb-G_Z񊯢imV9/֧͸Xn?v1gg}a mmr[kvm}>cڦR{]C, wN1qb;KK53,Z8gfGWگ?_ jhu-YֶEz󽲫HRvr~xMtTֵy=X1 Î iE,K"k+gzS_ jhu-YfGWگʳЕMG[9:­]YZZ˭{dHR0S/$@ؒY TG͖G[huYx둎1?N&qY7|nj{;mH89_UG#:lHT՜HQvr}t. OMUWPц eg!s٬ h+/?54e ڗDV#AmW_ 4:,?Tp3jVKwyl̿=)XMu?N0*=GP-2umbL1,fpxY%څߟ_ddt$d$)^íi:,[UG#AmW_ 5[F^'bjۧ{}ϥX{FF2ϵug<D Ʉ$w/.,u'ynZq$ r۝~PYykR,e^kkqW1F q+\,6d`dcE?S-Dv,D8F᎕$Z^$BZO fUQ|NS[9ti6@qh!ƦMgKu2;ÂO0u>Htu I57;aYF;b2(ȣ"2(ȣ"dG!n?[U(Ħ'*EdQXqſu+BQߞ'=~uFfSwp)4oXÀ@@]MvϻQFEbտj KI wvڥ썾(2.7y?xpycZdK+@\ݕ]Z3 *W2TqZ|#ET@|aufdO$ KiC5őg[`z {+wC:3Ϙ [y8"%-ml&kCs+[;CAʩad$|٥Kcv-&Yc 69P}} [+ KYRvUG9YȵSN4KO[ԓZKY Pꧡ4 L:amm\fYs ?}èI_ҳ>B@$dsQi:,7{=l=r弣+bNdF=?V]?~uo]?V]?~uoگXçVu6֭$ov't*׆?5%fր2Yߖ!]x@G<;_ieyhvƨ6(t9[mc-mKfyxTnY[$pFx8G4l;Xys+ `(>OV{PX` rm&cdY8ܡKc9$d/&mA>І\ed\a e~U0z2o\J\c01o6B:#H^д9 G=W^F>@G^/i/XdGWDj̑@ ゥy#%xR<h:~m&:1vS,H67cs}?M4M%neK.}YV5sqTz8qQEQEQEV/H׿qگ_ EVB P]6i"(cJo?6@lVl~{wYn,Q300dVK#4g`\E $1rEV={Z=}=ޗ#E}p0#rg皎@ɖ Xp? J L_lpdVtq> lt9ͧG ̆WbǞNA<:(d_YGF?Z֭RL,_.ͪu,E*μ%/ZXl^4?1d rw󊫧0 &Ae#F\sds] -QX7jkMT4}J>qufڅ,IčExycHKtow|]pxt}WX-'TyǮT?пƲ|1X2m 4]YzINKaok>d8=<)<(1vڒE𭰓̷Vw24Hvzzxl6"@|LC𭼦)@ʼ!GSz{k/YBLAUQd q<+JQxs_zԍU!gcpOLS,t j/piLRmrpèφ-5'am uR{8=;UBÖW|zTWJ^8M@@.Ğ$h:Zˤ` z9Olo= ~gk#ŞѭOi$z}+x"6W hrite$?_ ?G"zb@ؿ34'6/e#MmFmQp[v0~S t憳[ZK-%6U6tš!E/B@?Zw"zb@ؿ34'6/_ ?YV~[ڤ-aĂܨ3=[ev~ZXo ,q9f d9-|udI&†V*y'欮g6N3n0O=jD/= ~ghOBl_?пƏD/KMBi?T<5 2ɧPIA@ؿ34'6/_ ?HЕ .6 tBKޒ5l}.kRo{mji Ov*88{Ժ^wW^X$WxQۻこ+K#V=kjZio#O:7&(qlv-T.amL ۯrC>Ěm5;E@U9T0r t㺊8IXTc83Z/;{{UIm@>`2ÎW8}Ɠyu?c2M}I E qpR7}>[XBZG*[Z,qɓNI,{du)POS,e܆ 7K] éϧ \wi5y5 'Rf۱퍂/ lƹXBm_ b3.5+"!U5x̥K) W*5@GBTIѶnHV;b>F+c@WPZAv$bh%i%G -4 &M6PyVEϦ}Nw/dz2=E|]}-)Q}au3j5;H@kx^9_gEM!_FMPmjm+@֥ `dH㌐.zD<1BQ5eouX@#X !ʶp1WM!Mi ҆Gy }z'm@lb3zJnp})|?wHl<=#"4NNth&O"B<+󁸯#9Ǹмkqh#g=zt~c֚4OF啡A8gPK/'ƱBkH"q)V]aF@` NkVM;P“Kh$K2Ъ6`HGHWzV[Xrt$`z%u o*gVjOD<1BQ4!4 йMxc'hC.i?G"sI(? OG?\ ?&D<1BQ4!4C't йMdxv<Hq+؂ORiٚ$('h_xc'hC.i?G"sI(xcÖv}V25 gaYiZ gq{  {`c\H\G[LV7>4c`Spc'sVl {="FTԣ A;"sI(? OG?\ ?&D<1BQ5goH[@ QnU xR|̐1Ɠs?4h>n7lq=9=+BiZ31En$.8AǮ8m| >%tI#g4[ITxK&=_!m.8Lz D<1BQ4!4 йMxc'hC.i?L>9ҁ ?&5_O}&i 2I$2X$Zxc'hC.i?G"sI(kCA 6Q4SSƲR 9+:ˠsyt]ʒ٧ePA]}MT]; VaeeFv#w♢6Rt -lfv P0p o!4 йMxc'hC.i?Utm>L>FՌpD;uSt=[MKu X$RIHv&\xKtT7;zս>KRn5}1&(8Քː8;Ӡ /c)5c#ZR+[ lBMAv$jLwUK-ha&$h2H19Ͼ6εOִb#t$&Eޤcfwc[o-&?5!Dn#9t'3Yzd2m#_Fl/LUUVuOI28َ}=,vggm.by">Gbz_O5G:4Cp*y#8M'UӬm }>rId 8h? /c)4A^ShE A{ O ?G$/%?ƏH4_ Jh? /c)4A^ShE?&okEY\*!$ 3]KVlPnz A{ O ?G$/%?ƪZΗs\A%wݪF:*ΎXңѢv^+Z2 r@*|3M˹5[cP"tVd*=GJRn5}9f8J%ڲ!r9827Zh? /c)4A^ShEMj6d 0H3qTuhtB{?L!:#c}=:u$6ִ{VMR<7}qc9dchW)ۈ.'VI#S! 89q]}̍i" "8W(1H9kA^ShE A{ O ?G$/%?ƙ6\ ^yO D^#UG[C+\ E A{ O ?Huj÷m#]nbkf(ZVqH#v8KM~ ])-a{ptYH &-O<配.seJöb:%@X0<.|z}HF*m{Bq۹FE]Gb6-lpvБ85Ȧ䵳i 6/"!Kx-n m\>t1f'>fBc J1ִ!, n)d}4YϤ`H? >e>߱}} c(A~Q /_G,?YϤ`H? >e>߱}} c(A~Q /_G,?YϤcx<¬mFjY*ЛH 0>X_`H? >e>߱}} c*koo<6⍜op3 {;'1!hai0 `1#AkmM;icQPS @ǠV셴Ɲ=8,\/\~G+G_G,?YϤ`H? ȲVSkom?TB7_fOv߷pLsH*fSuQ$˸3*+}[CLP{/*6 hۇv>SێCyjpĨ mq5 />e>߱}} c(A~Q /Mag$t1Yo ְl`$?ZA~Q /_H}Ӷܷl8u}ÿVVQB+dd';sV^lkFUPI(>oҪGy Z]Kx/*v:U-c9&sAMu ma5B ~AbYϤ`H? >e>߱}} c+/O8|WQkKSPޚ!tV.pLsN NK.vUWo'w4/_ĚdbN=zMo.tDK,c`7žLG״ehY_-?ƏL<5A7h_-?ƫj(݄xJG23Tc-쭯j*|U9$x>n{GEPXqj ?Zxko ?ZxkoU>&msOF7I#{dU=^ jwG gu)s即z~ރyz&({v#0!<7s cP3h&H+Фh.' ",`G5~MHG*Hظ_-?ƏL<5A7h_-?ƏL<5A7h_-?ƙ/6ap54vT<7[cJmsNI#]ZRiaG&i4aH|aZcxFM [Zoi䙕i-#8[7=%aխB3)w`ch {WS]5>ԙ\'dFqUt =ݴH& # FF+<3z\Qk8-\"#@Urqq1F(L?r>?Z֮(pcFFkAH:̰3C,D̃ Z_'eVi|$T.I|7~P|ʩݒ~lcF[%>;C\{obQ1kFW-){BFK&ͪ ˕2jJN[9.G{d$(_ǰ$:Zm883BƻvS6O[3SF351[1 [79M@'_y2N_ݘYPݩ.^ieޓoI4WvpgcfPFANrxQӚqF6pgܡp3FSrF+OG͞Ai/|Kn$ 憙YgCrPu0"H90Nx޴.4z^ܻTڅ Uej-R;6h;"*X1B28L[6DVksI6Op[(|g">`ۏJMpOU([a#F%B@{\֪Rhy#OY' !7) Z$ ?i6Q Sr\w__(Zܬ{-&YNI]2[v6Ƅ:J,A7Y˶Il4W!}*a[tq9;\8ϸL^K-$bYQ$+*xUcoxn`w\:3g F6c# kӢi#*l1qSQq O I8[Vbxq; %Flc섗;+D$Y89QEQE?趫Wm?"EEf^%!H`uT2g6AV-Iط fG[@RP}@+mֱ7:ޥ+F[SLZ](i_S~NķvuedES+鏔)#cw t"Ő^3\_,1 1xߌpkGH/;-dX}|(=8Zڢ(M5_toEjE5:$xD5-#-{e]kW1]%f,p?5 m1>$ )*1F2:uװhK( !iqY‘S"ï$o|zpjIVkY"fU<NvCN=_5[I#ˈ|y$@=Ak̑jmwV 2*zf]rhy-VnV, D'N;Vn]髧irG3K̒\KF3a~ss*#XOO?G׌??a@~ ]WˬjG30[槒R<+ @k[D[3WPPP iʓ?t';T'QB/,_*,xN.Nf/ޟVӖĉp xdYa?=s$<) .|ŬA_=r<i^1M|yH&:nw85Lj]2j~N4w,&Ia}H!8#{M5gHf9kG+xËmy hȽԟ;'j>.U Dz_ߤmx''k??^0 IOO?G׌??a@~~ߤmx''&z7K[g20 ͏? ex,`XtF1o)>ak??^0 IOO?G׌??a@~~ߤmx''k??^0 IOO?T-_.},zC5/%0oWa@~~ߤmx''k??^0 IOO?G׌??a@~d|^c`'N?=T5oCY=Zİa@]?^0 IOO?G׌??a@~~ߤmx''--֐s`R8c0 = Va@~~ߤmx''Z&`k{&L%˃휒U ^FFfji }}eݐ c" RTob21ӥ/jz6&.Uݥ 2rzFX2[-QZFڼډ)?)T #= ȪEյ62LLgqdWo lזdrZIȖKM@,v`3kz-/;x%81 1q9֭[x/dHdU ( lOe3@?)⋫Me쭯g̊)I r]j.` :yyTA# RoєNVUFхs>)? u-zeU}S~AH\r{㛝Z&[ӡҧ+$)yxFO#[zDv"}CNkHW82esԚ(((_ȑ6E_ҿi\An(~E. ]yi 2(RLOJþԵ ty~49DLb n*+m0cԴQEcYoڵFiڛ݈";w_Sywsky ʊ͕2۷#cw8* _jB#Q`E%+̘;ߠhڶ]Amm"ǟ?|Q: y'ES&P:7xAֵh @#ι5uM+-wiWsFA;;X;ҍܳM;LYUǏ;r2FGZδ ruo5n2*AB&Kk5yqv}9*`.O'{4QEbݪץ5ciڞlV> BlnHßj;xu[Y|ݒ 9ZmxYbpImU#57ߊO_euMª2ý?c0Չ|Aq1O]Y`9<O3~w4bfے58%xRF0HDm2e#qcQr ` R2y-bYVKoya|C t;~^;; m Ag@cW[`5.g,I*:csOUV@mH8fc<[68A # #;qVE#W@=F`Ga):> 5 p 4ZݝƟy=<K@wpz~ ms'_cuT#߯:M]|ԣ4뎜y'vɷq'ߊP_mKq'ߊP_~*=gQq~*=gQq~*=gVWuK-f; ,IcmN\ӵlH:S ?~*=gQq~*=gQqg$Imp3W1M>yOV$(je8tez xq/ߊO_mGߊO_mYvG'_ <1y99F5t$WK^\< PMP(۔ O1 0әӌ0s3jͥψ,dK3y?jPpF;; q~*=gQq~*=gQq2]k&' T|;x? iihhƻqJW 8О3(W 8^)#/ ey->"c͆Ց'$y$x73k&1uaDw!v<? N16ž"?U=/ X2~YA6UBz?o_' ?UBz?o_' ooGIi`E笹\̓W|9_g7?5m.[exx HOd$z:dMB{FpWHEĀʶOXrAj&oBZ De@09P>kxŲ3$Nŕf#w@I +&ڤroxeHIc8a$%5 ai$ٴ/v CV@NpjXuMVZ%⤆'Μ4nz׻s.@`ؘ͹? bY 1sjQg Km/䗑 qӞX3#^mj&'*Q\:uϊ5e' v$ɒPxx?_Dn!/ wq@L]Arb=!M J8 V}IEV5z{9k7Q5I[,]F8 \=1;Sesm ڳ[LۈLd`|fCs\߬aq ΁H;c<=qu-ORmXGb&wG玝h)MfWE kZQMu OCJ+gOC?c#Y0 8?LV0DMʡDetVC˩Qn#Az޴ѠHL@Q= t9Ѣ+FW-)|83m}a f@.J`CK #NOy5f/*+x-$ 2NIMOX UtJm$C:ҝ#M/tOx.[\θ=#B~8ҥIu\o# SNɜ̂S'8B3fjVl`I{P񬄓v'nYAs4Q$^}k$?^jR[@г F0Tm;lֈ('km!g099#z-{}oce>t"(*p=Ҫ9+K*6Gn浣9 $ʠA;d%9)bet %0=xm#K*T֤y\y n@Ͱvu4NIW{x$HqI+J I[pہ rc˦\H5 P rsil&!-P%2 'VC7Wh,4u'vK7㞦Ko [K Qu `ڤQEc٫׽խlgfiB1dr84۫\iMHU9^H= IiG$rvr$y+ۡ'#V Y-`Ҵh@XsSES&R:7xAֵhF Ckgmeioy-$ '$z f#r`qJ$1ToSQEV5گzZSQj٢ǰXvAjͺ9a 63i衞h3)8:䊯sj+}>oZimɹUSFFsPR6TO%"`brr 1FRDaz=(\*]HHFdt!`Uٮ,YABZƦH.>yvᑔzR{ӵiwnڐcE,i2č]n7|n- kOyD/pY#ۉrd{bԯu+/ D7SE nʠGz߈nMeR<0&Ih;璎I<c5Y%XMAle6bBA ۃ$u1KC-7R %/!SvU3&֥ ,bR:\B )2ɸ Drwol 6Km(gra1dU+h#dԚU7Z #5#Uq>vv @ cbSG34kԅ׎2\Pztvkkeln#[(CMh;;: >A5* 1vzMs a\z{@<;UŚ%I-t\gJm:tAiˏ:}5,'[V/G׿qگ_ EQEQEc#f^V(()MfWE kZQEQEQEbݪץ5gĂ;kx.0Ygan%RIk&.{t=}*K5mN%.2-"Z/nk*^>!Uu0`+cM6opxKIY7*|BG\U/-ĶXUDk N%A|B5c}_sCe:ՎCެmm V@t [75b3Pj+D֯_&$+.88?K٬msF$bMq&^!#CV_.?vV?.?v[^i S$@`?V?.o;G|EA7~!,@r:ĸڊ=+]y5@f;M@xӎI51Տ Lww2wX-8A9=sW:R#RI"F8Q'|1ZܣEf^OM6g$CO.`T 0Wt?2ԦfaL `wjؼEA/7^"ݗ /nh7eFKe)|UFVOx*a[ۛC2= ϛRdEt,J#N/ ๿b\v5mMWX-1$qq޵~/ ๿b\vZxݗ\9/ؼEA/7^"ݗ /nh7e}_s>/ ๿2[/y/nOÛkiFO3?xv_.o;GؼEA/7^"ݗ ^(\ $<j;U֯mZtvel/_퇼k%nQ7" 8szdj/t[u)kǩZwݨ,84rC+\.23tgO^"ݗ /nh7e}_sګGyU_Zc7LJ7?5pSj&鴷DE9P9j1jQZ=Eu9VGت@`vRXݴ}`k2P I]Lec/$'R6.Gb]{' e$n}rG 2;5j:Eb/٢Qp6 @%vCVLZ UʑKDkiSj[gg !P2 s.OVlU\ӹ5HoRK(G4aLFd+0  UvX\" 灜v)@ [ 9ku={"Eeϊoڵ\jn9w0AqT <ϧL< Y dWlF\rj776_`K8便[Y/9rz;9ׇ$).)6$iTDP`G\r#&J(d_YGF?Z֭Rյ/I8oZvYC i)8^UdV#||pN=R-SVM)}ʸ=Gxn1g-ܞ2NIqY+FW-)^H5D:"(XC)exdK80[ FEMEsBxEF@pT8 :V?ſ+Q>!TxYV U{Uk{ w[f 2h##B:{{x|W~j%ŴFm08 ~- ~- ~-RմxU9$0;UX2 皵}mpC[5ۜ01S5/ŷךuw>)] 5c#R[AC5tc3_ߋ7G>C5tc3_ߋo7QCFė6|gǗ?ŷ`JP 3v0ےwfGjIC5tc3_ߋ7G>C5u#TIP,#! "cN O56r.6ۈlZ=+S5qm@1dS?ſS[??ſS[ʳҵ}QU r\Coϙ8oZfn}Okofn}Okofn}Okofn}Okofn._`uCZV'O_De ې`fC5tc3_ߋ7G>C5tc3_ߋ7Utky|Mq{-)?NgØ5#sZǪM8\(T䌠 O\XzM%\,<)[PC08ҷkOXrAjΜ\Z[KF9 <ҳEURG щWqHYv }2 g&6ZKm1Pe'q {Q^ܰyr"AAS SqnXcp=B y/2jaok3n#gJE8sR~I2ͮ=ZdVQ.#>FR2:kSGRU뛋VfI,.(P ORq+X/n]:X&g+2 d"a<- `q cN9R6WjE{@<0$Q a.# .`JDg}x89; .Κt e(b?7857mlZ[_?!>`y“YmE׫i=Ec$R%N0H@b[#5y]t=3]q>p$ Z((_ȏ6E_ҿi\An(nVڬ[o _38!pqUwk$O{chZmQ<4(9_Zi:eT[ y`n9TQEc٫׽իoY[@?t34R tQEQE2o/ ȣׄ-kV)1JWJca]hoy;,88 A *xxPtm'GMؖC"ͦVR7nfstpYZڳqPI8OSEi#v^՟ir WWS\.'>rtF$PpY #zibmmVFɗ,+ |Uu_7YVZ,U?u1`-=wڬYդ^$FUr21E^][Vvʘ+ U8eVVum[KKqng 硍XIT)I$}kC o5_7L,c0;O^?aMC}CxvYx:RD"msek$0HmQ)5_7L:+0jhxLm|5o  cebF6>5dh35_7YMYZĚ0C4rXT,D2@'N}gE:Pʑ(RvlEe$ -\I ЃҧUt`êP?na7?0?nu_7G :h?Z뺔4(mnpe TPaCZ,3?7?0?nu_7G :WkƉw=u+H#LwCڴJɞ~P#$i4KEa X3b:w :WsC}CUug|M' nK-3cOIbw0?n$Z?j%^$~;uo7KsC}CUt`êP?na7?0?n.p!s ~ShP֋q/-cZ_7?0?nu_7G :}P@81yuZOѳ[_j&,p*H @ ;-cW+Pfk2W Fim,EjZ3k[XC9qr6=Ư :WsC}CUuWF{?=G֧̜o7(Y?ѭURw6)[\Z HJ=,5 `^<.c0cd 1?37 {=-T'=^QӭyDl,L@kw~>tV3AswnRA&]r8˲_2# <s{[QZ%]fFHʄ9I3c}]ZոmNu #L"h\)*r>ݽa}&V i`F%X1) :S\2G>,oVyʎ~R g#?1n/u76:sj!@Πl "6X^x.ēiVy}:c]Bp\X.Uϳ|E>PRH`Q[OHk[ɣiv?+br 38fhRɦ4 RD,F|D8<=im,oF 's:mXRĔM+KckH[d(e\drO.~}}Z6rIw:3#8kb$x/MЭ))[dU2,(pN"K9"<62{{W8J6:gi(+$k mWE[+9ˬ{`l;/Iqk*My,\l[)^ %ٕ te]95ite:؅GsVƲV{oX[i֢dxV<;Cy`/oluk0 'z?{|;; ]6b:E\B3RӍX+`RVW[?]eXvѼCn0`'*NƤOn#ݻ3Ū0h(V-4}2Q{F1,p#ީO .766 ig~5{z=MK1l.psl!Lf j'I SP}؟zUu]?MtnMm$&8#$}8RhZTFA& mbm_p=+M3EUZ -qdcE֏am,0-ƭ,Ӷ5ծ9p9$ ˰H'Ҋx;"Ϩ\/yRɦ^\2et^v0JrDJA5.u@`HY[.ZtLsǦI¤b5ot1e? n?[?]Y[.F,VG#_xvS-֦p>pH#7voZhPjwtV[?]Y[.F,VG#_clu 8צ{eGb0me=qP\ʗZeF:`>wH>`N1sV^%o5m.ztF,VG#_/տksŗj5*ömR#u[Fp ϙޯyeDmwզ"Ab5ot1e? n?[?]Y[.F,VG#_/տksŗj5fD^j)YekMKB&pe@{ b5ot1e? n?[?]55fH՘Uꦝii-л,ڴW(A"B:hUaZW0Sϱ`g?0*ٴǔ]fU~S] # 8iw$ڶ$'hXdd&?1 U@FI<[?]Y[.F,VG#_5v'aI_Zgo79't>8.kTPϬ=ˣ\FM}ޡ@qgFc+%Cn69;kOXrAj-.s;M W'ΛE\/icèo 6pl/iwM5#M`o=}PzĚeug0Dጌ" }гp]EEũ8uTR!kvL $~=kGV'agmlcd[l\B=PH(gYMi8+Bo}خgӮ-T,3Wny*rX9`tKԏy\mh6n=[~pQZiP鶗q :tt ȓN:q+[L;4lVxuSSCJ[/2YpϼO9olaZ&&neR4{HYc$;+xPeP7zKEQEV/H׿qگ_ EAjKqQD ߒy0O^+6Wi]Z7`O1$RKH;nEupXd}\vEc#f^Vh(o/ ȣׄ-kZ) r°kE(YIaאH#kDY,6/B'qzd:Abq"w v@ȭZ)hk?_Ц'BLd:%.dAĄtV[M.NjQ$we+7Bx\4]+QӤ9fsŸl뎕w]'yl]eXoK6W.aNyj/g]mGE4'}s7ԏ-`Yc^˻K<6o./wX.dRB-ۛe4 c7J|1l]2_ i1ΰ]Tof{ 3U}mh/q<w114CUic/'8OIZD^f7[]lSMsal9 If-ܢ쒺]NV9pwzgWHjZ'<6o.Etst+; ]'yl]dd۾wemQΥL:sMh<>m( %!P2k%)y kG},1}9wsNWIw?7G"Oٿ?<6o.7H.6$͞|󻞕g;¦_+yF93uٍ{ۭXCBr == Com; /KhxI5QU槏K׆+2sWR wom'yl]?fWIw?7G"Oٿ?%!s_fꇆ5}&WB͋ɀA6i+; ]'yl]?fPBV+@}nβfѿV[GC6(T+!8ԃFƸ4ִtsPF7*Rs2uN ې @'Oկ7l\ enps'g]'yl]?fWIw?7G"OٿX'`WT6֭tؓڬtfѭToVK{}>FT;Wa@X9=6i|7W /sQ!l^Hp:tE5+FmcܷZBt-d?ikdROd Vծ;+TCi c`N0s>֮./&tk)ނ.Us˂{˙4qZ\31D ;qa6vmH gA9#޼Au/IX嵺X0syۂLk=#ՃY+n wdvد4MK#ٳP[ezkRܠJUWhl 9۳A͜FqG*X*kWZ4].64 8sn8GF5;Þ.ᵅekG@$ :jUQ((_ȏ6E_ҿi\An(T`c㸎$@ o䍇^R/ MflImx,W"+$i vOls;uXim;fYZB &Eeϋ5or-[×Zz}V ;cbSuj2ޡ2ZҲI69<ެpsv52eS\nFxt2}@̶y,xU8AH=kf(7toQѿE8sj~m_hY+`npS6?:lkP g[CYH}{: MIeIVE1b8'':V-QX֟7jkMCWLy>M#Hs'$Y>M;~u?ӿWM;~ub?II^UUY$->g8)ί;G"w9)ί;QASbkRq''ޥSN_7vE4swhSN_7vE4swhSN_7v#02vy֗M;~ukxCJwGiuVh(X%N1x?:ni?:ni?:ni?:ni?:ni&vsO&,RI#}^ԌAGjrKLDʪ0n)ί;G"w9)ί;G"w9)ί;G"w9)ί;G"w9)ί;G"w9)ί;L_i++̲G;b,p 9OOSN_7vE4swhSN_7vE4swhSN_7vE4swhSN_7vE4swhSN_7vM4_ؼA C qơQX pN;M;~u?ӿWM;~u?ӿWM;~u?ӿWM;~u?ӿWM;~u?ӿWM;~u?ӿWZ~g48Q#]K;̌=kjDd P  C A04"`R)S9nH[P@F)S9nH[PJFIFExifII*1J2fizACD Systems Digital Imaging2012:10:18 11:25:030210203dR980100d"u   $%#& '8Ixy!"59W ?pqprblFӁ'$erX8yeQ,Ԋ&w!ܪy{4"*Jv9jV1F0&~ ӽsvKHevH9WB 31J~^;O.}sJYVٯ@02R(|HcRۉZ%xyα{VJ5/UF .}p"G}&ѽl]8 Jex*YnzH'Iw_@-Mom%..05ݝqՓYB寵#-D\}נ]3[m&1ŨwQEm#_fZ7<;g^6ꯋ_𨓠߰ߋ4Ɓ!p qm٫nςlac(OQVPOkdh۶+E:C׍{L`[}m;'Z9yooU^)@D0H hn~p:G,MeCtUuV:׭ip',[*k>"J8VO),ؤiNp2Xd[ MaTc* p֝:׭ip',[*k>"J8VO),ؤiNp2Xd[ MaTc* pÌC:R/5oTޘH-&-nʿ+{(Z!zT EuYi|a Q[ ̈YI8زz{ ONSV#־O Y &p-RxVZjq8b$גRtdL;HMńumŞg'ds{FAI|j{ {e]wWu;3^ !zn6s]հ-bNMO%ߘGTLrZ$fK~#!1P./)7i.?죬@}]yǺLOيgfk5O/OϰKڻ" DbWv|jAU?w:;?z@W oMgu"/Mftf~^~#>)`:Tc܌:GiՐջ{l22z7q1%tEt6n_;cՁ5m4GHj([qpq&')M!>v^OxejR-6,&r,|1C~JjCo}->p|w߫~;/揘~;oܽɋvt8tXk`>US]by GZfTχv*-&V|l,>@'sYz(y]YelGNQHӯ'G/8DuPX*}0x)mV.b_jܕ$}&,Ē'? 靤ށa,zQsӀ|cbZe֨҆ӊ8bX̨!]ceuuTp_ҺG$Ca0׽z/le/p{Q6! ;<;-Xݩ==CTX8XrԜ-WlDVۇv]3r͟XD<>C;{uE5rRnd8h}q7š")·Q1۽;gfth`F-u% O#Ny}6[j^%$|qXDMxN1'O-}J3:ktosPm*4)Lm>o :ڪ(즗]r$ֿSҪ a(Oc:&:>]m-/Djg()iglIYʕv !y*'s!^; Tu3&-R4ŏV3;gM#>7{̚O&p%䇐Ҧ! XdfFZgA-88yOMS^3Lݶyo'G|KۦߔW\La=lON}DapǕ'T nڞBU1)7!5Mn<w,WJDCP'|jIwa[6Ƽ  6lNj٭xU~pb?/LN\2bWGMi'ŤXa@$6_T".(c "F}+vQ -dkyV!9K[ [l `m[h!t5yۭh_#9}YpT՘ 픈SnwBNôP͒CseگКR~\z*>#JK_Vq X}$: r?;0od7`!8INllwh ~P@q"7?]B( <(@ߴ\k:}ū6{jϨ:Tz )YY;l~sT?`?M$cwfA]DpaJD9mfZGS*OL])ZTca+> -6&!F&,n>~!Rq>?Mf-onX ܛ󝷌 ;1cFZvs܂-xze?kɋ^Mz|`f~sTjzѱ0]Oςm+!c T%dSz@?)nf 0UF&Ŭ 譡F=Nހ.$0l_ g>s]ۛ}YZ˅VXv?u~4:֨-?Otr51Ma|4M-Y+Bƍt\G3%@/\c:q!{)PxMzQoLY_Ɲ]_{9584LgŦe YDlce$zoQtShs]ճBNrpߚH([NcrWkv}G ÛQ]A.)`QPhz!qnDc/:RHh!]wEk  w jV[TOMG$)# \?<~!>wG]1c>Ѩί? sEgfTgi.` 8'Ĭج;$C*|l'@,byC 5 4̐vKRwy]8LIn@'Z+-aGߩ*eH„q(M4T]zbnZΛwF࿫amppmߺaXQY^Is{o ֹlf왗-o]ͺl w`z {[OƗPutPav9t-jYC‡7KϦjJfG{#]B9&G*W)J,%̨p?]J0Ni鑋1W^R\2!?ވ,}`WB39?s֨ʌ%GØd`Ze_/$s2ř S(q1Y8Yݝ~A桴#hCt*j~!.ƚ=d`$ `:$S5[?1 uayL_(z9E)+{1~/ \#RI Nej/mRHsIYi5̽vKYbm;!@%"&\N(f/Xhסtsi2FQYSHsm o>9X$sέjh5'4;(9_-ԗ@tWF !y-ƙ~ v9|M Tˀ&}x^Qa=/+??TL#\ԶڎyX⣩e:S1l} 88̋ػP|#bVKF;1sbtHiآXL2PXȊ f[k:p)u'_pbHCU̴QĀkLv1U^z(bbC$3"0D)&8&jRbc]L2zcdA5J|}m-wZPa~IT۱-NՔ\Z(+xrVTWTZAp=2Da7۟^0X9P]}m$l>m}Y5s_P8s ׿"ލUlbG`bM:eӮ8888qu_pĖϖ.QS%ET)lړ>0Lf53}eT\Ս׭6:5G7J&z:G"ihidWr_kA9n; ݟ;,38'rkV5LZW!CٍL`5d)}jk:لZU9zsTa:z~<ߚ{'ƾ_4q v`{{j}ܗ?yPA9_[4f~]9|50yEFfK{[rPli`E"TK͉L\?t[l4x}}"1B! 'i=6\^ە)?6j=cH \1dc\[3ǩ?)1!%vbSy1kދ]f3(!F ӊ8Qj!+f}M]">pJ"|Gh{ois|$]Zڶ˷A9%BOКvmX90pYSC1=888 gc}kh:96X)^R` +]Ĩ:![m5iKYO,r4_ziV$CbQIfmxZFT2*tN1'p6`v9"q:;Coqq/.B=g7]v _[w ʊ нSڷ@O \OOD'rEȦM}L4?!e}d!-ֺCh5 02B)Hfg(kJ\ "exV/.Mͱ*Yi.™gs&N=wNػyO-f5 )ܱ'q(xq]kWTe^ssM{^7ہ^B3yF5 z[Seu VPɄa/)˶uk.`GVqՋB|~_k@ 28~Lg'˟K+.5!2LILeeEe&YX /Z_}MWvScv2Gf(„ܜTɺ#6! 8 xyz|oG+.=bAުߨ6D')V"] F~Ju'u [7@l9m@&=k=|ƱzxvQ4ۇ4Nf׻7!!bg R=?^os:,65ƪ^úrbӛKN}9 FaqŬR ^%]M3]15hWN׋9ڬ#ʝ888888Hu @q2}=a8>=Pf[ن oy'Xeࢄίe}!juQQY YihbJ`ʉꁇ.).#H ^ ჱ11zspqpqpqZ*340UbVlVb!i|6hd1LF>Y(M'Gu3_pwҔ##،ك.888888888888888888888Dd$B  C A05RXv4D_F,vJFIF``C    #%$""!&+7/&)4)!"0A149;>>>%.DIC; _ }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz?j(i'+6%¨85jЀ(2ӀmOPE^~{}/642KqbY"2 qF{Quma6^=  l88uR4&6J=3x[mqݺ\@eN -$Hi$uD@YԓKKEQEQEQEQEQEUkBMOw!D-BfcA$ )Vqk1zԞI$$u{eSNq.V,@Y'?,rz:Ȯzt;YNlOlrUp5(,:%L($G++wR] Dc%9`b8'@@vK1Dت 2oeqx5EQEQE%аӭ𠑼6G @gj:n4*c;F2HzmiKujfhmH` p h'uA,yvo)@r^ +Z"Gtg\VVzլږ Zy2 K1A բ+PėiJTEH;}xĪzvWKE;v&7# FO { +MͦYeiPr_3[gh x$IbCUu VNMM&$c8H(Fj6zзmtf }̻ArpCn AݴsŃH_`&-2ÞukREry;GJlcIrPp.;dODwhQIj|Tkoq} Yᦵ F7V~$Ѧ9V7ZX9Ԍ*amV+&g]ьTNvz+&k}ga1,;Oɿm'djv?2o5G|I@;7$ QMƨo?c&T}ğ>OɿAj)Ut+[(y>V 'J=u'=2H$X]iasWW5b\HK*H(stqkZoz! нʣ>#=Ɗo ⫫D,<I_K0@97+cmȶdwGinq뎊s VVqۿ1Z7CsMNd%*xn>VIEQY~gjw>iMV`28:qZu:U(-u$#`NNs+[ G=_4qq̍QKfE\ $7 0xSƁo9-I >_Q3ҵ|#So+=W3-#k ڢ+.sG+YY+wY (>xoKɧXs SiS Wqo@n5}:Qg$<Ԉٔa+$c%q[IQ(D*2m"kIDx啋Mo&&bNK`}$'p'RЮnk͂\6 py$@!WB2EikHP:+QÖs:*ƑF `r"9gNy$$ 6hM '3|l7xɮMgcdFi,ds ^]:O,e,bNX c靽N$?5uvbrCFo$=7!T ԋj1ی {^k;x#KI`n OzU ihu5iE8o) #;F8(څUjFvcpA$ U52KhRnyF5i!Pp8h\BXHYXTi$c9UZEIYcvsFL;sN}b/HUP#۶-۝LլuiHS CpAZkR*)';@sq<`k786(w;p|q $ `m,#T\XP-=kR([iBʒ}XI}>4.Aydq)Pqm3oITML[]L>֑Bb*ccVW-%]6fICM4CӾsu'/VՌTfmdAEiڲkVowKYg9D.`ᓂ0w# {bi~Ғa#>E%{r!;1;i敼;+^~lwuA-LRc!ܿLO,{f  7r0]ǦMgmUb0䋏#mܦ;ݎ*鷚>uwFD[P]x1vԷr_@m$'؉"ߌq޳ehI#3Meyec'aX| [k'MKA"ӼT;"88sֺ((ťv ɴX\ ԲV5ı$mÉ*K! 6pKrI\uDmV7HOR#ufӵ+}N"˒9c()p~U(mđ܉F܏ 8d!Qzl7{X 챂`o,^O 椠 BB*0Wt2I{{5cy^R$;c$I?ROzEQExVRIQSanm4@y8bN0{V#V:mŽ۬O+T 0z&nf7vUnѰGQ9L}غ4KK h2N [ ,/KKYFUs%NBU윕oJEQ,&Ky- Y^H̉rseӬƟ[ه.!&1wYmA}{Xᴃl+ [nxŠ٢#hVFKso D|X:u)ƈP}ԼE=V@ ?H-BA+.x'fHۢ((((((*9 "ʹ2)*lA#<֞=J(.I帎()*: Q9QEQEQEA{}iIw}sx,W'$?xK&04-t (NpA:((((.jͨCtM_]ۏ[\M+#2mA#1]d'q[jWGo2[Q)c$rB)QЎ* c闍o /nQ$>򞸑_ך[å:YEꬬcY+~U8=x!M_Y.ֱMl(*HO 5VS| H.UC ۹Gjuu $VRA4PEn9c%IrqY_ڞ^ɡHI&= CIe4'L˲ p"[Ϯ}y^^imd /RpĀ7J>[_i+>gx #hK4D8Ld:֑ۑm䶁ρbD  8Ɗ(((((((((((,QXD=UA)"(d1$k¤[VEUpy5n}ai=w>7G"OT) H8*( O(Zj0o-xՃq0((((((((((((((((((((((((%Dd8"bvvB   C A 06R=%{N5_MӳC%2|F%{N5_MӳCJFIF``C    #%$""!&+7/&)4)!"0A149;>>>%.DIC; p }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz?j(()((((((((((}m@&v X*#;UPY'QFgfrbdi I j1uU%A -tK-"dɌY@\9Sn, ]@#8ƝQEQEREQEQEQEQEZN]2Fvb{*%&:ƙnYc7R۝Ƞg#5o-3hJH# ~jۓQO\#Z+w qF3˻գťО-]f?qej\wo L*'is|o=ꍆ7O6>-Ϩ̈B@O^ͨs/*F ӑ# IұLjt[Yu"zL=DaQn`麄3Oiy wdVܥ[`N2:㪚Т((ozly%]]܈NdX_?&wϡeak[{8XyV'''ޠ/[V5-UqpAQEQ\ד%ݹ -hf(ϨT4 ƍE%[O II` p9 hvES'إIxoghDf F$t:WaEQEQEQEQEW)mhcI݉=Oꪖ ĴQ"X {^:+{BjF]@nx9g#Шfh!Mr8K)?ME`IloaIC&Bp~n${iT8]!\m$`a?) Jaiu"Fꏽ60ۚiM/4$QF݀UQ$V64W>'ԧT)l$F Auw+̣peٞ/}b6*ݷ;A|8^KX8i_uAZOT}yX`dv>e {Q;Oq,/4Y#gjEɤ1B,o)E,#Lnl$ r+b3a ե hJ| 19G%ɨ|LZι>$P3XϘ9L-G'A['ڮZIJy Ie3.9-x:pGK(Łi1kXv(h\U$EWҵ^Qs[qvbUe".1 KrN63dsOqu5 yJ`Q7-jm3Dx7|dqu] 9-#cr)ԵmGMҮYl6rݣ-Z4:p\t=6mujVAA} G)$m6N+VOkˈ0 '}I5xU0 q*vz}8Јxf{+ô3#TJ/5 n)hKdd0 #++xQR8"*Z*+tx$2qco?YiTm;{j6-mS_rEQ=O]?ӿ綩k9G"w?mu([Nڧ iTm;{j6-mS_rEQ=O]?ӿ綩k9T=u8u}f<ʒ}_cb >KQT59mOKdٿh=xȵWqO<#&$ Rާ˼?:NY.n'*#v$vO9 Kz>k}qhَI"V$aRH`;ԢY_6Dckǹ&9Àaʵejv]޼[xU 兌?APj*LsW"-qAH q ծ$`=ԌFNqkMu\Gy+oeyR,RB,z̑I;u`D+8ds5~ .D$`#oKE YكcB R]Eu4E 4@<%ke$#q 0*cH'4sF4iwoyo}Hz#(]bKp()sЌ֏_ɮA,~O]h%RH A88ڎ^ӟTYs̬BQ,4lS>|n]6JMh3W`1[q8\?'6@3ޘa M FhA a9즽.(Cu̚qL˖`RC3c OJ̰ƭH`'"JW ceg#Eƙn?cϐƞfw>o1UKAawqZK<,<6@;.I8;KȲG"GC`yTwvVstRel@?AzcHfy $N nv'$8'Cu$ʥ^92WUu9ٞY DS͕M8`ؤEڸ"ҚʮC+ FAg2'ǟ*33PcqQ8$|pHM"{_ōBʹL37ЃS Z$[:¡MB9?dxH Zͮ]rāYR@W Iu-㞊uivY}<IJS黡;\A #y8A(ǎ fٗ7z^G6n烷ڴ3w=t˩ X,@p8kO:WnoxݱqkkƃuC  ' GO'Yk33xL!IvthoőiURuI8;I$ J6K.ʯ @ /F?[I$ְ4& & #TQEyYYDoD};'PhH/XLc+q bu%[[x }clp38 \J*I+ޛuim}lv\A *VjZZ|1\h" Ibr0A"oa *h+xR#HB""UP0^îY]4)tk{Y$Tra$2+NF]DR,$+`JPyYOoKXn T veg8޴)hM! $XRXFH>W?hW77 G 'J2y{}ޙo][h#Lt/ښ|`2+) sM4?PU Y%#ڴn! MnےD8lnS>ǂ .Y"[a)e*-wyvTQMwXiTOOF`D22' w`d9Q\KiFnѰk(P]'qh=Zh1 c-!6mo!*H6`xUf*і@`FZɵPl,eޫq&g0:[ܼl򬭱bg\ Cs׺ yd`OCFN[k8W$" ry$y$MX(oλsvTn/ƅO;f3،ϧK 1[AEj*~whd!I u qRxv{M$f)%gApHy5E2[+K86ohXi)eߙnǶ1٢WC[Z2fݖHA}^@l89&vDAe zi-}o: o2FFnp{UoxߍFTMi i[ 7%3ۀ9YoKjΞmfanrB;kР6k.FpGcRV~{5]qϵ8w'8ɟ|օREG4Bh$RȬEfynZi$_{msH.HsϾ;B?QZp)<$Hу+)GPiQER1’8z>5XgIK[?) }S[QEQEQEQEQEAwykڽVGrp2OHfڮżriV[J e H+U?Mcu瑷+r??ˠU(((((^i>I| \*ۿx m+I,%&ES9$]KEQEQEUҏa/%t()%HJKԅbBdnj/O~EQEQEQEQE[P{f}> }OpΚ/WTy>(Mۣu[gKEQEQEQEQEUMOLdx$9= At5B*F"n!#`[AcepH Z((({Z-B&oC*rW_zآ(((((#YVPH"D<8rl B)-(^f&YQ$E$F82'RxERKy60P`ǽcȡh VyVHڊF>a"cԞqՖurUS5)4v68l\x~PЬuKQkw$(F  ң&g=\ǧIJ xV$nọqV5;=N7o5Qn9<4~bIVf~K#ccY'Ӭ徂 !O2/0Xp0}e귚VEXQ ̸vFޜsNxS76IkwQ+ɰ&[dzt-YP?0HjOIig+| l#XT rkR![;ؠHmH$uv5׌MmvUי7^@@f۰r2T KP˳LݶhR%k,r!0>$4Zx.Gq@#àL#;GF:QwѮMp amհw0tht7#W˸#N((z/Ŗ-[yJyf2rP{76yc%[YGf!B?#3)m жe)QQftɥ\G%!Hڮ!h=Nz桰5^lglT"v -=3]esdž/[AƮEiGZ+8t2PO,lUv8(ԴPG$JJ9RnG9yϯc Z\Bw6+Jf9ʯn׍mEMH#K4IknT:njZKI]݌VґI&r@鷉H1>۹ȼ־kugf [^// c'Y_W[XP $] 䂈@ݘZ~{}TmD.pG~=3naӆVO`%0ݕF1|+ZN]f+ !%{qҵ((((+ ~T>|W_"I.f#IlH=EcKX4kw#M/,h-lۘn==Mo]&ky6"mCR7gSE5ı"=21Yr_ILdz;|CKh-uX7 sYy{֥aLBʻX,Ey?+drxq(Ku)L+)Up0E_텽@I%1=K3XRI%l'HXX+f_̀fb FRf9}͖/ڸa"74ۋ8e[X7*p2ši4 -"3#;0@;'$`>fGM\O#Iu4ɴvJ Nɥ:dsIs#?#)I8ޯi<ҨU 31QEQEQEQEQEQEQEQEQEQEQEQE!Dd"yyB   C A 07 R !#^KGo_4[\ FT !#^KGo_4[JFIF``C    #%$""!&+7/&)4)!"0A149;>>>%.DIC; d }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz?j((((((((((״%]:3ȌUxvW +<#8#N,B\,oe26A@GN=.麕fvn 1P^&ҭEQEQEYu 'O[kq*x r9f[WkuCKpZ0sèm u8QEQEQPcl721I$$@rIsXbY$X[鼉n@zgo5zQ;Gs[iTT 0ʜWk3Ŭ6^o=.ev w#l|Px^7hO B]cG{3 ͤ Wx*s $X ȚOC5iOoFX,y$9Ai\FFcr<j~o"HyOQz{Iȥӵ(58^XGY)< 89n(((((5/&{}(,߸U$rXtw#-KFX./*n[,/qcFGM?RԣvGQoBzEVSi$3/9cԮ\Ekc}k yՁ!vj:Wt"(/7SCs&pqލK +HX2A>c<9!X."1I\* Heˮ_M˧hRƊ_}LsSn8# Gjյ.-E ʰ<n5QEWIlCg5{Ke*$aܸ`t#!dڞV .o>^^$ y8Q17zGo_u ?UYd2qH^Eͅ:e|ܦ1pq 5/ta]vFMXK&ۍ!m66,x=:Z¯BzᘒI:EQEW)IF--LZArDvrDKqI$P8hbH'%U(WR0A#`xz%[]Mn64-IK$,`Tv{S_AN5 {o,clF*FZZY.fI:fTF;OQVR% B]$NM>尿ֆmvl[q󥵱e`AWL)47jQQwt =ӊ-&koeaNE y n `N2^a# r٢(4EեӤ3ku#?>ps_mcKHEtgEQ*sGAL-W1ܣe;W8})kZTrvr-&D8zxEy/#N}NA?4HGnNu <@9:[\w ZڹW![p$?8}f`w)@`"+FVSG: b}goo57.GGKѮD|jBJAyRyuѼ-X] ylP$_-LW(se8[.?:n?:n?:n?:n|)Gu~3wj/ xPxb5OPI,OU\_SKquk$p.rI Z[ Z[}wl~)Čm=O$@V}/Rkdյ';D2Fԟ3 ? Cظ'vGdƃM>Ke}5Khe{)$t# z^]-ZAGHVe 00$]bM9:El-$}I\nl[KuHd~YWiu 9 's֥=yG+R&p}A2A}nK"99e软6bwfdmwxdp+][h&4$-s<ȒTB7DVV IV|F{[jW |(-Iv6qT5SFUJq/0r Y)+[Izv<WUwdhpF.of+ Z-p+*Dd[x#ɿCv׳]#&P@1[՗sp-JEvSn̚PVvb=C[?oi*sNnnټ:Z^F\ѐ*2҉ ]e0$=om|pq#9xsZ5 q1_wXw!CtZ]Ŝ1(QB< & QqlF c C ism؅_yTvm<y:vpX%{#OrI$O$I$I$jz<`Z+\^hMc;w2㑢EJ7`;z}?LQ4t;y'tUνѡu}PP͎"`*TXi1Xwu nX3QMeknxC6vObUp%!FMtF$i+ΥDd$ud{=4=?ÚZA5ܒK`2me〪>`=^(((B VéC.mjo$yX* ) ۇFI5WE̫H=LOb7 c&epYNCЃSUԫAZ~lchoaITtE䝫N2M^#I>=7,wfXku)0%@'VoYL.>ےm!=z|@,,E\e,eΡS###&_1I#O4b;vYD$c>8]-l int#&ݸpwcJ’ےE E>KwE$fnko-*c5%3΋Y|#Zhy$qwchx㸂E)P::R2*J_NA'EQEQE|Akg[ūhFdXyc;~l`K@u.b.B՛%@*T鎠((((((((* ϳ6[yl9k^xV ."I,2du30`p.;ɴԷ:Mk+{yZJJLg'y$}>OiFw,Eż`c{e]ܓQa%7"og34.` ޻pݜ)lZn&EhbȹibfP@NZZH-\_VZbA1߬wp00 2`BlI1r+ :]I#ԡ14D-Pp2Ǩhz֩㹖QBBȩGgЬQI-g0f. I3׽_((((((((((J()i)hJZJ((((((((ٹDd B   C A 08 R#fo ;AJbdFfo ;AJbdJFIFExifII*1J2fizACD Systems Digital Imaging2012:10:18 11:47:310210656R980100"p    % &($'8Xgx ?" """ """ """ """ """ """ ""=I>ۆq,Cluku5IwWxWplEU[bL:_zzakQPoskyW:j-KZtTzѷ] l `Tjkc?k)#ZÅufZkH;e`}|_x*cӮvil-Pzޠ~λuA^EGÕb3<R Ao]jFXWc)(QńrrkYhմ)r1VCR 'on5--#x#+m;kt4#nӏfpk*g=Öv4*TZ:JU ;gU -8|0%ʤk~1j9b`+i;jFUm]߳A֠]6VҐTfȯڿu3aL:DDXVЗ{㝿j2XTE[;X`$޽=Z2v%Ǩ쾪N,=}iwUm ʀn;_lgBDX;ړ9WEb()핼>c5 F]gW mpoYߏToz,onW_0YTX`Mq]Ӭ(:p+q`T2pYh8)iv'o+`Z6Bω_> lzˊ "B\ SR{"֌|vt>Bp;@X?qO.BkpĻ(@[QJK(1X-dS]kq5@qwASSEwiMc]Mkōɍ][C" Px ˋKA!!A rӣۊ0*u~::@YMO xܓi%zC8Y65Dc1m7U+ v)H4\xdZ YSo`bmvNU흔A+ٙ -|eƼ :Vӗ2DI *@(Lz+iiK쬱9{]Zh%@ ?"tg\2K+z oSkGgqYYYY\c*kW]nc-CZ5oѻClUt dK[,*)>kqB2+" ?I`8gOwl%?,=~W4gJcRmpqGx-ŢՖy4t4u備wtW>"" """ """ """ ""V.kiNz3yh{ZV`C;5xӁ~@MPk]egbR^G8Ak:q#oܚ~h9|7kavNx&(&?hd}\O%hveQ/'VV,,JrrK@ArV``Ws\:,(,;]p@JJAoSEAESissi]Y]K]_ug_߸߃S)_߸"MNP+ۣ#[e~>]WtџDDD@DDD@DDD@DDD@DD]= opȖH8LX*Is׈V3ʸʮ'y,jD=W7`T~hk>}Hg`:uRC}cb$0#ou|3<(1DQKiw#iO?Z%(,qD_ꭒцG=ONj-}U99fˣ ".iξ;1l"?s 3x0K0|x*i{Ǹ9h-2y WZ7̯tͮ%UʰƵ`YߌLsj/.% :]JknّܼU,E ݇N]B5lW&kt`Kf3l+;)ebZnj(mK[הQ!N=ٸokoTni.*Ij9{-V%i`GA~Z2 ?rYMU-bCׯrNm/k9UDpT;$Vi3}}"ڜC(EhZQ NX U1D6-~*fjJ)i"Lʻ|jKRR@s S]kG2p\" vą|^jɱ 3( CܭN/}Qߵ笧rSk쐡p}h Q:MHY3d^L^Lѭ~%A.-./3K sN΋n.XC[! e^; Sϼv.t*Ky*̲\'ekG+&+_:h,ȩ_$9qTƶ<+hwJi$ `njUC!E)|Ug~}=}/afs9;k_7K楙lWϲuUVUO|W1DztɆG3ּG9mw@;s;x^m_jbYoZ5c\! 1a:^$K KXz#(߉9{G^mƼ [|Ę,w >>KſOh-b#: (BE&-?-0=@ٙDۀEK6 Z` +vZql?wL\%5We}zLr /';V>nKR20ŧړT^[`"-s &(R, iVU\fg]eSdq\UgsctcXaXy8Mg}sxiӴ7Qh[(\&,!G+qZ+Ь:1R0: yބ MkPmRӹn3"K \; |ug[ƴ8Nӓ߫u? XY3Z7hڎ"" """ """ """ """ """ """ """ """ ""Dd5B   C A 09 RB|=aqTrfwF|=aqTrfwJFIFExifII*1J2fizACD Systems Digital Imaging2012:10:18 11:47:47021015{R980100{"t    x%89$& !"'XY ?11111111111111111!m]`n~o@MS0\UWƹ4k͗}P̒:Bѓqvֺm5y"n/s6f,[YLrvh)\84ߣ!(U.2 KZWQ`)dũ5+Bd4yuKHt9f7F\Tu/jŕ4 ]]TAO '*#YvtUzp"6֚93^h^cVh%X(ZD&l(a/ I1` lGEH)/-.nj$C)36Գ@ИRxx) pX̍@IGS./1tbx:Zc^vN(v-8tbڶD 2*kv_ (P9us*ӂע0gc>K{ĜP;݀UCE'gY:SǙpEڽPZL{0v5ZJJ4AQ&mMLv5s%WYJ:z?cccbD x\(?wWU'Dq_Y+:Y % l?ea}z4\b].4IiK2tҙڪ| dKuܽ^Eߒ=%]U|ݧrӯ#u-le111.F;lq3:SzAC5'O}~Ol퓧bAv\]x-ʄr! 9Ppeţz))J@r%~C~sŞ}uR7 cT5k>9Vz'eo"Stt\If/W Ԁv9["453b^-. C#Z9߻]+{{uz8/o>=P|t~2/D"P0$6uy ? Cc[^)JAO_">fk?Ma F6,hY Aߜ~JS>WG~-}䯐<w/>zh7Il%Hd*Fּakҕ]v+^hfgНVUY+6εb™>eV@v1KeS.MG04?0u"|~c pPL[ 9VD; >HtulI[BbA% Ql bh\Pe?nRjB,D>vIZt[$Ët{ ;S*"OEW!Z5GIa-r*~5B5)&^ NTVR[RF:ƮlFm9Wl^P$jͅQy ȱ%ejׇ2V`M EfBJ4Z4n[9q[Al{U˳f2&9%%KhݤtPE~q0yL[pyW! }Ɩ;VrKZbE)1eniGVҨ7ڹb&;V0,Mm7FFVH3*PI"YQ_ORP@]E.Wj +/)ǭ>F`Ug@@hk{:>s3t s\ZsTw g_T]^c< d-<'x`p, SR{"֌|vt>Bp;@X?qO3P]"h/Ho+UknF]u*oMkkGS2eM%%j5o7[ϼ_XXO֗NFbX`tTZV`EI$X{>c% q ˲ZkƪB "ej!˷+te{~FbC͇|`X0 (XK` AF L.E 髈 ƛS{A{S2]]59UuҤDnnN> :ie-ai۝V{ *B%0Lg oNiG-~5jF mj忩aN]]N+E閨%^+0ZYc]OK^zX}j˝&"$঻j6^dUWf )I*Y(h8P&fdTQC+$yg+߮u)f a`Zz,o: Y4vǗ6e67S-zlI/}$MŇ,]~} _Gu[ccc]Tv;e"n/s/1|8%BVLoԹvwtV ۛ&5z3~]kZnMlpWI^i6LB/߽}4e7WP{II9 &MYF/1ҫ:0Qp+LdĖafL*񽯏J EvЕ}LhV5Pf, }}PP.uݮOXׁN+A<0ΜCm鎯Z#فp<إAFlwwmXdc_5Jc y'm݋R7"1CY 838bd 9>W.[;9dZj5[q\ũM0[D]SUi0@)uDhZ-irV Xp]kRK(@hyo8\WeQAS?>?YWEfrzɻ֗\]T/=3X,afVλUD UJZT`WD4_O+"C[amP뼳:ͣ}^pT47?;세Àa;.R!t.m,>-apu9oUU쟭kʡ(u&X#W9Oa^K݌W~QiҖlio_S[ޱrUB% -ܧK#];_2,}AK ,X@֖ה~`YSlΔ2/˂uY&4)F}9G{gSʡÞ0"aѻhŦ}/Jk(9{y@ @>KwV=,lMM^"i%Dq~V)ǖ4fS-ר_t@ͤJ6, hF'FXSXz1r5 P͉G\cPg3C v+$Eŷ]~Xj~* MJn RR0 k}[ϬTh@໠3?ԝO[e [/h5kZ ^}{kz}z}Ƿ $YZj/m]_',*g֚d6Zk{W_{:N38B c c c&1?koc/4]~}1`1`1`rkoXlWeZ rq[_I{_G}%uccccccd3P)t#r;߫[uƉ%V 3B݊p ddp}/RAՌ1ZhW('l ϷxKuǮP{:f c+P#>#: f܀gᰁ鎘WRM^CTLJA!PFA[puӮk-}::h+xxccfX X䖀0$2tXPXvM))U4TU0\L]Y]Lx#prr^-uke7dLEy)ۜz Y[[xZ;?%}pqtccccccccd ܊m}5b~1ۀ0o}I[xS] ! αkh +jvjb{;+ַ08GILZaLޢPF KbVg- mL2LU WqS̮ BYC hcccccccccccccccccccccccccD0Ddl  B   C A 10 R/LF=LQݛ/F/LF=LQݛJFIFExifII*1J2fizACD Systems Digital Imaging2012:10:19 21:34:240210625R980100"    1!$%&'9Aqx "(678QaGVy ?ccccccccdke>/N?tO_?~7/OHH|9-\?cq{3dWֿ7Ϙv/_/6ccccccccccl㺏m/I3| [obebK.+%f4؅DBD$Ck l`d#o1RݧIRj CM ';tG`:l`/a`IAjz$2$5k޼lE|`7jUN Jq&a2Zֹ+Ρq ^~28F3eYihՅ0s9lZVW$,ZX?(,jA6bv,vUә`oIS.`|92H7ЬR-ZE'/ J!^(P@bk~ܕ`27޳Ix׉Z#c_ 9r+@[ 1PВ%}q`=x`\wJwNJ2\ //ѵ>XYwJCqdQ߂ѹ+ЁdXb/#{E/UnYOK _{׫]_}wڻ`_W1|z|TuLGd%T fhGμQp}ı1@Ţ(SVrccs'g}DAiK5/#XNHē)+^?UZ6Y3]{.GBII ӱr&䷋Rdku:YC[]z*Md!yGa,+8XOdLM{ ygpy~R0Pb:))՘% _jKAOKiCLEjHFHknllqtwZu^L>~&[h4cPc (12 5, -zYw# }^hRHZ`1Yv5'M`,,} VY-zzjhܨ.Jv:/d9 ]Z[+uFrO#ր,H-9@kLvVXQw;97C>gv]ɈKTtf<ݏ1;He|>_0 vnj|=8jj.֖u.WMUO1 i`Gڨ#ˢ.j+{aUHͻ"`&m玳|myY" ccccc}yXY$q : R 6<Z^6mhaJF*ԦaS<м(CQ!w(kZ]F?1м.mji&<vp|.4pX X0$2df8tXPXv;f`_gJ&  'OnRffSsR:2;Wg{{g[!jEˮa3xVuk{R ;]KFgjF u3Iʃ+f47@H1(trWm71Un1J"ՓG4|6Bm.NW}hXZwVY**9XֳΏ9P6UPTqXZ{@*∿MCɁFO+~n8AMvr$*&eȚܟ܉_-WJ%J:_ t y8xUk*`|H㧸A;%&2ug4;hKIt5amyՄqMfOe]ۊX)8c#9 JllϔlAG,3(湡] '/-OH-uKUgsHGv"pq$'6)U݃=`dJjR?/_,V/iPAUV]PM cI"!AI9c5~ka"" N f7+&{ΘX"lQ]B#e0E;Qf9TyL >]Ū5mulִ ADb1Suit1hZ׀nR ;GzjԶ2J3kL_n_ ֈ҉ӋԎ111111̆ޭśݞTN1ݰƩmg8[&®-duwV53ԕ9g$f g8#a ͓: 'ONAQ[̓^.Z=E\ Uj }2g @e(\oM+-u6X4YΪh]w^'cyZ)4Gu&-4/mK(ve$8@+ "kީΥ5ɮjDܰYi3`:dV&=YM{QWulӬL2]Tv۪n3 {*E%-J22y{&lG&b6D|ZGe#+)3Dϕiݿ3MIBYQ`O1V 5):>) 8- ="zȖk׻xo:aǴ"p7EvXᐯ5m#l֎>W`؍5p1'̲,K̾@f۲,eMkŪK"Vq6Ü%Ѵ+ -@0uYd;zR962'a__Zn֩5ߐgxt@ iz6w9]?d4 QFauzIo;'_2t ݓv%Y?c c c c c c c c c k*ȭBG}:ODaW'7#)i\\1;؛>Ί VAjsC3bQ^Tx끠٭h/XQb'WZrů i ̬<wDH9llfޑ$c5 P}^ו=*3P-\vV¾ ` >rs#5l2ڍk3'wjGcA3<MihKLf˜ɹՈV2~VX}60#ۑ&)^8@Kw1IlRTj;_JS(Udp0oglQc#;?da3#VIɳ7#յg?}/灘d֭,gRy񑨦>J"Q~̓ SC̝<&'Be^HUnj{kAo8TqǦCiYH>NdgRg«SiQ5k! ) $ی:n:ZijӶvҮ+2}Y>)iK4cSs58[\^R@OLjw6* *:,P]I}:GB@U#^aV4n 𑍱bSm8,VML3e^N~uTj띠h{/dyQ]'WG[ qE9h\(w\P,8Hlln?1111111111ʂն[K;ZbsZA;,ZBiáEayZVhY}ZJt9dwbd[}[KlC *$%XPVE0ِ}҅q+: ٮCr"~S8g v "GknE3U~5j{ ]y&06$.6ٍ8h˕}e2IXn W4\l|<s2EbEdॐaLE٬|z~bC)jH9\f":D+ NJ S.vJQҢzDTX f3<桺m4\咳\nYFD? Z zeѵT0t{ aYiiH(0>5g*L1;;<b"B:GEaKT|t t~w1WFV\]GNw!4萈vX+c|eMJ%"'[C* c[}(߫q*35bIj))zpp%kyfOu D&TQ}g@8 D: DHg͇X r>H7sn 8IjP*eqdELC 4f+-@-'.;ҁ2",$鋗ge_*m.VZTIKTXĐPpN me!^Y5TfH"=~65?!GI[$ {BJԂĊ &AJq| Пc@pDiGqHpusrJ@ss3Vljư,3)2c*ÎgB_1111111T;iWCl,"[h]A4C\-#YhDؓ"l|WE& )1/WY %9Xi}x؋hUo'RՎ- ZT+ihՅ0s9LZV$(ZX?(,jA6bv,vQӚ`,SNiyZY V|Zh4h`bØg򊾐񭳃8&1DXiQX3MX/g-$C /ݡr";?\kpk E`9*/7cIx򽸂(]9i+"@Q/[K] AILؕRU!J kc뿻 i[GVc%&tCLt^\`A#Z0V6qH5%U,EN,c0^A=gV>W~^9ccc75h%;?[@'j^3S _s8=8+$OC"{3r{!p"d Gv.'ؚirX5R [㭓> Gͽu`T HR3]VDޝ1 Mg5W{$LJ{2c)_a7 2*NpY]~Y'Dס^D;2eƧ 5oFݒ-ҝrix7ـ:؏\\VÚ꼆4"۾[ ._}c |*y>ŏո ={鞖3J_ a=7j=㡣rs)q_*NH׆ Z,ZVdwv.wMkePt$5aI}&ĜsG+;l:/vdbT?}-V;Vz&/amѥmy_P<,zPG8VkgF1gҐ  `FT(cj¼ ]GsdC9^hhy^Ƃ2kʄAjl??Hf"l >C=2 f?aH4t$#f5٣˫ )9 ]0-j^~LǷ|R]cS|콼'Z_:px#[bŦ1gaie_@ 80lÑ^-tgΐwN :!>+<,bǓ̅VÌGV[wuU+b=qʇ-~?UKq]8`X+v6 e@$NNϱmq>r8/]EsjSxKD-w2 zN" @2jv Ëh >Kd[%SwܫGVUJ`P4_ 7E>O=կ-"?a}M C ϟ jv:9̳k#l {:nʤ-'"% Q$wva ,q.忹8>F7=(~ :70-Rqؗ2&jJ03N1#4u4uۿjוePլ*蚢`]҈:y:g~qN&jiU!LwvF n_Xۣo+]k,ԛZïR2jYC+(p Wr$J%4jz3mn8 ~_?>P?{HQ_ Kz#_lۤjQ)sJkfKIuGiݍ~v)<@ 'j:h*{=CObh`& _]Ř?ݛb\UH=0[m/ I=(#?ZN޿3N*q/䫋`EQ)aOӝ吉Sϰ"JekXh&`qz2jT=&Q/ud3  S}/w01'OEz ۘXnybȺNtR/ FzYM1MS)շ-bK̓̈́E"30 Ndz}`! HJ [:Sww c c c c c c9`1RSXaAarRR m8((=I=HM nNn koO./wbuiylx5̏G^bRDTdbܳRrҬ2J60hLICF ֎,u!Mt)&5fRl4W6  D@?qD>9Fr7_sS~Ѽg<VR2˕XRJp"A22o%AU9>%~[%[$'[Vw^|}n)\hrSA|Z27J [F:VWq&M(Fbae0ӒQAнTacؿsie8H%ROmW{i]YO/ i:6"Y&jj r&T1y1K<8{~_Ql( ,oX71DR@NhfYdҩû8햱J-)fΤ@{ p /Aȍ:J ZD gr o%00Sae \|T 1joNEqِ)81H)nM.),+%89% +00+ٗ %% ҉۔ԎZbkhsR0,b 䴘V%%pe2UxY-yq>?`V QHRXnb![NqHG#f~(ڰYsl5k!iQiӀ@x-.)cpClku JoW~ť&=)`NtHQm]Jwc>U\PVP4j 9K5ѽ;CV]dk[H9 BL=+P}?T+G,jo܆w mzG܅"-o^~&ZE*|: :*P OB i4 =㧩]L[o+lUDQS>U> "D]F[f%q0]i'!w oU.X[|+1Q[ =^ÊZ(ёݙxd {:"bEh3ҪV0+NL>M~߿f& #&RC-7)cOu+uu'^0ZLC8ZW} ", ܈),=`rJ~y)o֥NY]bEVI{\э$jсV Y(3חU}BYmkPb5K"Ý+`֐iNtF.NL^ξt̮F/'LFa,AS!.՟6Ld%|G!9aK:1A`1a`aa@8ha1ahm(((=8hh=HMm--n n>>0+ 6cLF|zCjF xx!bie˶A>٧FR w}6)Iz Bn$U-+-i=unȽ1KD&"zm@%uH(IE,*XԚߌ%'O| W*X5zYjYw?M.b@gFD@DiiI?9 =m͎~ccccccccccccThNzaf1h1 {lק@dJ˧;8|iq2sOyU~1=W |ItzX(}xS(>t֔=pN.qYvWB65!=B ~;"([G;s@ [Y 8q%”)3 _&V(X8okOt|T„h4v췊;s<`^O2-2Q(~tQ(wȬ\w#(T^ %00& bTcf%հ-&܍-TXTh"t՗߇`1ɱb5b;{oQ* ǴRy3rK͋54! ," ?cccccccDd ` B  C A11 R07^YMʇp  F7^YMʇp JFIFExifII*1J2fizACD Systems Digital Imaging2012:10:18 11:48:250210828R980100"l   %9x!#$(8 ?Ň+FWk>~'Y\TN1ҟ⢹zjtI}^̧ `;\J2 hooyk_}7Ѿ;J??w~~='4V,g]nK@WS~X)h5s]{]RSp r5W0t<._ Қ+m;j=~~" """ """ """ """ """ d6N__|yx0{9pmMЅy^'gXHy4ZZ0z?vEzUK&Yް=>bh/C4FG\ oLtqa&bT:=o5Bӷ蕝u?vtŴPb]|龔FhoF$ Rjz,VI;,2>\:ۀ+yzwP^E:Y"e\餼&)Mb:,4?pY~ymEAMMhrW-RgcY]XK 4~E%ΰxp ͜cTU>:z ÖE= `̠o][uR]ԪꞫ 5NXR}  O{c=KŤmEo*E() OJvINNnMjrXaxREcpAqgo9ٮϯ"Ŵ#/?ݫ(~wlEykq]Ϛ#>vuFV~c_&{6Qke:`6UlW=Lheg'WN \j>1~k1tN&zc]oН]ui lͿ^kuզA#|ŨCQǟ7>$88˔ozp:4֠0Vm.mZ'*Jg\w89?e}\)%m^gή%G\nױ٭y[+<3B ~$ץebbħ'$!%fw5â‚õ7:U4TU:{v76Օڻ;85d__'#~G:ci4~նY?*. 5td|:`O:W ˖?qxuuat"ep.2Wk!v!ke/0sh//wIFĘd _S#ssGFNϣ]g#{Vrj6(V,x,4r K@fgALV`)s\D,V,E]p>J4AQS{A{SiMsW]g]_ bT:= 㢿zxiyLvq]>ryXy: [dQ ̋KsMr}1t]!`ī\Zƪ܀S7<ȡ \d)e+d,G8Fi؈ OD|Fi@9`-b/w&84bټҗU#: }~%KW+UE} /_?/D@m=":~&w?z.<:+zJζS u0~uEglZ H]Z<ѱjb2VZXvjۣ B\Mv|_ HxvMȌCQT)ti}@x #uUsZLu{'"=Qq:mT F:Qu>9>z^4~`E # %iaOKk>O-ZYj)uj{yl?*MagN6yYӗ8RwfQu^ `'~BEs_vہ߉’Uq(~Z$3g<}'(vi7X#H`l$N#: zDg"3 hQQE= FsNخjl1m[j-ST -YweNl)*ENTsY"X\s֥f_Hp(^KⵇX}*YF⭪Po0 M\| Jw-z۞*}}vB@G](WjK 5Ox7-9 )9"5ՠ0  )]h>RovjƊ6^Yή[ \"\A] ARH_ߓHF"p6Eu*[ץ;;jpcUٱZ 3A uj@e(cL+b: =oTPTZڪ687ftӅOu_O=bb>sOhtame56/(,7FrWH}f$DdkE\{/ a_YK!> qz*6SZ {sgN ŏAh L).kňF*6wjoh/jw4)j6붵v55"iVo+I ڨzk%X R!;`㔬$;5?,Q#k{5t\Gsە\-ZҜduCs:Tj[]\b*N`]ox/PUiP=ckn׫B_ /)^RY=Iו>[Y#ƿXj6:4YyQ]uya[Э΋bq( 0,oZvcީ19JUקDָ-V_Y)Qå~Z6_Gœ~\5-) Ӧ~%X.Vic({%]J0YJO r}qt)OauN13,1NXn-˹ֶY.06Z\T)+U5VC)a0f3ug"p VX?~sV3SBd/l =B SNC]/)9(5?9v)]A,BaYiV t9Cn;P֦9IC"" $Hϵ,L÷^1ބlPŷכ˞R 7D)k@_.(aIU|EٴpJ JǯW}^w1!NNWP"|}R (Ce0ܱvs!nXn^g{  ۓPz~: ~5 ?ѐ[|l..aў:봫fACzB*t)Mb:,4?pY~ymEAMMhrW-RgcY]XK 4~E%ΰxp ͜cTU>:z@DDD@DDD@DDD@DDD@DDD@O5oRR`=*˷ }~&i;1Nhs2`Mv{ǝwg?_l egc;s6\"FҤ@DDD@DDD@DDD@DDD@DDD@DD>vt X.yv1wSӥہԝ"go6C6v@mk~tqi_]4^N5U% Z$Fj#>QdZh k$-Ҳf DdrB  C A12R| :SDA{JX 3FP :SDA{JJFIFExifII*1J2fizACD Systems Digital Imaging2012:10:18 11:48:410210375nR980100n"i   $%8 !&x ?++%99% +00+ %% ⩢봹䮬sx<_HwPOKJ"Â/V忯K?&#z+q_jHf \,[~a?ۙZQ6eyϤJ֓&?y }wsbZz, "`Z""%SGS! kH^tSUS߄4I{}}5V~?-0FmB%:awOVi|4sˀ]AZR%)>W +&Ӫ4:':/,V:sܵ 5*^<3M۰A 3`3_W[/tI!Unw,?^_Wcxũл} SO9亖bvݤl;[ ZpgQ_զ3-&ո՗Us&}Vl_0;~Xͱb Ϧp~zs%9+>'ߺTwAO\m(AMtd=_pibotkRPLk3 ymbZ?ȮlXPo?ٸ+_r5ݹO`WMMrb}5F3C|;ty R$S4{y*d=_- - 汬%?u痎vr-;D\I\ "o][j CkXhp:=G&aАOXǗz@1缮f%(U/$iܟ5~KBoSe,0يwƅ{A%`VT >glPԊ1xsgNNq3WN`q-}h(A"8j|,S+z=M T,D@DDD@LgBi1դ [3n^Ks\׍F+_8峙MmwWsգovm}<V[10'XPC4@i W0-ݑGyyww䢅E]ॴf Ut ~ ca)JYiSW;RK%w;c؏ޓpit u}5a1al .G/^}8M\MxoUu=*OU[zUd"NvqUg:aUЈԫׯ2c#s 5k),Уf1WNS!B?謹j kG;;|^, B w]7jlz:: |v=U~nnhUPz9uw6>[[*o|1e]j0 jj))_ot.H;L=#7jЬAF@0v5ى/F/j&0TtGO|Q[GZ8jz-,li~Ny+YI6NkP>HgX&Կlu3Rw~8;n`.U_ꁔ]_i5b&3.2mMbSӈiljnc5T> yojPoFt.p[C}/D޿n бGà/Vu0(x{(U9v੒md(R6,_Q{|`w&eo͗fUЏ]ѓ]I&_V{LRTR4ׯ[ l#LVBHՏ5(m49e_[5UX!|ҀPW]XTd4 m7KuIW- qfm'Pi0E[ [k WPS\Uv @KL&RAiM5TXNyVF  BV/l+^sٛ0o 4j """ """ """ """ `OU>~,J=w\@%Z-Z̿+g3؂Wh~79ecpk W7'yyZ7ޝծgO1t_>ww~^~bsoNEttJ{~e;^?ï}W.zMgٞ8 qx7ҢzblI>N.s)Ƃd3M/bDD@DDD@DDD@DDV3[Q%U{?En 3q0DBsFb4eh9z7*K\o%8)h_v(df7 -Q~2CrmU`br.YAyGw&/l_?""" """ ""QB Bky|{͠v(CNƋ՞QKckmsrdQP+x5ڿQK޼exf!~xM]NW|(.e:\?ѿl%c@K{\Ncog@&( |6AQ1M^m>)Pmh0 - ukڇ|{ P-KjtR6ml)Mg8RS:ckE`S4qޝGʇ`u6ٔ olqApX\8 #;lhߛb Zښ0 O> 7V¸?~}L`8=AT4Y`8ג>qG~׶g7_`"=9Ybi$|H~] jn1kKǨ yipM!2*%0ZL ]ؤ[""V $u&rF$gD sC@ ^k&ƫb8*YM ,,D(6'?6& ;KM5)|ik_[)u#տwаcר[[`n4-LtqvL6c']4Ԁ-AP,>XQﺸ* >ʾٹۍPb^>0vw/>/_+&1;;pHK `}r>t lo@?Ӧа:z ~܇KB^gr8r9..釰-*@OGTj[zd5V'G& ;fln MrlnmZI"[mU#@,n U>`UXWdu<ĕ ;-뮧6|lƧ)BnDx{խ6/Aw'??0?4T a )R[1A¯{*USC:D,`=^[E<]A61\ڦN@x.2 Վ܄Wa4 0^ p?NDdbB  C A14R9x^ ÿ 4TKF9x^ ÿ 4TJFIFExifII*1J2fizACD Systems Digital Imaging2012:10:18 11:49:1402100~R980100~"h   ( 8Qqx ?cccccccccccccu[_W*_'K|GA| ~o⿹_5.? )Y7iQ6e|$G<ƖCqrdz2b~Pr>2$^٘ z.۹`kzDIn$rUcJصMS6i7z dZrd@nؼ Ιyc$]sזI8 0ЕjloH=ꁺ:Ox2T`═3qޡV:afP`AKhD~#id>M7,{?,V- --#"H?}٦K"@3&V%r pUʼnBYű̕\?TtWOGIT ůAxP_5kz5lbx*6e@-)BJ;5\)1V5s:O:i"|j(I[vS-;, U|]Um#] ݥ-ƗYOT2Qbx2ivtP=i  C L GsLDtNqCLuGIuswqtso׷?BX1a~i8bXBB2XiN.bPca`Z̊CFKqh1`1`1`1`1`2Ͽϯ /߿ϩV(,x,J r5fg2(`W D,X,E@4J?/;;3 )'ͻf(P D$XK>pé "-)F 0ť"ROƜGD7zTZIwkbEV'~^P0000000"V,`=iֹcBk 2ҰKR#bX<{ӨCP/lØFG,LaJ > )ulPXZ++|6ce?éZ#"?Ѭey#ґR=mP H5~IV+VkKzdzn鴙h4JR=ak#QF8gv Gbׄ9ɠUsjr̈́ &EunV%V [>)7BT 5)tj&֋Ak*+ )Ӿ2bb.bchHP l)5:]CF+&S ,jCS.*?" 7t%#arRƟc*o J4A;;) 3'Ϳ^,W(0`|?#+Ҟ(h.S#S9̖ܺNHtLJKvu߅=FA)ad1XySDLDqKAOKqCLErHHswqtӯo nƎ60Ҳo "2B;:[2pRPcG;`ϒJV= ,\OIB־)%Z~d9s`yk\^G JM♀Vr  _=[%-Sa"O +A`̢/{1o%4r@]{geCR^yM !9Ϲ5";镮3LwTѤuU]6 1d)D?RfG#5rX9> I|s\Eė386gE8`~/:BWG1Fby&y ߹'S;xKoT+,-O~t?ܔ6IW }-sMrkKHE(w+]?hfH:lcJ-BSeS6̎G\k /|r( ~!=lWG\k&v^laTX}b@ӆ!-gWY ƵW?= cccco&H^&g3&ny}Qѓ({d Lg}Yj8%8+m^L_=&%&';K {N΋f&XCY! d_!bвa':PG[8%*'5t?ˑOG7]!KvB/AEBq|<%e\risf 6^&XPdǟnAױ`1`1`1`1`1`1`1`2w9;$:R-} Bw6vմQY)m ڮ&(d[B[^ 6},2Ym2ȴ P!ώ#4AJ cya#:'cPgX/,'s{}S>഍Fu *9`3 BR @CejYc/ݤ":/:Y`,_!N\ܣ J8蝭4` ^uqV% ^N@ZHex瘺4kIօ@>:8 wk䏌a(0t=冇; [-@8<Oj` ME7Mި2EURZ Ahed,?J3>0Q8*qMw}!_.dMyإ kQz*_HrshnVuSrj2*R BH 3ɵSXkfזPjD0ZtDw6 aH IoaC9(}d}.?h<͒9B ;,<9+)3,% "Ӳbg<8L[DgN(HPccccccctoe39|BU]HmcLvb=8dĚ ;f~ ͏Aٞv4m~pRΕ """ """ """ %Sz,V4a&ߟ8;{v0#v^|$+^b߇tIm=4vÕ̏Q` PꐱuQ@e=K]h (Ƭ{'floý|k644?QSEAESWMMW]Y][<~! C?oa47}q{1 ~M{Zl_#?比Q"Uh̸LtPB_J_\q肒ΏXNj^Ut]Ց$1, gB ́+e#5ۦDR5-?;s ;p*7ܕ3}YmfFQk1 >p*7ܕ3}JFIF``C    #%$""!&+7/&)4)!"0A149;>>>%.DIC; [ }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz?j((((((((bkxV܁*ddg(Dk%E 7;*rH5d#rSovzӨ(((((((((((((+[jzv>t AnQ;cy=|;ʷcx݄{Z-86; }Kr0{ɥf*ӊ`A >'!alY?qq*<%& X[j&X|`pYKL9nLP=kQEQEQEQIV46n^h\L㍸ etݤ&dlW8V>YW I$ gخVԭT[yVp*=3FܖmfX3]F2'ϟ1#~b*6ټDۡ63c<\95Gwo` #8#RU;^Mx㺹T`LP.^Yqb cQ_#`ldAAQEQEWSv=.B=k2mcWdKoH/b@m^we񍽏=)(7ycA#³۵-F;>xdzHF [\ e=I/$j!oT\zc[ {.d_2@Aw?;(a^MRMj)DbLqfܦ59`=v0FՎ~V2ʯj6)v7Y~|89$\jw(Ѻ$lr6 *Fӗ^)MF+=>Y"%H!~@Nʴڎt"reNv4S EȻlkJ(s# x}[eH1* \`{FD}+y9|lߟ3qY! Y35{GewQ0sEX9ƺM΢Rbel* X>k:RbeTmO  ÕaephW'}+r/ څ63g9{c8gˌm#-ߜsU?[kkiu5Wk$I'9W>;TW \`t ]}!X|mBhdY#Ց0-6#+E,4>=|F"^( 68K.Oinj=JǀZ =ʣu±k^^ǧ=̪TAv$Q2I<949y˦l$ڤT EbxZ{M2{2ǵC̈Wu;b f9A1HTC"]!37[EV}ڵCys"6CzqP[4 h0i g`2? ådG%KƏK|7Co/#d10̨$` 5kI״v6[^y2(dnTx8<ЬXݬ$mqan! >޹MV%rW+S^H5/MH?mݎ6=U 2:YCpWv `W'|_$w0(O0n 1nQGR}UPEuOPlЂC˟*Լj[rp56x컬cl$BեfOYDz4W,-qKe ܿ{#?91^Esea>[;KG8X4[wlx+j)`^' =EeK H,//-9Av[>Mh1iY%w9yrII5f+#\e&KjY4Wa# C:c-5M2+Éx{Up) 4 \xy&;(bEd͖4;wۜ )':T0N)vDA4a$`; b*1|޶,g-w1߷cx$~lUK 9kys~w #2^#˷f-E|fC X*}f|E4O7cAP3p}:B>myp\\92'q۴lɧ.5RkF-n}.3OX2c!}Fx$sRԣ`s䥱]aE,\sI<1}[8uOdhq>2I9P:W_cB5?YMڀA(b;Ⱶ.qyϨݼ=GUq( vemCo\Y]#ë=k[19fsYc#1x;P׭meXY#?R RGdǡQEDv+A AE 孅^\EmctE\ Ra\-Fc2U&hd $|?0:(+wUv[co0c1v*Y3xE5[ \!#ovDvs0B?oi,7e֏nLn MUp_$ 5ZA\}Ao{)Y%hU u(]?xoQA}eZ؋-Ń^d*ljr6'p[:&oa"tq*{ 2Җ4'E܎Xz֙mimf-m X('׊uMkp}G׆K2I#$ rNJx~h" B:nH 8lR+M,$/%S0|.Yx_JӒm#sQHs mݑ1沵cH!FN٤WhbABBȪ7Fά ]z.!دf>1H|7NO\ڥ /[ zUWӣ(Pu+ oAH+Xuga|fw_C48>Q-6K{!dp}yXOt;]~Up2%L-5O?&V{~Y8': Jo5-iaT9:+( B?lUrne7 dk֖FyaL~b$ra `$`[=(tz/Vzr ;đyPG$,Fe.Y$@=QE%Qlgkmk2rOE沒Ķn7Ejlmw%U~U|Ř<~$w׃H8UFU;ŵ7qo"RQKY>%LixgA_Q%kQ\ωoMB%iɥ[ie*€66IP3cSC 3Bk]GNHE4l[!L1b4j֯\mstM)UD=IcGO-5.XbW60`x +u; Lt[d%Xq*pwx un"׭Ӟ VFhca{w63lt{VT+̒rcœ9aLt7LKSkp<[G$!ZeSvq@ :((((ȝ>կIEs~2-bM\ o,y7qZІso{C+Hp2dFr&{Q!Gk5]DH?g:\SntQY>&7ZQ\o+[mxmmQ}II70lg<@ " 9 `qOK*}o&WcI!?3a)5:WZ,.nV %; 1H;)R>`3tk60YܤE$o'cepJボoEsF$~Eón9g1[:Y匷wn΁yrspq4;)4*g$B%y6op3Ѣ fUuJ $#)ޭFpPqxqWٜ3 3rN7N3qZQ\ψ|-&yspRY6qÒ\Ӝ]*h݌tڍj6HX2K7r#2*.CF~g%ռvAq1Ug9  NQ;j ǩ<1+)p(vXl ڀHl.MmvPFgd(+pj%R c[ӴAu\y11;NA'xj3Eqs*K$F dGPE>(((+ Ėql'aX K`ҹ>Pz=Qn?ڱ6dfa2ͳ--cO5K8y ͦ)6`/[{p_.I.eijGÐI'Y+I.eP}"T v_@;HLHp' Frs*)%TܒZuVGaiщmnaXP\tORC0z?"1<:R/,vI瓎ci3V$(AbFqp*QEQEQEQIKE%-QEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQElno'H"Rw8'}I8t 4rFVQEQEQEQEQX>7OJn YKHQ#8~_^*_7x(Ix]P`Qס[4QEQEQEQEQEQEQEQEQEQEVOtu]dIRhKMl2vBH5]t:og`Ȯ%2Iylme&,g#((((Z(((((((((((((+8Dd RB  C A17R ]~ Fv ]JFIFExifII*1J2fizACD Systems Digital Imaging2012:10:18 11:50:050210468R980100"m   '&$%(68Hgi ?O/zpJ}B t.?^,,fBPE C^_[k!р=Nc?a^]mEnE}]wȅAx.Q:s񍂄dj^2/)C1|,ϡͻ#$#,?OZWeK)A~""" """ """ """ ""V'K*TޤܶVL|y((;-SIR`/V sҖ))~tp(Ϸ7]ZB-*mnϞ:n:;k+ӚtX$E#%DgmY,,)#)8i4:nF]uUM!uSSCSSE@7GF7@2ZB*uzBt<h/ňůJZZmW]UmtdSTTQݍޒK`т`D@DDD@DDD@DDD@DDD@DD >5-4 hWAEŧӥf?AgW{:z8A(צcP͡,S]WgvdVKǖiP[Y}/1UV<KNrmx+nȣJ~o ; QB"SRz3U*vu@:pC@X?MscJ,E܄]G2v W@NEh.yOz6Zg`U+WC!A FUQի~ f"*~g7K|nA vo0ubқ詷k 9ϫ - 6F~+4o$ yW"8 aۨS"g}LߓmrE_mM6S}cq Kg^)zN"BNZM;kIu͈4{ym۽ -3T򪊃!8R~4 j-Zr-^`L\:JU[ΓV $'zǁ;kf:a4ʹLز'Usr(louևWcg nS^]Fs*(-܇w Nf#:d\|OgW[ML/?!?VP5i~;m5ۀσ`>֛c_lݝD鿱Fi1"T ^"A*?E Iӣ@ȣdXU|y/ҤD@DDD@DDD@DDD@DDD@LXq(}MI]էXaHO-uwM_oH5]7W1`}Hǚ~ߏ?("퉋WG2vAqߠm}#"p-e)bC_Nbż:  Yt]]Vۧ cҟ!gVm ϴ g+R^\$D3.V|~`+j^Z?Dd&  B  C A18RMx̥PС)F!x̥PСJFIF``C    #%$""!&+7/&)4)!"0A149;>>>%.DIC; f }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz?j(((((((((((((((((((Z(((((((((((((((ֶ,s*͵wܜT]yV+'G  *A8$ aeFEi=Jld$jhkxҲ8 պv`sAK]K?XO͎T jIGi{i JšݷHy?0#(紵[Yh;] 5543G H2HU~xnIIq6 =RQEQEVeƥz5oYGpc"]6rW5k⩮<xa\Կj*wMu– sj(|5cCΠ,Io'.|)aw InB5@7,Rx QK sN(پ%%P$p:_PY>, T >ޣ_ X$Yn#yW'{݈ڒc``m Cso,vIˎ 3ug :nEQEf\jq=u C *lrv;W9Q+xn-Jن$Zܧ`ozI2I|7wj#I#+9fI2p sK%n~\쨊&M۶c8sLqaX YlٙHA+Ifs%/mחS=2w"*(WeQ8߼V8羁dѴYhso )︂axib֖3;jMt+n쑗apzWZ&IVG`pT EQEu-6KYIFm&e /  F2II.Qxd&@ " T$uiC* Lȡt(TA#"Y>%\?Ҙ<$v|kNAԴLq~MZWx]uޣqkj&fUhtXxvc;Z)"8a{TwhH]8Tz'OmSR#K)lg>Td 9!Wq>kCx.b6qX$F1i>OqN܂<( !l.﮵+7J\y~[q#nQ &epYNA+)|1iLK@bk/i7J1q\*G *I ']RfXuk]>[A`#*<4|w9ts淳wvVY-Iʺgi#nqԌßzlz̨ΧL;rc>dI:QEQEGry#0zgת|W-,OnI"}}=*X=@nYSu .e$K43$nY̤|F7)l="-"I0 ŵ@2J<$QER2VGV[fMlܪĞd6P0Hҳl5N쇾#Lgf 06n}Iψ5KVh5ċUIpw(#Ugg Y8QEQEQEWMӮo IdPI ȱIMas2/9 @n$dNEH' Yh}(F'9'独|O![b9o66ڌGj"˦ai%j@,N$ޥ-:\R,sƶ2\UT}w B/4F BbrEB~v 5Ex_.,L@~d⺚(Jк~b!5ht>c N̑$UsZ·_ӄuſ#_Z_Cx Np9ҬEQEQETv1-b @Ip;QEQEQEQPQ]ImBV@]f rO)q+>b}M2MK(Mdb%:(V"cUU uQEQETpj7W) )20FGN PBlMRΎ}2gˍ䟽TgXnB_&%q#]qrFvqو2ʀaאyW5-4j+[%$l,2#0AZZml('ڥ+7QanWd]sO=kJ((m3CWOׇjV2ϽҪ3O|j7iQEQEQEQEQEQEQEQEQEQEQES_wYv8q\WGMQ5(^_yǘ*w":(((* ;]Bom):6FA*x{D-F[tLdq=kF((((((OƷ K]J&'e0ۋRH8zڭ|uwuko\E FbxżF0[q]mWR5x)vDS2Cț8QӧsQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEً Ddp5B  C A19R 1l-+uc F 1l-+ucJFIFExifII*1J2fizACD Systems Digital Imaging2012:10:18 11:50:390210109{R980100{"o    (&78$%GHQgqx ?Yi;6(aٗx˦VUb:';M>I)Z=$X w.{־)%ZsrE.%rh)MN+iF(Ns\jy%ԙ r$F)kⲑz_ɝ;Zk̢&ʭj⧠i ȶNNB =]-~u{%GP/c+W+DgN"" """ "'S{<+PҽRKv r9őkl͎ؐOT\3T<\,^%NҬ+)w%X Pi ++| icAm,`$ qW*K+[2N3 =}_}+ )%aKLNhrjrFAP$΃':TQ6H]*6Eu)+9[ fቈ ҝ_sSt[=%!lEΉk4զpZBP3QV)Ofj֎m&.fb*CuO+-ջ[ͤڛ6ef"ePylWk1~p7f6}y̡.ӋE*RthYϕ+n.ATjL/ZcX"M9螟u_xuE?^ ;mB2_O?_ȌVݟ^?B\'C3]]z,nP{B;,` _51h0Od0jurkчsTT+Zjc3m+Mxjvb^ikb7}QXkxAb`^D|wu @ m%$KZ Rsyv c bSc X ^Wcq\ PZ[t ZWscUe+)%5ʠ +3)%++͹8 ɫ+~hmK7\]%yg@m G$_J`}W־G=5cKXf@m_31 jB,C6(3 odܷrGy5=U6vYDD@DDD@DDD@DDD@DDD@DDD@DD( DdB  C A20R 'h=H LTn &Ff 'h=H LTJFIFExifII*1J2fizACD Systems Digital Imaging2012:10:18 11:50:560210859cR980100c"k   %(8$&'Qqx ? (gw{O][ҹGAYv2^gHi 9{OP|4DCZ@~[xJwZNF0΄HO :Vt2yӮč}N: D_YP ۋKAeYAd5skkJX*L67 5v!e= mQhWn½ ;:x2l؇4ikp٦\Ml6&U5uz%ĠJ7l-qх>5I]1-^!XHN-uv51(10e6WȡHNMA5efw"" """ """ &ba:[Te Yt2ܼ NRP$W"Cekϸgs{m|Vmck>P-mo,Ou'u;keX6~"6(O QUU7K K.6 8-f05o܅R_c <MKYfV>}_ri 4؄]9AsȘxQ#ަKsB R|a~K%TY$e7G &]u-˴d2.jhjs/*hWURBNWı--RGNUV0|fîdq/B=$c@mw*(x؜T""" """ """ """ "d0%yNݭ=){'5b2E?KXh3KH,,H4a "ˬ#z 'kR gβ}{\Ӛ-Or* ȚOmVroV2g ղ}"" """ """ """ f/啃/:uoƟyOY[/ޯ~ݲF7yջ-懈p-b,(W|ztP 3y}L 0?b7qu٪Dd B  C A21R@Sd-B/5o NF @Sd-B/5oJFIFExifII*1J2fizACD Systems Digital Imaging2012:10:18 11:51:1802100R980100"k   '(%&6$8XH ?!Mط0 bsDIƱs8[!+8 @BŮ9 M/k%xI;"B;6`ЛQ[אbqYKi/t=2(NnʊEysPi$N2 ʷBlXb,c%x(ŒƧkF7!H[h+N%*H舴`=uSDْS8ҁ M%7{9ԆDAGr(nCGءXQ6pX,t:/ooG]a`@dN; 9:5$A74d N^/41۝ܽ8S[{;ˉ:/"gE׳xz,~԰4{7G's^~<`1bSVaAa뗂RR{&&&;GKF[*UQp\ Θ[7q_ Έ}+= ϣ6wv, .~uǀ~uVVWKtOk r6Qnymt/]#o~49E[[:|5hs|sݭ󹍅h?/>?yxyxۨ~||!VΟ Zzwk|can.;OϏ~}i6:5E\&)̦i95VL(aT G2b~ۧ\:g.,×6 8X "" "\f=?i4[Qc!?ih 'o_7J1``f'3D"3D .<{qؔA F$Yco4h!{ӇL ӐP&7 XL.fL 97:Y X=4?4=Z[UqnfumRٺ (EgM ŧxsn{Z8%|@;\s !Yo-\'rcwϧ{fC v-VJ@Y =&َn!&H|3; )Ѱ$hߖe(3Gd*Pi5g+{Mݟ. G_cے]et~F4-3\ӼQAtjF2 }: ),Sg24D#]Kf.pf1Y75lmǟixu#O?qe%1$YL4Kח(Ym"כ{{nyR8GK2'?&Je蠠00`Hc0xx3p谘u@EKM[33]scu j4)dfX%#sp~4o! 'xAݥy> hu.Ϸgij低Ʊ1dTa W_kCŐm|x(tUF#U$sNՍ-C4 "D3KS[X|JBͥ6-έD 6om/mvtm۞]l\[8]Ӫɏ=3&!Q m|:{VQdL0{9D-r5!u) D۳=yJD0._1jc)fG@ PjyJUFroJ^] _:X6a8YLXxlVs3@[d8fSg\jД2DkrslzBjw=5_E+_ Ff1w{F$(ݝ_\=on+~?JDda&B  C A22R'OYŒQ6F'OYŒQ6JFIF``C    #%$""!&+7/&)4)!"0A149;>>>%.DIC; g }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz?j(((((((((((((((((((h$T#TQ$ͭ6M>gwx;*͜ca':zmxgR8Fg+`;VQEQEQEdz̶?i>TKm/~ lʕy8QEQEQE%-QEQEQEQEQEQEQES%8!yc5, rI';M?M,GT@CH=A:մnm^{{覺v 8x)!\p[\ڭKnfG =C'0J;yyYs$h< 9d]?H,$257i3#i(qT#Su/7fں:p(Aq:7qIPH5b̪2MeGowBp7`UfPRH4Mq' GEU[)tqUt6-q#BD E8bA+NӇKM*)-͞\8]7GnH#ƥxyխV9E6 B53]=QEQEexºŵG"`%%եƥq mI-mK1@4j-jlC#]}Bʪm*2y?5q\9Jl#O}kn(*iyi<\mTrqO@9$i,uk]A6h!e$d88a88$U֮&HZٮ.'mf 5ej:qˬ};Xܷ.,e_p%a_^Mu%ՐjS (gwBH$$q]luo.)T20JyᶅT$R0UPI$KEQEQEx*!O*L'Elz#5[6P yǞXrt{$ YdaW+0H yy^k.42ݵ,&B_7iO)k`|_{o} \oalE*TgpHEEoVno<T̝Uc Iiw1^$q"][qU ;Ҥ+fy졶 `$+*c"bp4LI݄C9p G:#$`~gK5́: ṙX5k\ Jj3LOԀAy@ 2Ey85I>լJ^P&ٚ5RU9Ur`@$ͨ_r˨׶;,Mv`y ¾MZ93CW ݎ8V|Q%I[0wLoz'Ս&m&r=;(h!$6O+NK}0Q"y+Ls)2)n  {q4Vg9Vk& y/4W쑀dPqRK(+X9+8<13"$0<]mlP$Ǚ4^GMrN3ǧj˾Yl2qm$̪>xNFN^)߶Z gYXR cbL8aѴm"͏4͙Z\t͒jsejdCmpD- {q;ȶcf,gqjťvVpş.N55dj7M ͞H̎w  9jH4IWRϻs+n8PTp݋m2, t'EQE%su{d7*&!u?ʢ_^>l lSng-p@1ܷCNo!8"^#QK.Oc$nF !^"V'gۢMQ:kohŶۻ"z5-` k?^ b7:u4cbDqqƚ$ic;9EQdm%!%hvFdt.22G V"GE*vV_N<=|t قf9ݜb`KDDSEoa+*jX/糹O2 )$nV##YϠ\7+'@,}qVlm䵰wg,}Z(+<)iO*lNy)xvҡRJu ~#RO$5JKre}4Q dpObrJ_}MY3Vc`ASB?*m ?כ$Su)*M&=[e( ]} XSVLL[7DMS>Ix͓NepDb{g-XIy\eݸVox~Ft4圐2Gv0${8uƞWưDNp~RpNy())j k S$1zzjᘥG&X#5)V$: `ppFp@-/º@ )$rL#nH#=;n}ku<fI$by8:a6]K*<[kݙcpm#EfdA$ȥh@g t d=-uY #PNrH]؜d Rbkxw\2`T#$`dD:ϟ䛙u;q'N6g=[]Go U\럙$tp ,~p<Km4AhʱmRd}02EgjʹZܞjbz` W]H5VA.ɧ۽pʇlqv̒~HF `ďo*imT1!TUْCl*1.u7z̗vR AGܤ{{_q}u^j{sk"٫2E t {׷/.Z!Ehf3(pwG,U svsYy gK"ɼ0_jŻx8RO&X4Xo`98fcS(: p 5u>)kJ%' |$$ V b>#;ҫ1.P2X0$YCӈJA$}fԔQET-o/-ք9: 0;G [Mv[ʑk7=8E%@{m|3Ly,,nuxC2ݎy?@+F-5UdyfH_ʉ^[n dpTuSַm-Z[o$ 5exW:Ҽs#̤{#؜Ҳ7El-γ<)Xȕ_)4|aW c5iţKſy*3ss[SCMѤ# pi #P_ƍ3Fj`nczT"`4TEij+k{Z#&d) ZBC1(¤j@/'{@A*OR6-3vvZwI{i$ 6FPtBixf"M&c?7 670O[(.g`Uʨ[C7Okn5Ρ2)9r[89뜌]Mgi\A{mtm! 8(IE SY}.xi=Xn69 dʮ2vIc{@ILWDyCTzGLr:j((((((((((j ]Й$0r3=°L7Z- 1+*X9ewfbA-og2$q*3m @ d{dky+S+uS'j zLZLA-D[Bvݙ7+AZ W|o A`EmlcL,I'$$I$I$MOEU{}BȸW+u#}O>+Kt6GŒ>REQE[@)tFgD(N q*Z(((Kˈm%M> ONb\IJ`an X((( ¼*~<-3t ("9 HjUs65ޅ-+^VD~O5a뛺K]пZM OUJ_nOvpO;8_wyH@ HD0Yd%${řX`+Ѷ^n\٘%9BDD@DDD@D{p'}u fȿC;*{/cbg?ށUT߰vl^z̮_/x $bӭ}[Y -C, Ԝf->uEKCHwMF` , ȸe)҂v4 ̀vQآ_n߯l 4v>9oPA=yhɣBYQ}r^M7[hMbxW)])̂`O4 ]kpaJǞ|Y ږҘ/֝kЋ%Dm~XeSIm\']nMN`quV1FY;IŔNUmh^\y/J sn*LƓj8>`4:rmvY2yN,rlG 5Z"zQuߖTf4W) ;[l}SeGGբQkqe[dAX^9 tw R7n@[g~_Rܠm/ܯ [-ZlG1F&XƻZ'mNG|z(5\,4OR)AL5WVXRzS]E]WJrspBlgύrXaxREcՓpAqgoD@DDD@DDҊZl2TeZIV8KUm`.@Nwpb;bB/5__d؅Px*dn*'ύgpAqiqqJX\\XKnZt~t[qvjb_1NH /.r }ZVؽwؼGYb%j= 룘nazI;U@Q/,_c8ә7~ κϴM/]#O0Ƈ=Kk&wߴ7??Ze^Sd=K=O{>`T.Ձhd}C45q^>S %sqP6rB- $Nf0JtP Ut;=zԬt({(Uj_UN4 ֿeJ,-(B(mBi]" """ """ """ "&kRK(@hyo8\WeQAS>}?ϸln@:(Eld{7zɀ"?bX-{S-CU8Yfnг Ukx``)-  <,>%_WZg //6_V>YWRWW_ /L;[mtkN 3DD@DDD@DDD@DDD@LbD x\(?wπWثjN}}fWtK< Cg1姩TvY@毶F?>[ڍ |<[wmW9+]&X%{)9UgR.]E)Z+*S@m u lʡCbbz*ѡlJv*\ca>63UЬ@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDDd&B  C A24Rgw=A*TCF;w=A*TJFIF``C    #%$""!&+7/&)4)!"0A149;>>>%.DIC; j }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz?j(((((((((((((((((((((((((((((JZ(((((+x^iHK;U$N wMaK$>X߆zCZW''(t oL^WwG<gJnkZTq fRoK#[ƒ (RwH $㨵(*I2F9#3jj( u.PyʝEQEQERW>&nzsw"Jup RTdGN(((*i3y3gQw֡o<-wc 1NQ6dP6J)'XkRPV6G є?KJO vU/$Y+j3O6t1ܠ1eD\Fp1ɡҤ(-`UE|+$/#w[mt $Cˆ1(Ðx= '8= 43G H2HU~8>i%yrdky2O@gEQEQEV~˥hV.%X$/c }sJo$Q:'$BI` ]WFYJOX5yxfc`rc,XdbuPzd2²62,b nG(pq)~uq s$QG0i+JF]/MLq+M )cRJVFݡCpbS X^_DNgѠXnc;,$'3cH'9F+LnXFA 袊(n3B%3S۷ϗޜⱵ(MKW pѝo/.1_X J#eO{r> u5LSK[6 Ś aQ3w fq5iæYKef#-[y62~l4]B indYfRn.R ;1qɭ*((((ͦoS*&h ʄ8-M?vk!a l8jwgklז@NGЀ~5 [&QDŽ٤ \pÆ99 izufUUF.=$Fd Uo" s<(UR}CiKgqhqd{C+9Uꡮ˧Q-ǸdnT$gt%K˕k먿OtDcc Ԩg8r gMR G rr*)$ܮB'cC s Т(gqsc=YN=y42AKX*DҸ_ ȯ׬JO(h?ƺ}Q_E Kx`L0r;]>Hfx 6bUƊ+9dnȉs;MlYZv.5kmo'jrH9Vp6Y(ou4mJ[EeTF.NIYV:7H)&Av0Ǩ)ӿV=X^GIo!dݖ34/I9RvV+q(BBI3χz(} <B>Уχz*ιY\mw[6BiyaIL23fP5X顉̲2l];rz~.nta8xy >`wry>#ţF N9Isժ+;V֭oayt;.yS$˹RP73G=zժz?[T`>g=zsuE[ GŖz~e6rXɰmJ B#}Z{KmUH%ǒݶGۜskzcE<^0Ȱ$W$T#5F Gʦ%ӭX]FЕI$zOڥLb;>gٸrY? Y$c=H pJ̓OuHXVYcͻRY6`"MpIr65YeXu{)[7x|qymkoH[ߏ_¸i"6w~pGgt"yʗ(efoH AҵzSCmslmo2:Yoo VP#E `IEDХܗJTXݲyU,TcVoΥ-R%TnF<Kc1FoS?MsuA2e;V`ن8xIX1$AႰʩ U I8вԭ .c2ɔI dž8##U(KsM28aERc`hd @I iUAEݴe@楎͡.&k AW܁zve1-O*h&|m09VS=}rF/?ư6ld:VdZ)f{o.wpfeŸ1ϿLL跒Ҥ /J6,lt\ I:VO ك0>PzaE)RyC"CqңuPԮ/ZE?8{e 98eq 3<#94oW?7'>[zFgmm$7fG*ȾS2$/E6]Sad?CO`i[KM\nr0BgHzp>\h[ 1}KN#qX+nqsv|sxYDA"wyiHvb}bD:᭣Oydb^SԌd@ait1Ҥ@GypwD)Bmsi!8-ٶgqm(tkr85-cO9Ǝh6M۔oq2[XjzfiWrAYD剛;Ns#j?"P%߃*A۰ ,5BVrb1]:Mq ݘ9A =k,7W ҬW0;H ;c/iA_"W>qI>T@cϘq'?*" !a#P3EQE!i4Q*vyB T`rzIhl}.P-35-qGol,9f5l*  Z.ݲL#=RE)~ӏBEJʮXMK3aH^# !p fqg8xnňTQԪU+x7ǯ袊*Z]wmak &W|9<uiD&Ne^ "́ KGGe[$WwScM͏dc4sy>ݠEAmE5v(Egk}w[Eq j 9:[Om**(TP:0:4ej..$}O!@Z-*3# &DZDcWf3@#IC! {FӁmUѬu!/-ݝ63Q\֟DQEg뺅\]Zպ(Y"]2 sq9=3T|t)9[Y<\c,NxŻ۽ޛum@Bp E&vo[P4J죢Smb\#Vm%\9';{U8EzĪUI7G?VQEVҌ"f#)uޣд 9!m8FUGFT`+RxbH'%U(ʲ=ATٲJ Zt. w>1]5Q\χcYckvG{oFӹ-^+#^}4[؊QbW6hhd2GBGzb8 "5UP0EG+HFYa@v,$l qx*a`hs+y,6ov-t|&MLw20}e74īD 'd:hEW`*$"}-iб_^&b"7H[s(hۜ[; WܷF?xL!J# Ww {vGt 0dFZQEQEQEJI\34gQEQE!6va#\3o|Cٴ6w9B:n6~mi$2L{O ( p QEQEQEQEP-ԭeVf0y"8>_wy+8.>yr83:)l(GiDш:wN@&a+hcJɴ`n=N5=QE@6zktӈǘ[8TQEQEQEQEQEQEQEQEQEQEQEQEQEUnMSBc{w; ܥsƱW“eYB .oy\nCUam:rڔ/!xܳ`3X;p8#ɬ`,_XˆR=*NnDJa]xqYc"v0V5BMnͰE=0Tܔ jkHgFY0Z[ ѓF{L[\W>ƛ]>n ;P<3Z0{*Y5űTO#.OX316T~C ,t] 谯lls5Rv`\&b&wp؋va^װwߴmIvs/} xOvU=Am݀*D39A;1HB͌sDDD@DDD@-[3 JϳIg&.l.ָEGzXC\po1\W uoU.&8kMi^6y10b'GcS\kbi ]a3+]F2/NR5vmaV^e3!Zdz0*Nr 0nJLo吟crrP?N*uc\̿P.JA?Rt~W~PhZ5Eum!jR74fX\c*ǧVװ E&@-Q@NOoG!H)ۻt^/~k#kFE>zZW Sڼ8t{\g1!Jڊ mk{g+}Ŗ}WfsZK>*(`7̂_H)pd{sF."ɢ_VЋuҊZl2TeZIV8KUm`.@Nwpb;bB/5__d؅P2F蠱+kArPnSl d[oʱ+Jwb#FcG+kXɚFyx {VޓzZt쏶{Ӣ|.:^k¯??81rWu,z y5= ?cnZ9:k5iXA2hw;j;a1Fsx@?f`b53cyr$99սkN!IחeWcݯ}"]ou_Ew|GV{ƴ>;oM5t3NckABWtUesX(keiI@:?)ME碦cnGV~=kAx|ji寏=ѿ8o#n]'{xߩ^-MndkWhZ+Es3Is(*s/*h2plr+y1:@DDD@DDD@DDD@HQuJ*4]Kyhh_kUgf_BMJTi0ße"j>afScSU]y7S_[Ҟ U?OTexEGu:,]{n]n;wZʶ0]Ckoo,;y?ӡi{IM#ky=tET;Lu}yF3f6hBLí [ UΜ))D0oIS5DrIlmBo겂J #8VfpZR3eN[b1umma_c 8NcKG-w&K}.I/ #dl39U-a{wӎJePjv #lur&.խzmҫ\DDD@DDD@DDD@DDD@DI {Ic4iX Ҙ:G pV#!Sv #fivB"|$j0Okblnw=MhW^Z{;JZ a#_Ig;wk@z%G7$;;w^_ۀ,{ZѰZո{zzwUE]ptW1䕠:5)2K&/yut~vvvo~ w NVOa-Л;K=c%/Z'g(Xm!e˚XD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@^,DdcB  C A26R+#gAeѢ^k_p+u F+#gAeѢ^k_pJFIFExifII*1J2fizACD Systems Digital Imaging2012:10:18 11:53:140210203mR980100m"o   W%' #$&769U ?cccccccccccccccccccccccccccccccccccciZ_ -d``-6@ֺ|.FFO)G]ib` LiMX"Yѐo/dbU$f:$a@Zi1s%|Q-E0YeCUN~EmxϷA=_zg댪 O!5'ޱor^%>}I>-q!kcɑG'?~KAt:Ȓb_ eAV7%e1,A^YyqkYdaa>Ɖsu)+kJX(M5bnMcۺCHy"PR]:wX-Ffh<QRViV چ;X]?̴a% %S V]*'Y _LSұF!h hL1111112KZjO{Nslv {Xe9>ˀKxݲZJgs yN^N{P~&[Tȟlq\c (2z +r- >] X7#-9bXSt`鸵 'e`5Lͦ0}#+ұG+`Кȡ3nbr9rӘ+U1wF)o}XFPdzZ(Eߏ}j̅2>9 Ks,3(=%30֟Ӊ+%+))Վ֔%96 0)و 111h5թYƃYzg#޵1= rQ>?-1%ۻq 5٦DR%Nu\3W'"9wii쎨vLÌ5RZacDs}Q3[Qu^ hhDxPRvt:):jIp`qҒQ-)֓ֆ,,߅mY9uhT r q5xu$jSwakU=|(79XRMԭ leF1vcEƼ$VL1YD%ě9½%ӺK|uYVAgıMul'x=ʋRh ]>nG\Y@ 3zp ]C4!Aifs0ͤ V5bt#i@U&Em q`mOk砿6phP;E +K2+,G]) H; m-"dݫ/%qSݟYX c [>Ơ"bH 49zjsi^ ["i#s8XCk,D.Rh 3"'JI*&X!NtԕnQVsf#$+ÜQD KٜV:sjjk>TxV'jvV()f/nܜ s$SqܰYy>5\=L9aTƃ>zҜ d:US+ (j'bP*KXPa7/ʼn} hSNԸbvݤl;[m ZhWQ_զ֕3-&Ѵ՗LKx F!+ !N#/SŘl(4CQƥk6f`hގU lYzR^,b!O*A봫+KjzԸUm)(%>']NB@[o׭Vp#DsįWdUij=-mWx2(9B5 \V쥔7q/k]xAzzW ץ}D}4 giۋ{V&bT\5W|%qTM ZΖồoZ4Cn6νo%vv[|%m-4AOĀ[uN0k TeVmϫ*a[!9ծHI[,@fhХ&@b@7xxV:,&ֈw iD7t1zzqښZS|<|}"MLAj5b3 3oL#"XE@%݉oNm̲e4㶶t58!GTIeQ sO=t E[Si`24-^#trڋ3f+nN?PCG&:PX vwi0ZE# ͉CbVjϦ\wiJt0+0omNjdDN9dTW& )$%YnsllDAisrrNImp{}PUڼ2u˽]*8O= ڀ imiI~ 9]K]RUU4FdIG5:٘ ,d<48ٰ6ڛKC7$Qm >>x"vQSI]_<'ٺV:ԯ+an>syCF=5m F+Z [iZ㻂>!a9qCAXϵjdfֱ&9BG*W:)%f mOkLqNtHACqDlE#6BMд@tiTx{`Z M[8>5$r5uv"rAI N I@y1ٲ(-/Z#bؑg {z~Za"CJ]?UiI~[:h4&kZ YT:Xi}[-=*h ϟI AKCDj52YV/Mbt"LT,M"k0H4 !de&w"dOw6J9dcccfbK>D]h<=s"Qջ`BXl,b;dbYZ ԇޓ^4z rv fISF* \EȜ^8Qr9ϰjsS{L=ܖn.}wD福ZwexB{v"AgU%ҡپ v"[E"^F5f1ahQ7?l%eQ\( ׾7WD0KC}N/E86ADkmcXBȉ_Z[.B ?%fEe<}a1cVNa5.J2:[ǎ!4Vm+x,A,oOƘRE2I)x oI ߌ--. Lh~7>K'+(>SC7В`%c,GO 0Rz_K~WXi N4ţ^s$*v="MH1ҏ'yODMhB,(DT'GߥFS؞{I {XZ>ܲ1RZ fPAIj ŤlVupcCP#9^ x^cGm)L~JVO p8O= Il(ĸ.5]^GE(. й^l۴hR}̟_ Rx+ tTp}lZu: j­#~q-kQ1,oBlRHr=8yvVT̠}t_ˁDZ&5%)36 s)toCKQ4Uw4Dg>Б ?˾7d C.V=JdLGrg s!Ǥ| >|͝>J[7I8̻Vq=mVVv#oK LU})'_. ƤNp5g ]VΈUvQl?T.\kC;ejB# I? lsIGkqCؒ|:A$qq2[HȂugL;~ gE$uH!&;ĊODCAHkJo j5AvEj' )RtO%@-}5܌Wh)mWC,oxv}sV!%wlZdUU'Z~d$U_#KAXE/Ӱ\ϮJyGxȠ>g  &av'_W1ĕ pPPX Xhj0$2P<EdT [" Zo!V ^ nL,)X / 1WBGnX+>_"9"a%X̀l-eves7%$#dբ l@+5Pk -d|ŭ1٥,\X{xA+z]};?daϺR`EE4'3$W)u>V=3*ꗰ3&WmVW99r[N1JZ,` ]]l]& 1ܯ@vAZ٭RʥՇjw6 ӉaVz,`)E^6(}‘5PkV@@ڦ^qL'e,\ݘlJס5pk"v%%J &`f/PtZІ鎬,@GĿILȑ L ONCLnHknODL쇗 sNJmw111112*8e{|]Vm>jx5$)OM"t6`!LHm^bYmįGL1D(aOo,6¼FX)e@_Gx􄶙ld(؝z]G?Op5tOֲyBQQ +R]zWh9ajiخ^]Qo'W{Ѭx +emɂ!W(|.5lJ$%Pn0nj:-mW93N"O\>J8PΞXhu.;Ea$Y0z@sqs5ݶ-S4l\F(w-~u? ~[wrG.+>њ*["h` @PtGO\֭wLq $؄ 4~gr !V%ųz"+AA^\5Qxհ~6G$R1R&w-~u? ~[nN ~m(٨vQ^ EҀiW5Q =JTN~{WED^Mƒ D;x5*=ilӮ iWqڞ>vE`>ﳔ b)Ϗ澎+v-~u? ~[ ^ qi@/38( O>@CqcXm=mמıj=urTf3{mN9MX,^yR7V1r0e-@_UMMB^حlIwpD#}{]Qo'b߿{O,-_ n qQMX[q,Pƾ즩h4ٹ0zDZuh:S P{!\J|o˞Z-)+/I8&\Eچ|{^*3A3q}eإ sH-:ҳ  鬒!@нdMf(׭8 x'~~[XqA,yeeJ1Hxٻ--S =p*ppd ]j+vC,2J,vZ<ޑd Ŷb@u$vŠX1DfQ0[3RoToԥM;߻>b,<{ koAl1cDbLIguteuh)@q`+](-#}BnJu7l m;qiTW6 ccc_&pIQfk 9BjH ܶRuOu5d8y6y';"k[xowSK|oz?Hgbf+d:gP j XTᲠBbvrW'&?\<2lsԐEwzđ-߀"z]swY~&W2, Q8yD3T "8Qs 1aRh@zTg/k#k.KCyܳ, Dڶv[p :Pl{l:a8m*k Ѭ111yM e='Q5  NoxijJۯlb;X.Bnb{ȧ auxlFє/F6DG,x$K-97X#5;#k\b7 Q|;Hpٔv4LH=x< R.%ڙ!bNC{X }26Hl.Tfp ]js0L"lFG0""[bE.=CH OKA@CCJ iGkin ϑlLL pHlADE")ifӌ.~uTԀ`V2$ۜ[&*pmX-nRh8mmiai٨{iK/?_x=^|i//p=?Gޭ ȿ(؁I+b +ҕr̫U 䀫 hVm R_D!f+ͧe:3 F̊LWD@&cvVm'+PV?r]Rj 0G 5/!^5Ib'7sB22mg[ `7ccedS y_FΡkˢrUF)?PiqJgp,[&J 8;-=2k eh{7zm?h8G1A(*S8n8S)Å?8Txq!ڶ"J]>-̣dCmԽv R)%&AE}jORu+jMX=l4T6cr!\j[Lya)\:(WvV`iNp1 [,^2–0a2N0lD!"$N%'kW3( WUH_5ڣpbwK Lƍc!z Qf[? >p6T)RQE@r$_~}l =70_ȎA0¤gEjm1G4sްc WsWeKP@g׭FQ/+0+]<Ѭ`c=ԡ/(MR c=/ 3MYU汸&:RWVz̒ I'3goz3=jT5_{ $[gĈxɣ€'|4m !(ۀN`-~񁘫[JUmuY[Eu(Zƫw B@xp]q?113H\Pw+D\x5*"hӮ iWn=JG`>6r)Ϗ^Wo?w4h)Ěrl+Y]-#B@hEqu뷤 :CȤWT10000 ʣ)[3U+cn0XSݮ X94!rPd$s3*}I5JhZ^ĥ`ZX)B 5t0K2_8Ck1{ b.t500Pe\uzQ͝I v2H\{mƨl}mI/-q1WJ'l-n鰿>}# [`1`1`1`20bR-Y3g|=el8:֑ol{K^; pw¬{G !3ɭsr.JmޔJXYNMVR/2y-&x# 2,MXhC,If0Pq3soۮܨA%*E%uERz<&kN+<%Q:ȳIxd'\I`6A-Ž1%~+nYk]N; xįj2Y0h [# ?!s ndѮ000000000000000000000000000000000000000?ٖDd !B  C A27RPK8-G{)YXLFPK8-G{)YXJFIF``C    #%$""!&+7/&)4)!"0A149;>>>%.DIC; { }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz?j(((((((((((((((((((((((((((((((((((GRhl3GTg`Ia2G9|@].Kl{[i$d/2`d2#@뭞Y-bx9YtGGҥ((((((((((((((*9ĭo"۲d5hm-KQhh)G\y{[i+AVSkI?d-bhE&eR{,ݻsx:of~j29f$w0 m{h_-|nl d((((((((((((((GҔ9Y#O# rٕvI >y|-](U{pFTco֙iu-KYRnF=A/0p * SUm;P%V ٙLcq]2 + ۍOIn,4BX F MUmGJfYD"l,dqoÑV(kZ޶bw0_VU(جѯXf_剼 ҢZ))h(*ޱ]%4YTeA4ic"av7BFpzJ)((((m}o\{GKq "Tp:"w9 !M^Oq,V"D3*Q679'bzʆY"#mc}:((+,= IMh_IRe6H xn?u\˨L5ƄMwgbS ,7 )ܨ1+xXI/&Wao%bP7*p`ԼCٛ}q/"Esmld/ڵ}[Nh<40c  ݜw5]t ?t0U\Rxx,X.-thm{7譮`drIV-QEW=csO" ԕB)r{3͗Ə'J]GgfdKc۵ն#-bS;I U"m LxI'3(($|CNiuf>x.&$XB'8%@ .fOeN_LZ?=<Ռb[t: }APkW Jd$7mM7F1D~ 'tsd\sBV4Py;q3!bhn]# Zvxu!! UG۟nTQEQEQITu &7J;ƩC[;k8໽.Vfĸf,N99+N0$@(\y$ܓެRW7vMmK%u;ǘ&g\Z>%!wk %ExlqԥC@ƿmv `23]6HX9]eaW=y麶 "W ٥` * -nn!yb2g\㡬 :WQ%lEQERW,i7ّ!7GpQ2w0]G=7P<H0ȡs ЬmڕH'o1"I@v2qҺ*e2\K˘ q"rd#=mF8QqQ>zܢ(({z Iz^\Lk wqڧ "¢*txh>mnc@>N?^Іj:sʸ%NOf\7};QҮL{Uɑv883W4[:Vu7!EH3m-{r٢0"[k fWc(((dЯ'{cݩr]ocn1j)iI,r%ֳi2ŔE|x1论Y鐉o.cs9c+jK|] o.c&[JLׯWaT/+ E3tFV)s:ԯ4{{ŝ̒\ %1H7,>q"kFRgp*q0{{=znu0Xʓߏ09K@д-drI^gաkth\˫QjMݴy_?`n9z;csqm|gW9;T8\۽ 92>D5Eݙ-J+B1/\`0PXF$e"OS!?4p4G@UquQmG\R@5μR]-ZܘͲH4/3?9Gz+csqm|gW~U-WINmBuT1'g$|5us1KS Õw(뇛CQ(ogڬEQPim4-O,Yd>MEQEQEWQMkUH;EIg5xzmU,,]K'B*>GZ袊((((() dUN;D ,g>rX38Kiwm}l6w\,.[pyTQEQEQEQEQLXE8ԳI+:ĺ-w[jPIgfЌ犊Ś5w-cnZwlEQEQET7v[=o G rU}?KV@Opx^5&XGkc2I mrG@_j,u7Rw, `&6 zVQEQEQEQEQECZK"x$SRW}}zmO/5c%ж;44 eb!*}z֖g[ iv>乼xJI $srTp]OƁdʕ 8-g*(((()y04Nv“ .q:mĖ1hjׁ5>{ӵ(,t`( tb6 98<7ϢvM7s[B9A+N(((+@֥Ԛ{xC&31ިs:aq6[9#0,$U= t.hZeQFz_^(((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((4Ddtl B  C A28R^4̌T ,-Oo~D:4idF24̌T ,-Oo~DJFIFExifII*1J2fizACD Systems Digital Imaging2012:10:18 11:53:490210390LR980100L"   #$%"&'8 (45679GxDFHWYXeguw ?cccccccccccccccccccccccccccccccccccxwfmsmo$_ }9GĮ)Q=-ږTmQZihkcP=6++%99% +00+p@JJAo&ML9v76"WVWE:t<(j CM ۽BK\L:cV`Lu%61Uw؆*&VV[~n8AMQU H>w[&Z6:yWF E0`L[)<`<=,dF^JuPN&nQ?|^0zv}+=P0#W7-+Ϡ8spZ0o%qZQI@̧ct1 H[U";Vl8MspH *:VYMZQH*![o,611111111111111111yIrg,NT5!L[;\jӌpl,HIj8]X-[[.Rғ_[/W'g ILb&IBFzRVսx(%ݷ a4hQȚv'YyE&zޔ0-qmd}J'ukOJzVGqߜh` +aM7qEZ HR_Ztg+͑٦&z^Cq7U^+h2;yqꉃ}OwUhUXOdU_W؁,NKQkv/\xh_KdلtQsKlg,m˝sQxӠ[[k;fyN@'?:W٫xxz61XaU,(W@׼;񄢾{N:QX#mm!; !;J@^CP3?YWEicpu8Z;ai@وA5"9N͉r/x<&W{uݨe(^qo^W.,+?@:}o>/M?_{^+{p[{?l/K0S?gkuMD_;Wod j"4@&/`.aƱS}wMU\)V5=Df\^a 1] 'VsW>F;Ffm-,%6\mЈİ4 INd_0-`iyCxCQ5K!kŌp""Un'vПP8퐕jnP'* ZS3F@D60 vZv^.yۏ0I_l9OOQe&ZBsk?~>dQ F~ܠdL}GbU, YB0+W.ʙU\0gҡVb"ϯLc:{X`,kx?pt&~f / ~H1uˢhY1%їz,ӋL!}zߎ*mN Tց50Cs*6Ԥaз#B^Ji%{HWI N,@Jժ#硫֏{(뽤y?͑N8s=cccccccc_U'/%WAX `lFšqVJvYs\;2HZy4j+x%sMG:W[?`3 +\+M,^C%= $F>rߟ 1.- t~֧ٚ:޼W\l|\P\UP\O,.%PZ ~ [Ov]я.·Bh )ccccc-mm@f!¨.+ٟZHr-Klrk)u( N`QZW18ז))FqM%kS8 8$ty1@m(b ik V(V#1^s!}H xKRҀ+ل>F\4G&67%"lUO5mHk) 1~ⲿ].e~AΨ[ر'[ vG@~fxab`h}cipBVߑ̢(܃fLAٿ&eط?^,CN%(che88:ʿy_}xźz5_@"}CKUWuY/]QãO^+M`YXg=\$Ѕy=O)1!y,eIz \wYkͱs:xAKeF_rT"F8O>t.-Qi`p]z߶sdpTk޶G$.CG9SuWN^Ö|hݸ P>44?QML8utpWVWD n<|}1m7/ BA6 Z{}@{SE>]<"֬}96Q]r7Vw⌰+wTVSz9 ܠ}tٿmqpv)ar.A%fz tʩ⨩!;1Rm9}p٥$U |HӯOxwNZm-ƤmP'3Lҫd["RyT+7c/diwWq1imQNT4 #mWo=uL,fƮҘRڎmj!BP k+a9EyjϭFmC?\Z ڻf,GDŬ޿L|?vh63[eY :k?I,HvG"O }}mWWX'^A: zPo6ufVÔkb?bxN)_oalٚsۊ}'KC p)UOzZ('k4aKLe!yM]F8dr}ϟC?&0000001nj5+b=@5 Z[bЮfJ 9"kpARW) WEu5S)`pKJaxv'^ؚGV ՒKe9ځMrֳ0#p$0·g3+7J1Wh[KHsA(yvyF"mmWU$VT@::&4=+bWʓ} y'w70>YX)-`HeY]p谠tRR y0h(a˴,ӤF+O89}#[82wuw܉4W6JERUxWp`?k7PXjjqd׵J@pw9% 4ã"\]#4TaUX' e~x%=~-c{/p/(q [^׊r;Σeszw!PR[xvaREڋOnx&y}WBm{kR{)퐡uUS- y:;JˈquM \ إ2Wҁ~pJt. ~F jȀIת]J1`XgЎ^S}6հo5ZWiˍML5o@zlOTR%KYR|qsAH4,c{+b: =+ǩq]EOqe_Y͍ן9[‚]t:܀jHZ\WY؆oJ)6lny#LTrñ+$SygP}au5CO~yu6~!PDk 8S|]tN[gi}5Bny֠:$9vpI4:G϶k*ΖdH gR'wPLcf6ue붗5.ltL Qe(_s~T_=^i9ݐ9%h%jsn뎒 2T)v=*p=&"{ tčM9#ϽJ;cj]o…ce Nuuw+J[k;n-h @ֳNb 绋lڬGm<ޢλ^0JuPq w~nBB@؟Z7 1~EHg1 )z*7wO)6R\f1B*eP;bZL Hͫ$`kiVŻzx!=/'J#tWVQ'dOֵdǃN<5<򻟄 9 ?誝J1 ̎3Z~Dڵ]۶bi~}H0?Z-ML‡Nz D,e*;nT+]්J'ʻh[o8$W[oAmojk>GVW)s7 WaoEe,Řrm>:p |mdꕥa-^% I"%>a>)MLoKF2f'gAW<0000000000[4E!igK6XZ;E*gSA%FBV_ -N=6>-qakcˑ&/C.JkKɠkOHjxEpL'Xtd -oiCUpTtր GQkƭ0 Z=,[gUB]c_p5Chdk[@j2d肼! źNEPA(2[\M tW]ɩmTTv*oϭsIs8Z5cq[Nbl޲*!ZviW\4tΛ[^ %SU@GQ~q-4ozR>^S Z9ChWmZФ9ǰpbWp_Iin.oFƹJOӌRN wk~Ezu@ Y;TjE@eeCgX +tAHWծZ6YY?Zb+GOH|-\)eoAmomhG\VOSaHChijκ?%˰j<tyil +h-jpqV(nMXuL 9GH1vha uM!Vt>S@f.}hi<:1" Q#<Š.?[k新h~._oTb*?zxrbXťʛGVe\8j0j9L~@ ]mD#`|jS!rM u9@cV[I =mP܂4%%k+,\$ 2<͛OI?,)?N*ȽroX{>Jj5VA0?ƎVX/J=)aNHUGK*oNڠ YUs:`5|tj-j5dvB)sk@>_~xjȧaL mP*jES>R}%<A&Y?1{cʥmN*A[$%ްP~]quf\lmH-MO=ɋWcq?KfM屲 k_ :Ҋ[l׸p-tڰ=U4jwcDVEN3yk}M$)jQ8鍃4+Љcz;c嫔NURrSCȡzp\@0znC|]8;7hk_uK+歐P@4қΚKYCI0M]G'B6 ^AZlqrUުŒ ĐZg?-ԓi8qZ(T0닅\F1,$q߿C[ZJ(eM]vRtj샚s Wy.G6%'{Nܺ00000000000!󁥯CA4C\-#[Dؗ"l}WP ڋ]2r !R3h*[{jYe]OH|-y 7+75W]#n++Q l1|.K Ssu=o%;m \~vҬDq[+&/|6uV,2FKPVok9E޿\Z \YOn1}m&!qF*+c m}9B*,LАņ$ &Dko43XLh,nP2:TԴ֥j> 6$dۊ=0o7,D9i!2CfV{ s K<圍']wkӂ$U;"`A1-[dsCGZR{J%e]gw+bK϶qt1W@W5ep٤㌥Cw +lLv-pa]uޱXS}L펵qLV-NkZbx޶ZP&U#D/`؆>#Vvk u@>mD xc;I2!NkϚUx ^(I4h'+9{g_}NU:އ%ە2_.G;SU[4g:*+WzOfk韎ԻÅ[`"-<]MUKC(1-ZShkwoh%SIcw4nyv@0oIj(XQMj6uK´0U)e_!`ؔDj \J Zlq|M_ު%P ĐZg??I,`aZ(b6#닅Sɷ?oO: K `(],4qv:~~SF1ZEf )!˦)TI鬛ìD;j8Ck:Q1ԣ^Q@8%+x-`;R}kszrB2]]U]h'чu2ʯCUYl\Ah:F^sόУ-,,ƵuQp{* R{bpRqA, MBA-%ˍ!qlO7*$^Pu8mV)v[dj Z^mM;%°zgtmzj;t -g4L7J/H.YC+j_x c c c c c c c c c c c c c$=p4HvaҀ#(&k Dr s^xMQz˸PR޼]Ad*YW^c8] ʠK9;Yi3Z؀'m*GJqOq^oLwjKnILK*;Eb@2>8dŲpz7e7ÊpW5D)ܻp?Oj9&zYlM̲ZFZ}O[l޹~hCJ툀Xޞ;rKkxEk#ȁ|vbS$=-޼~Z)+ۘi.G 5xG5`{{nDyCb =8*X')#H:w\魏íw~}❮ L<=omAun)c';!{E.xkKYŸ]ιe%hфލRpcaZ?AT~mUžHu[1:opəגzJ.OfQS5Cs@%:P.V&eN&Hsmr0V6qM F~7r+'^W%h( c K#Qf!L%E()սmk1hvԊ2l_دkNa0ukN)߻@sf~L]4mJaI֭ D˃Rϻ. 91 YOteSo1Kx[oEWrx! ,-וT3.`ժzDcx Aٟru0}lamֽpUɛqve -1pqVi$^Cd56릏؆09HJ KO.[6FcP,2uoSN6w>^4SlEӬcccccccccccccAPw++P̟{*:~ Cn+i]mcqY_gşbm2,mbu:~v~}_k+_uoS0z7)D[O0Vˀ;}8X{=Ĩ/y0>i6\Nxn>'~%Jzp1Vi`c9):,4?p4ymEAMMhrWW2;ЦИRxyn.c pX̓>7GS/mw]' *[r.BPj Jcgis嗭*:25Jw"Ϡ$};AkAA`1a`a a@Jja1aCCTPQTÇWMMW%uetHСFӨ(9a2hͯ(F'@':=bZS2y7 C;&Es`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`2CK^4l6-(;1hGVW)s+o#!T)}b]:uw-/zKBwX)^)+VM_Im4oʶϺ&t|jP%'>_)b˧n#%IE I"~5/Sd,e4MC%TVNJsiLUX! DHM%$C$08>2ߖhg'MMT8[y^Vhef1ivWn|mEO qe>WM#3cSq*G_ݱ{Иpt;B/`v 殻>.F9PEGD-"(6lUՁN.*V&)c-f7w &5yۼL U@BDK jPMVWxh*[{jYe]OH|-y 7+75W]#n++Q>Z]?Hu*~[Q}YZߑUh{ugڎ{+g BTp6_QRs45|hU:v| @h@{Mn gэ]2mv8C3~(CH/:|$\[s Z׎ G)4W \+PRx c c0Dv,e 32v'YE6 1 n,~/>4"qkC{ tQt̠7`Q K0Gh%F3ފw?X7ʮE!%,eB6J9C,r)O]G@4|fPMU/ok8`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`3;ii ;jq-j_ Eo~kh@:&~ݞd?4Hy9acW[UZ޸aZVhڔl~y4?[8ojR;;G8+j]Wl߻W`ԪVPk4jm}q u"H3V}cBXķ6+. ٵDd$ ;;B   C A 29R2.rlz]F2.rlzJFIF``C    #%$""!&+7/&)4)!"0A149;>>>%.DIC;  }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz?j(((((((((((((((((((((((((((((((((((((((((((((((((((((//`pW8T1G,O "Ik[mjNp|.w.gA#n3j*)˫ VݤHp[ ;qh~ Ym&*H6c9exZQEQEQER@dڹ wzmc< 72xS_&`pH85XH&N.E2O7op=N1ɥxT Ӥ#w-3! 2R(|Sx=EQEQEQEQEq:t>k}iđ`R+tGAcZOd+ ʽp8P''YXZkZ\[M5̨éds2i\7I\crb5Pr۟\g@QEQEQEU-KR]:83IA[CHK!FXGϱ I!q#^(TVeB;:VO@"ErN';*O$fP4$io_"3mIQ3! : ԫVIʩU M.m-ٜ2$_H0{W6YY ȭ' \$HqPcqv8φop-.]hYT(w zQEQEQEV~5$"/1Fu8ԵJ,%#cŶy4ઐhV[^{`IJȍepc㏗g9`Qm/K.JlA}ke ik'??}l"ŵ FwH cn_o,;X\AqoKu#g>C1'<+R((((|G!zmZڬostIӮ?[S?EQEQEQEW%zZoo*((((ֿ+?ZԵxBEQEQES](IQԓYGU4"UZ8/r=>Pp~a5oK.aV˹@@ aYHlǫTv>#v~˸7<'Uʓ^Cng57b;0x a1ECqj-w3o͜l(-PMoRXu(dB;s, $7owomy={u[ pypiajMT4Z9IzB Q1XPm+4@3N h n&]e"w/An>\;][Ul9:UuF q(':Wl- 6UYf,ǫy$՚((?E:?v`-GCTY](Er>V`A# 6,{;Z1ܢ{y:gidg#'xfY ]e&>`Qdr*cfI+3=9r`񑊥|K/dwl Q%}>VI~pqgMy7nDKf qvӜ qVX.^s&FF37RKյykZJeVMU2b6d 7\!KVi(խ%v#gȅq#C/>`qZsxx丁tdRE,W1~#WAEQEQEQY sS9T7Z~Pimtb7LaKlqg=k3¿WW-ld&u*!+*F [`ZVMzgz\Pֵt6GTE1w&Q˷ʬ jQEr?ò$ FdCF82YX'J)O;یH9obC6p,hGHcB-<\w"+]FnlIl}  (t%$I 9$YhmKx$vuQnp@l7K7Ve2MݸDGQi\_]|Q@ myU)g8om+ՅK(Oq&;O2TiXq%7ٮFA2{m`y&HaK<0UPI$g].(nki!gDFHd*d25Z_[%͝WH2Շ85k-#>#fixܠ y՚RO {s#~H0G=+$p+B;NEt0̇) #>ճXVu~ז6In֒Bq۝}\ u/>zg<(pHa]8sg?[):W[5Kbi';;iI6h$TW%x,{.x@$+PGԬV[aj(F;UFK7 gUPlSO\-ͭګds8\clms|`stv u+luW VS22fXብ8gcu$Nt%dF7@sr$X+23֣m[yk|>=ƯzA6; TpP+fl5J|v6kcf0߷ ʫ&6Ծ?!xeq-BJ3裂Hhii4P=˫6n.āAZ(U{YB`a>`zsyΟ(+kjssoBDrʰ)%ziQ650_ fPc'-M뷂A2Śvhcc۔h`$g% KQE,qDQtvKsU*AjDxO8kI!VvzGsYX@ !vIO=q 6- "0Us<0' Zmt{[rҸ̎NQz ~ouOoDghy16õ$f#Wn[Kݷ[s:n`Gni[NNszPnVRR\uYtCt)FZeݰ TpG䊥xڽͬZv(D{$#jh7{/>䣴G<3lU A(+.kO*6q}Ï.D[~f pFT`Mn[[) K".?RI5 ڍ5i:FbJ:AW}DGi G 8<;2NXLy^LtǓ* iiX+1`AV=+2FֵgKkl|5fC}H !o&T˱BdhԲTcz чOҵ+yX?'IoG-2Fڤ0낪].@}f'=cur1>TկBn6,1/L7,-&wkƲmdF&8sTnbLG:֔Fn#m`6K0tj1[iuwgnLB ݸǸnʃ0y8jbSw5mc|,\3|we;E0ƱDAP8U +W-dԅ,{R >oAYn.{yu}sIo!cٙJwg& B nnOr{ɨot+DRWjB995 R)?0ag~=vn;Ix%H*{;.#hBHܬ0GƦ((ͥZOAJ&ib|Z8fyQMwXѝ*$\jIp^̪ 3<ؚ)ҚO/7M6ưX3ddҴ @Y dp@#5#*` GE*"0(((((Рk<\\,A3YKJ|cp90\$՟Mc=WȂ8lpͻhvEP3n>{t&]7FH!~u|N $[EQEQEQET7vyg=Ḟ > qya},qnG.(`꠩8jcOi6,{̤( 69U-.ayo#I-l#H#5ށT6>Ama5QEQEQEQEWQ14RHܬ0FG#ڲ_]?jh6ZLu}̠شhX>QW'0j>MFɲK Ƭ@*7`<'-m4}r]ygKcwhXU6IIEQEQEQEQEQEQQ\$6$Vp(ʆokoڏ6kFݥmy #FZW=M\W86|t WIEQEQEQEQY{#N퉘c xO{'wyaA% -#tA{z In鷉s$ H#EQEQEQEQYZ->{{mBm('Z_X/fXјh8bĺ>x-,Vy/9UQhzԢ(((((KwFQ VR b:ح1 EvoܪêU|342 +K-vuː;Ӛբ((((Ou@l7IwXfDnO{+[ 24[ nQ6\k*=F"=68O>kJFIFExifII*1J2fizACD Systems Digital Imaging2012:10:18 11:54:240210171R980100"|    $#&Y!"%'(x 589AGHWy ?X)RV10(9sg 3lPBjAk 6\:ps9냅8,rR5\v" """ "'hAo ` ˋKA!!A rӣۊ0*u~::@YMOJ K~E߬@i~Nݘ;,{j (g4nȂIp] wQۻma?_e!1Ck{oi 쏠ϳ,,,~ bН"t;Noj_sO!:?L^{0PTQ}G`baqpc[c]׻@uuԿp)lⲓNNIoLT lHJHW9׷ٙv76V6v9Y99nfkn+cvwۗL ubHRUN6A>Owr"5'ɮ (/ZYľ.k4I9 .)[4>Ml9hF|Yh/ :A;~y߀}@O EY}g_K)p{q(w[ N=J)d3̀4gNHT#U[WcD2k-yf @>󬣭} C|tfSi)1dF'H.No L l܇W cgY r;N6[ꮸWdwe55/Ǝץ-[SZ>6a#9]4(,#~A ۆ -&;/5J8 ZOL3 Y~<>ӾRC/¿䷑|eCN3Sw<|ufΙ?qůŠb-Tm?0uП4:ʊ:0ť m7[ފV^S3+Uvx44?QSEAESWMMW]Y]@DD WzjWy:ͼ]e/֕{1 }MOP[WeUe}-~o>?Vo}fOJh-y 7 [{MMUgd} e}/fcsD:MBkPP VZVGC[-aVHAM-'77G7&(Yٌ )}CxfZ:+Ų,ulY5NfX@T\4]^}2usQl`l]`:m}}ϧomܸRA)@‡J֫.3fELƩw4- ,-\?>,*͂)9l*kktVTgqm{ x-ҵoWmRe!"z oi쏡,,n~.D;#bNp/BPS¬S8YZtrA5okESSEMiwM]cɍŝk_ə ۋnm(BӰ~iU5@A.]SDX_zznO1EAe8n`(Z[TfT-uLBf:0Scl;Uw?*N_A?xOFA;-luCSmt\vXdExFcVkף"$@l,ykZKNA Q# 6Xؖ g7rpixo3rF2[-p5ݔx0!=]/ .݊tX K1סF-bX8[8MQZk lW8bפQ%n@Tݮuºİ=&]1ÅMGyv-_Hn{ !Qi/G(05x(5x&&'FwS-5ؘ^TߐX4;}o<i2Vdy)mO\rWSMn_?{־Ey{RPFET6+l+"|``;QB;&lW6y6 o@aHх9f[ _2@z-cEciJ s!&t8\w"fUY5u9\sER2*]z[f&Ykr;$/3gH?ˆƶ(hZ܈\oI׏D~k>8Hߋ7iV(SEۗyuGK^ v^F5jA cUEut˵ҍhi01Bҳ2kngh[c{8rC+zn ~Jev R Nb'y:ՙl,5ôpevM8p.ܢ9yuc[[UE'7'$8UgfD<]v$E79y'Ԉ_{)6YD,$^7{J N*|=}sY쎨+AYJ.^z7@ 0NArЎc{NJ9{[Tƫܺ}5*dl݇٬oR87\^eUW@?.^PE=k>8Hs'O^?(&|rأӈe_[^ EOjp[[ȼ-{`,>!^}`$ ;Gt}Ot[{ەK}b$3=BPejP]~\5ټe<D+-1FGR'Ԉ;[}qu]{iw7㰬Ÿzmʒ8~4}%|gX'LIp" ko&rw0;bYn? -1Yͥ6=eN6!)fnI(P`p~5.mOMMVv$ "A{g.(Ɩ[e%'j0 YWWgāI |wgAKcNЧ,\ ^Z߸ 8lmsX}[uMjomO #0R1MR{\w1ʚ+k@b>8buՖ8ٹd`ݾ qhy*.rCx+2yGhq-qsc5;(kg{_S1O᥯͕\n)պK{ ujلn ڢ:spj"6|>KK{L49IruõF+O̲*(#TV|܁@jdfFc9lD;;g7M+(=ر<Ex=Be[ɑR LQV zy˘1˷ a sS 4`[Ż"'~⼔PHk>v :]P\wY Ky{14v/:G̲fDbk|x?N?]udrjwq*7Xj}>2 #K[Rn6X GNj"Hz>Min+Z6if?vFkjZ'<+;mE_VֆgYuw=uͮOF5_-C%]]Гٝ<~6 'X*šf^ɂoCMǩMPeXj T] 5o|i{&SǓKE&_uڐZV}=FGD^||`4ք8e%~No؃^qI B~=USGiYqWYϸ*h.y&m⩸Sj:7pҗe;Uc* [ڹB^2H _5l:힪^5_3Z+ڵ_x#Xޖg)~pߊ*( k(/6@":#WNM K>ӷ+J(DbIUAm*Ap6/09[ccYrz=4\zr?J* U#TgUS^ TE^*A "K7J;puFHo-jo(ц/xh+nbqm*VSh3X*ie.;|^{73chITE bĖء:%pa8Nm[QP08X38eȩ+ܬ~]Vx[ Zwq-(mQK2 2EYu^%~aH+vj~7`-IVV7Eu[ `"2%E*%h ~4g:ՠ "|rTuj-O9גAol,r L5ə{k[Z:ݴJT6~1G1 S"S(KϜ:6ܣ&"hR')^]BSV}uԽ"KwF{vfNӍ]*mN"" """ """ """ """ """ """ """ """ """ """ """ """ """ "e6nK(S9j>% N9f;,[c< uUoS:rQ*z]cNҷαp+V{CAܪ \b}3";[Kp{}wcGbޱ5+#'&\b*"Ձ6UШBq횣[xjU~A>ou$ dOxW?hrM*fμ`;Ξ#c6a%cEs[m.z 2iqNr.b%ieZ 7@eݖWd0S^"}DP7򹫞HS}HW>:}K:Jl sO m&ŲZl"Үƪ!ƼàörJ:&/$a,:;v" """ """ """ """ """ """ """ """ """ """ """ """ """ p *dȼ*lସ-:?:- ]¨ΘWSz#KZyL2lE`N0AxKJ7wNW q&=uE;9Bd@x5puuhHJܐZ3MȽƶ^nۦqKs{'H >J%UTa{IQv"Z3NN[O8HVkT6kU9oڪ-:5 af%J^7#7傍WЕ}&*JE8.1rY2W] )J`R-]M[qr:WCZnUWOl]՗KﻸsuPߐйa|xrؖGR_|_05BB‚b@T!âbõCCU4TU8xutxxՕؘXX<|}>Ҏm拱=_!k7\Qjp#9WSҁa"␗dyUVa4ѵڿQ\7)YI0FU6h=E{~'޺DeO0Ϗ5$$m$rݱ0Euc{*˲`2ʼnQՀQ \NJ2w lİY!B=9n dOeRmb#^[a ilqjE#anWPc_2턵ؙ^"w%-֏ۨM>EG-c@k+i3 ]k][=/NhwW_G֟u[HFEKȳkܷv4wģ֭GX_4ۜX;gljY @7ؤƋl/Au(ۂ3t?4*V騫ηI%{cGTwJ6 //c5Ptla$:6"mf(WfRn%ۀmyf":l}Ӻ0rTf״H̱_f{gɩoMɉYʛ$n@w:AS ؇_A'_5T V :Y6/,Ip_?` \p_Uu_ڄKi1UGժwCHq/U|[1z@m]_RT]Y̾)W\8vvhޚ !(@, 6\K.ˊ1ZKɈ3X3r|95?YshP_A;oܟ7NY%pm=ݧsr7wIź82c 5PհC3]Z665/6 *Pil^(=)j\7(joX68K 3Zqp7LF˶GoښW69:v-y~mcڏj_"!,oY5 `Ŕ֜msْ%"m/ q('n6~/A!m '5k޾8'Cd\gi#I(]loLS65AYox +k|mm液-foZ)83%z1VY6|]]d,4ߌ-W[;WSR\)%~g~싉W~xFQ 3x,jbJ? ڟ=]MS,!w5G oy*d6y: I/y*ȋR/Cĸj~ws5o?CƵ;z*۽ı_kekK1ֱ֝ [U tel5!UcD 3GZ S@~xj!D@tZGz[±Ó+/ ]tNm-A5]{4鿡! cD2UuagHpiB)-\IMƻ]\4MEp'i?4qGy}㑭o+R~-^\,<8@ x.Y+unmк}VqƤsAI)?Cpޠ1fU\Uwwj*56T\BgVjYb-WykA׫:3w̚RUF kz1, y嬪=|&!e_ 'nsiSSG!X3g^,Π9_()Y*z̀2ʌ: }tl! A/ VW]SZ, 9%¨ÿéǹūDZµ嗧((,,4 5@AL()M\:,&,;]P>44?QSEAESWMMW]Y]DDOؼi.Juk~ N,]͂]2Л0״JWgH{Kƕ;1, ^\9u"" c?u̐-7U of1G7V>]&.ʼqz7@b"ź|Mb e ٴU5(8K, g??I.0{H\0Rw[:g&Z6?oO: K `(],i=xn{ߥ#B+0\pC.52RX)}JMf0`5-B`/U*LPlFK&*{+>ZN'k!bQr;k jLal:,"C@ܞ~+lcn{N7]y(p`}Ah))m=u@t:8!,BE-5[kdz'A^sQ~DW0h0>J /"~^[ >](Dd B " C A"31!R|'NFz#Ǜbv6lX'FP'NFz#Ǜbv6lJFIFExifII*1J2fizACD Systems Digital Imaging2012:10:18 11:54:390210265R980100"r    %8x!"&9W$5 ?ccccccccccć[ʭ{27,u6*ASe䨴`E~LUgZ I>+q;g8,z JzLq9.咖! _{X8#fÓSn.Q0 훟/">a%+" O iLe#pivM#"}r$|7#*RfKhkA+Qp;%]bš=АRyRrDcccccccccccccccc[_jsm06=Շx'ûyVHAxr (0L\FVq]j)iA~wR/ jmX pz sOD44=%+u)Ad@'./ڏbK~~1"bæ%*]Ub&e(f6،HͅYU6)YcБV&]b{UuSwlS $vw@$ٻ$cJȻV̖+"}1Ly:Ps`07:d/7NNX6zCf5mOFǛ]KV6h4- kkZ؀]aufⱍi*gkMOG)Ug)U&"mDP;Fdc6}…bǂG İa&pa1BbQD;3;r1{QqZ[;|A #0l 8j>2E}s &昏%#(5SG+v՗[] X^r,鳠E;pm/d^hR_]XZCjooUk (Tt?i\1lb0cA]Tk=ٌ](4t/b`L丹VXƠ"bH 49zjsi^ ["i#s8XCkRNb mY RP.'#+?CCH8p`0r“=>i⎮( +˷-iϿQap\Q^*C`abMg՚iG3bK~\uIj Ai"訍]hHȘ(8>Yh.mMh>>ŽNij<-뺪Uo(F݄ʴWQ*_6Ҙ?ҭcКE;H.c k/h 44߱zy~6 s$KH 1b#sZIg1111111111111 tuw'ڏl ;h֑IMeP%a"V$&Tibxt*`F$Xw\k~%\y(ۍm \wm{Bi3#PuW6ՔnVU5[SL KHϤB @m ۳)Ӯ~|]UCp?^mʢSt}YH$IH{s^o68@2x*>X(1Iȡy\4q`vA(LN\4tvΖƷ7'Uz!CV)K93U.~xxFžlY`X(6a^sN4akmJ!Q)Ko\e5!O^DQVD-'bK\X]}F;tF8gƖXbVsyƾMjP'l ))aK0+ZB|`oYQ*#RZ5PPX Xhj0$2P<~9b]h?Tdppy6PԾB=zIwN~>A`Y?4ɻAد_?WJ0TfdLnaj% K#Cg++%99% +00+٘ %% ҉۔ԎiGaYw>9A WUtiCC~B5_ٝ@ۣe N>PR f lA`I;A/ ),a()S,  ݗӟӉ؆ڔבފjpNHV[:+,mhD9 OL:xU鐘T}.>An XȔ}Np(.:#uZsV>a4T^#PFO7SpB!97 ,"T75f9x.)j{>zAkZh>B8#9O<.&Ҭ/noh%bPpvfҥ*[Yh"ʪ :"i<DDH)1,~6[D3[ (9jpN[8 V!^{(# nؙsj8j`+V6&d">1SΓњX V8I"Sm ;HZPjޞ˙5́Z$):)3#x8)=D-L'}tA? R_kxN}٥c8x-O|\~PH %4&_CLtc#ZY+$ OG%L29qc0S`P~;g>خ;=btgnRcjz;o8Gjͯ$4(e>֨zb@ӆ!ŶC1ƪ\ebtZ_ tچ2ܰDcYDߑiXAhMdPl1iikĪw:lAloY<څ Ν)ZHH2$9TNS ,0aZr#-pYm8y{4k)}#x?ȡ@sAǻ:\?D&j7 &>`3㗦wABBo@[Y"fa++#`e'%XqFbGNXJ])ڂv)lsHuJ*XaidxnmĀxVhYpj%PD㸇{eF5bC晲@q' @(Q:0[}Oj23\~b.z>8@xVln#h*Y{jYe]OH|,y 7+31S3zI+T?o~Omv4I qAW}%j":`ahW.~}no &edVbIy=āvW0,!o9ħt:!8,9Vl'Uٰ_$%:Oyc_l}' JrQRYwҵ!(NChip 6V4ZájR)}&0IaL̼f`r:E#+%a3ͫ8cwPt$CkꄐwLf VK&;@'̶| }# _*o+%%YPRwPUH}k"s5xzvA; K(y[ЫU@춗oMMW-bt%R2.)ND~3UTY"O#- 1'(hjBx>&έBM= 3ۡn,q Vco 0 7S= n /Ю03r&ºq6ndMbHe2J2TE.V 3 "WiS] %M$eȰ2r?=n{"['$hFb/4Xg\ʄpVv$,d`iA{I-8z-|XbS iȑH YMAAB(Ma`hb#c9}m^^8a@’)hiI}=.`^6 {YE;.[+S2܂=(49/|ַ\3)\iϢ.9R5K,~cyJkBbGZ6kV2m{SgAIH'lkL>vLZKM/<N/%#Ŵ]DẄDZZpeK;hT*.a5Wa;+Q: 3kZl+ B귞 !s1lZ"R VYmˈ7n%}gH"ق~/h aNI\u2ckO̬GN=+y ߱5fb36ZV.(3ՎI8dM$kLisv'Ek`D?gu1iûgZN$Ъ3(񚄰"P䪇x>ZbBN'^WQŜ`E f[ჳs jqCWaWM\GQͰ}g(pBÜg\dL%1۠ےKw0Sw CesEM @g E}YiVLfsNxWYE)~kVj^I #ik$`.Ꮝ"75Y>`gq6\os5[(lTʡ2Tn=ueS2Sr~o/x"MjE-#xmUpvHJX _(kY[:Q:$+D {CdkLzN&2Έ؅EI1t7y8:5`kK+BX8 /E-#Z#bO׫[i( A;cSBf _lp-;?,Q(+&TIҝ ƕ06@lcDTJCGYB{sPJuDw\~_߶@6V쥔wyA8^k&]z~k}/>j-ak+A4d-ԩ8NG0`kchW^qYfQc",UkY=)eSZÆe;" N[x00000000@6vQ !ַA8S\"0֐z쌅~"ť>YS!75u9h[[I+x$ϳ9[jd̈XEa~J ݉oN?eK6㶜Л;朽[1L-v=aV&O$XNj0QЕѹ!D-zsG[Ԃj^b5gcJdR7~Jޝ1Pv,:dND1 -٤5 ϲ: 3x8!x9ŊQ3[1P2`׫yZmKWjBC7Ιd"VriQoOU4[q_g[\,h9 cOS% "}dxJCfGzbd"O"Ʀw`uu_)~/:_ W}b3~3kt88] V- XY@ Z B_15EeӞz>Z~[Do8)X^ ~Z EQw2&t;8 k^"+_WҪF\30"Zri cccccccccW5)f a`Zz$g: Y0rǓ2e23[=2$Mؗ1fb$ p"Yd0[sWlhQ j;fa 9VI˭9'ӵ/c c ,5H(_1SqacHZ4F:V#H@|~'NN&vn/Vc_OG^:fWKgZCo^00 jti~YjYw6cS2 -gHske%FYܡłnHmZY=DX[N1ELIrmN8)*)!$,ˆ*jүux9% ~;V#9cg|~w-[߫uUp;뼳8u_z2.Σȷ+_ +˜p_z"'O'zjֱ氌֗,ǥJDvߟ B(V`B!e`d(0.DT NL\4vď&6Tv_պ7kR*+mB̖tv8y, ЭGݷ UBB(ķd'߀111111111111111 W 2\' @U(/6V$%B&%Bedbj?_g:62Y#: (d 볧ɴMX4Rt*LJ$f[?Q}t e> nU} ?'|OWq"!x/~_7^'н{x-`D[|;/IC(1-S15@ 7??;) #1ͭѭ!˅ 0:Jq aRUY_lq&9k':~M\9eajNNhS %hi*=G韆Orz!ΫHu&)b͢q " Ӄ # /lj"撄[ŏ1EItKYd(pT>FןqX7P,E?շ>]d)d2mb_' XJXD* l?<[,A,\̓GJȟihllAqT2䋶hX޲7R|I'@Xf:-S{͚M[ #ޜovOLE&OThu>nl[V3}VݔKN:;Ӫ.WAۄ.y7iKp ,ҧjh(X1:[MB4:i( ŏA` L!&cňF"6wbg`'bw4!b6㶵v5z|BX1a}i8bXBB2XiM-bPca` m.9C"h}=.11111111111VgPf1=1SpJ"'OEA}IGj_@ĈpQP~`WȫbNb>3k:Y %!VrH9 BŪ@:g? (p(x3ns(Fk(ڀ\>3nJFIF``C    #%$""!&+7/&)4)!"0A149;>>>%.DIC;  }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz?j((((((((((c̍h*^Oh"^%,ǖ+Gt"*[Kh-$Pitdc`N[QEQEQEQEQEQEQEQEQEQEQEQEQEQEQEq>I_[H|]8f1Iqቴ 6c&$vfxmKl2`zzztZ]oD).6gk0|9hQEQEQEQEQEQEQEQEQEQEQEQEQEQEQE`[5Y%mc8 /ddvȭ* m:Kɖ"Fk-sKn~g{)>9UТ(((((j~[ܶ::I$jsE-r_[%Ijs`3CncQDibr J#'koKCJЅC[km2v J@#Q'c/\7`"曨K yv,;IAG"QEQEQEQEQErאKe<7ykVxv jF07}n!I6;wqƬsChDܭAG " _\X fkfԮ m<#iqqEs0>ο(-vd p:u{TUֻ݅uwu505O,r$˼mn}v:l7>cFF $cbMG6_d;Xg[F8 Gg% RXۣQO?RRɱ¸^JuG kƭ(2LHnҧ̑ 籢OxMjd*uf'08M-e#IBG̿Ctwc^ `qynxsz}}I~O%cԦY\inM#.xS':VQG kH*ef&L=Z?)==k& {\FC$5nl+|`nG ֺrK)&{\9rI0MOCQDwcX)[*7hviRr0rѮ_J5M>ݞ;WM2x-rdd`Xm<8 ֛=`ͭý^QYU`=6i$=08:)+¿ WW-mQPݭ[8(!tP'x:GǨj/V*)t(P,#1f sF=kf(?Ŧ^<i$T*傒 dpQãɩ*Ҥ" s% xǓrr eklq{4G`+(|d`v5ms\Ŭr+kVhDf,ZO38tԔQ\f|])* 8Ί)+:b4q}P%i&ٲ90>O^ ZhmPC2 Aү.ිF_6UC"H@=̿֏W%cQwsUI' T+ Ffaps! drG8Ǭ2Yj"F<>V?6Uq[TQY>'Ӯ}ʹfY<$;V55K+mͻyzZJ_ewpXpw #C򭣂$!D̒49@qTnQ-c&&}rP!}l9f(((((((((/JF$]]4ieWzme1篹^H"{uE+&a+N {Z"C{q길R6+9O X+10F#;0 9 r}HxdY]ȡ余N[\AǨ[4V/"oj6ϵUrIǧzHA5^\Df!$c=IjCG.=clW w@#7<:B>7!L!3wɀO2Iɮ(((((())h((((OIk.xhX} 䢜<{cgaocl`bI 3߁SV>شԝn ⵅ…2*=+fiɩوWE9Sʜx-Z+H+v9'}]% !bBȥIpF+WGu\pϣܽa=3σa*H>c 5i6XmcF8#K9(((((((A[?^Qp:Ržf' һ(((((((+,?4 $ճw#tx *oG\aOO_;3yfُ#ǟ~zfGi79iiXQvcẃ3sV5`hѦѮm+ 2ƪ#rxʊ*2(NN2rjg^X⹉ydYW8ʓױԢ((((((((((&^q[147*8<qӭaA\\Ekv-$4ĨBB|2O'Np7tE+Wy! CJEVGn.m؅[=EPJʪ#8&Žɨ[ڔfpK!Vys؞nahg% U dF-`Znu;NT ]!-Ԓzh8Xx ~Ju׷^\G,1uRrGE`j)>X{soj,>6օiuQ>I߷-0y<ԚI #p7fSAj>S;iTw p'@eꤎ6QEQEQEQEQEQEQEQEQEQTm6=cIeXb#ŷvG##~9泤SMu6}$ >W'Yʒnj` qoequ!bɓup THu4Xud1 O~QX) ? Y6^+C$Io[TW izr-ܴ78{r6d$=sZd:3Z"[(*#ٗ9ǻds޺J+_!<X)=Ϙ+fƄlI{xzܳ.gy ;j(((((((qB?2/85Ŝ3Ҩ/oA=c2/"?c/4/oA=c2OXTon^ѣ x&8q`sXg%G\i$Hqrk:柩YMvEko,Ov-K߆`D}u>zUmRO6*G# 239@&:̈́Q5JHuǧIQ( ow_UAZ5K!Dz͚$_ИGtIåZa`PJoڨhp!(K X$dys EsZNJ}L)Ɋ% i@n["y.@c$3ers|e'?tvRȇYXz@ U [Ak2yf {iV#o<%fmIo ;PLIZki䷑e,`IZkeo āTd=I']zy5m(%8 S~F#}t5&\Omsu) w!ܰi' ྎi2C8sx,cccccccccccccccc Jtʼnvu`&vCdCJx#yGL!e %%u4IbM$`e4uxh&v}{ftV(nJek >¡eT=gidk/ՍƮr.JEA;l~0)ڨتZ4 y嵑_/'pkŝ<+*y ] $BZ?%j2?z( C&eMsh\gd_jjNKY{'C+H8@hT$䪹&0000000000X X0$2df8tXPXv;f`_gJ&  'OnRffSsR:2;Wg{{g[1+99A]>ZK`n4>\$0nC:P{#`u/1`1`1`1`1`xs2#ĤP31`›"e&r1;B[g$:[<%R!X~MfW[:ng,LqqjF*tV޿G>;gzox:<;wȿ7Կ`mK,)H;`BeHނbTXG[Tu4ʹH:ccGg!595?Cj w^zhۀoWcJ*D5 hwCz]s jہ'894Տ>3h{ 9ΖVfHF4<\&#&C'|'͠5DZMG6 !ypgūWgGT{,= wQ:[$Z~&#mWkJre+YU`XT?դ`M칺%q>lo I/ȣulQ)KT0wYI5a]q[E n\9r@ۢPY^,WCqp$HY͕] ævkUz#ߧ]^Ү<}v }g(S}WsxLX:*2*F@%Eh䲖?qǦ )ݬ1*&g e/^l{=#gNsWڒ4;@ ]E_""ng)#k% .ÁPsz+ax=mNI'Fn1121:n2:&V$!\X{V oHiKn@nKAMlHJqllmm{]Zh%@ ?^b:~ C>\)%/-32ra!_1REW7] Ht!М._Zg$פ0d^btӪ)`5c`5Cu݉fj>r2|Ju6WT=ds;eJ)C} QDpId## ^rl?%9+=)`WA-doE j|SBM ۆԇ.r.};*wFdG,HJi$(cї2C;D Oˍp%☥d`A03CJG7<-#"?I5*_kD6JwEﬓ10 'Tb;~k-lfFהI gz'[*f"w>r{N_ʱDMUPdvB6֍ߚǷ?c}3'oֿ_"=O+/?r`OdCW2% S 5W<v=Z[k'"y-%1#*-2-9Ty3L\sr֣#X4C\yf4l0GTX:5Y [˹B _0pWNR IcDŽY ],@c c c c c c c B#m%|(+Gbԅ]± m9Xw F 7FL&<, e]|=r<j$Ϸ-S0+","QD۱3;qs0Қ{Qq[:[ܜ}A;SwnEML.ubE5,t)ߖ)q ;omh0A%|#A&cڼ[R;:2[V5;[i=Ho׏kOw^?lb޲+{gl nj*EĉL4W'&wa +[Nֵm:*Z'Viؽ@FDwFbs_ݨ}dл E$eNXz>TtBBMѻ-ɸʷjXfҰB d"ZS$-#15@ %--) # ͭɳX<}lMvy(T&% KJEk,fuwCHyaj6O'O+s=Z -j8`W=pNӬeRb")[lq,, VV/ '!~D>)5R7jZU5ZII˝B \B U6ٕ[U&F9U,H<$V 兂 ׀3iO[OITXyea/bZ&aB_liޜ@6Yeu}cգM?UU+ΚutLKKև^í1 ޲=!?+9qנ'YGv$ȳlMWeL^`Sͺ{v5em82";NWqmC&vT4?RKpVd hIN0E|}#)=/ť\z-Fi 55w?Tp@dCc7B}4MꥈJmWkZ[U5ZII˝B \B U6ٕ[U&F9U,H<$V 兂 ׀w~GW gN& w?1Vvc%ѩZzK7pA!^-!_n@ٯ>vpJU J"&3N }ه؆ӀӯӬ¾p1n iU[5ZJ0(&+W.hEY=WC[ 続.?zHf*hf`Vu^]{w0^!ށ/iGDg7OԘ.oX> K=c4*8dVUTeLFsC&gu \uRa%6-V@C[܂v\-hDX~|Zvf,SX[p2FN;gKHkPh'j|wgbX8[GO[jv'n/j]Ҫ.q$nz~zYI/RQA-PF3Ͳq^峦gd HiRt+ҌYP_k}Ǖ[1KL fʦO~ȿS0,q=me,`H8{h1<_gwJY6\Jp Z @Xv0wnHJ '1D3FMihϷY;-~_V:P} .=c?CǠ LӇ݅و"~hx % ZW| e?{<;}Lh,Ot& G$:&`N%>4-z18Bu5I`E5Ƕk1:ذPRIB?C7Wj5S~+vEkk߹q-Vإ*K;DE;CGuEJuݶ/g}U3)(r_p&@\bE _bQ$psٹ%l*9ns DDjʼnkD\hyX6P`0i#ܰ oG hE֭u6b +pnCpY&h4;[鴪;t4,˓⣾J=`, UgvlagZ!Ke ǚi0vex$E5blZiUj'~$?U#(tHW+EӮcOxx(d/ aTu'_Dccg9WoW;P7Cr#n `+0s!J=ֆZTu%Ox+!jsjҵ6Q$yC#DDp J*9L!Zܐ|kbO $%zvYX╆Gt>Bл$d.fJd2QIg+539{w#%qS*bvg,bB =68JvpJ8v)ά9,fVğFN4 AF L&E ᣈbGbg`'bw6a4㶶t58&/pz* XH#h `Tk![Emt:|qYdbԊ 0CR()w\ۤKVyG+WcqWâd0~~MP8M/mlW,HK: -k+ }#vH:Of7K]08Ͷd;Wfk{vfsf$1 s['A./O\_݋>8'ۍIU]!`٫ JL1 `@Nr+^YoZ*:H@huXS,Mw7zOpO޶'·XmhZY 5sYH[/AN`kvd7g%6.^fRBpYxYr8[Xn&΂ͅ Xe;Mhֈj5xtڅR) ܟGyҋ`7.T;Kqr"`Ω]HVEMq+Begf~n*>0,$Hk%PMtXs+0w !ۇ8Vj؎:H'\NL9*:cI$ y111111ʆye[}{&-A*V^La 4?I$a{bahrΏZ鷜n=m.FL Qq [Ć5(R)l |bhOWo-$whDlZ>sg;Ѵ F2Վ#Qw9=hhzdd<|(Ew)} O((@a #-RgE&ƦH8c'"@%8$gcet_ccQZMR$?! X%GU`uctug etWc,77x68`T7c(ҰG,d[z~ͤ6O|bYɹxgKt>"fZVt^C'Ӹ;o9’ uڳC衖u*5Ɲ hu/?wmHgГjfj#X@hK?_KXE%6ϹOt^~S~ՠVGRF!&fw,#q&"8]a(5`%;jX_µ7m(8mX%;MhOT3( TXW\@drfPo~^y!?,(]{_i ܰ\g< QLboIy/AsƇF000000UN#d97|i26.) HV1~B>>-7#Urʪ\ϮJyHy/S &^[Nx=Q-aky_SBFqE;Iu| Kcʭ;B5iIĆO&KEgMw7%=x9Xx.27\yJJ?b]ƋMn&h Y-wb(ߌ5n֯(($7=Ƽex竐zzz'zW~sjK#_-R]xvӪMVby|Z3v%pjy)HحNO74fV/uXkrWG%uX$’T8VoUKg*˂UR)D*c SL t4QªW\,s`  rܰxBV& Yj۵9o=TBӲ38C\. zư00000000000+"ղYgϿh1զgE%LM_\KMVa5NƗCGLACaZE=w>|o:Ĵ/;5{P߅WKMbJ /?F+FZe̳hhӮW/+yz#a>^g!OJmrj['w>G8;3%Ao80005 }B8,IAC;`@6E+P7`&У7vvkX_f"sN;[rOkPv!4{TWxlMB{lґPe`NnM"ǒx? AF L&E ᣈbGbg`'bw6a4㶶t58&Z1h}*Xkt]vB*e313dm..elɴTY? Lly4DKW%n &VhP=, VIGEDnB@DODALlGCEislkGmccccccccccccccccccccccccccccccccccccccccٰ;Dd#\ZB % C A%34$R;SL|GD}~:frF:SL|GD}~JFIF``C    #%$""!&+7/&)4)!"0A149;>>>%.DIC;   }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz?j(((((((((+;_%t;JOo.3Ak̢[ZGfZx_3;1]x$WmsJ(cVHɟV72 RG|VQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEUMONU" 7=G=FtGg٫O>ոcbv?zEd4m: Zi$Qp]ܳ  8SKEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEPl&-Ӯ䵅wvr1g^~4MXKqy<͙Wx?rOLEEs]nJ͸3[EnXq 琡p7tQEQEQEQEQEQEQEQKUu2&`cRǠ=x<{TwZƗewޥioq(ܐ:琤?6]力MVIEp $P ##>~(((5 &/-⧘mī4QEQE[b1|%k]?Ż(u*2 }--V#3%1S#S9>CP\Es:HceC12@#5=m/#wonl2DI' |2FO=;PuЖe?ćo8 v(((((((ۭv Kv?a$*t?yLu1ݏ"10p_ I F&XEʑ);V-?P8p)lfo[=9PwI8Ѥy=v[s}5}iѫFA;Ӵ-GG"lnB,D@s僻w[-@4I-nnXaXU /Ɉ#pvq@m# e)(6}zUG7Mi]G<12'x>a|Ia7J]Ú["o/(v#(Qms_W4{Α2(uB,p$~=ԚƪKW6Kr3y T$x bOEJV]+Aj)hTPːA׏8ϱ`TdVu櫩Mm {kL, ꤃*4(%XE.K"ȧM̈q$sA+Eb"ЃXy﹋sY]մnHŽ.c>-8+q%%p$,ULaL᷐_ܸ#@DHcE UQQEQEQEQEQEQEr*[MkDMBkg*` ,v6TCOOo<=vB3w :6@47RVG? h"4ֲEf{=I$;Q y[\G,)7GS0޹S;[U>jojw$-{̐ \n9^-&9˻CxEF 0*}x5חxnKi cV 72/ +mkh$3,6<Ҥf)9m3Z~j62yMuM*([}F;CZY?{$ vY, Iq$}Igğ?Œ_'QsK {q(eZU*ۃL͂s׌z0ށx#iT@ۂr3RQEQEQEV-dž,6w ,$1]p##0HsGN6ڬ6lѰ!Õ_gAߓ{+sŝGܬN 6T?ei:qkqx!#tm]X , Ɲe |]nS;(#p3St[KPݶI xrx9$?7!um4L7>k0C*)9ў#OiT|{C#@9l<2S;|xL 8 d^Ϫ2Eo2jiw+Cw0$Ȫr1 l'$rkk=VM"Oˍ7$w 񃊱k*+-HvܩB2O GK9-4}SP,C?xXv?YYA(-M(-Dc ;/$HQpz 3Okse]9*Hǥrhg.5I'1ŴǴ6ņpΊ(+X΃_Zp[[*$0eR :3̨݂N#7WSєɸNu((((((_fuvg`eNx=+8uǑ ͜ )_; u ̹ե.dmLVirg| 3rsֱa.6Dt"~l41'-BW%(33h,qEy \N}XƯhKm2d1HzТKirmKkU6Wd9籰`}CDO|z^$my-6ZHu_##4J4hc,ch$ViF @%, ;j/uiӭfN`d"kNF{z([5[[/Ғ  NwFzdlay9|GO 4g!Kki-+ ;&%OQH<ʽK$ΒKLt楢(OZ_Kp5xXB|n_n4{+XVdQYA{UDM?eh6 nFq,-$Y21d 4| *x1ZVF!MUn^{]-HfyP&UIQ *f"_Lyo-kuѹ(䃁u?{إI`yrM#ۢ((((((n`{kFH# A L 63fFݺef8df]בB,` u@`pI#5~(mf[[[t'(Cd֯iVaYHG"gҭE1G9dV8HN(-GPuF!g1]7)QUמүk/q$RId x 49OUaq_JP°'h #ob,xvkU=V ݺN;>8 z[+$ 9iw9N:Zk$2X ohFC+eNA&tYZɐ,aV\ 8QEckY&,{RYc(s{|1$SxWHo J .O'ԬʰYVD1 )?؏<;&b7ުM4Jʳ7!mRzڢEo%Z5S.6ܤJpAUQvT!%LFZX9L@ۻ!zWEQEQEQEQEQEQEQEQEQEQEQE#} #&:<^kb` x+]Npv7F-gZQEWԭp1KjB&a$20;灓R|;VwךƟcs4`o5#F-d3؊oQ.8k]w?[QEQEQE%s7{uIR QQE0 kS@ ֒s}X}%ʈg_fAlpZSU;, m>뻨xÿzπkL_g,zv:K3]9^68Tiϯ\["Ey\쒈GYVbRF*01:r2?kx/6A_5Fn%.cj!. F+\y CfXdg7UEw-#^smml&Kg2#;_%+Z(((((((((GiQ^}=2.'v3SZ I'TQEQEQEQEQEQE%rڧ^Ģh yd!{FBws'5w'Xs,P\Y;K+M |ƭ#*ʽA}GKOss5ٓ`wyrx ϸ`Т(((((((((((((((SWӭUbf fʉnQUoK-1LBJF8UK6li",˸' 0*QEQEEm*EJ]v dO@WK]Mpp㚹EQEQEQEQEQEQEQEQEQEQEQEPӴX&V`2sSqc95t\O_r\`,,ѬUƒCg<דG]:;lq6s'P]?ZaUkQ+h I܃fs $ =O\"si!id#l($d}WZ*$,"! ʌu@ %GO~_^dPDFy $q7Wr%K7KK;[VhQ6l 1ƻ[zVk=.Gle?,2㏗'c<[T {hdPӮ^pyz\y"wnQ3W袑*=ɬkCQ,Ӯ`ꭹ s" =V F!3ViY@d0Zd!bro~=kׇNBW䫽1^nBՊB֌yZX`HaĪ1-ǻAjZ,5˲yAq1)jo,p4_fD9Yr0S +B)(X{J?ˆllH8<㊟:u֓exD͂&i~RďP`kU OS:s[FMu!(e\,@Ҫ^9!b:zgiH5 _I:1SQEQEQEQEQEQQ][ݤh6+`mEχ㸀[9 o-AB5jΣڸ]xHRh bDĮxuֵ$y!h-"`zD`(C*8zkk\m=Fd ftŘ$bdY{{FXgstQ0YLYUUp:} jҶCR[Cr-ÀnEQIKEr^N8t?Y7 d>.5p\[]űbHʓg/ ȧפzlK4I @n[$y#Icyh0a>? ěGmjfX6{$h6㜘殊/kWZniokK ^41vɗF<펇fO^{O{<7󒠓: ѨQ'W1OC]]S%z+OCbuF'ͷ(ňHsH5X|?aY^^-US<ˀY{e~=ʕ?r((}bMFMkC4`\ƯtQGq Vw |%v~n=Ҥ,*Z<|7RK.?گŪ!WWhxUvǹS:q)Hh-\)YK8'.V~ܪМtr3nSzXm li"!fXB@Y ؼLvVqm3 .`$sQOA"X]!ʩS X[#!U'ͼsmy*\%W_gB-%R#F=m7mbxr3F}b m[ejFς7Y- e_wZk<3[]-C@G\vggWT&ԣ(և1f)}x*im%i(-:HR7 0r0OSvGJ66[XH^Zآiy2Ⱥ :}SV› o?");뗇QnIf˛x S;V !A{VF!4Eӱf$(' EbNkn7dP0+֜,/tb%Sv9yc9'@NdY73YD~x] 6 8jn]]63E<,J{Ν6\s$u}SS}[[#hBY'ۅ2) ?}ݔkmp*I+Нk'Ƙj,Pʻ3*5PSGQnx7J4* t}ׅmOl/,LP i#<0 %z|MkK&!ll"8ܐR@5][[^J` Bb*0mgit}Ig4< q,A + ԰c :ȇlʅ$2GQB# QϬY{lN`8,F,Fqy o ]Е,W eWPʞuŵ ?fv\:r9[-5TO߄$QAf<>xU-Ɵ X .r)я%V+fug,H81q.lN}pomg} ,Top9_7y BٛIb]c۴2q֗#-/$uuxiF节6NsAig ga*LY%Ѓ1  Ql5-3Kӵ_˜$($d`gxviu6FoRI%'':H D.hۓrǨȨ-".*osl6TW|Kmj̶ٝ*ql$`8YQŧYAus^Bo# R!_ۢS-qldzZZQES&M Y:,UGb9ޱtkm?t'i%kvz k}jj4Y$bYZjY8yHŲauQ_i$N1{L##ʱ"$j#p@YJ3f@UƐđDUQtvQamp,&x)#*P+sӚGDUiFs'? ZZQEVGfm6+mə!]ˑW ;y-|-jPrb0>p@#ݮcųGC&he-g"K!dx`zgN (+k+<.ͽv,|u]xR7^Y!~\pkWZDm!ʐ9Pitͦ-+gWR!W!ra5\4YeUD,5P-.Y䃹yZ(o3u1,]|2+Izʥɀ[I6"(|)gExJu V{#,I¼[`W# '=kKX{Nc8UUf=GNcfC~kUH1QEu:sq"0HX`,r6cZk$lmV?x}@Ay.n[ٰ$&Urvޭ,ph(Oa\ơu])ҷڦ9;DmѪ p:nBCngS 9R;ٺNx[Z\[l♤~qn'|6y8導iүrw6zW]E# _š@u9İPbxB1C㝸稬Mf-* ~Ai-M=T.U$H1p8aSgVX_I=1Ȅ#qZtQEQXUFRϳI8lpQU`yV x"W'_HU8!sc'uQEQIKIKEU[:RcY>F܏20*ha5("" P0IEQERU[m+MO4Brw0<[nkMԮA-;Mݸ u5&*T/dk.ʶB3=(MŦCiJĸ,,yfcݘII'Y.SƲwIbv8) cIm|'i_O. ~Ѭd|e%RI'<;(ڍ:eՋDf^2]/N)'8(UBu$?:aoX+V<Tc'72BrI0y!V%hte:sӢ%~2$CY-W;G&7y9W&n`|0#2n_E X;׀:kKEQE^"!"g d#W?}ic+ݺ;N$qqVm5׶[x羿/n֑c61`OD5xzn=dŻI}H7BvZ{|tM0%u'a@ AݞA75>|;z&y+TOś4 ~$p"8 %N7\ z-eKP$Rɼ(a7`g;U((((((Ce h81/рqRzu{{r$F|}7ТúxMO6G6B %.%C^C{{heW2'_1F1n((+-kWYn(4vs,wIQq#^*2`gyz 袊((*z5Z_N&$<1#y'MTz4l^FqoXL1He q*QEQEQEQEQE6HX9]eaA~g$&<\^ @CD۷xU`C xt9[d s+NUvc+N((((JZ((((((((*&sw9nr=3t;Se4ĭm"O1̏=X[8!A4 REQEQET2Dd B & C A&35%R1$iw1Nh0#1F1$iw1Nh0#JFIFExifII*1J2fizACD Systems Digital Imaging2012:10:18 11:55:470210140vR980100v"~   %&8x#$ (9GH!"')IQZiw ?cccccccccccccccccccccccccccccccccccccccccc!~=V8~%'Jb "6-,K36ڀ,܎И/&يФr(lOrysHB?ZNiV_'3&%Qjof DO>ҰW1h#F@oɮJ'D$) xMq=)g+syy,h]b^]WǨ)ʁm]W–x+j #Uhh SΩC.YJ7n?,'jUԱ:އ%Ӄ+g/ęO||ׂMe6a h8dLOم1pWBJX2a\4,qzqwkkqL-ܳ%}u`O]orr9:y-ɪ l혬ā, <ĘAV@t~&A^?$LqH<,WV}c c c c c c c c c c c c c c c c c c c c c gkRK(@%b4 G@GjbȺjic\4}ԯIݫJՍk~L4ub,7'V V|r*E SXUmQF: yDgvDRKBIǙEg!800000000000000000000)rv[KQ:CSR'fyh **,ڑ'ב'(}kGw!7>z"V^)N+  6J2aGU]SiswĊ3e1cIuEl`O"ol kq^Z7d䫶p)G|\lN{c1'[Z]0('09;@~0 9GLÁ;'EQfޛ="&bh QiX-:VT{!n $#;imqBglTt)&2]> #!\xW{1l :鯨K"- bR LT\X{j)ю%8ӟӉ՘׎֐gr5@V% oAW<"B׆GD(q(!;HC۲!9HV:rr6h@6 Z̮naI= WL3u}KL)~)»jo^t:^s>%?|<sEE„॰aLE٬| v~bCGMwdlE$Vqؐy(e"b82dR-R85WE#+t8n؆`1`1`1`1`1`1`1`1``KC1)q nA~c4Q'ݿ4hR+:7 iX]+bfǺ[L)lċi Z(z'ϊ1"W~>3BK_KO,28&,H5#6ccc)m}jsC})}MAŠkMKL ?#q[Bբ;JEI?)Ԧhêv fv )`(惵eGQV8gBf8&bB}KmV-{8Xj(x-c 46cT_ (qӄZM9uꊸVEP7eJ zeնfÙ٪mGH9,)_)7TjJR88Z'ii7y+aci 0Db,X4ֹU؊[OEp(/YF!;U 2;i)(0]r4R$2Z"Hml$,qfmUq*fxSL1Ӑ=NNʱf+ v*݆GݟӺH]?o ĪqC:LBmh9;)S,5s :k `>(K"f-SA 4a0&,W-׷ K( #;)&;=!38~KMԔ39k8+_RbRcvn~=9+J8NG򤿑~ 8AnEK6XYރF 3 [6%fs[A3Sm6lѝW*9W T}n#+kW:_ND gr֟B@ kXɌ .;[~sGHEzۯPǯ-sb5 'ձ֯ ͣaAmi%4bW7y"M=x5 -)|"@!#f8["JKK3`7嚉=)eEYU`}ܨuTiiNjFT6ٞh/¢vJ 6Izf=b:%laQMϫbޠȕw;MlhhTd"~h1Ly]Q@Kk\IN-W2#%iBHHUn΀i`{ Pv0Vt^^FVDr/tm.Ȅ ƫP`p1z"Ĵ Q* :C[vKIUX<;aI$UUSpS}9(SU?~c3JRx#L&G˻wlb'OYb@>Q;K^LT֑j0t.k5ggYx-}go#[NR[9SR`7_ {/#/")+*Z.IvK!kK1]܁-;iA| B#nQ!gU``$br$DLLd4k2uKƅSvO[TFNZW;lء|\OKKDXLKOVh 0Ynfs^q䷍- yV'iYײ84[Bp:u?<еNjYŁgG_^5"K6bRJ9[ɑH.BN׿]]yJYd~"ʥ-2 :+<9%3 3+0"+"֘% ݉Ӕڎ/w0t0`ggCC$ X8YAj@ٸ0քQ,g:}q\Z]P ]$)%jCy~)60W!&;$d6Kq*b!F;ucׂ|9ߥȲ}JoX7Ф]>S-#4_/+{\ ]J(xlb24:!:XpR}?۠ڷHej]MUj,bv0lXԣb[q|RȈ,n0UvbI$uᕨ7lJU׭0?v, =F.g+<%93 30+","و %݉ۋڎnSRv6@jd%K+#*:>aӬP̛EumYD{[]>3OQ P3˚B$:a4śSf<(}YwBw:cUя/k'GVZ7>߫~߯??ߍ_پU=7'ZU',]?ۋ8'OJKWݽ^sڅWMhoL{!P+tIg9h 0Ł?,jY8ӣφ+LPg<\SDݑt/?k`cJgT+]ೊJ'%]OH~b<e%&~&*v3l{=_A?lw(qGzSG'ic-#KF OWqXv12h'wonlLHxRХ#](>EOk \[nG[Xenf$g,$s:tjlۈJ-TYOw1Q_찕,>PͷE7!/DOқ#dvy>mx+YIf* By)쐡t̏oOFLh{wP>GXe$6y?K(u|=3NšbYP5>Lpbl덼cU=Qn)`Hes~Ѿ?aꨢL7ÌEm~p }]>Atjӝw0aoJw pNjBex㞻6B0h>B R˛ ֈ҉ӋԎ]58)hiO}KOl-_cPR2C5 1Sj=au>*Y8~ڱ[U?JO`sFm4bF@٪Ʈ.f47zvԡ1( NDT} kU҅Od|3)BGuK.i*8J3-M<-TDwOT/AHʮ|)PRI>< X>̈́(0(XYuT|R4o^u>{YV$\qPܑ]^YQv3bldOJG`?EymS_0Wo?:+R`KCWE2mILuO49Ȯu,(H KfX #[3wdR!5PuN@˾>/_uv,cW?ԯprG=A וo4E0è1 e7‚ ;OT¿NW B"ϝX züNްz]jsPVΧBa}ĭQ~?<%amXg'ݾf@h}O$!dlUSQ+phvla5u~:zhpBLڬEq2!+wAsKGyNaY]VreI8 K:S|棰Za:2Zqc\{=]][A/e;ޑqr;ޑqp/111111119]*ٰ .F6lUE^XHMk][lQV灘3. ہIȷAGMjWOCB“2$BDrӰ2{"ۅ!2qۻ`ĆA;S<;!B:{<䓱=z_ c c c$) qsZy㻢RYۉExto줏?C;y]YFAIf2+p21ߔC]G"__C?XaV;ѯ~9wyy@}|1lZ!$B~T%e:L"5cdG$ZRQ;0[zڲp<[ұ|AXs]umyQO ͗[.;4#VEH|9ZvbMn.P#&\.XVLr>}ÿ0lc>PK4 5jPC4LMDD2O흭y&.@g%Tccfbɱ;zY=y7ie ( bY_F͒J,p?Zn@G2}`+-QY6hb5҅k˰ 뒺d;ksYFLSggAGcy' a- -dP  ?P]!ez%1 S](Y؝98=yXy=-)Yn=Y{*oiѾkKߦB+?t#|_wȾKfl vdTR7dvwKy`C=R1S*BH ^{bI-q- ͇plNz~l΁f3 ,б}vʭgw6}ìgzӨ%GPkpʆU .=cNL}YxH"sp|c G߹6_np}| ŋˈ>Icf+] &VGY僤%c@do?0oEL:Tk\sV(.킇iLO/Xz}&#"y #zq2N׈vuab\uc: Ư떱;}5}mx;s-V0p)K%=f#Musa]jiYuLёo>K!'@lsH7Б\ml[,GK`̪v_w^IkZng6R hȞeֺoETnKBle33Q ig*$+sW!m݋\􋋖uҊZXm&d\>$X 9D)Վ%[d-U8D }="fQ+H=n| 1#?8g?o; 龭t^$S;gUPv,̄PAs88 PӬc c c c c c c c c c c c c WhA:;bb |' ATO@KHh|dƇq\]039i,CgXFB=]V&g;56) Y+4髲_l8:X{"mļK;qelXA%+PBáfCNufYXtjq9bCK;y11V'et"fuq- Mr\hב^O2v >UmdS 4+@Xp T+R ժY_ 5rv5s^< ;(#$;sSnr)_,@Qy?bqinXT4,WKNJ^vUژ(5h$/o.00ϾНA7b` ө5#S[H6,Tη\~,WOGx[ncJ"V [cFr7Vq,?py39@!Wv#gs0F.b|b5L,{ ms+O-Ryz}?>3ӓחm v )8 I-HtR##GO=J9>in#1e~39l:!/mo]Xhy[LYqd'ջ=쉱M#|Qǘ(Hb j|R[rw1+ԋ%=X(jrf0i83IRIQ}O%xp:`Q¢`q$)I}YvP>\|j~v$CCH nv JYϬ;lf11˧RV4?ų/9w3]KוD[r Cu颎> E}-׏ Y %pmSJR[7>=ЍVaNr: 3|& *XOw4Xt9K:3[9NhrPVH{1111111111111弝/J ,Mno+B-Xšl*zDtɿڬYc C 4tlW.[FVKFA}OUt%_\VnD\.ϱ18ƴ0@(G,ށ> Kęչ}\lV\000003lsVϺekXi~Qgs#[z푥X닜Jׁi# ̔'}*?ҝUdvf2]&_҅{W[nUM黥h*/Pcy9|+_BbIս࿍CwbW0*֨rAbql1 n10Ҙ.lF!Z$=Z ؗ#p S͐+)i':c}Yˑm^YpM6$dG="Һ5 PfK$@ شeruZtgXdUNDR/ ձCOuņC !!EŇcƆ5` tᡢ##55xr~R~H'?8ָ-4y&3^p000000000000000000000000'"`Yvb6`=9^wP;#E% ;oSASpP|? :vqnY`Fb|ԗc$`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`1`-DdB ' C A'36&R5-U9 tKuZt-jF -U9 tKuZtJFIFExifII*1J2fizACD Systems Digital Imaging2012:10:18 11:56:190210296rR980100r"}     #%&8$'(x!"GHg69QYq ?r^“^:,픦ɖvjJe$|OEsaB@T2[4qئvHU"]e e3V,5OVnkSKܷ;C`3qq+Zqt?l1111PKC1)q nA~c4Q'h_R+:7 iX]+bf籏t#U6h{! c3"xN6_VpGA8drځߑ#?V8 9z`a?&]B ,> ccccNWqmC&vT4?RKpVd hIN0E|}#)=/ťը{&U0P;(]d<׏&M ħ>>Z[gc2r*JN?wK_P5r9oe5Bˬ Z -{an@ʭm5 ugNSEV 1Sb o+%>K *tJd]ikjB@lqq;~fѪ?p/!>%u[X1#-E_Ic o\JpQ[?/h{j!> Jp0R=H~YKNbZ}e 5CF-bZ%k_qHo7 `KC1?9%o֑{MX'8:PXXh$Ͱ$C&i=}KHpq+3&], Z܋VV =Ye`#{W*x7;s_WnUli +)~FNCmgYF ^ץ"':sYUz#m+HЏ% *#Oو >ȝ?c Txh/ wjFbb%m}(.չ<i;;fl,]lJq|);{]+/"U/M,n '{}jrZˤ@pHP8 йO; 4Mz!'* 93X1Q6V@AsFIÊ7$iAZ箣K#݉^?9I.YDIc  uj@qe(cF(LGC|q\DOOEA}IGj\CnS0XcҾAJ4,~+xljئAI['notTTPmeW:~O:X#M2" ˖ad+Cp^ -a)3ɠ$ƠK:EOj3wa{[Ba[ ְ8b։gX cÜxio"FOcX O _ւ >`1`1`1`1`2/7w]*O* FǶwVˈr5nZ/"Z&N]W+)dVΈjQ`UXM8"i.zDq?> yaxeRR`'2MN@(vS5_wYOw PXjFUJtxΎ*£X >88j;j|PqٴR\sp_GXuJ:{uc,utRevx@h@jJVHL#+?)f' UNN.C8gyLۓNG$2~|2IlTP4{{W;yZ^93Q n6-nqa[EF!}ƴ_?+ԯ252 a_͎{u?q% }i'8=b p$͂B+C`O 6Js,&(voԊWX0gff" v;Lg OKodb*8Y_BDbO5AaYqΖ8M'y7HJ[FYyLYYITF%?֪ ?xSOe`#&׳~(I>aXx(?}O;&ծ*Pߙ Xqkf`nrm-iŗ<[XxnU: e/_uv,cW?Wwa89}G=A וo4E0 g}$ bz wV eF8Ŵ;m,wf H5u 6vfb c89vzz T K*T2pk:ğ2j²,q݆qO,oMK [ƌ=^9NCKI^UG@8َ񱘦iO6,GMM%gP};>ETc߸+xopq#To6$?Z,ܠRL"!H4U ' Ѽ_n/V)n;C,!LQ{w[ƌv a=Ji;4} 'wH7 _kbZ}Οk&>/ؿc~L7(.ش1HҪOT0H~BF>Q7V]TƟcQG^1(N.hE?kqaV 2`z6<[9L}>S۾ 9F O|t֘V5k-Cxi~='3Ha=Z+?%,2~~ $YoP̨œap %2/^On6Do[~+16%UPg̊O-ݕgqa*] AnϱK- R4AU? БB:M$u૕U1UZ2%}psT6(CqU:ZFA+t&~ޅl"Ak ÁOKNItօz(j"$,~FTW%iaWY/zqcG W331B=pmMvG}xy(oL4eP.94Sq4Qc޿)]$E'H,?V2XI%(WCyAA1&҉w66aWv6r,Z*MdFk&|8\b.+*7 OVHĹ=H-Bs.݃O5ZZ!$[En-# XqdXy^)sJF?[h24#qr7}Q D#:P* *'Ҙ$ZNHlI Fib.*%x~Fd;ѽ_JGuv<IT.:Y$?\hI+CjWlhW/ɣwaS r-87X| `wq%0;E1bs?AZ `PKqVp)p6Fi{+>W9S:%w6DT$p.'> ș:G ]&Q]#嗽Kqvvַc|*XN&QM-wvN>ʼpHg1r7siа_=?GȽ[/sw}}^;(<=s~/s.'o^ 7?rLGD5M׼xCĮԢfgD$DPdQ\'ojХN(ܵ3%dt(H;,@̰u($V4^)19yuHb8)JØud*O( j,]Mu k@}.mBuoܣr2՜#Um\اs ]ǫ q6)p׮v3tdfMHl]>1do..EvMU VI-D*{B$ 2 rǑjh$<7.  C L GkLDlNiCLmGImkoilksc 8t 1V#@t{#ǡpJ"'墠>C_$5[ww["u-Kv.)s}oc5 }B;b)M>E% ),ak!O82h(}H: \g'Qp<ըR2.eTU[rKHr\:.%9լ~Hֶċ /RJ/TV.ҷDKVVPypmPfuo}Jx#o^''Q?/;7@Fpo=BF35)׊B%I1-R,f[/^)sf6G;tkFܟw]H9>95Q,F6{%q.7Ia_J (ƠvuCJ. o;~ANc,M̀놟闟~}עǦ~Mjn3P_-``ꆇIss2qҲ04? qa )Y2Ϥt'}(.չ<i;;fl,]lJq|);{]+/"U/ORj]ejY^% =p' ;"%btpL^`'jLvv77W𵿜2s))yR]ڙuVNGkR֛z0Ԇ*jS_o>vEoX/8xkVD:sc=k,Y 0 +wVP<2(Ə@sq )KxhX$1NWqmC&vT4?RKpVd hIN0E|}#)=/ť1ɲ}=Wuΐ>J`YY-Kx&[R#cqYhk~zΰecan/ tUהXCX׹/3p_ečkf5ͮğW ,`:Q20wn/B#9$͸ykXM}Y@<,sY Bu ؜E?:>V82N'iac)aTՙO7's&S4-J byuM4Lz!oȤ3l60b5+V0=t㆒H7`'Ro=H(QȎü djZpU._̩s/]]1yZPc4G$!'k2oqz3ccX(1Iȡy\4q`vA(LN\4tvΖƷ7'W{! ŭZv.i @l 9[ k{a'AT&#f[ U"SНL4lN5fNu5M 5 gE$JƦH8eew9㠤LvHv|{B "Wa< <䑛c,%% y9GL[ZBktPXXj$dP<8XX;f h~_[v&vv'sn.fSOj:N;kgK{[c[3ֹ )gkQo+r<}n cVT2{H n8< fi 4 J,NWqm &vhn7t iNf9 hHS6|{#0fU;/ɻՠOE w;3AGPZGZ:`V=3*fzV|/ PO=0&x(/cdX[ds$~vd@5vVp85[vYuv5ʹq@U1r&;Q|biW0v ~V5)f a`Zz$g: Y0rǓ2e23[=2$MخOI}M/'k-e:_whZ8&{H{ؖ0[X:B[ݖRB–_IQWA Qo zAg%a?0wׅcE^Wb=b,?=13-c- mXm[rȷ1T ,k"ժ=K*YJU# n YS{8Tpk xJYރrΧYIxn%";gc`6@$EӚF*KanSN0[rH9ag,Er0ay9 GxR3嘋 %Ȼ^Ig DGKL# ``VB<&S2,mqA/1YlcP;8_î.kv:P$̂Ϋ,چb-L"B&I1D^6޲ɀǰW1 1I+VLɱҾ>>Q7# r_ĪcOxyP>/ ^ ۅ''ON@s7;xX dGf|Vgab`hzz! [Rcjm`1`S;֭%M9\h,Z8Q *en;HÎUV9JsX1lI-fkiqm׊RzU|[{9P7=jH꘡y\4HH h~c[JZ ~ [On.fSORF2GSgK{[g&1 PDH^Jidue,8EhѓWw#__i ?&˧< M!m6Zs;y-QB6@m YL)K-#D@k1ǬP̛Et5kr.YX e)=M^; H4'uޛ?;T7=\ҧ"r ְ_gr+߱^DŽ&|{JmmgZӵ2SJƲF" X}1}_8P,9yTJFDiIwI,"nFT̖ւW/vJŅ5cz!Y-7od҄g4l!֝hlQF'ᲜNdU yXj}P?ޭ*z[uihCzfzs`S7}!+9){B[[*R!(忺6ޡBEULԈN8b4K{0000000000000(%ܡy^tA t1Pl~(ݿ4hڀ]xp_w4e.3sǺ[L)׮Z]! toA^YK>NFZng= byGT;[&t3 rB'#~sJ C c c cPEeD ~ۏ߻÷?qt5z7RTrǀBi0;|j1gK$G- %h-Y*S_1ĖU*e`6F5M8}#)̓bȡ QWv9pU.t00#:B.=|\aL&I2 `pLkk2m_TQQuhe[DR.61t000('چ`fea^v;E:?h\nBȈQ?6;qY_e (\`1`1`h%Qmf `F^kKˇ%r@pd!#PѲQ:DsPHPciviiY?-=1ȆFfEO(zPQ{LPp1Q⛮/D#V%侌ޢT^c_,)M "6tF&V |"iM}%ue05n?b&K 9k ,"ShE6ٺ5-E(Gn$RS֛~I*6iҵ=)T\ y&1111111111111111@FqZW~3Bw]߅zPqc>d}О ojzOKb}C[N6^t aGo@KiCS0mM UkEr@R_rG7b5fC5S N;2.jOٺ%UH"ϜtMl3!`6ZFuA2k#"|Ƽ0ixyw/$XF<\!> {NOd5 kiN;=]$`vKH"+k06}dZ-+'$5|\)%/-32r~CcLFom~bYx+M$s7 Bip'78JIdwtLMR~`nń]*%ZT`(#J0SXjUʽcjH廄Wfb3<*[qIn9i2͉ ~Z9\kY(alRfDXh`R|ZvfPd[p2FN;[wtPl'j|wg"gd<[GOg|v'RSh0 S+"Ssbj5b~E@jE:PLhƐցܦ6v̮F̆/.X(,SC.tA@Hha1a |hh~#[J&  'ON./OR:2;S[KK[[cYvؿ"_x000w\V wb'uoܟ qv.cccccccccccccccc6K]r!9)mZb)-[{.9"rA%;U䬂c^B 7z ڡ?>Xcg# έ|wa~&3ګ4p4,w>[8yŬm` Z,N%2bαi^H15fĕwq d cwb~t,qф>I\1,^XHNtv(10dȡHNA4dGcwb~t}ccd s['\_݋@?r%ظ1111k^›R.K-mb#5(q$)B ȠxP|iorDd2ʆsHq{ m]`nƳLah_ko qkVp- %9LzXZ[?5?)8<rMTUo^蜀 V ©&J(L1113?I"F+q)}y+?w[_r7}-`tk?}d&|!mY|Am E< ;o30dVW_{C䋗+ +]U*{tŹh@iŮkTt2B-/r]gl1eJX6Dp1  4Qv(tw6PLp(n"VDZ?ŭ՝B,XY9G̛޾1>X~LS8PӐ?UEydoX&)U RQmA$V\~!_ V|T3~+ '\f&IJ`e.b}&+\5bC晲@q' @(Q:0[|Oj23\~b.z>8@xVln#?`1`1`1`@Gs1|"aGJ7?U"ޔr 箶>{ZRd/ya<^bL=v9߀5BV$"XPSjGxZHX ݘ܀ܖ؆ڔ؎ފbǂĠ#Pa&p"pBłQ1D۱3;qs0Қ{Qq[:[ܜ}Qۋ~Ef7}IӻlVqȃԬHn~ mi!PO:_!5ct, 1  Lh~7>K'+(>SC7В`%c,GO 0Rz_KPb/]idڵb^J0k-ql znU-?]%51زpgxÖ]0eȾYlf8s. ߴ,@gOZe W{1mqNV8zZX|]?ۄzR;tsL,׿ji@En3k,UEǪeHJo kKiig&%3Jfh Y($m>v[:~8j·\p ^bi(oZ,+WJ_4XULdquyb,[z2;~h7U T`R@^Ɠ&8/ ?I+?=;_z@o45nfysKEmT'CCslFwDk|6hb}?}m+z@ĄfՍ ߔ'6n'≮ lm`+`(`˵ScduSʯ*}cNucp'ut X,s"6`5_I\lھ,5`i͛P8½(2u9,1rK΋  ,炘 >OٔqG{}>oOGk)Kz=W]"M̒mNlRjb<+0yf}KD6B?Ca[1b֌4'px@c~C7΢GxcX%ב2}"1FVdtX~j.xYhh-O9/7q%`>dpEiƍ뎇6|X9]V!1@o4'ۏ鎁R!WQuҖYIJIt ͩ av'Ulph&V[ZڴIAkB~D,5?25)i,贬~*8pF6N:Vhnp|*]> FE4Po&֟~K[&vնR֎n>[IP@b"zpC07H%ډ㷓Y@vUp6\l8#^m~$ 2bcX*)4KB^G"5}1_qP2RJ}@9Z3#G:>qpkB 9@0dzBef¦r^Q1E bN5+}P`yP/OK{ %\hx8/g+x,A,oƘRe2I)x oib3~3kt88[Zw{w9ݐEן7>l(h_n0r %/4Ԁ,AP,=XQz(vbJ>3Wwu:[:~ˋu&ks6]jZꨁhU\~)ggmW^HkJ#RF'ぼӦLV Sfӛ(F X~ E2"Ñ$Sps픆 EA:[<= ^EUBcabX08bI!bb(iQؙ ؝9Hiͨ8m-n~>^,t؊] &"I5#}j>T#r7q̰ WlN`0ϯ _/w0t0`ggCC$ X8YAj@ٸ0քQ,g:}q\Z]Z(=y셟~%=O1Cۑ>u+`wHP-y0:եqZ2+|}ȴ$ߦ ňb϶QZV+f%=-,@k2$ta`m%5deb`:ku 4EC@D hV:6eƀҺl`S(CAn}l^y*](Adqw)[!1Z`;dw __'ҤB*v[2tn$> |354d5@ B)f!lN?wK_(tʹuXټJT5 x9,iL+-վ M8f5x`'뺏STi_ Ȏʑ ‘Gϴ[[ԯv_-?_>W࿐JLE֦[BC1ec b *?Gn'?T TV)꾻Hi,p;sbJdv}idQ%/QYɆlImMqY8Ajs_ugRVgg~T)Z=(YŷS1 w1g+^|]U YoŨußɗ|Mwy|rY4hҳe&ݾD}JE+, 4Q$ؤ̈OJ^ZoElhO&C9Mc@$_F /J?zb8NK) 1Pse6ř?&5+ko_r^wyw[so~7><#߸/}G\9rX<ACflwx?ayj:|SyH8TeWi0ܤ{ҌLJe%teQI΄Q!&b:"ѥ-%P֔Ĭ출޼6ĎwG.(@5txQ 3Xnpf K SN\7D8xiY~I `2n. +TNcos^Ny,.?6^اIөQ:Csl,,mP@_YOɮME&'H$$K ' gF%9gn*+lhe{KDM}d^YpO-A! $\ &Dܷ)0LLn-&$S֤vj-`e"ҘE6eO!%E&O'|a` 7vL+wokݝ򏶫(ikx%$! doI/}G~~cä9Ѐ-K#-djplO4%6vJtᷦ"bu!$)܁;j?Nrd cwb~t@?v/H111 a^ ]m,.2z]hX =)ףS+SԘDE10hjG)* o^@FҰ/FUY?,>Ɔ;U"xk5>go;zw\V wb_x01:X~˨`8Se$;q͒7 ÄVx|1kL^zOd /NcXSm{v/WD3K9"̈Jo%_-J׀__~a/]jP~c.==I>ϵӎXڙ۔ZwĽ{n2%೺w- 6fϯ5Ԧ pd\Rjq9kt+c'*N,;$crE(. mͩ","u'jɐ!h0ɯ`xb@P!âbñCCQ0PQ:zqpzzёښZZ<|}>11%Z-)MA^%k#h8!GLvsʀЉ=D>d¨qˌ0殨J2 5yo ^n͵O+iIiz6ݲ@ibef5aVA0 ryk ׎qL2 Z@E{~ ӴIO &!(0 :_BH>9(zcN*R6"1qr)#ӂ|d>HGpLAm} em^F,L6Q%.a1JdkJӸFWPdD IYԽRf&M!?$;;M7F&MXk*֘ nިF[}bJi cj4jȪM] Aa l.D׍LNWp0̱Ijq00-г1=f:u./s/%Ȳ}JoX7Ф]>S-#4_/+{\ ]J(xlb24:c=]#zri_P$Ӏg2.j#eYʯiٜK`G_Gb6I HcSiw=MՇYĀKiKt,:"wv뀞1%2q(Sҟf 4e>`%b f88hnE++A0ǽɫV#UխJ214_ ƉHtxC,=իpΧC)=[$^ECUb]:xl &x( -ZeՓЭ2zWswtfHHĮPrfWŮCjM[ C?꫙GU931ķ|ADDŽ*3V`t@,Bh7 Gs:z]^Ō->@(X?S:[LYgiUC!@dHl&iCuEsnGA ΁sLY%"x@t>{]|(oG /~>֋ ҁjkmh/^|T7?ߟ{304L j>(8nrߝ4WQ>p+lEbp-ynX`[[Č?RaJuɈޭ Ѱ{vk#k==lk1g '֕~aHgkB5Z+7+hrq$bkBՄYڎ\D l}X=&niiO%6Aӯ#;*@;K3/X 8_{_7Z짔zhI ~?<}ؠ*8Y_BDbO5AaYqΖ8M'y7HJ[FYyLYYITF~ ֈ҉ӋԎ^UFh+ 9'W_h?Ѳ``j{n`.<ko;+' CׂZEq!,?-0!H2Ig5MP_S 8]ԃC$ X>jP}Z6n75%8K1Y\@`WPWiRL- os#G BSoX"MC*x)U"H=Fe->9?8zW:Q/sؿߓ4^:E|{Ly_:d@t|A%"WK^iu}E^ ^+}Z-]Ivl 7 A9m}ѥZ=-mÂtƽB/ܣel9agS9.k?[HBߢ)U@܈z'q5Ab\Aw'_"利& v Lqաe+ gszK(@lLpǛ(q\gj&h,Gs R _Kk8 ;l_uqr\111Oӻ/;+~K;p/c c c c c c c ;}PCPž*?kr&>6iHW2}'W7]m"ǒx?A^ccݛ&80Pm{3 Q*Q4[WixlOq0{ PgҦjoy8pڰwy'Xi:gGWzz[3ZSs@'yVxG5sDb-V@CKV*yDW61ևim lm0$VJsp5a49 7k9!fYi[$k1IJT&Юz mӾemzYi3&$=Z@bX1μccLj`DMMIHRn[SB]`b@ig)Ȑ{fRg&>YKixB`p1]2~'B t J\eLɠ>N$S[D0:K X̷~~[|lSj;P`7,I٪{ n.`!ւaH΋}sdp4:x\YUH"L;ejsYCCǐhM͘~1_ zXx 4hAX+K ;qnh#YC9Wcs~-HƫA[4)S,qV oЙQ!vQAaDQܺ2lbbQv^U v~?SP/9S59 iLf.d#x}Xs} S@E%-f%?7>|pHTWRvn0JA/ $x_B}82=_Hl/B`E/cfa @Xw,LTWC"8ӝkX)oq Y7͖{mŶw5 ܎4$`D1ų^?b?5.:E-ꡀ ~4 ]qtyE,(ȂC9W X(">N0vؿ"z;9ը 3:kw;HA7C$`rpZ#Qg31zEc;\Sad G'ۅ(Ou-9':ϴ|祓҅5ka|wy9H%%d6u1:PVN5ڳ'NV`,)LEduewy7ME~kHimkEFtGAEr jKr Z'|o}8Е:h}޲MIEG>5Ԍ\#=&W%[JX'+nF~(l`N +$XSZAԖke5a6$Kewz9x)cccccccccccccccccccoXySdzjZ(Eo}HSjES> spl31Q/7,(q8A&ҿqw턱gjO+Y۟K"cBt';7E+b h0J]V^-&6!&[ɴz5A\vĸyhaqM3-67EkOГ\R|Gި$?0RCo5t:IgcAkqd=#&R.Is$-OQ(ܓ~d8-KA?+%;컲{+H]o+qmxT t]V']sWs}>WT ͲL]IU)&XA(Htk2+B32U je _fS "E#|f9I{bolNm3)3Uw6r;U?{gcg?ջwMFNY K>^DjiW#%##+%(XFii'vyNhYO> 9E *{'t$>)}߃|濴;)E_ |~{Gx{o~^cۃp WɞܣiYJA43PW7;L򇄕є v܍ 5gi[(uK 1ؗx8bυQj:ՖZ\9?(&֨>挧y795?\ ߻CQg7#>=yґ4b[2VƤM`P=kUtW v&2WxqfӺ l7sjGrXBdpiL+ ~pϳ6Ge#~/QU30ݤnb.K  BU5t1*'}%z[s{ҖCZ:cccc}P>CP~U?k|&IiGy'k~Hbz3r"__uYbG +y(rZF8ŴuPPc\\z=Q]:Y{ ^cP("dC' V;-c>gTZ.{Է܉+'EcmbWkniW9ysؓ;rLحIĶf[M{FN"pӭ>(Pl꒺Jl2$B(XMYhҖL@kJbVv[NNZwo^VRnbG^;[zVGgsπT+R ժY_ 5rv5s^< ;(#$;sSnr&'M:V @?--O8m. YMe[ ٵVQfFKUONccccccccccccccccccccccccccccccc>>Dd2 B ) C A)38(R=ܚ7XJԛM =FF|=ܚ7XJԛM JFIFExifII*1J2fizACD Systems Digital Imaging2012:10:18 11:57:000210828R980100"    "%68 #$&'(x579GWXy!)Yiت ?AǦt 4`YsIq M\cul"Գ b }:SP+ ys;~`ݝ+0PeR7_Et=(A~} e4| )D\T6†dm}9z ^^MCy. 3קg_tV;rOk Ѧj_E bZ7] .ظ}I퉌0~~Aj0$(*qOFD IcX'TMN%`5pN _T%A8e|iSqȿm5\ėt/mJ\ Tll j%pR*g$XS[ǠZOjNQ(v*AZt/"Ay{ b &Md8A<ַe@eY* 0q^[lP jv*_[,G:1IC4A{!:ngSu bil&o)>ks}ZN_ݔkepK(Sg~5M6(X8ocOp~u8Z-2ܭzͶ;IjwKL%y==Ȃ΍sV\W WF4e.;N{[[&M[A]LƠ :ݞZm4A 'ɝ=>Aǫ>lڋU߿CW'8Ub?A?O?'_ ^qV̓@]_&o^}Nq"46#AN!YU߿J}}٬-_fZݿ?cc-i>װ_&>F|wOؿo>3T?/D@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DD ܻ=0mnvvt:U7p[f(+!%,zL|GM~I'r̆U8A:hun~RYڭuuЖĮlK}9ؤ^MŰWpp,_+bħ'#ArX``W谠vM))ƢaPQT\eWVWbgdpr5XxJG_> *ewo<_&jo}D!Wjn ɻ{4ZiF6hWաv8c嫔NURrSCȡzp\@0=xQ !>.kFSP^-cX[|6u]atj. u[0u^9.m>(D&ߣuU/R׬yKy/NfУI`_󺩞ɒPnQﳧ_P"- ) &=ҵ i VZaR_c\qdcXeMQն Ah&3Qb'WXrů i ݥ=wEH9umnNh@]y,{g)))qa@ՠ:k5V#lÆA ImdVdrSS׉`S R-.M<)~]@PbowFVutY<{ڌ)Bth 6M_OOB FK-@ 1Sڼ8t{֮3n} HRկol»,77#5},+D9Ⱥ>j>(Un wWxE+u`D,]\~bCBI}sLbZ7PjTֻmǾËݖ?20/A=gf=Q 'fEb!UlGlE&ܰk'_G4c^ùϒ^; _ ) ݯ)r_*vq[]|-5ƸopcTl6[ahd ytV-HK - 3 [鶺5u;n|sMۦّlU!4 x-ҵo3WmRE!"z oI쏱,,n~/{ Zõq"6/+[6!pHނe-bU2,}He$T(f xX<r6Pq nµPj/l>z+滽`']\an6@j˧VuS =ҬQE><mn TNCa;j~0gMev9GL UBcHi"%)Sm25wkCh19ѥVT` IQ;L75uʐ='nS!85dϳ񲶠wg9pfR6pXF({2Kmw.UX)8cct SI>N)?.0?=rq{[RqfܳN6_`3xS睱UիŪMA+[oJ- awU?@{<W䎩v"G_'խ* s0k`}V硲 @2=vQڟmeCmQCGz~~:ʜ.~-4uo^5M O(@)˩8[tE ʄ({X&@qcsooH$R7<_@ǨhЬKygH5w6$AR%?56ʇ_uR>\|F(_5YYSRl̶9z>3a{ @]qh;\N5bWR4aNv5JqlŎnZ;(G*ufj7XGp^7L,Rm] @x  P\W  Wd f^eZaWYedgcdcsrqT-R+)\Xi{HXw6V!eN&6&I?=uU[.KbI!W=4Ap(;Mڭ4M}eA-¶.`ib5w &i߼`򍂴_ZeU9 #-,ԭ`5BfU<i^ J֪[ņn2r7&@>~%'0lJ bi}OezY:ݑٽV\u~AuO[ ~}=RvTj̇.Hb!=wMhB;ZWlPMB+SXEtqB%>u [Πp})ipvǡ\Y1ZTՀV ŏAh L).kňF*2sjoh/js0)j2벱r1z - <7͂)S+G-hkV(Qm{H}ul֟:{3.>ن=xקitflYKϥ _@">LeWWd5sM^%QiJ ij7a}" QkzZO+U2gVj/8rv(0 ;Z4$=KAY][l~;t}uڝeRY>Ѻu@ֶlW*>ȳ}U`W3 łUߑGVb"" """ """ """ """ """ """ %btK=ϠDq".ʚ[ Bˮ8* \X+=+}V9?Mgb36vF0H7X5?Kmi؇z%-v,oEk/Vͯ*ځr L NQe k'Ob%PjZlt_2vnobE@mWӉTݸ)\kHa T7qָ M ƨ©ëĮ W0-ݑGWϓgp?qWqAq^J(\$X5PZ ~ [OFjb]P.ΨNh p\i+Cu MKiZ :;NH=~|9YD@cZJ0aZx%#-V)lO2`usl y9ϬC Ӈ޹:5n߆s-j*- XD>?yWhJ64^{/cޖbK;iӀcm|T~G8>p~=KFɯ|%Y,ā]満v̔TH*bʇ\Ak&ni+kpP&ȃAy=` EуNןH _Wɗqَ o6֚J}2^\%hA+uX-l[YF+RYؼIŅr`P;>)%f'P_*+B i]m`պ6qX5-ULN,+4>{bg_^3{]9߼ /swO7:̭ܭs-H?0s^5ܱ:uSR(9Z:lkڮ>\|V6,R̫P&/U95M}glcfRʃi{rs_xYGo'xԾEEeEh&aلcEF $VW}icE6ڈ[7N Li^\elE:(w9^Ml"8PNt: g?<+en{p4"X~BGѮsmk J2I=QEbaުA\|Wn;lU{3aV+ƥ]ª'4Z]1x9Bo[}Ub^G(0Nl ^?-mؕR }/r;,dA#/q 7r)0S},vG%Lrl5tkDhP S4!W,6(0,Ew9klOT5ׂ*01s=p()e7sLbկ.%qkjյN+iFQ2=>r0P bU.yLȁH4Q|(R5o_k37٫^]bK^իjW4 >dz}`5\!u虈A;e`||=_x*#Ӯ6ilPxޠ~ uA^EG1DD@DDD@DD [;wu E 6SR`5n[S)qVH;x kh@YRŧiWHlYf+~Sf+Bim!ڭ=!:깻UyyQ`(Sί펱Cu('u['.Xl~.pw6pݘ9lOS\rPiΡjf;2G2_I>q(|2:m0kntR=R+)"{1 %1@j:lrƅ0ryh2 2iJ9q,2 AF L.E 髈jGjoh/js2i0벲p18Puo),tm%?Vڪl'AL:'ܒMuu^38[x+J?Woݨ"8M9][ߡՋt\!e_X)d>o> K um F* iI˼v Nqy43Mv"" """ """ """ """ """ """ ""SnAv5a~ Mpmn-ȑe6WVΕ؜YV%d+ّՇ~ g%44WAe+ euU q^lo]ql:1J+~L.zPMWv(Q\6G\l@v0[)I0uUcA$tP 2>CdZΞb/Jm{eܓzz{z}ZǖW W ؝AC!V9!|" """ """ ""@;\={)^Q!N4oz'+0/(W@VO]_Wb75qn0'̦2fX>Zخ>KfD(z7мpHuv)MyK̫-+<9%3 3+0"+"Ƹ% ͩôʮ$oY{X<^_PB={4)vyh|~?v1vl be}^ۭkk)Hm"" """ """ """ """ """ """ """ ""PN}9PMs&ߠ!ҭ ]kϦ5PtDK ?Vvi[-lN5Rަ3ݡzr(;6ـ[V ŏAh L).kňF*2sjoh/js0)j2벱r1z߈ ={Ӣoč!4qh1{Y;!.QмF&gt)?\.\ _g]DŽfBOmR1M)UmPECZ5GI0m?N:~)!P9ۮ^1(u'_E܀F⟛^Gmu~4k^܍ tYcZrP12n\KzM\ (L;m7#"6 Ԁ-,P,=OƗjQZ!1!Jڊ V ϳl܎~cwboޑJj؅n|fe dck:]j+ȯPO-虛q}PoCGY8+||[('ruQzFRItPa7Y a)cV,PS{&bũe.G_دk3L,S[;('m݋zF-[M7q/k]xAzzW ץ}E}4('u['.X:7Yc~.k|H/zxu[HGWZ/&*oDPXXj$΂P,3י={ӢDDD@DDD@DDD@DDD@DDD@DDD@DDOjX>&j,P&7$hx.+>vǧ~7W*ge)W'q !|.euMAkGt+—Wz*<=zkPո,B/ԦNyǍϷ-B uNa.=񓇓2˰.܁ϱnc3&5U(E[fo36̧I7_P;f00P޻RYj;s{lsX:jآW -w3n{h4^ttWCmNYfܥk5 "֞KV vͻ/¶5.= Vo(-cUġFctn֛ Xhv̜@":"%f,_'llJiL:4./>mD!n-:eI5U4# @N"Mx>ȳWꮀPeHXK7OLD:\HH뙈<iulhqL 2o2^e ^]Vwly-@DG!h]?j|k[W *4zYӛB96w'6)=-ǭ[ [jĔ6ovcA.ic2LԒLUE6qxwڪW%>H&_H kVspl} N᷌ucRYԭ)`e3m^NKوܪL,uw|F÷8-MPwwQ+4owI TH3tŽ_ <j~]A^ٰ!Q W߹a;]qE]X6*-pW2@0dF 5=F0'L?1 ݷO`GKOοp= _ٟu\xt~@ 2`FMm-2omr\o3ovSh6PI@hmfbgX<m-zy!nXdn5>O}^UiKMTV ?KOU}mAm{sWGsc]ǓͅUcʼn#U{׷k-*[R=c$ymFq.*jm@`v!g<K:WhK*?>1> ;q{a,{\ \GF!KmqSͿYlQ1:hϱ  ^fפdQv=b73X892 ؁lB?.ˋnii͔mkNPFQcpUEośєnKngzo ͊nԇCqFϨF.n qG,"zr[s`o0n0@t$դy]Nkax1ȸSAX8*p 7 =; .h8f6rnܛw?Ln~ڿX+ } ΫZUIL52I3ig‘Z[/`lWZ5zYjYz.à޵qCsbB>mk{gqegٹa|)STߢvR(ȟT6\7"ƪLa2X*Vᆴ3˵Rѹث;"J 9M)~]>J݃Y]kV>SW(v՝, 30ߣ7Wg`.oTcT[Zh PӚs Ė>e,})"=JdgD|P`„i0l8,sVɫTWp!Mfl*nnJFN5$3,Φ 2`FMm-2omr\o3ovSh6PI@hmfbgX<m-zy!>rw`@Q_ WYfۧ ]EvaѠ6:U--W!3@0F_ {~FԘWj=;o7pe^_n(\ Pg8'>c*'<4" """ """ """ """ ""V(,x,J r5@fgAr(`WM\D,X,E]P@4J?oS{A{SWsMi]g]6,V+mF%rQB`UMn "U6̖-0eUuv~6FIU- _Piʍ V:Jܦ `AKl㠕@3IWlylVSipUmcbI\[_P-  &(=, VYWUTf珃RPT_TQ\dWSUasdcWK!Kk[ Ak"ꪌ\jJ ʚ*:>[j.lLj>> z"D/shӌ~M:Ӡ9%ꮷĶï!,Ϫ))+#×V(,x,J r5@fgAr(`WM\D,X,E]P@4J?oS{A{SWsMi]g])5ٹUP[}{2P]IKq|iȥnrmb^'(.&EXJXinAB%_l@Clb] UWZ؟gdd^rY PmoPhNuuUFi.x5%NeeM^UN-Eu5V6O&5~-MndkWhZ+Es3Is(*s/*h2plr+y1%XLS?EǗg(d"8fS5JX " Ƹͱ䢪zjvZJfH%N4#k^rѡP:1KZpl!~ ) ""B&ȋ`lJAB +tCBե85ֵD8wu7ux|v86\Y=||&׾^9h*Wʯ޿؍~ni{>yiS@~(߱53bl=$7?ϟ7t ufc_1DP(=6P02ғ,+3$t$Rw^00`He0xx5p谘v5@F6MN]55^%uev&677O1ƳZ?WPY:W`C\˭)jg Ū` rSԒ؋ }HӯMؔUWVZ4Jpkj0p)/ponn1qmpz12C1{Kխ^V  ז0}q rLHJjTcp߰ g5 p {z5.A Bm _Piʍ V:Jܦ `AKl㠕@3IWlylVSipUmcbI\zxbǂĠ#Ta&t"tBłU5Dٵ79uw4֘yUuY8Yܜ}^@~(߱53bl=$7?ϟ7t ufc_1DP(=6P02ғ,+3$t$Rw^ ި/Gh"^ӫ_>ޅo {M>ޛg>?S][_P-  &(=, VYWUTf珃RPT_TQ\dWSUasdcWK<`1bSZ aAa웂RR |** *[[U#] gZv]4:VnB4'ٴk@s{:ctť O-+PKldEuޡ}_ Z%A1jҜ꫌Ѭk;:;Ll;z늬lnk >^Yz|dmIךּzhlHhQPN+έ!`)Mwszt"_Ǽ{+mNwG6]q82剰Z)@ mٺBd.U 'k#bT:6߂>b"" """ """ ""B$& `KB 0tE9ַCXt94Wv9ֹXܘ|jکZhl ndxn9Z{>!$):C˺Ϻ^ŴK\ٕ7{w]3' V59j᳸2i 8c*v*)Gvvht"kfi=(ZIPBGL 6sc0+B`]B"s`s[:WQlwW˺<龭!e+qI9o, o+E+sio,psg'Z_Үښ׿a5b$;qpix]pТ ?6Zc*Oa<r]m՗foߖ.|^uc}??Sۿ1oKȽKGiD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DD DdE$ 02B * C A*39)R2 1Ks" F 1Ks"JFIF``C    #%$""!&+7/&)4)!"0A149;>>>%.DIC;  }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz?j(((((((((((((((((((((((b[x"?闒`;I¨fH!qsrL8M֡k[v-̑c;.N@mEQEQEQEQEQEQEQEQEQEQEQEQEQEQEkw3[}8%0xU]Z%m}[9D!{ ]w 񬑶ܤdzQK1ℑ$V\Ө((((((((((((({M_r`3yVħ5MLG\E"E|dR:'b)((+/H/m&V"~^Aڱ|?̳Cm4'%uXG))h((((((((*@ `H'dY//v+5xV7J@n@R"H1;JMGdHVi6fŦۇhefF*s(P7r`avNEyP0<QEQEsZՠMV[a0o>.b 8Ct9-!f%dƥ((((((((*6$4 )^X ; tNVWPCЃKT5@5OHyZJۤ 7ٴ{_.o?0#W;jR!#)ak2Hp۟*A #c7uVV!`Yۍ kr푊T ED;HQ4ʀI ]s) $9$c&eee9 B >(-Z [["WsFX !Dzv0~Ugb6F;FRԣvqI#=p2`2vՍ嶛D#cAې F++:.ke S p': VR2% %rFppz桟XFNFq RDqG A}j RO|8 P2$ Ǚi=5/]cNofkXL㒻:s u]if0:Ϲ^('~ I-ncE )noXZX`@j(f)$Қ8w'h>$Ɠ¿(Zբ(l:[Isgzݗ4n~uO\t7e?: .?S?]ΩK.ݔRS*ڍo3'F6R2儷҉p2֍QEQEQEQEQEQTu=M4ԍ2dE  e՞&w vY@ ! rpA#ùO\q$R)Ѹ 5z\:M\\C+ɏ7r.q~sJۖu @rۅ;r>c]w]ckY8   yK{X#8*\wMC7 =ۓtqx*v`ݾԬ䳻̂QMw ~~i[E JV: WI$p1[b(*mi8PB9=X檭١?vшzPdL5`/&?J“˝ݖ ݣWqtFG(((((((((Z͵ke7u=& r9$1mwk۽ߝid2h E%=I\QgUPɋ˳DSHw00t%FS:(QtoH{&&/f <F c'9egEwmzƍeE}H8 LSIQ֞DV7 2WRYީ\^}`-ruqϙ ŔV>e٤(HvnH5;0Fih+&FK)Z,e_ F}_97p=utQEQEQEQEQEQEQEQEQEQEQTot{B;0+ :9`@5z()H0:iQEEEK*>W~sG"\CwxMߕlC4W,ȒF*'T$gv !Ʒmg}s+̐䱔w"g{!NwP$ubx0*z(((((((((())h((HO%̓jqQ07‰2vg}X9HY~bx@sEt$g[k4nMGq!Wni\Q}6rK q\ bGʤx:((((r_ +/WdL>Nmnfe{KbpN ֕dkw yf&bWٕlyQ@ ,){&[+-mb~ajEbDWP:pKNIOn͛|;6vNUJ#DZ7SH EEqs\7<0UQI OլuO0O @ I2a{EQEQEQERREQEQEQERQKEQEQEQEW3FVm1LK `A衆+h#(PƊQ@Տw{i-VG;(3w [<jvzzU֫p`YdHߜF`>3[vV}apө$Id@Lz=>2! Z]8쬣r/W9/'}"t+ > 9cחb[-Y+Xey*oͷmRJ}rXZ!#𙕾B X,59d*-H,l 3qV:ݘ;X:22FVb|K c_9)<3 !{2ֽW!rNm/w%WI$hǀFQ֬,.YY)v؛3p c$t4ȼAMsI7$[6ҀdA+~*((((((u{&Ln[V\r8 _{gG4Si O=dG%>{gG4Si O=dG%>B2%5԰H8*A'Sa؏6͓Oqq,A.*@UcSE/tAM?,>=vAMo=壽[E$M E| ;g=zx[$%\ q~%&VHd?݌1h{ylsk^ǰ&:H{2ӹآq@]m#ݍ8ۜVTl$+bha3G1a~*}94J=V (H`=H*QEQEQEQEQEQEQEQEQEQEQEQEQEQEQYP.-d2Еш%NAz([U7eVN P㎝k;KY.n% XL01AL'>hZjA3n,@p1JѢ(=O3#Z/O$s r1ď1Y#EZ[YXΩ>]dn(8[<BZ1a }k: bZBB2ZkM-bPca`X܊SV[i`)n箂)U_[b2#W6"U^KNY!A=6# ˼rN+R\;1z&]G=NԼ=B ϿawZ-?'+0=2 > o 9]S{_?7\PPX Xhj0$2P<%E+Oz]@ 0KtI9MhNyp~5Au]%%siLOq]b%U.ZvCu[=F>`Cj\'""i>ս(BZ.և~AL]qZm*,qN_Sн4 ֟9O7]ddl;DY.دxyCYfnt082W *5z٨zsy?cZ?}M_؏}_C/ӿ@8:L1hO}\ucGOWsQ>. n\o~vre1^Oh+\vE>ζ ; QB"SRz3U*vu@:pC@X?Ms ZyOtrz񍊦mlQ0*7)k-?} d\侟/!.)Y, fr?;е5jq<'EFXuֲ:8kztT'}xϒ *t'1mc {YON؁'y]Ȃ֋@:L.Oƽ͕cG@~O^WMaYP*P noIe1!zu=:d:4"BK^_΍ B>S̬fRI_Kt U} :WS kuĨ=>{; KR]rӣۋV#u~BppB@Yqs"1N))Z*͋◶O@`W t8@%~؀ uMMשVlTttozv7:j֛tk45O0NrxE@Kf> .0Cճ<K:JJ`Au :Ot)؟W,?MFW5?nz V+:Sヹ[Jon' y k jSk X ^Ar4pV{l)Aim㷻L5hpgcE]ZxgW-߿ٮDd $ 77B , C A,41+R^Eǻzxc{#]sF^Eǻzxc{#]sJFIF``C    #%$""!&+7/&)4)!"0A149;>>>%.DIC;  }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz?j((((((((((((((((())f ($Z:m_C,ɜ$##uRV-q.M Bkmc;F=v=P>$@없HI%TAUɌujxsVXҾp{EHFNU'dtZQEQEQEQEQ\ϋuKU6=>*|"Fw0s](((((((((_XL\DIªA6W`xΊyx0rœU~KW njZ@\pLDplYj&\2nxved#/OW [ڎE6?`- 11j#q)bXʙڬy''e𾔐$ r*"JQG)⠓P,]zniy%37' #n1u;ӭm^{ !pAe#tqjNy؎} `?-'=6Lkrdgk~ZQEQE-QEs0ԛL-L(xV dR99@3MoQEQEQEQEQEQEQEQIE-?O%~sL8ZuOA5Eb/{qdE%|6ၻ֖9&#m UOfGj++EkF*ժZMH: v6{xX4exXPN񏕤GN3TMVF.R%,895b nIIq6 =RW9}[=ףm :;361݌ *ͮ'ud$I6A FO dr2^}H#R.(ۈ0K @@!a6E;1t'e;G^ =Jq3 ӯ;]?b!2˟*dg+Z,^Oimik`$2^e&8<r˓J[--. ;{>0yRGZϻ!;Acw'u?ReƗl@'o D!!f9HeU NbcpA=7mc⧇YӮ;+ncGV௸⤰ԭ58{I|rJ`0?@)lYku]̊2Ө3Z4QERREQEQEQEQY~%ON\y(c.\8@$⹭&E/MgK( 7b@mR=[ KH+;ٰD1|)* \[a ciݤoo5&6P3 )N #x/kp|pyuMzkKkTS|H(dCd`zngC (-@l~ c$dnTmn|J@c$gO X F1 H~y3UyKr+Y5[kIWX/ln#oI< aC) #m?[`z\[<,R3vN*5Ms2[RV1?qGY \³A*K}F?R!oZ/KhOQܟsWX-ZUYe|( !UXO< gZaqE,1*4m,xFW9`Au^:Ƈ35G)e[D +b'ޢ{;.#hLX`G[Vs=ܶ%V9<+hnA(pFG#M>]o2*;D!q1RAU=$E;–pä w }̟4mv m,`Ul ap3A<~H. W[]gE E71bLuĖM$l\1oAzOR[em5QP鼅8uxXR}ZK#u& "bwp3;n/h..`V}T*xʐp3r. V&iK(~i 'G/?O./_4]_Li?<֙uL?ZH"];%&HexEBy{㡢((((yag"%W A"##= OXݥsZ%wDe%U<, H ⽔E6' \KDmf AiHc28`89lJ(((+/zƗKyn|ɮp `g $V߉Ai7XJKgw"*|x((((*+--h1䑂RON}.*ݭѿc%Ynv`y/՘7cTG/F8]gunX6M-@Ԃ`N8 EV 1]E$98|"} nl6G4r7c3Ԭ//d:tRM,mw岒nR,O88y=ic5G&*qg QTk 0ƗIgɋI.12͌vG6i }V?OC{NEss"NC)J(((JZ((((zȠ;)VS yמ5 (lh 9EkzIݖ A9lV1,)jobcy'O(((+\a&ԓȳ5C*%Up7S]UCuk[F7FH A sƅi4IK2H9af/bA9u}[dF[dD).`=qVA5m*Qa%] 1ޭ_𕍥nⷍno-!|fI`;'Q{+[;gKf 2]u5H1j֝{Avc$8 %|_5k%F / do `(F&ef2ʈ̑SW'po;VD$=s rpxs9zP5Yya@ 䎹4k{eҮek82Q2|2 hF|>_sʒ=k7"Nvóe_Hwc,sm@^:!x(<Cm4xt rɼBN 퐻aG0+ko[Ko,6q$ |nq((((((((((+?R~,PEgq{q*< l]]pYF3zuT;Z[i;h Dw-ԁ2ztO[kwH˵b3y; Bf '-O ;G)C"edجsqXigX [CH|j] X.h./niR`1+0Ayx'XZwiw,pȑ41 (K.(\u3il +l yg<f"-N-y4vv5p$z6:[}ƃ!ceLq}yaq}r` p:+ʼn, wv+< İ*o3 0R8Ξ&ZjqC,1ijFA;IQEQEQEQEQEQEQEQEQEi]wovַ pQʖ=ϵezq^AewjN)\9U*3TtXmUKQKŹc6Ȓ  i#\f$Cnm[גyYDaBy/?ֵXm9A o6Do,H+Fw!U(o O4 y{5{Vq~e#?{\n+iڭo:FBeH8=<:Tv:M5mEZS%Ēn*A1#z YuIơ^L($lzdqC P=Z$oӤѯifymfy:$c ǩ?Vo[ y$1K+XU* %1JCEQEQEQEQEQEQEQEQEQEQEQEQEQIKEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEq>4-|AZkeq2FX HC LKdt$.Ht x?wއdDZU ]$)$?5׺< IG\L<zTQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQKEQEQEzDd+B - C A-42,Rў%WOFў%WJFIFExifII*1J2fizACD Systems Digital Imaging2012:10:18 11:58:36021046%R980100%"r   &'#(6Y%78 $XV ?" """ """ """ """ """ """ """ """ """ """ "'-Zed 0 0=iQIIQkkiiUv Ո}u!!u`jZ6[=(!FqG ;Z*q]խ竰+ EpJcJsV>_o@DDD@DDD@DDD@DDD@DDD@DDD5!2LILeeEe&YX $2`C# YY^" """ ""D=ޛrQQbc\[3ǩ?)1!%vxyL]ubúտ>.a^)TVM+wj*z³:bc̷RU?h:?ҠVڌM]\5ki ^k<,[RnXv"u詠V ŴlI;WKM_l`tI,&⯂_xuydϫs=bKz$s1uia-BnV-vv" """ "jB1\mw'v 3[L'q+fp-eb2V8FW@ec9d. w?Z7OWA]Y[z" """ """ """ $#݅6|c-jywV*"Z,ӗRڡE~6_%~ CjC )`qUwUk;k[e]6lVu b2a^E@]$sї>[@ !1j0~no/?-bӾt%A~Bث#k7?; f5BF\މ /)D/DBW 2Щyڷac6{gԟ @EkBz^o*rl)*]RSbfP#$q>Mϳ"" """ ""'-zE9h]6RAYzglKAu{֌^ d 3cCb6nn7\beaہ00wZF[0^ ]AV|V ˍQ'K..JC0O36x/|mD8~;cy?H Nϴ+֦E^^/v7:s: L.5> Nbqٲu;Z?ZC2ZTٚe6Տ?PG_e&uZUf@IZVl#glL ^t^Suw~ZhWwo6ղ@aJ[Q8 m&ܗ`:Givl, %%.s5'H^4׷([yt L.j׵SߏIJtgc#+\C|(SpuQYYiKi G1+510ʴ#'4IDa d^fPcr1ztEVpwԵ@)@/L/bUN=twj4~?>/zʟCMsJu*`ub%m_Xi`z׶`Cq@宼>ַl4[g׹Wnk4'^Fxjx&U~s~SWf7$%ynZ>UíݛvܶEwyh:妥+?t@pY6/I26ugyLJ`־ճUu1z" """ %Cnſi瀾 Ry`~KzIo!'@\*[@z)/+Y{/? Jꏿ*k>n _ Z%䤊zm*՚;gKv e rwP`)։7Q C1#pkv!Vح{ ufوtKhn=_ ;c+c冡keRkXDxκ|}Kfɳ-%v_ HT؎V`EtOllO\KjVHW;]kT=LQl%[ns^moW@ܘ"xj en5Y\i=Ҫ.j`rSiw]Ԇly(9#[3pXٽ_QNO0cV*Z_7w8CA7""" """ ""`lZZQ}l}=ҒzizkJ4zu&O7 u`y퍙T8:6D_?=i[^@; c;a\㘫J?1S\.t_$+k`4R% XjE꤮3Sӷ7rѮūx5 Z#)#cs jeƯ1Wn6/o΅1^["䞤1"yI:m~8#6r _EE_-~>%+-<2sIs=P%ff!Vd:2LvV6vNF7?/Pg$bݝ2tۍb*lILB4iFtcU̻ ((3($FcsG)vso oScIh'NZ-wgEj:F)e1`=w.{BꩲzȾuw~Zh\MCT~' Z/|x2TdCf0,V<%Ъsq(vAZTkV|VZyFe3Z{JjC/0t9e8l,n~>^ukHŨG[v ].LԹ[T'm^ܹoˊdt!z *vIpr(K[*-p{+w7$bYܯ:${TܲW/:í`ZxDdlD-꡷qsZXmL)dsb/r Q*leBt;:`-՟0/Z íh|5-PF΋+LVNokD&4Cʇ̭T܁[("9"rVQQ%>N//(fC/('37&L(5eĵ /Q q0QC.&2 tNH ap@M͠ڝ`ܕv'jQ,hN=Yu6`3ʫY3[Q5'2!I(O !cQ0 Ֆ3(FF6QGceFy +ʣ&=9" /;gYiR4Y}BfgB:F϶B%3]kd5 aԥ;ն¡Yi8{bVnDz? a5*׶w]EdDuKu⃫KOfiK!A5GѦƮUuUIntvӟ7 ""SwTiEZlZ^v9,lڅkIYܕ_U߰@:GnVI>':g|UU_P' .F{m޸ŜH}m5M׾ VdgTCN6B s]jN/ϟ݁+F6d-bal܁VmeH@N}ݮI X}e(k?zzw1`_m~S?}Js$ɨpꦽחnBwpw&Jk jUؐ|J9i05_ 7$CA-tA9m[3c]v則 q0~ @UɵVﶖ>y˗.> b U̽RmVv}l{껩Z[c} "0za+tUk^I: rmwA AWn[Nۧ&`A2á:vW0 &@11" Rfe8CNWUFt+@uPC+ ̰iZ79Va+,(sq2z=Uco\Xy*KX8UO{gkk`5miSJe ]ͬLqib^,\mdoGS*TW4-eFӟsm׃JRhY#h82bUuZ~נsm}K:Zeo[S&aCg7762mzzm0mıMz<060g,"ívҊ7iNg[!{aC ZStU=ع6nrL*[-AtURqJ s=6ҳ.sqyF&+2kKy89.[MntWʺLal+ +]t^lF_UFQjNk^#ZJN(㣱ac2<]vL?eQ|J D@6׭/ў ojuz_j;1z}مM"^[ֽϼrpwf-omq䧯^"sWE-]z%ۖu3L<> -_6bYpmBam7Rw}zծeڞׁJy5N\ռ{Adh{j6kn(N%^,ۢUakf흉SVBz5WZjs穖>:$s*ʟkVpZ2qRTK fp@-*+&PNaƼkAa'^6&79Gf&]dXN`1Xng7ulm*$QViMji+ iTF.Cp:l^)|>28㌕!˷bL=]X7b2 8R%WVV"(j{2ـ3 S(6Ng(!gscrd{o!?y/>~0ſDާo>/|㿐??-|ʖ"yKJǖ}^|oqyKO+G'/qz?ֿ}y8ڀeq!6nL3_ƿlM=\7nʽ2 u%0NVs[+NG+pvvNF)+ÊdebsTONTUٵ5Qza KK]ŀ.d /z l,,VR;Փ[q6\DmR6$Sq_ 'U/eO-Jzq3L yt6H&׌"" """ ""@NWz>|}ſa忳:ɏ_"?~C5! V.x[|!ߍ?%Ű,>8{o=~Ay쿉΢ """ """ "%Q;]CٴU&YzaEk>{]aiȚߔOr! b. ЧhꮷcYYa~(&b>͢!5w: +X{ ND{o&`tV>SEgUuXW..˿hxpũOnK'W\iT]V# ޸LsTo=5_Z iJLMٌGs֨ʌ%GØd`Ze_/$s2ř S(q1Y8Yܜ}Aol+?(j-y ]W&UR׳4-z&[mnv} ]<_TU(:P* c]˨޴c=ϡ* O,T? gl܎~+{V X7sv&޴=ʼÃ-ȣ(fڽ]523yܿSYIN:x,WǖK{೨XݲV7za6U9nEE6s7P YJp1b<[ظ/D@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@NDdB . C A.43-R_w8UF_w8UJFIFExifII*1J2fizACD Systems Digital Imaging2012:10:18 11:58:500210328wR980100w"l   %6$&9x"#57X ?cccccccccccccccccccc&!^}(# o ؙsj8j1VlLD}}l7OgV%$?*B6/vbZw-)\kcS+R;|%'{n>cnJ XhRLrT(aC2'j[RA"|>V+F00001"-!e*v\`)'7`8?ӵu,Q02-eQ ;$AfZDsc)f)9cȡ%o;cϒA Y?OvXq62 Jx[WZéF\Ҵ5g8 ʸ/1+0~f/}rҟ6^4S!+'>0X^s3+Pxq(X|A\a+ )sӾ2bb.bchHP l)5:]CLB.9R5K,D6ZT X<ѳ[o(c(&ܷ:~> b_釥~$UizZqDeą*>0 C'lS9m/Q`q;N uA1(UsRL zX 9]/ֽZM$Unz=8__˵aG/c\ |[0]r|my.c c dĺJ sJ~ ?=bE> T.tmu;n5j/(IrIT*%wt䆵8? ! Ix#it~/b#Hp~EVBpgh|>vv?pQb,P5 3`+4Z>_:[/< ۀi"+$xIX{+ԥ ?flr QaK+"R۱WK˥d"!K? [.< 0ݿp VA4Ǜ(qZL6X f1H)^]a - X W>3ӹ -*@%yLD3NÎgt˂sOlrY: cHn5?]:ҵ o b6dCI&JZŗ[AyA\ȑI6\}:)PdKFAmaJub@0Fy!h4L)?աzkT^6 Ip\ƥ-"zP}0¹q%[t>XYɒ r#`ӌ,ijUӮ.$dA?cJ|9n׺(\\5 &J'^`X@pPbAˀLǯ1p{Q1kΟ>\ng_߰czUа|x3Z!vҼV4I :I."PuvkfASi HST_j K22s^b:~ C>\)%/-32ra!_ѣPDLv9ZtOQ:>)B5,}w)<,1חbP`Qc%B;{;84|l_T8zTeĮaM :.CSj~ uu#<+oU%r{yk `0ƒ}-Z:Mrڑ1BPH#inQNT#[U)v ?WB^eX/=97S-Z0n!?R+GM(@;`:#,Br=1GbzPHL箲3BiՊEXՆz.PХwC2LXΕ)uq)CĈb|ԩv%8 e^V`ef1]Ç@Gcgą#b "}~ZVvO#bKO{z7HeDHchhGL җ}RN8؂-xU҅l^]6{DgĴ5Q'Srƹh111113x2ol=_D;{^>Y`KS-ONw uzl؏U̾ -JO}sqs5#B3VtY{ݙ Qyҙ|Aga(G>2lv1`aEh 433(o"E[T<~ vY5a꼲r=U+u!ַ`n#ÊImy\ "ϡnr;T4=K֡wduV2;X]Jje=lFT,`Ӥ;z lLD~6dX6ZRX!v&RuZwg^ZT"k?@K1-O9S]N?-%}ه"8#" c'[K]ع}CzEh=!߮[ʆy0KM,< ]+A\)l4LPM箝"#K3y`iv?$<Z%Tk*Тv,v{/\0[02u/Fx~eUМxZ9.`9U5'aILߕoD6F9j'Y[gN'hwpҦ'dsYqZ yL4,_0C,9 _d_j}+Ob"RS;?33 (,'#&5shk;ͿTD7IYN>m]rB(+)%e7k~dL`{V̢Gph6M[*ↀi<" `'ȽLm%r[ c /*ػ?m}w(jp*>q54=߱ HƗcφO-luxw]R[+XA=Pk)W{8(z@`;z!Jԝp&|VN2gv}bMyFV"`2R%%~飀!,BK*릲h2@6BN#egy1)'_M.*&0qbz2 [|Jso %,..,%-:?:-5b1 fΘS'$=a%i-_@DuR`EE4'3 hHml[,G\T쿖) G,Ea|2 xa2*Ҥ- _It597o>wATIKV V\_Ȅ02YV9ް ַhGlNGKu6J VQj g3K#Zj++-V?,z䧩8|ғ%#Jjm~O*G"`nQ'kyWwGm{и~'tI7;41a@x+^!61ikɷ}}Sʏ<[E,{INU-h.p<AcbPc08 Ch!bb(Q~nؙ ؞θiN>8.nm5g!xp}ʜ;k4y/xw&NQcG(VGb,/ҽZR',UB"ig8_P˵F̙\VbH eؒQzldKNs:?m>(e- mC' X :!l m_[ P/ &1fV ެN Etջ1111111112CwI[HVeh{MW|XqY :)Y7d 35=ߧid !N/p@Bγ&|`9XqPPA~'Φ!*48z )CF4Jۺ .\ϤW"x/D4a4)I̟c L3r>38`k111111111111111 d5&?<4ƱӅy^$<O *Xa[d{!Wzta'Za)x !z!B~q.V-#`)(G"N 0Lv^03Қ-ȿhOho,u]SShqj)rE߀4pwQg4`o)&ӬccccccccccccccccccccccccccDdB / C A/50.RWGRLݻD3V3F+GRLݻD3VJFIFExifII*1J2fizACD Systems Digital Imaging2012:10:19 22:54:130210187 R980100 "Z  R ?t ]x&iVCeY84X qʰlqR䛌}ohu߈?`յ1źUIQONk.\HVV.>\j|,g6d7+)pZrJj ­HerހY#%%36AIH |m1ٖZݎMII/LUF$0"X$- ÿXU)t0"bgx ƒFqxx? >xtDd B 0 C A044/R#M; ?Y#:9&F#M; ?Y#:9&JFIFExifII*1J2fizACD Systems Digital Imaging2012:10:18 11:59:120210125bR980100b"n    $'#%&(HQiw ?" """ """ """ """ """ """ """ "&hAo `;8+./-./+ƅ-N΋n(—k;!@@e5>g"A!:D[|睝MUХY)Ѯ ӿөڦc]qU[ZO.Yz"s=b?Q\P;{@BU[oª|zu4TU:zYe.3z%J0 0 Ĥ|#ڕݤ0 MmW@?> )_8V7kj4cƪ[a JGM@EF]Q@+1rw """ """ """ """ ""VV,,JrrK@ArV``Ws\:,(,;]p@JJAoSEAESissi]Y][L5 ,(Re+jpzk)섮KKUP+񐪺[OGk䫠Nu:]; Là `VWU}+BXe3Xf2?K{oOVٸ++m:JyA(-MPtՕ YUEg#TV۔Z:wt;6qiZ-T qsh )\Ziݦ<]؍_6(spLr/,)%I-59Vi/pwE18s}~+gjq籦,"0ϿR`Tbck#(Ÿ.<7FG*)>`mP"j+ڮ)VRUP_Ti\UWlXͥU]Sy#~YGկo'zԿ"Ƚ̱~M曁=F9/+ԓ[%*}DV_@Pm~WDd";:E:% 9}eR'U?أ1!t-$̫ϭIV*H~Q2 ukh$v% '1!_lB(mB!hu=1+g `3j~}( 6clEE=`' 󜞴?"tQ?1 T-+_=a(gJ?W;uUR-0S\|4(0B FK-@ 1s^: =W7>$)[QASַ][{_ͻ?H.4)Hҷ2P oŨãZ+V`A(fޘxp%Bt3ڦnnl#<AcbPc0: Cj!bb*횂Q}mڛ ڝͺkM=:-ml1R?nz'UO{5i-neY}u\V: ,(΃ 5 ;;Ɲ}I6SF Ɵ=+@T/i#Nz5S0?Xi>{O+SΊq HW-LlЯB%uy˗)UKNRko :9yD@6E+P7`M]Fn&sQ c3 }j: 1e C3 ;<͕ޤ^ouo376xGs9gWjFkn2KuƉy%dl6'f{V%3y$.C)TM6&iW|GbCDZ>5/^~X,R^7)ޜ} tJh+A ] tT~a98.=\t/I ?ERyAlQƿZ.|Eæ^j"=/b|qoŭVA[{wyF$;VS@DDD@JA~i 2>vyhVE.&NjvR_пsB1o??"}P(.8&=3'O3 3#QHN"ڶmso2Nɟ!n".,aWu*m+;Ŧa&Fp0-`rM6qb\bAWVvr<;B.͔7|חcn- .:lYj$`Ծ]?ηDgZmp*q'8BE}Y@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@DDD@_DdB 1 C A1480R׹n~1x#F׹n~1JFIFExifII*1J2fizACD Systems Digital Imaging2012:10:19 22:24:370210484  R980100 "X   ?OU[Oܖ LiVz+!VU2l̓ !?4zۅw ]%,4i^t[i}A.Ԋ/=|I8 ܣ2 ( ?:$QD"H15ږY<qDyK ref_TOCqDyK ref_TOCEDdiQ F 2 C "A2 pic11RZEܺɔZkf:6E'F.EܺɔZkf:JFIFExifII*1J2fizACD Systems Digital Imaging2012:10:18 14:02:390210734R980100"      WUw!"67XY#$&'(% 123458GHQbv ?)@)@)@)@)@)@)@)@)@)@)@)@)@)@)@)@+?&~Ǭ|?O<tk|:`փԮps-.u1,g3_KY[K4gT%j  g܂s'hj^Oycݫã0Dy?/r$^춑B{9!8ll2p[9wkyc+JR)& GO44RV;- 6?^H*|[d({KA JCmzt1AEҸz3l!nfGphr$cL=,{!{0@HJ6u?l'iZ2$xL6*Vj D+) Igp2E`c_i&m)-Còx2Py2F\l%25J>&ljНl^Vio\u"n|m<%gfB>bmS] ny TW1RlI mq4˰2gdcߖH`PVaБ+;c k_yrikW6}667A,e}W^CbEI0IdQ 5C=Ě;ŎYkrY.n2ŜJ%ML^:(9ACRkWy/ńN?R} $Y*I;LϗLHNO#@c>zEIE YĢE&@&قXI-ٲr#8.01tla04&vJG EBr)VE!#]ҸC p)zs~'(h#\0O#* Ur{g&b!>s`Gt*aZy _n/ctc-L3$ 1cӳ2'{׶mg<[%02;#$PD;őpF"mJ`@ߓysu[xMiď߼wL~`{E^bGoɼFMyOdHmoG;bj r&?0FV:J B\IHŒ22۝ZYd٥62QKI &D)?'nD,M⇒5\ wgo`?ulRDlѳA Pd%1_}u xgG|>%}'վ uo'K?AŃm#1d0A&rkNU `.*d&)v3op7C`iX<RTB\^B]ViPs*0tvgfAӈt :O >~F֣n"|kzuP@ł6MO4Lj沁Y7V:*gD$ qc !D㕺1~yVqi)p5BKNBHqJ6ͭe)jsKw W4<* ;NiR"PrK>'wg(QuΚgo`4&@#,fFb&mx06%a-n%# LWpvQbyGX]wat:RԪ£BT ƐViC R`eΓnPTA葼O &(G!R+~qȕv'\M+xaʷi6|Av+PPl:TJ q5\lXMK;y~bdwb>҃,T/_P#);6mdksi joi:_txI)g}?ES,;x̼wbcѓd2b[M p3' йH(ZG DpeavObF՘ΕV d8]Km623Gjq̤h!@L!zjca6vv‰&yͅ#ѼOz`+O603pv]͛aFQP --w ]󈧕UGBM{tC8k|Sh!p1L h,{=U8C1Lԥjc \qkJlY57GoyC ;Ja؇MY$$zy$ unùuX^3Žsmmh898 Ԭ\bH"|y*T&< c.[ۮdx^ si6|IuP0S:T6q \CXHD0;聈N~Br{w.eΏך 1$g#LF"Y~;Y3ZWmdK/G[x}?EzZ)J+pc,3+$9`PP 1 ɝkVڗĎ;w7xِ, eUDkۺfݭu{̌DZ~\S,xh }*8AUJbUq }*8AUJbUq }*8AUJbUq }*8AUJbUq }*8AUfّDd7U?#h:O8+ NDR>ؕ}x}ҥ^ }*8O>ؕ}x}ҥ^ }*8O>ؕ}x}ҥ^ }*8O>ؕ}x}ҥ^ }*8O>ؕ}x}ҳT26h!R+Q Dr4(dҘho6+{k+-Pp+Ÿ>*BlJN>UiR>ؕ}x}BlJN>UiR>ؕ}x}BlJN>UiR>ؕ}x}BlJN>UiR>ؕ}x}BlJN>UiR>ؕ}x}llE,^C*H3 62bhؚE&T_ <~ό -]ܼ'I8iZT%_^'piЇ4ZT%_^'piЇ4ZT%_^'piЇ4ZT%_^'piЇ4n_ -,lѷzݯ&Mu@͡Vt( U>l&xX/k ]4 \-tL,JF?$e14aj(+qLF: ;3ؕ}x}VAQ$-%I@g]]2y{[ υtMlG ρ+g-xW\H0>.'L]n-UqbM5#vh /Or(nox*<\.L>k)\"qhsZ$$۸B\&:)cuM{Rl1rݗ7J6{ER.lL}RTs:Rl- ͅcB ,2G&K_ .f{P߅ “0lT%_^'pjZU"6%G3. V4 8$rd팵 gPޭ^,)3ʮmҕ[A*ϖ&kxޑdmɕѴb ȧ+ܗ8`5쁃gU8xzX"FN /׉>-- :,N80ʟsk: . luxݬ{?_HȳQyBL23602rZ7 G_#3 K(}ߧN"| `•*\8LSOq;mLJvۏ,v[f;-mm8Wk /\Enk8Ơ̱r+XZgTR3Qg}ru]uz-HV:-HڑJpB <7VjN"TgR>Lxpa~\e]AuϹKeij@(֍"AqruقF XW~oX=}—.5-0vDV U$#6v ~&+t\ʶ}J_fY~D1NDAb%8qN|mMjU̳.bP< n4&4{Kb^9Q}/q\Sê]-xwXrYukXpGO˓q1!c$qJ(kbkB8:?iibnД CuQ=UjU!E R R R R|U NUSGC{j)JP)JP)JP)JPJOX'UVS'Gެo*@)@)@)@)@Ty;}!Ԫ<YVZt aTTJe̝B|lˏ6 r[~X\4R.Dڑဈyf׆GT!sjtoS eL.l3ɏ'ƞl^kK[ve( ˱9 {խtuxNrcFɖIuO^~.(bFbص\æZ?qQ(xnRY5^%BA uӊc1ꞑ1X$a-Di%a1ǃcpW+boj]|W6Xֳ7V.,~JrTt8; ktFF+ȣiJt 1dkx H1N*pǪzDcpӊP(}ϩcz9 Uvzp0-*F2f;./V+rɒ̶W69a4yy0t8k<ï2bAb2\ZLDP/LOaa#.$:R2{+vd6'`ܷ#wq3i>N.9r.V7Z[rM? s[|@rNupCotg}ŇN"eVw !*Djl_{I+XG 1+b)lk%@ ;"w@Jf1|kKETšśdF2\7 ٨dts*G ceѱ>1t6ά"enx" DQ?ʸ)/ | f=PK˃SOF[6X3aSlRܭXeE/;w.'V:B"Ñk0,I2__/fIUrsqPrK.\.x+:ifF®L"ܩ&%.م|+77_$vcjty*M"m[BѦ$ L-0+x"%tR`TyАk{SHfvSEvQ(Ԕp:Ǻ\fS-aXwvϑ=3a9IsCmg6[/l5,bV BҸ9A_ @ed鞰Z-1G.턝@ ™6I'ŏt1ً 8Xc1lx[oZRJRJRJRJRJRU!E*BTyUZ)J)J)J)J SGC{jԩ!CӵUh((((%S'Gެo*REV 7ǕURRRRT<YUjU~wNznJRJRJRJRR xLuUT&: qϝ/Miӯ{"ۭ͋eLSHSjiphTS;+v%˅*/^cv2)ȺEQ?l]FFTX+wc"5M=m 37%L!pzg_{_m5lE2(K1Ejtp+N:@Zcݳ ]` NJa^-n8{|Ym<7)N],{ :X1OHn|zqK+?%GC@O~db,6@FWPtt zLV7 >=8 0lSȂ&f. hއIG^@ҿtN-(L"91fnoDfTҍNbl#3]NFMi4 I\R1%r}! Q2՘U1a^IYl@%9_V6Z- |5ddd^# L:#z=hJ>z6>l9Kٌ shw "ԉR7&MaIx =A D;:k3g{s(\pxU$:؀Jrl[k6PȽFFtF;pz7n-qh}1fl}sL 7xM$Y@Ϥφ .6fdq.{^,Y0f%}cuhfyٛpI̷ #@v!;UEgf̌1ZՏys'E?;غJ}^QY7akQCq:{37{28wKMxscwh.xxvu.\\\׫^kf`=Йc]`1}E;]Gh_kH3zd\Y]R'΍ 0}Eh*K{=0~{_s0/䦞x9~]?SP?T}]iܳꏿ׽˭3KJi烙%C{%5YG֝0~{_s0/䦞x9~]?SP?T}]iܳꏿ׽˭3KJkq^.90@>i0#HD@<{8XD4F++%o .)S/npJaeiJP)JPJЄ7U~VPOB?tY@)@)@)@)A*h7uPtUZ4~?ovdhՂUjU2~h}? R R R R Gӷޫ?BJU! UiJP)JP)JP)JP*U!wA?z *;WAU2Jf2.Gƽ*%OgQ8ŭ]ȍSa`drF Éz,\**޷@V%3S^'3͋JucebրdFǰMT9#tfĽɖd.oZJrTt8; ktFF+ȣiJt 1dkx H1N*pǪzDcpӊ]Ye%9*:Mzwޣ#dQܥ:w5jJ`8c="bI(h b)lk%@ ;"w@Jf1|kKETšśdF2\7 b)lk%@ ;"w@Jf1|kKETšśdF2\7 -ͲT2C/Qtcƽ\Ĵ[K\ZzYq`6Dj%~ -ͲT2C/Qtcƽ\Ĵ[K\ZzYq`6Dj%x|CҔBTyUZA?o'Ļ*z>3 |#sDvgv[Q­ +Mtrbe &WӾ&WV^E^{N^E^{UZPJoyz]=;oyz]=UiA*U)wU)wUFoHnDeQVN ˭"vۻg|~oٻ&ݟ)QU)wGX ʼnFG=0="ݝSs;r)Pz%%ϛ\y.(!`H,1;[(4X_FԱ""wkgɞȊIpeun(x.^E^{N^E^{UZPJoyz]=;oyz]=UiA*U)wU)wU&WӾ&WVZЍTO[.W:$tϰ/}N?ڻggY;._WȫRa޶=-!mf|gvqxxv>wdj-,937)xLJ%킂x/ΟWra/kc;vN+^E^{N^E^{^5Z2q!oHzl2hd(/>Gn!-&lዎGd`/͏- ,pvaA*U)wU)wU&WӾ&WV^E^{N^E^{UZPJoyz]=yB{#EEI:$a?l?y|ViJwv>ojhx't\(0D#6%L@A$#ߎq)dBvb6>-D͙8ߋy^E^{Q,?fN 5yXPD90=Bh8DI#(bdJ2kK[DC6cLsIXƵltBZ 5_#irwfG7Ň7-Ӫ69m' rxAoyz]=GFDns ʆf#]a3N<⁕=?6C%eqR`wִw*z(~p ͥH~Ka9򨌨-`zN(w [5eC.78ON)u(%]7e. 38D@¡3iRNb?#*8 zg wtFVkYPˍ-)" fS]kJ7ߊ?T~*˗U^<65eDDvB0a!rs&4Ls9vW[rpN˅:mwi[%rCb7FC y dtd#.NܡiԐ;c:lN@`8 _ç4YJeDm;İ/p0Hs?e#rA}gZLվy7دǿ^˙ ad T:6ǣrc*']`Q7tLJ)bksgװt#ĉ5l~Cf|_D5MY2kNkS7Vr".Xs]0X#kTv(Nzz\PUgo_9e37+y7دǿ|]g 71K} Îd)+BҴ+tר Ͳ*\:l;Zu̒+?#' lP5˸k< DvMTK&3g'VSgo?{&XӞV_>Ǐ xq<-xǏ?;-pq-<,m ZZPkkkF6MX(Y:Diǁ2dYmme{q]5_HxTn MŞߍhћE58ۿ(LzH8Z9 \֏HxJ&n~tɺacQb%1/hɐ6:E_bksgoVo_9e3[8շA/9|_BR Qy&K膤@>3qM W/Sn| 5 렃H'[dr3T 5[d1*OkS,7TtMJaxY9Hޜ3"Nng4i/"*aɁ'Ӊl]BȆ*ÍXG&AZ%g|"4{^W>JE/b Dc$CCϭ]Qnwfxk]B&F**ęQ.vˊ EÂAɫySቤTk|(+ eg L052SҡiF P+~SvG_v"ҹLA/hg5Ab)n~]xZ-e&,チA9\ NT X4x_!.4܅6ldeJkCKB&hMw n ć/vi{s&p!1qᛟGIT;#;{O~6܊ GgWEx[P`ȭsY1%D\YTV&, cɛ6Kqu_nNŰ.mɛB%c a)jUxJՍʰٙYNf;嵲6\PZ1H[i0 ٟwcܝb~ ٛH! _};hIVv' qbÇ xp-8[oG8~.8ppG . ._܍F8(p]q)z&srp'j3:SÀչXh2% J#=h6g`sbVr<%,TjbVckHX?0k|U;#;{O~6܊ J^qT98wFk5оƙ)=<"'Ť4yoNl˓v\(>4D[ 3Զ.ё8\1DgO;)!bNC4Op[4tH:9$ҋ].QBn*V7Z*o |lњǗ?bi=ojGrq'eloBޟ|$h':cm7+G]٩3oxd= θ -1a_x9XPבV`~Vu,׼$p=lm#ʒd3JfYG Z x]w* )J)J)J)J)J)J)J)QkM-@@0ШVEGd! Ql5xYKC 4`KkS@X)QRK4\N`ַdd opSrv؋,I| >KtLJqauʸi#Nf7W{,9A4MAR䏡pـÅw#A{&n ]% 6y+ktz$nȵ[gMG*l$C. (L /-)@AЗ@F7r )ؓ v(e'f+x J@)BLCفJ $ Bb""c-%rkLud BJ+`'~4Ú!*mNgu}iF@woo qĉ5eP)Yd67PI , H4b;$Cr uoD$yK߲. EmsHo )eJf!-,m1FS"BL? ̌m)llo.BQD&]$ i%nJT&D2LE/ļXH#YX ="qR:(9;7ym[(Ȱ葆z3' ^AՉF(Ek88-Ir+ʛ ˺ 3 v@#t%69܃<v$AݼJ5x@":Iٻl^dҐ&l#6p-܁-跀"s@!԰+E(Nıd$9h;2pg48=H-c(ũ:tzڕ&:lXl$SLJ,xَmmo hU&YUTTP4nk!16YZ]Q#i~`%c|~'d&_ HnB{'d5r8%?gQJS^Kb1),c~@PI 5UBI4 XL*Jbc@3112ҥMM]&f#64 Ι.\LaDn7&gftwZ`[ 1I6gdtR yAdg}&Đ;ώ #gmlҜxh Vڭq6Ng#2?KЗ}/*p1 3b{@{ $|@P)JPs?!ni!Ru^"\ϞOeeɏ-(2dK_s+V5K. (((((2.ik(ʶ&_eh)ȣ2ģmg$Ψն;#fm,̹csKDi)D޵V,)q0 FqZ 4$}L6fDΚ6}[~.QR߫g>_J)J)J)J)Ja`IZ-n[a;] q*[s9ӓ 1bas,2Lj-Z9nP)JP)JP)JP)JP)JP)JP)JP)JP)JP+ n_ ?@jo: xYN'pxߺEӽW?Zt(?~gyX& ߀fyuׁ>cH^0$i5& @my ң;V3Nme[qEqlR)%-P?v"S:"r;LC+|>hBIBth&5%V5,y|P J @(9h>8MwL\3rU8ˣ&®4zɯ|f%34l;b bɥR tgX.U :s3CF¼jFrrՐs PTs!k3v\t6f*mk7,&N:#n܇..}ݥ{$m0))F)QtViMCLIKrd$ &:<݁ ҳ7ct|ei q_*gu,ksFvaB6'RCmPd vS3>3L­qLCuLedebdX5ƧdD!6BPqxPNq{vc]` 6ך0*83uc4&ڪUW"Z)n Ga\+1S3' ,wJ[sq,Q,~$bjd`䈀G!Ȟ>&(0/s}qd#3$pک'Ȗc0V-vpV?q@ka|tA_=n$2N 0wzL[;@3yi~EmD qfʳ4B @ rؐmD_9B)M ,;%)(>`e"4q#(Qr@x;TP;Mv"Pb8&IZ-)hKy_\crgR0kx(f,5vM"$QM;Ktd:lΟlԤ'Ɯ\b@G~&k{D38-0fv;/t~ƀFإUMjPŲWj-__a9J'D8Y]"W(>Xg F:JB+\&rZ?5h* cAp3k/&FtOeG@Ł"o-bmɞFYԬi~~iXՙZFI"S6|YoRRRRRRRRRRRRRRRRRRRRٜDdF 3 C "A3 pic22R'˳8V[ߞmF'˳8V[ߞJFIF``C    #%$""!&+7/&)4)!"0A149;>>>%.DIC; o }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz?j((((((((((((((((((((((((((((_P+]LC+6ylsuPEb'ڬg&hbeW^ 898]IRåx2\\!c06RIPxǽ. 7r0-WT20H(]sHe UpeW#:Qz,Q$6[ 1\EQEQEQEQEQEQEQEQEQEQEQEQEQEfV3^o%5"1#i= [)k&X&ǖz,@N3lxuY :,r1'IXBG#<5DžfI "Ku1"ssW.kX{dvtL&ASwdk`%X H1Fa.3ϽnQEQEQEQEQEQEQEQEQEQEQEQEQEQE%NUnDQ.~&EQEQEQEQEQEQEQEQEQEQEQEQEQERV5ޫs{tvCcn*晥[q8twMdžIu S9' w5ѻh#E, 77~%&; $Һ=\Wwj;[XRcTA*j(*N?՚(((((((((((k#Eq5>z +ֺm)ԒxrMtcw[Z&tV ~i=\7)h(i^ծ)QF`N[ aYA ?i/q _( |7Q Oo7G-?n/Z~ _A ?i/q _( |7Q Oo7G-?n/Z~ _A ?i/q _( |7Q Oo7G-?n/Z~ _A ?i/q _( |7Q Oo7G-?n/Z~ _A ?i/q _( |7Q Oo7G-?n/Z~ _A ?i/q _( |7Q Oo X6Ӧ"@5WSC7_4Z,Z=KI]M?JՓQVK[eXpFXc1],}}/j?cQ E}KڏX/_R6>>_Կ V3XFE*O KHo((((((((((((ni]|&5jI~@tT*iQEQU]M{& ?2kqwiIm0bjomSmSmSmSmSmSmSmSmSmSmSmSmSmSmSmSmSmSmSmSmSmSmSmSmSmSmSmSmSmSmSmSmSmSmSmSmSmSmSmSmSmSmSmSmS«o5]2DglTFni]l_A5FEmIB%t+3ʑ?*_g|$?_g|$?_g|$?_g|$?_g|$?_g|$?_g|$F{wRHTntqƑFƻQUUwqЖ_ʍQ?*6GFڿWjt~Tm_ʍQ?*6GFڿWjt~Tm_ʍQ?*6GFڿWjt~Tm_ʍQ?*6GFڿWjt~Tm_ʍQ?*6GFڿWjt~Tm_ʍQ?*6GF毋Qo܏ASC7_4R»((f(((((((((((i%\Mu?3u^CJk.+((&2ʲDʥryS~714}och,q|YGf?&?Me?>714}och,q|YGf?&?Me?>714}och,q|YGf?&?Me?>714}och,q|YGf?&?Me?>714}och,q|YGf?&?Me?>714}och,q|Y\֯:&qu *)> Z S{6W O?wK;kuwF3բ(((((((((((((((((qDyK ref_TOCqDyK ref_TOCDyK yK Hmailto:info@dr-roje.comyX;H,]ą'cDyK yK Hhttp://www.dr-roje.com/yX;H,]ą'c s666666666vvvvvvvvv666666>6666666666666666666666666666666666666666666666666hH6666666666666666666666666666666666666666666666666666666666666666662&6FVfv2(&6FVfv&6FVfv&6FVfv&6FVfv&6FVfv&6FVfv8XV~ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ 0@ OJPJQJ_HmHnHsHtHH`H wNormal `CJ_HaJmH sH tH dd t2 Heading 1$$@&'5B*CJOJPJQJ\^JaJph6_`` r Heading 2$<@&$56CJOJPJQJ\]^JaJDA D Default Paragraph FontRiR 0 Table Normal4 l4a (k ( 0No List @Z@ 6h0 Plain TextCJOJQJaJF/F 6h0Plain Text CharCJOJQJaJ\/\ t2Heading 1 Char'5B*CJOJPJQJ\^JaJph6_`/!` rHeading 2 Char,56CJOJPJQJ\]^JaJmH sH >@2> S Normal Indent `6U@A6 m Hyperlink >*B*phFVQF yw\FollowedHyperlink >*B* phVObV  PCentered$`a$OJPJQJaJmHsHtHPK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭VvnB`2ǃ,!"E3p#9GQd; H xuv 0F[,F᚜K sO'3w #vfSVbsؠyX p5veuw 1z@ l,i!b I jZ2|9L$Z15xl.(zm${d:\@'23œln$^-@^i?D&|#td!6lġB"&63yy@t!HjpU*yeXry3~{s:FXI O5Y[Y!}S˪.7bd|n]671. tn/w/+[t6}PsںsL. J;̊iN $AI)t2 Lmx:(}\-i*xQCJuWl'QyI@ھ m2DBAR4 w¢naQ`ԲɁ W=0#xBdT/.3-F>bYL%׭˓KK 6HhfPQ=h)GBms]_Ԡ'CZѨys v@c])h7Jهic?FS.NP$ e&\Ӏ+I "'%QÕ@c![paAV.9Hd<ӮHVX*%A{Yr Aբ pxSL9":3U5U NC(p%u@;[d`4)]t#9M4W=P5*f̰lk<_X-C wT%Ժ}B% Y,] A̠&oʰŨ; \lc`|,bUvPK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 0_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!R%theme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK]  = 3<VİY*=!&|,#.v37: @1DRGcLOBQ;VYt^fvx5̇UD 1    !#%&(*+-/023568:;<>?BDFILORUXZ (\8RkG87*#)`0+43>E"L@Q]\fpSyD։S)E׿R 1  "$'),.1479=@ACEGHJKMNPQSTVWY2=?[hj46Qpr )UWs *^++?,45&5*Ef5')Pa$W`b  : tUUUU]p]]sssw6wBwcXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXL# @0(  B S  ?$ref_TOC _Hlt338443522 _Hlt338443534 _Hlt338443544 _Hlt338443571 _Hlt338443579 _Hlt338443594 _Hlt338443743 _Hlt338443758 _Hlt338443770 _Hlt338443780 _Hlt338443789a01disc _Hlt338443520a02intro _Hlt338443532a03depre _Hlt338443542 a04antidepre _Hlt338443569a05homeo _Hlt338443578a06disc _Hlt338443592a07study _Hlt338443741a08chem _Hlt338443755a09clin _Hlt338443769a10appli _Hlt338443778a11after _Hlt338443788a12ref _Hlt338443800 `T>|:++45*N  tUUU]]ssw?@ABCDEFGHIJKLMNO__g <<}}((DD22~~[[VV   ggiiR__L..7>>z66>KKgg˝˝CC!!ӫӫܳ++JJJ ``      !"#$%&'()*+,-./0142356789:;<=>?@ABCDEFGHIJKLMNOPRQSTUVWXYZ[]\^`_abcdefghikjlmnopqrstuvwxyz{|}~enn  %<%<//LL::__ZZ   ggiiYjjR6>>BB=JSS'Nppŝ֝֝PP&&٫٫߳88MSSff  !"#$%&'()*+,-./0134256789:;<=>?@ABCDEFGHIJKLMNOPRQSTUVWXYZ[]\^`_abcdefghikjlmnopqrstuvwxyz{|}~ 9*urn:schemas-microsoft-com:office:smarttagsplace8*urn:schemas-microsoft-com:office:smarttagsCityB*urn:schemas-microsoft-com:office:smarttagscountry-region9s*urn:schemas-microsoft-com:office:smarttagsState;8*urn:schemas-microsoft-com:office:smarttagsaddress=[*urn:schemas-microsoft-com:office:smarttags PlaceName=Y*urn:schemas-microsoft-com:office:smarttags PlaceType:7*urn:schemas-microsoft-com:office:smarttagsStreet>6*urn:schemas-microsoft-com:office:smarttags PersonName ssssss[Ys[[Ys876ssssssssssY[s~*4QV >?ij56qr VW  N W A T ,._aklnv[j%    & 5 M V X \ h q !"."""&&()+@,A,O,P,U,--I.P.].f.x....0011455'5)5051595e5n555:;<<p=}=======)>1>U>]>*?3?W?d?r?|???ABBBBBC!CYCcCEEOO6V;VVVXX^^/e>eggyhhXlbl3tCtFvXvzzzzI{[{}}-7{ozimŕ?J.9%/pz,23<*GIgiklrëޫ[efoڲ#, 2=R\o()bW`-6T]NWɼмټ&ʽӽBM 1;<EvXbvCL %,;@Siw /;fp^e7;V_ "08FTp|,4inow#Zc1:yv(~[^~ 9BIUVY;Dhr6>IQVd4= en      m r s z  ; = ? @ G      r|^g|:;GN' '.W`Xa09py&bn U^_h"   !T!]!!!!!!! " "M"V"""# #~#######$$$h$q$v$z$$$%%!&*&^&g&k&q&u&z&d'l''''' (((("(*(X(f(w(((()")?)K)**** +!+-,5,@,H,,,,,2-<-----3.:.B.J.].f........///Z/b/q/x///////////////0 000*070B0D0R0V0[0]0f0p0001111F1M1N1W111111111,25282?2G2P2\2e2~222222333333334%434=444445555555555[6f6 7 7x7}7~7788Q8\88889B9K9999 ::+:A:J:b:q:::::::::;;;;;;<&</<;<m<v<~<<==>>">1> ?*?????????????????@@@@AAAABCCCCC+D4D>DLDmDrDDEE!EXEaEEEbFkFNGWGhGoGGGGGGGCHHHwHyHHHuI~IIIIIJ JZJcJK$K=KFKKK@LILmLwL?MKMQM]M|MMMMMMMMMMMMMMZNaNnNzNNNNNNNNNNNNOOODOLOfOrOPPFPPPPP_QhQQQR&R4R>R`RjRRRRR SSASKSSS&T/T=TGTtUUUUUUXXXX_G_X_b___aa%c.cccccpdydddeeKeTeee`fifgg(g1ghhRh[hiiiijjkkBkEkkkssssss,v2vwAw^wdwhwlwwwxxxxxxxx-y3y4yCyDyIyJyUylysywy}yyyyyyyyyzz%z1zAzEzIzPzYz`z{{{{||||||*}4}}}~~ۀ߀.5lxDHV]&*1Նن݆pv5:3<ʼn͉҉ډމN]alSW[e OZ`psx|hos}ŎЎَߎ"'/3=nwЏՏُȐ̐ԐِݐV\kx-6J˔ٔ+5IPw}).28<AƖǖ˖)3AHLTXb×;D!%)6D™ÙșəԙĚUdhs$'rxŜɜϜӜڜcktz؝ޝow{:>BHPU`j>H$(,3<Cơӡ١~EJX`*/<@OUdn:?DIMRSYlv}fl-2˩ҩ,/V`ªo|S]ahluv !îҮ ԯܯAHLSX\~$,16#19ZgŲ̲IW?F5;}3;?DԸ޸/6]a"&08?in@G -4ſ38<BFO ![abgv~SX]bfo-27@ [efijp4?NRV[p{%:@v+1)jq=GKRV`KRclq}  %+8=TXGPo`d1:LP #kw \cwyV]35BMQY]cglmsw|"',18=Br~u .?W]bhmrv|)/4:`k"Yafo7@! )-/3hr!0 (<CR    Y^L _iWX_%g%cg33333) >?ij56qr VW _+++@,4'5:[:[()*g()b ; *+LMOOuvhi!!!!|#~#####$$$$%%y'z'(())*)=)>)?)?)**(+)+=,>,?,?,,,,,11111111::::H<I<==R>S>>>>>AAAAE EwGxGAHBHIIIIMMlNmNtUUU]]sswCwc>?ij56qr VW _+@,4'5*g()b ; tUUU]]sswCwc     |p}o~ .`B}XJP@QAD`E1HUNI6BzL?BDV3:T_"cd'xrdm @L\]@d@@p@UnknownG*Ax Times New Roman5Symbol3. *Cx Arial7.@Calibri7@Cambria9=  @ ConsolasACambria Math"1 h |1 |12LPULPU!4OQHP  $PfC!xx ?g:\ARTICLES\KINDLE\Novak\Templates\Word-Kindle-Template-v03.dotSULPYCO METHODUFORADIODr. Maja Roje Novak4         Oh+'0 , L X d p|SULPYCO METHOD UFORADIO Word-Kindle-Template-v03.dotDr. Maja Roje Novak2Microsoft Office Word@@D@lg0@lg0ULP՜.+,D՜.+,< hp|   SULPYCO METHOD Title  8@ _PID_HLINKSA {ffhttp://www.dr-roje.com/kcmailto:info@dr-roje.com`U`ref_TOC`U]ref_TOC`UZref_TOC`UWref_TOC`UTref_TOCRQ&http://en.wikipedia.org/wiki/Dopamine"N)http://en.wikipedia.org/wiki/D3_receptor "K)http://en.wikipedia.org/wiki/D2_receptorRH&http://en.wikipedia.org/wiki/Dopamine\3E1http://en.wikipedia.org/wiki/Receptor_antagonistB1http://en.wikipedia.org/wiki/Binding_selectivityk?mailto:info@dr-roje.com{f<http://www.dr-roje.com/`U9ref_TOC`U6ref_TOC`U3ref_TOC`U0ref_TOC`U-ref_TOC`U*ref_TOC`U'ref_TOC6%$a12refSV! a11afterMI a10appli4:a09clin16a08chemFO a07study>'a06disc^Z a05homeoET  a04antidepreEA  a03depreOB a02intro9'a01disc{fhttp://www.dr-roje.com/  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~     !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^`abcdefhijklmn{Root Entry F02w0}Data ^Y1Table }WordDocument8SummaryInformation(_DocumentSummaryInformation8gCompObjr  F Microsoft Word 97-2003 Document MSWordDocWord.Document.89q